a:1206:{i:194926;a:27:{s:5:"title";s:18:"Racepinephrine_ACN";s:3:"nid";s:6:"194926";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:261:"Composed of 50% of the D-form and 50% of the naturally occurring L-form (DNP 2009, O’Neil et al. 2006, Supported by 4 citations found in NAPRALERTsm 2009).  It will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81687";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Racepinephrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194927;a:27:{s:5:"title";s:23:"N-Acetyl-L-cysteine_ACN";s:3:"nid";s:6:"194927";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92698;92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:159:"We have obtained references showing that N-Acetylcysteine probably does occur in nature and so we can confirm the classification of N-Acetylcysteine as an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81688";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"N-Acetyl-L-cysteine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194928;a:26:{s:5:"title";s:13:"L-Alanine_ACN";s:3:"nid";s:6:"194928";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81689";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"L-Alanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194929;a:26:{s:5:"title";s:18:"Aluminum oxide_ACN";s:3:"nid";s:6:"194929";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:178:"It occurs in nature as the minerals: bauxite, bayerite, boehmite, corundum, diaspore and gibbsite. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:99:"Classified as an NHP under Schedule 1, item 7(a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81690";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Aluminum oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194930;a:27:{s:5:"title";s:20:"Aluminum sulfate_ACN";s:3:"nid";s:6:"194930";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:44:"Occurs in nature as the mineral alunogenite.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:99:"Classified as an NHP under Schedule 1, item 7(a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81691";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Aluminum sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194931;a:27:{s:5:"title";s:30:"Aluminum potassium sulfate_ACN";s:3:"nid";s:6:"194931";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81692";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Aluminum potassium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194932;a:26:{s:5:"title";s:21:"Ammonium chloride_ACN";s:3:"nid";s:6:"194932";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81694";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Ammonium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194933;a:27:{s:5:"title";s:22:"Ammonium hydroxide_ACN";s:3:"nid";s:6:"194933";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:442:"Ammonia is naturally occurring in foods at low levels in both aqueous and ammonium hydroxide forms. It is commonly found in manure and decaying organic matter. However, all commercial sources are synthetically manufactured from atmospheric nitrogen, usually using natural gas as a fuel source. Ammonia is formed naturally by the decomposition of urine, manure, and dead organisms. It has been observed in outer space and galactic dust clouds.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81695";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Ammonium hydroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194934;a:26:{s:5:"title";s:20:"Arachidonic acid_ACN";s:3:"nid";s:6:"194934";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:410:"An essential fatty acid and a precursor in the biosynthesis of prostaglandins, thromboxanes and leukotrienes. It occurs in liver, brain, glandular organs and depot fats of animals, in small amounts in human depot fats and it is a constituent of animal phosphatides. Arachidonic acid can be isolated from liver lipids and will be considered as a NHP, under Schedule 1, item 5, Priority 2 (Essential fatty acid).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:114:"Classified as an NHP under Schedule 1, item 5 (an essential fatty acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:121:"Classifié comme PSN sous Annexe 1, article 5 (un acide gras essentiel) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81696";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Arachidonic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:4:"ESFA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194935;a:27:{s:5:"title";s:14:"L-Arginine_ACN";s:3:"nid";s:6:"194935";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81697";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"L-Arginine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194936;a:27:{s:5:"title";s:19:"Arsenic sulfide_ACN";s:3:"nid";s:6:"194936";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"99896;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:1792:"Realgar, or red arsenic sulfide (As4S4), is one of a variety of arsenic sulfide minerals [Merck Index]. It occurs in granular, compact, or powdery form, often in association with the related mineral, arsenic trisulfide (As2S3), also called orpiment or yellow arsenic sulfide. Realgar was, along with orpiment, was used as a pigment and both have long history of therapeutic use in traditional medicines. Realgar is widely used in the combination with traditional medicines for both external and internal uses; for example, a common TCM over-the-counter preparation, Niuhuang Jiedu Pain, contains 6.4% realgar, and the bioavailability of arsenic released from this preparation is very low[Chinese Pharmacopeia Committee 2005; Liu et al 2008]. Currently, Arsenic sulfide (As4S4) has been used in treatment of newly diagnosed and relapsed patients with acute promyelocytic leukemia rates, resulting in complete remission rates of 84.9% after administration of tetraarsenic tetrasulfide. The dose was administered by intravenous infusion for 2-3 h at a dose of 10 mg/day diluted in 5% glucose saline solution [Zhen-Yi W. 2001]. Arsenic sulfide (As4S4) will be considered as NHP, under schedule 1, item 7, Priority 5 (mineral). References:
Merck 2011: The Merck Index Version 14.1. [Online]. Whitehouse Station (NJ): Merck & Co., Inc. [Accessed 2011 January 18]. Available from: http://www.medicinescomplete.com/mc/merck/current/monographs.htm
Zhen-Yi W. 2001. Arsenic compounds as anticancer agents. Cancer Chemothr Pharmacol. 2001: 48(1). S72-S76. Available at: http://www.springerlink.com/content/46dymxmbp13qmjfb/fulltext.pdf
Liu J, Lu Y, Wu Q, Goyer RA, Waalkes MP. 2008. Mineral arsenicals in traditional medicines: Orpiment, realgar, and arsenolite. J Pharmacol Exp Ther. 326(2): 363–368.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81698";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Arsenic sulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194937;a:27:{s:5:"title";s:16:"L-Asparagine_ACN";s:3:"nid";s:6:"194937";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81699";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"L-Asparagine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194938;a:27:{s:5:"title";s:19:"L-Aspartic acid_ACN";s:3:"nid";s:6:"194938";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81700";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"L-Aspartic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194939;a:26:{s:5:"title";s:19:"beta-Tocopherol_ACN";s:3:"nid";s:6:"194939";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:136:"It is one of the naturally occurring forms of Vitamin E. It will be considered as a NHP, under schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81703";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"beta-Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194940;a:26:{s:5:"title";s:11:"Biotite_ACN";s:3:"nid";s:6:"194940";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:364:"Biotite ash is finely powdered biotite (or iron mica), it is a phyllosilicate mineral containing potassium, magnesium, iron and aluminum.  It can be found in granitic rocks, gneisses and schists in various European and American regions.  For these reasons, Biotite will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81707";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Biotite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194941;a:26:{s:5:"title";s:14:"Boric acid_ACN";s:3:"nid";s:6:"194941";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:323:"Boron is mostly found combined with oxygen in compounds called borates. Common borate compounds include boric acid, salts of borates and boron oxide. It has been used as astringent and antiseptic and also as antibacterial and antifungal (VET). It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81708";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Boric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194942;a:27:{s:5:"title";s:20:"Calcium chloride_ACN";s:3:"nid";s:6:"194942";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93094";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:118:"It is an acceptable source of calcium. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81719";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Calcium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194943;a:26:{s:5:"title";s:20:"Calcium fluoride_ACN";s:3:"nid";s:6:"194943";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:216:"Calcium fluoride occurs naturally as the mineral fluorite (also called fluorspar), and it is the source of most of the world's fluorine. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81720";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Calcium fluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194944;a:26:{s:5:"title";s:19:"Calcium sulfate_ACN";s:3:"nid";s:6:"194944";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:287:"The natural form of anhydrous calcium sulfate is known as the mineral anhydrite, also as the mineral karstenite, muriacite, anhydrous sulfate of lime, anhydrous gypsum. It is an acceptable source of calcium. It will be considered as a NHP, under Schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81724";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Calcium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194945;a:26:{s:5:"title";s:12:"Chloride_ACN";s:3:"nid";s:6:"194945";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:309:"The word chloride can refer to a chemical compound in which one or more chlorine atoms are covalently bonded in the molecule.  Chloride ions have important physiological roles. Many minerals contain chloride as counterpart anion. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81725";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194946;a:27:{s:5:"title";s:12:"Chlorine_ACN";s:3:"nid";s:6:"194946";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81726";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Chlorine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194947;a:26:{s:5:"title";s:24:"Cholesteryl stearate_ACN";s:3:"nid";s:6:"194947";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:332:"Cholesteryl stearate is an ester derivative of Cholesterol. It has been used in cosmetics as emollient, protective and moisturizing agent. It is one of the 'Cholesteric liquid crystals'. As stabilized form, Cholesterol stearate/carbonate complex will be considered as NHP, under schedule 1, item 6, Priority 2 (Synthetic duplicate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81728";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Cholesteryl stearate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194948;a:26:{s:5:"title";s:18:"Clinoptilolite_ACN";s:3:"nid";s:6:"194948";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:410:"Clinoptilolite is a natural zeolite comprising a microporous arrangement of silica and alumina tetrahedral. It has the complex formula: (Na,K,Ca)2-3Al3(Al,Si)2Si13O36·12(H2O). It commonly occurs as a devitrification product of volcanic glass shards in tuff and as vesicle fillings in basalts, andesites and rhyolites. Clinoptilolite will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81732";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Clinoptilolite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194949;a:27:{s:5:"title";s:27:"Cupric carbonate, basic_ACN";s:3:"nid";s:6:"194949";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:225:"It occurs in nature as the mineral malachite. It  is prepared by adding copper sulfate to sodium carbonate. It is an acceptable source of copper. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81739";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Cupric carbonate, basic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194950;a:27:{s:5:"title";s:18:"Cupric sulfate_ACN";s:3:"nid";s:6:"194950";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:293:"Salts of variable compositions of cupric sulfate and cupric hydroxide or oxide. Occurs in nature as the mineral dolerophane. It is used as fungicide for plants, seed tratment. It is an acceptable source of copper. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81740";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cupric sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194951;a:26:{s:5:"title";s:25:"Cupric sulfate, basic_ACN";s:3:"nid";s:6:"194951";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:293:"Salts of variable compositions of cupric sulfate and cupric hydroxide or oxide. Occurs in nature as the mineral dolerophane. It is used as fungicide for plants, seed tratment. It is an acceptable source of copper. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81741";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Cupric sulfate, basic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194952;a:27:{s:5:"title";s:14:"L-Cysteine_ACN";s:3:"nid";s:6:"194952";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid )of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid )of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81742";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"L-Cysteine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194953;a:26:{s:5:"title";s:21:"Dicaffeine malate_ACN";s:3:"nid";s:6:"194953";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:325:"Di-caffeine malate is a combination product made from caffeine (2 molecules) and malic acid. It has mostly been used by bodybuilders and in diet programs (such as 'Methyl Ripped' by NXcare). It is a source for caffeine and malic acid.  It will be considered as NHP, under schedule 1, item 6, Priority 2 (synthetic duplicate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81746";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Dicaffeine malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194954;a:26:{s:5:"title";s:21:"Dicreatine malate_ACN";s:3:"nid";s:6:"194954";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81747";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Dicreatine malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194955;a:27:{s:5:"title";s:23:"dl-alpha-Tocopherol_ACN";s:3:"nid";s:6:"194955";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:111:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81749";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"dl-alpha-Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194956;a:27:{s:5:"title";s:18:"Ergocalciferol_ACN";s:3:"nid";s:6:"194956";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:13:"1000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81751";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Ergocalciferol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:4:"IU/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194957;a:26:{s:5:"title";s:15:"Ferrous ion_ACN";s:3:"nid";s:6:"194957";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:225:"It is a general term for iron compounds in form of Fe(II) salt (Ferrous). Most salts in this category are acceptable sources for Iron. It (its salt) will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81752";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ferrous ion";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194958;a:27:{s:5:"title";s:12:"Fluoride_ACN";s:3:"nid";s:6:"194958";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81753";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Fluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194959;a:26:{s:5:"title";s:12:"Fluorine_ACN";s:3:"nid";s:6:"194959";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81754";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Fluorine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194960;a:26:{s:5:"title";s:20:"Fluosilicic acid_ACN";s:3:"nid";s:6:"194960";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:1074:"Fluorides are released in the environment naturally through the weathering of minerals, in emissions from volcanoes and in marine aerosols, where the main natural source of inorganic fluorides in soil is the parent rocks, such as cryolite, fluorapatite and calcium fluoride.  Since fluoride ion is naturally occuring, compounds releasing fluoride ions will be considered as NHP's, which is why fluorides are already classified as Priority 1 NHPs listed on the Listing Of Drugs Currently Regulated As New Drugs (April 1999 Edition).  Fluorosilicic acid is an aquous solution that is most commonly manufactured as a co-product from the manufacture of phosphate fertilizers, therefore it is not found in nature.  It is used widely in fluoridation of drinking water, in which it hydrolyzes to release fluoride ions.  Since fluoride ions are listed as Priority 1 NHPs listed on the “Listing Of Drugs Currently Regulated As New Drugs (April 1999 Edition)”, Fluorosilicic acid will be considered as a NHP, under Schedule 1, item 7 (Priority 1; New drug) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81755";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Fluosilicic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194961;a:26:{s:5:"title";s:20:"gamma-Tocopherol_ACN";s:3:"nid";s:6:"194961";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:190:"It is one of the naturally occurring forms of vitamin E and most abundant tocopherol in soybean and corn oils. It will be considered as a NHP, under schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81759";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"gamma-Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194962;a:26:{s:5:"title";s:17:"Glutamic acid_ACN";s:3:"nid";s:6:"194962";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:321:"Glutamic acid (Glu) is one of the 20 standard amino acids used by all organisms in their proteins. Glu is critical for proper cell function, but it is not an essential nutrient in humans because it can be manufactured from other compounds. It will be considered as a NHP, under schedule 1, item4, Priority 2 (amino acid).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81760";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Glutamic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194963;a:27:{s:5:"title";s:15:"L-Glutamine_ACN";s:3:"nid";s:6:"194963";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81761";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Glutamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194964;a:26:{s:5:"title";s:11:"Glycine_ACN";s:3:"nid";s:6:"194964";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81762";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Glycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194965;a:26:{s:5:"title";s:14:"Halloysite_ACN";s:3:"nid";s:6:"194965";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:336:"Halloysite is a clay mineral with the empirical formula Al2Si2O5(OH)4. Halloysite typically forms by hydrothermal alteration of alumino-silicate minerals. It occurs intermixed with dickite, kaolin (kaolinite), montmorillonite and other clay minerals. Halloysite will be considered as NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81763";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Halloysite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194966;a:26:{s:5:"title";s:15:"L-Histidine_ACN";s:3:"nid";s:6:"194966";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81764";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Histidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194967;a:27:{s:5:"title";s:16:"L-Isoleucine_ACN";s:3:"nid";s:6:"194967";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81768";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"L-Isoleucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194968;a:27:{s:5:"title";s:13:"L-Leucine_ACN";s:3:"nid";s:6:"194968";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81775";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"L-Leucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194969;a:26:{s:5:"title";s:17:"Linoleic acid_ACN";s:3:"nid";s:6:"194969";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:169:"It is an essential fatty acid and major constituent of many vegetable oils. It will be considered as a NHP, under schedule 1, item 5, Priority 2  (Essential fatty acid).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:114:"Classified as an NHP under Schedule 1, item 5 (an essential fatty acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:121:"Classifié comme PSN sous Annexe 1, article 5 (un acide gras essentiel) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81776";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Linoleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:4:"ESFA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194970;a:27:{s:5:"title";s:12:"L-Lysine_ACN";s:3:"nid";s:6:"194970";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81777";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"L-Lysine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194971;a:27:{s:5:"title";s:22:"Magnesium chloride_ACN";s:3:"nid";s:6:"194971";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93094";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:120:"It is an acceptable source of magnesium. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81782";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Magnesium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194972;a:27:{s:5:"title";s:21:"Magnesium citrate_ACN";s:3:"nid";s:6:"194972";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81783";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Magnesium citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194973;a:27:{s:5:"title";s:22:"Magnesium peroxide_ACN";s:3:"nid";s:6:"194973";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:343:"Magnesium peroxide is another kind of oxygen release agent which slowly decompose to generate oxygen at a "controlled" rate when in contact of hydrous media. Because of its stable oxygen release rate and environmentally benign character, Magnesium peroxide is widely used in agricultural, environmental, pharmaceutical and cosmetic industries.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81786";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Magnesium peroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194974;a:26:{s:5:"title";s:44:"Magnesium phosphate tribasic octahydrate_ACN";s:3:"nid";s:6:"194974";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:284:"Magnesium phosphate, tribasic is found in nature as its octahydrate form, under the mineral name bobierrite.  It is also listed in the NHPD acceptable NMIs list.  For these reasons, it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81787";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Magnesium phosphate tribasic octahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194975;a:26:{s:5:"title";s:13:"Magnetite_ACN";s:3:"nid";s:6:"194975";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:375:"Magnetite is a naturally occurring ferrimagnetic mineral, where the largest deposits are found in Kiruna, Swedan and in Adirondack region of New York, USA.  The chemical formula of this mineral is Fe3O4, which is also known as Ferrosoferric oxide.  For this reason, Magnetite will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81789";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Magnetite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194976;a:26:{s:5:"title";s:23:"Manganese carbonate_ACN";s:3:"nid";s:6:"194976";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:129:"It occurs in nature as the mineral rhodochrosite. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81792";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Manganese carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194977;a:26:{s:5:"title";s:16:"L-Methionine_ACN";s:3:"nid";s:6:"194977";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81793";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"L-Methionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194978;a:26:{s:5:"title";s:19:"Montmorillonite_ACN";s:3:"nid";s:6:"194978";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:549:"Montmorillonite (also known as Hydrated sodium calcium aluminum magnesium silicate hydroxide) is a natural aluminous clay mineral derived from feldspars or other aluminum-bearing minerals  that was found originally in France and now found all over the world. This mineral has some detoxifying properties because of its ability to attract and absorb toxins. Montmorillonite is also present in the NHPD acceptable NMIs list.  Therefore Montmorillonite will be considered as a NHP, under Schedule 1, item 7 (Priority 5, mineral) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81796";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Montmorillonite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194979;a:27:{s:5:"title";s:15:"Niacinamide_ACN";s:3:"nid";s:6:"194979";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93582";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81799";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Niacinamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194980;a:27:{s:5:"title";s:19:"L-Phenylalanine_ACN";s:3:"nid";s:6:"194980";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81805";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"L-Phenylalanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194981;a:27:{s:5:"title";s:21:"Potassium acetate_ACN";s:3:"nid";s:6:"194981";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81813";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194982;a:26:{s:5:"title";s:33:"Potassium azeloyl diglycinate_ACN";s:3:"nid";s:6:"194982";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:542:"Potassium azeloyl diglycinate (also known as Azeloglicina) is a synthetically prepared compound used in cosmetic, usually for skin treatment.  This compound is typically the potassium salt of the condensation product obtained from Azelaic acid, which is a dicarboxylic acid found naturally in wheat, rye and barley; and glycine.  Since Potassium azeloyl diglycinate is produced from two naturally occurring starting materials, it will be considered as a NHP, under Schedule 1; item 6; (Priority 2; Synthetic duplicate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81814";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Potassium azeloyl diglycinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194983;a:27:{s:5:"title";s:25:"Potassium bicarbonate_ACN";s:3:"nid";s:6:"194983";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81815";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Potassium bicarbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194984;a:27:{s:5:"title";s:22:"Potassium chloride_ACN";s:3:"nid";s:6:"194984";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81817";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Potassium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194985;a:27:{s:5:"title";s:21:"Potassium citrate_ACN";s:3:"nid";s:6:"194985";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81818";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194986;a:27:{s:5:"title";s:23:"Potassium gluconate_ACN";s:3:"nid";s:6:"194986";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81819";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Potassium gluconate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194987;a:26:{s:5:"title";s:21:"Potassium nitrate_ACN";s:3:"nid";s:6:"194987";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:139:"Besides its industrial usage, it has been used an diuretic. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81820";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium nitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194988;a:27:{s:5:"title";s:13:"L-Proline_ACN";s:3:"nid";s:6:"194988";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81824";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"L-Proline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194989;a:26:{s:5:"title";s:10:"Pumice_ACN";s:3:"nid";s:6:"194989";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:358:"Pumice is a light, hard, rough, porous, gray masses of a gritty, gray-colored powder of volcanic origin found chiefly in the Lipari islands and in the Greek archipelagos, consisting mainly of complex silicates of aluminum, potassium and sodium; therefore, it will be considered as a NHP, under Shcedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81825";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Pumice";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194990;a:27:{s:5:"title";s:13:"Pyridoxal_ACN";s:3:"nid";s:6:"194990";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:169:"Food contains three natural forms of vitamin B6: pyridoxine, pyridoxamine, and pyridoxal. It will be considered as a NHP, under schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81826";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Pyridoxal";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194991;a:27:{s:5:"title";s:25:"Pyridoxal 5-phosphate_ACN";s:3:"nid";s:6:"194991";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:255:"Pyridoxal 5-phosphate is the pyrodoxal, with phosphate added to its molecule, is the form of vitamin B6 that is used by our bodies as a coenzyme. It is a source of vitamin B6. It will be considered as a NHP, under schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81827";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Pyridoxal 5-phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194992;a:27:{s:5:"title";s:21:"Vitamin A acetate_ACN";s:3:"nid";s:6:"194992";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:1144:"Vitamin A, or all-trans retinol, is an essential nutrient which occurs preformed only in animals, but metabolized from carotenoids, such as â-carotene, in other living organisms.  It is stored primarily in the liver in esterified form (Vitamin A palmitate) and it is a key component of the visual system (when oxidized to retinal) and gene expression (when oxidized to retinoic acid). Retinol/retinyl acetate/retinyl palmitate will be considered as a NHP, acceptable sources of vitamin A will be all-trans retinyl acetate (synthetically prepared from retinol), all-trans retinyl palmitate and all-trans â-carotene. In addition, Vitamin A is also listed in Schedule F as follows:     Vitamin A in oral dosage form containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A.  Therefore, Vitamin A over 10,000 IU is considered as drug while below 10,000 is an NHP under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81828";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Vitamin A acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:3:"CIH";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194993;a:26:{s:5:"title";s:12:"Rubidium_ACN";s:3:"nid";s:6:"194993";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:163:"It is an alkali metal widely distributed in very small quantities in earth's crust. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81833";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Rubidium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194994;a:27:{s:5:"title";s:12:"L-Serine_ACN";s:3:"nid";s:6:"194994";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81837";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"L-Serine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194995;a:27:{s:5:"title";s:10:"Silver_ACN";s:3:"nid";s:6:"194995";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:358:"Since Colloidal silver is typically a colloid solution (a type of mixture intermediate between homogeneous solution and heterogeneous mixture), of silver particles in water, and that silver is a natural occurring element (in earth’s crust and seawater), it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81840";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Silver";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194996;a:26:{s:5:"title";s:10:"Sodium_ACN";s:3:"nid";s:6:"194996";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81841";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Sodium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194997;a:27:{s:5:"title";s:17:"Sodium borate_ACN";s:3:"nid";s:6:"194997";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:933:"Borax (Na2B4O7,) is a form of hydrous sodium borate that occurs in arid regions, forming from the evaporation of saline lakes. Naturally occurring borax is translucent due to water in its structure, but develops a white powder on its surface as the water evaporates. The name borax comes from the Arabic ‘buraq’ meaning ‘white’. Borax (Sodium borate decahydrate; Na2B4O7•10H2O) is the refined form of natural sodium borate. It composed of boric oxide (B2O3), sodium oxide, and water, it is a mild, alkaline salt, white and crystalline, with excellent buffering and fluxing properties. Borax decahydrate is an important multifunctional source of B2O3, particularly for processes in which the simultaneous presence of sodium is beneficial. Borax Decahydrate is used in cosmetics, toiletries and pharmaceuticals. Sodium Borate is a salt derivative of Boric acid and falls under item 2, Priority 2 (Isolate) of NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81846";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Sodium borate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194998;a:27:{s:5:"title";s:20:"Sodium perborate_ACN";s:3:"nid";s:6:"194998";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:617:"Sodium perborate is a water-soluble chemical compound manufactured by reaction of sodium tetraborate, hydrogen peroxide and sodium hydroxide.  Upon contact with water, this chemical undergoes hydrolysis, producing hydrogen peroxide and borate, which is why it is used as a source af active oxygen in detergents, laundry detergents, cleaning products and laundry bleaches. It has also some antiseptic properties and can be used as a disinfectant.  Since  sodium perborate is acting as a source for two NHPs (hydrogen peroxide; plant isolate) and (perborate as a mineral), sodium perborate will be considered as an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81847";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Sodium perborate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:194999;a:26:{s:5:"title";s:19:"Sodium silicate_ACN";s:3:"nid";s:6:"194999";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:811:"Sodium silicate is a compound used in cements, textile and lumber processing; which is usually prepared using molten sodium carbonate and silicon dioxide.  Available sodium silicate is ususally composed of different forms of silicate, namely sodium orthosilicate, Na4SiO4; sodium metasilicate, Na2SiO3; sodium polysilicate, (Na2SiO3)n; sodium pyrosilicate, Na6Si2O7, and others.  This mineral compound was also used as an egg preservation agent in the early 20th Century with large success, which is why it is listed in the NHPD acceptable NMIs list.  Since silicates are sources of silicon and that silicon is currently used for different medical conditions, even if it is a synthetic compound, Sodium silicate will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81848";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium silicate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195000;a:26:{s:5:"title";s:18:"Sodium sulfate_ACN";s:3:"nid";s:6:"195000";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:525:"Sodium sulfate is a natural mineral and important sodium compound used in detergents, paper pulping and for many other uses.  The anhydrous form occurs in nature as the mineral Thenardite, but the major production of Sodium sulfate comes from its decahydrate form, the naturally occurring mineral Mirabilite, also known as Glauber's salt.  It is also listed in the NHPD acceptable NMI list.  For these reasons, Sodium sulfate will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81849";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195001;a:27:{s:5:"title";s:21:"Stannous fluoride_ACN";s:3:"nid";s:6:"195001";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81850";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Stannous fluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195002;a:27:{s:5:"title";s:13:"Strontium_ACN";s:3:"nid";s:6:"195002";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92722;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:798:"Strontium is an alkaline earth metal, soft silver-white or yellowish metallic element that is highly reactive chemically. This metal turns yellow when exposed to air and occurs in celestite and strontianite. Due to its extreme reactivity to air, this element always naturally occurs combined with other elements and compounds, as in the minerals strontianite, celestite, etc. It is isolated as a yellowish metal and is somewhat malleable. Strontium commonly occurs in nature, averaging 0.034% of all igneous rock and is found chiefly as the form of the sulfate mineral celestite (SrSO4) and the carbonate strontianite (SrCO3). Strontium chloride is one of the acceptable derivative of Strontium and therefore it will be considered as an NHP under mineral, item 7, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81851";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Strontium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:3:"CIH";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195003;a:27:{s:5:"title";s:15:"L-Threonine_ACN";s:3:"nid";s:6:"195003";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81858";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Threonine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195004;a:26:{s:5:"title";s:14:"Tourmaline_ACN";s:3:"nid";s:6:"195004";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:829:"Tourmaline is a name given to a group of minerals, which is one of the most complicated groups of silicate minerals, since it consist of complex silicate of aluminum and boron with varying composition of sodium, calcium, iron, magnesium, lithium and other elements. The most common tourmaline is Schorl which consist of about 95% of all tourmalines in nature (see Table 1 for the tourmaline members accepted by the International Mineralogical Association).  Since tourmalines are naturally occurring minerals, they will be considered as NHPs, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.  The 14 recognized minerals in the group are:    Elbaite  Schorl  Dravite  Chromdravite  Olenite  Buergerite  Povondraite  Vanadiumdravite  Liddicoatite  Uvite  Hydroxy-feruvite  Rossmanite  Foitite  Magnesiofoitite";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81862";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tourmaline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195005;a:27:{s:5:"title";s:14:"L-Tyrosine_ACN";s:3:"nid";s:6:"195005";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81863";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"L-Tyrosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195006;a:26:{s:5:"title";s:12:"L-Valine_ACN";s:3:"nid";s:6:"195006";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:236:"Valine is an essential amino acid. Foods that are good sources of valine include cottage cheese, fish, poultry, beef, peanuts, sesame seeds, and lentils. It will be considered as a NHP, under schedule 1, item 4, Priority 2 (amino acid).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81864";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"L-Valine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195007;a:26:{s:5:"title";s:21:"alpha-Tocotrienol_ACN";s:3:"nid";s:6:"195007";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:175:"Alpha-Tocotrienol and beta-Tocotrienol are two of the naturally occurring forms of vitamin E. They will be considered as NHPs, under schedule 1, item 3, Priority 5 (vitamins).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81880";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"alpha-Tocotrienol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195008;a:26:{s:5:"title";s:16:"Coenzyme Q10_ACN";s:3:"nid";s:6:"195008";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81895";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Coenzyme Q10";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195009;a:27:{s:5:"title";s:13:"Melatonin_ACN";s:3:"nid";s:6:"195009";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81907";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Melatonin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:5:"NHPDM";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195010;a:27:{s:5:"title";s:13:"Melatonin_ACN";s:3:"nid";s:6:"195010";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81908";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Melatonin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:6:"SLINGL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:5:"NHPDM";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195011;a:27:{s:5:"title";s:13:"l-Menthol_ACN";s:3:"nid";s:6:"195011";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93320";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81911";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"l-Menthol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195012;a:27:{s:5:"title";s:33:"Acidulated phosphate fluoride_ACN";s:3:"nid";s:6:"195012";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81919";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Acidulated phosphate fluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195013;a:26:{s:5:"title";s:26:"para-Aminobenzoic acid_ACN";s:3:"nid";s:6:"195013";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81930";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"para-Aminobenzoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195014;a:26:{s:5:"title";s:29:"Epinephrine hydrochloride_ACN";s:3:"nid";s:6:"195014";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:786:"Epinephrine (also known as Adrenaline) is both a hormone and a neurotransmitter.  This chemical is part of a family of compounds known as catecholamine, where Epinephrine have alpha- and beta-agonist activity and is the principal sympathomimetic hormone produced by the adrenal medulla.  The natural source of Epinephrine is L-Epinephrine, or its salt L-Epinephrine hydrochloride, while its synthetic duplicate is DL-Epinephrine, also produced as DL-Epinephrine hydrochloride. L-Epinephrine and L-Epinephrine hydrochloride will be considered as NHPs, under Schedule 1, item 2 (Priority 2; Isolates) of the NHP Regulations, and DL-Epinephrine and DL-Epinephrine hydrochloride will be considered as NHPs, under Schedule 1, item 6 (Priority 2; Synthetic duplicates) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81961";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Epinephrine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195015;a:27:{s:5:"title";s:12:"Caffeine_ACN";s:3:"nid";s:6:"195015";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81970";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Caffeine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:5:"NHPDM";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195016;a:27:{s:5:"title";s:24:"Allyl isothiocyanate_ACN";s:3:"nid";s:6:"195016";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81971";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Allyl isothiocyanate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195017;a:27:{s:5:"title";s:12:"Capsicin_ACN";s:3:"nid";s:6:"195017";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81972";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Capsicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195018;a:27:{s:5:"title";s:29:"Histamine dihydrochloride_ACN";s:3:"nid";s:6:"195018";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:490:"Histamine is a biogenic amine widely distributed in nature; present in most mammalian tissues (mast cells and basophils).  It is produced biosynthetically by the decarboxylation of the amino acid Histidine and responsible for many bio-functions, such as induction of bronchoconstriction and vasodilation, stimulation of gastric acid secretion and also acts as a neurotransmitter.  Histamine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81973";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Histamine dihydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195019;a:27:{s:5:"title";s:21:"Methyl salicylate_ACN";s:3:"nid";s:6:"195019";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81974";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methyl salicylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195020;a:27:{s:5:"title";s:10:"Thymol_ACN";s:3:"nid";s:6:"195020";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81975";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Thymol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195021;a:27:{s:5:"title";s:37:"Racemic epinephrine hydrochloride_ACN";s:3:"nid";s:6:"195021";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:57:"Synthetic duplicate, Item 6, Schedule 1, NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81976";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Racemic epinephrine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195022;a:27:{s:5:"title";s:33:"Pseudoephedrine hydrochloride_ACN";s:3:"nid";s:6:"195022";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92648;94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81977";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Pseudoephedrine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195023;a:27:{s:5:"title";s:21:"Magnesium sulfate_ACN";s:3:"nid";s:6:"195023";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:204:"Magnesium sulfate will be considered as an acceptable source of magnesium, since its heptahydrate form occurs in nature as the mineral epsomite, while its monohydrate form occurs as the mineral kieserite.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81980";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Magnesium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195024;a:27:{s:5:"title";s:23:"Nicotine polacrilex_ACN";s:3:"nid";s:6:"195024";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:83:"Source for nicotine (plant isolate), polacrilex is a carrier and considered as NMI.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81984";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Nicotine polacrilex";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195025;a:27:{s:5:"title";s:12:"Nicotine_ACN";s:3:"nid";s:6:"195025";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:466:"Nicotine and its salts, for human use, except
(a) in natural substances;
(b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit;
(c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day; or
(d) in a form to be administered orally by means of an inhalation device delivering 4 mg or less of nicotine per dosage unit
(e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81985";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Nicotine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195026;a:26:{s:5:"title";s:22:"Oleoylethanolamide_ACN";s:3:"nid";s:6:"195026";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:547:"Oleoylethanolamide (OEA), consisting of the amide of ethanolamine and oleic acid, is an endogeneous lipid that modulates feeding, body weight and lipid metabolism; therefore, the biosynthesis and release of OEA from the intestine are stimulated by feeding and reduced during fasting.  Exogeneous OEA has demonstrated the ability of reducing food intake and body-weight gain in rats and mice.  Since this amide is a naturally occurring compound, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81988";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Oleoylethanolamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195027;a:26:{s:5:"title";s:10:"Inulin_ACN";s:3:"nid";s:6:"195027";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:232:"Inulins are a group of naturally occurring oligosaccharides produced by many types of plants. They belong to a class of carbohydrates known as fructans. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81989";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Inulin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195028;a:27:{s:5:"title";s:14:"Eucalyptol_ACN";s:3:"nid";s:6:"195028";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81994";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Eucalyptol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195029;a:26:{s:5:"title";s:23:"Glucosamine sulfate_ACN";s:3:"nid";s:6:"195029";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81995";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Glucosamine sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195030;a:26:{s:5:"title";s:29:"Glucosamine hydrochloride_ACN";s:3:"nid";s:6:"195030";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81996";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Glucosamine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195031;a:26:{s:5:"title";s:11:"Taurine_ACN";s:3:"nid";s:6:"195031";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:491:"Taurine is a conditionally essential amino sulfonic acid present in high amounts in meat and fish. The most abundant dietary source of taurine is human breast milk. Large amounts of taurine are also found in the human brain, retina, heart, and platelets . This substance found in bile and acts as an emulsifier for ingested lipids and assists in their absorption. Taurine may also come from synthetic materials. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81997";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Taurine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195032;a:27:{s:5:"title";s:22:"D-Glucuronolactone_ACN";s:3:"nid";s:6:"195032";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:201:"Glucuronolactone is a naturally occurring chemical compound produced by the metabolization of glucose in the human liver. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81998";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"D-Glucuronolactone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195033;a:26:{s:5:"title";s:10:"Terpin_ACN";s:3:"nid";s:6:"195033";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:854:"Terpin (or Terpinol) is a naturally occurring compound which exist in two different forms.  The trans-form has been found in Myrocarpus silvestris, seeds of Protium brasiliensis, Chinese anise and sweet fennel oil; while the cis-form has been isolated from the leaves of Cupressus torulosa and fruits of Schinus molle.  However, both isomers are usually synthetically prepared from closely related compounds, such as from oil of turpentine or d-Limonene for the cis-form and from 1,8-Cineole or alpha-Terpineol for the trans-form.  cis-Terpin hydrate (also known as Terpinol) has been used medicinally mostly as an expectorant; therefore, to increase the expulsion of tracheal or bronchial mucus through coughing.  For these reasons, Terpin (or Terpinol) will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81999";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Terpin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195034;a:26:{s:5:"title";s:16:"Stigmasterol_ACN";s:3:"nid";s:6:"195034";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82001";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Stigmasterol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195035;a:26:{s:5:"title";s:11:"Inosine_ACN";s:3:"nid";s:6:"195035";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:194:"Inosine is a very common modified nucleoside found in tRNAs and is found in meat, meat extract and in sugar beets. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82002";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Inosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195036;a:26:{s:5:"title";s:23:"N-Acetylsphingosine_ACN";s:3:"nid";s:6:"195036";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:738:"Ceramide 2 is a synthetic N-acetylated sphingoid, a family of compounds related to the naturally occurring Sphingosine, which can have different carbon chain length, ranging from 14 to 28 carbons for the acyl group and from 10 to 16 for the other side carbon chain and commonly used in cosmetic products. However, Sphingosine do not exist as the free amine in animals, plants or microorganisms, but as acetylated analogs, e.g. Ceramide.  Since Ceramides are listed in the NHPD acceptable NMIs list and that  Ceramide 2 is a synthetically prepared derivative of naturally occurring compounds, e.g. Sphingosine and Ceramide, Ceramide 2 (N-Acetylsphingosine) will be considered as an acceptable source for Ceramide and therefore it is a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82003";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"N-Acetylsphingosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195037;a:26:{s:5:"title";s:16:"Benfotiamine_ACN";s:3:"nid";s:6:"195037";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:391:"Benfotiamine is a lipid-soluble form of thiamine (Vitamin B1).  It is perhaps the most effective of the allithiamine group of naturally occurring, thiamine-derived compounds, found in trace quantities in roasted crushed garlic and other vegetables from the Allium genus (such as onions, shallots, and leeks).  It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82004";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Benfotiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195038;a:26:{s:5:"title";s:22:"S-Methylmethionine_ACN";s:3:"nid";s:6:"195038";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:329:"Vitamin U, or S-Methyl-L-methionine (not a real vitamin),  is used by some naturophathic doctors to help healing ulcers. Since this molecule is a naturally occurring sulfonium compound found in a large number of plants, Vitamin U will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82005";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"S-Methylmethionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195039;a:26:{s:5:"title";s:28:"Conjugated linoleic acid_ACN";s:3:"nid";s:6:"195039";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:869:"Conjugated linoleic acid or CLA refers to a group of positional and geometric octadecadienoic acid isomers of linoleic acid. CLA is not a single substance. In contrast to linoleic acid, all the CLA isomers have conjugated bonds. CLA is found naturally in animal tissues and food sources, including ruminant meats, poultry, eggs and dairy products, such as cheeses, milk and yogurt that have undergone heat processing treatments. Vegetable fats are generally poorer sources of CLA. However, CLA is produced from linoleic acid in safflower oil and sunflower oil by special treatment of these oils. CLA was originally found in milk fat where it exists in the form of phospholipids and triglycerides. Also, there is evidence that human milk contains CLA. Since conjugated linoleic acid is found naturally in animal and plant sources, therefore, CLA is considered to be NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82006";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Conjugated linoleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195040;a:26:{s:5:"title";s:26:"Triacylglycerol lipase_APN";s:3:"nid";s:6:"195040";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:280:"It is an enzyme (a group of enzymes) belonging to the esterases. It widely distributes in the plant world, also in molds, bacteria, milk and milk products and in animal tissues, especially in pancreas.It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82007";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Triacylglycerol lipase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195041;a:26:{s:5:"title";s:13:"Nobiletin_ACN";s:3:"nid";s:6:"195041";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:574:"Nobiletin (or 5,6,7,8,3’,4’-Hexamethoxyflavone) is part of a group of flavonoids called Methoxylated flavones, which are plant pigments responsible for flowers and foods color.  Flavonoid compounds are found in every vascular plant; citrus foods being a predominant source, and are known to be beneficial in many medical conditions, such as cardiovascular diseases and cancer, for their antioxidant and anti platelet aggregation properties.  For these reasons, Nobiletin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82008";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Nobiletin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195042;a:26:{s:5:"title";s:18:"gamma-Oryzanol_ACN";s:3:"nid";s:6:"195042";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:240:"It is a mixture of gerulic acid esters of sterols (Campesterol, Stigmasterol and beta-Sitosterol) and triterpene alcohols (Cycloartanol, Cycloartenol, 24-Methylenecycloartanol and Cyclobranol) extracted from rice bran, corn and barley oils.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82009";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"gamma-Oryzanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195043;a:26:{s:5:"title";s:14:"Vinburnine_ACN";s:3:"nid";s:6:"195043";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:323:"Vinburnine is a vinca alkaloid found in the plant 'Hunteria eburnea Pichon' (Apocynaceae family) in form of (+) and in 'Vinca minor L.' (also Apocynaceae family) in (+/-) form. The (-) form is obtained by acid hydrolysis of Vincamine. Vinburnine will be considered as an NHP, under schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82010";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vinburnine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195044;a:26:{s:5:"title";s:17:"Mineral pitch_ACN";s:3:"nid";s:6:"195044";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:786:"Mineral pitch (or Shilajeet) is an exudates that is obtained/extracted from layers of rocks in the himalayan mountains.  Shilajeet is the most important drug of Ayurvedic and folk- medicine systems. It is produced when plant decomposition matter drips into the rocks, and centuries later, is extruded from the rocks by geothermal pressure.  It is composed of humus, minerals and several organic plant materials (such as fulvic acid and benzopyrones) that has been compressed by layers of rock.  Because of the diversity of substances found in mineral pitch, it has been used for many medical conditions, such as for anemia, arthritis and diabetes.  For these reasons, Mineral pitch will be considered as a NHP, under Shcedule 1, item 2 (Priority 2 or 4; extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82011";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Mineral pitch";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195045;a:26:{s:5:"title";s:14:"Citrulline_ACN";s:3:"nid";s:6:"195045";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:513:"Citrulline (or N5-(Aminocarbonyl)-L-ornithine) is an alpha-amino acid first isolated from the juice of watermelon (Citrullus vulgaris Schrad., Cucurbitaceae).  This amino acid, while being part of known proteins, is not synthesized during proteins synthesis, but generated by a family of enzymes, namely peptidylarginine deiminases, which are responsible for the conversion of Arginine into Citrulline. Citrulline will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82012";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Citrulline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195046;a:26:{s:5:"title";s:16:"Sulforaphane_ACN";s:3:"nid";s:6:"195046";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:340:"Sulforaphane is an anticancer compound found in broccoli. In the plant, it is present in bound form as glucoraphanin, a glucosinolate. Sulforaphane is formed from glucoraphanin on plant cell damage (by boiling or consumption) via an enzymatic reaction. Sulforaphane will be considered as NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82013";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Sulforaphane";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195047;a:27:{s:5:"title";s:13:"D-Mannose_ACN";s:3:"nid";s:6:"195047";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:226:"Mannose is a simple sugar (hexose) related to glucose. It appears in some fruits including peaches, apples, oranges, cranberries, and blueberries. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82014";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"D-Mannose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195048;a:26:{s:5:"title";s:22:"Phosphatidylserine_ACN";s:3:"nid";s:6:"195048";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:247:"Phospholipids are found in every cell membrane in our bodies and its molecules is composed of a combination of an amino acid  and a fatty acid components. Since phosphatidyl serine is a natural extract of lecithin, it will be considered as an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82015";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Phosphatidylserine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195049;a:27:{s:5:"title";s:15:"L-Ornithine_ACN";s:3:"nid";s:6:"195049";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82016";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Ornithine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195050;a:26:{s:5:"title";s:16:"Pidolic acid_ACN";s:3:"nid";s:6:"195050";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:296:"Pyroglutamic acid is an amino acid that is found in small amounts in the body and also in foods, such as meat, soya, fruit and vegetables. Researchers have found that it possesses brain-boosting properties without causing harmful side effects. Therefore, Pyroglutamic acid is considered as a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82017";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pidolic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195051;a:26:{s:5:"title";s:14:"Octopamine_ACN";s:3:"nid";s:6:"195051";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:498:"Octopamine is a biogenic amine which is closely related to noradrenaline. Octopamine exists in low concentrations in the central and sympathetic nervous systems of mammals. The two isomers para-octopamine (p-octopamine) and meta-octopamine (m-octopamine) tend to be found together in the same tissues that act as neurotransmitter, neurohormone and neuromodulator. Octopamine HCL will be considered as an isolate that falls under item 2, Schedule 1 of the NHP Regulations and therefore it is an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82018";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Octopamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195052;a:27:{s:5:"title";s:27:"Tocotrienol concentrate_ACN";s:3:"nid";s:6:"195052";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98073";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:175:"Alpha-Tocotrienol and beta-Tocotrienol are two of the naturally occurring forms of vitamin E. They will be considered as NHPs, under schedule 1, item 3, Priority 5 (vitamins).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82019";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Tocotrienol concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195053;a:26:{s:5:"title";s:20:"Androstenetrione_ACN";s:3:"nid";s:6:"195053";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:706:"Since 6-OXO is not listed in Schedules I-V to the Controlled Drugs and Substances Act, it is not a controlled substance. Since 6-OXO does not have direct sex hormone activity, the Therapeutic Products Directorate does not interpret it to be captured by Schedule F. As a naturally occurring substance that is not excluded by Section 2(2) or Schedule 2 to the Natural Health Products Regulations, 6-OXO meets both the substance and function aspects of the definition of a Natural Health Product. 6-OXO is a Natural Health Product. As an isolate it would fall under Product Compliance Category 2, but this is superseded by the Risk-Based Approach to Compliance (see the accompanying Health Hazard Evaluation).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82020";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Androstenetrione";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195054;a:27:{s:5:"title";s:14:"Pantethine_ACN";s:3:"nid";s:6:"195054";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1460:"Pantethine is the active form of pantothenic acid. It has been shown to significantly reduce serum triglycerides, total cholesterol, and LDL-cholesterol (the so-called "bad cholesterol") levels while increasing HDL ("good cholestrerol") levels in several clinical trials. A naturally occurring substance, Pantethine is produced as a byproduct when the body metabolizes pantothenic acid. The name "pantothenic," from which the word "pantethine" is drawn, literally means "something that is found everywhere." It may not be literally everywhere, but pantethine and pantothenic acid are found in most foods, including vegetables, dairy, eggs, grains, and meat. Liver, salmon and yeast have especially high concentrations of pantothenic acid, which the body uses to produce pantethine. 

Although Pantethine is derived from pantothenic acid, pantethine is not the same as pantothenic acid, and it is important to remember that the two substances are not interchangeable and therefore Panththine is not considered as an acceptable source for Pantothenic acid. Structurally, pantethine is a more stable disulfide form of pantothenic acid. It is also a more active metabolic substrate that is converted into an enzyme called "Co-Enzyme A," or simply, "CoA." CoA plays a critical role in the metabolism and breakdown of the three essential micronutrients namely proteins, carbohydrates and fats. Pantethine is considered as an NHP that falls under isolate, priority 2.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82021";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pantethine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195055;a:27:{s:5:"title";s:21:"Mixed carotenoids_ACN";s:3:"nid";s:6:"195055";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96758";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:549:"Carotenoids are organic pigments that are naturally occurring in plants and some other photosynthetic organisms like algae, some types of fungus and some bacteria.  There are two classes of Carotenoids, namely the xanthophylls (where some of the double bonds have been oxidized such as in lutein and zeaxanthin) and the carotenes (the un-oxidized carotenoids such as alpha-carotene, beta-carotene and lycopene).  For these reasons, Mixed carotenoids will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82022";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Mixed carotenoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195056;a:26:{s:5:"title";s:24:"S-Adenosylmethionine_ACN";s:3:"nid";s:6:"195056";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82023";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"S-Adenosylmethionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195057;a:26:{s:5:"title";s:19:"Oxalacetic acid_ACN";s:3:"nid";s:6:"195057";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:776:"Oxaloacetic acid is a four-carbon dicarboxilic acid produced naturally as an intermediate in the citric acid cycle, an important cell's metabolic pathway.  In vivo, Oxaloacetic acid is usually in its ionized form, oxaloacetate.  This molecule is also produced in the mesophyll of plants, by the condensation of carbon dioxide with phosphoenolpyruvate, a reaction catalyzed by the enzyme oxaloacetate decarboxylase.  It is important to notice that this diacid is unstable in solution, since it decomposes to pyruvic acid by a decarboxylation reaction over hours at room temperature and days if refrigerated.  Since Oxaloacetic acid is produced naturally within living cells, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82024";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Oxalacetic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195058;a:26:{s:5:"title";s:12:"Fucoidan_ACN";s:3:"nid";s:6:"195058";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:539:"Fucoidan is a sulfated oligosaccharide, which is composed mainly of L-Fucose and its sulfate esters, but also small amounts of Galactose, Xylose and Glucuronic acid are present.  Fucoidan exist in different forms; F-Fucoidan is composed of about 95% sulfated esters of Fucose and U-Fucoidan, which is also, contains about 20% Glucuronic acid.  Fucoidan is obtained from various brown seaweed, such as kombu and wakame.  Therefore, Fucoidan will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82025";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Fucoidan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195059;a:26:{s:5:"title";s:11:"Diosmin_ACN";s:3:"nid";s:6:"195059";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:227:"Diosmin is a naturally occurring flavonoid glycoside that can be isolated from various plant sources or derived from the flavonoid hesperidin. Diosmin will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82026";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Diosmin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195060;a:26:{s:5:"title";s:12:"Naringin_ACN";s:3:"nid";s:6:"195060";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:211:"It is found in the flowers of grapefruit trees, also in fruit and rind. Naringin gives grapefruit its characteristic bitter flavor. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82027";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Naringin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195061;a:26:{s:5:"title";s:14:"Kojic acid_ACN";s:3:"nid";s:6:"195061";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:582:"Kojic acid is a chelation agent produced by several species of fungus, especially Aspergillus oryzae, which has the Japanese common name koji. It is a mild inhibitor of the formation of pigment in plant and animal tissues, and is used in food and cosmetics to preserve or change colors of substances. It is used on cut fruits to prevent oxidative browning, in seafood to preserve pink and red colours, and in cosmetics to lighten skin. Kojic acid also has antibacterial and antifungal properties. Kojic acid will be considered as NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82028";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Kojic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195062;a:26:{s:5:"title";s:13:"Trehalose_ACN";s:3:"nid";s:6:"195062";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:261:"Trehalose also known as mycose is a 1-alpha (disaccharide) sugar found extensively but not abundantly in nature; Trehala manna (beetle), locust, resurrection plant and fungi. Trehalose will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82029";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Trehalose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195063;a:26:{s:5:"title";s:15:"Policosanol_ACN";s:3:"nid";s:6:"195063";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:411:"Policosanol is a mixture of waxy alcohols derived from a variety of plant sources including sugar cane and wheat germ oil and also beeswax. It refers to a mixture of 24-34 carbon alcohols. It is used as a nutritional supplement to lower (bad) LDL cholesterol and increase (good) HDL cholesterol and to help prevent atherosclerosis. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82030";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Policosanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195064;a:26:{s:5:"title";s:37:"4-Hydroxy-5-methyl-3(2H)-furanone_ACN";s:3:"nid";s:6:"195064";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:843:"Norfuraneol (HMF) was prepared for the first time in low yields by heating arabinose, xylose, ribose, or ribose 5-phosphate in the presence of amine salts. The compound has a caramel-like, burnt aroma or roasted chicory root odour, and its isolation from beef broth (it is a component of the flavour associated with cooked beef). Studies on the formation mechanism of HMF showed that it is derived from Amadori products formed during the Maillard reaction, but it has also been identified as a natural constituent of raspberry, guava, tomato, and insects. A rich source for HMF is shoyu, a fermented soy sauce. Zygosaccharomyces rouxii was identified as one of the shoyu yeasts [avoid confusion with another compound called HMF (5-(Hydroxymethyl)-2-furaldehyde]. HMF will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82031";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"4-Hydroxy-5-methyl-3(2H)-furanone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195065;a:26:{s:5:"title";s:20:"Dimethyl sulfone_ACN";s:3:"nid";s:6:"195065";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82032";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dimethyl sulfone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195066;a:26:{s:5:"title";s:24:"4-Aminobutanoic acid_ACN";s:3:"nid";s:6:"195066";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82033";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"4-Aminobutanoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195067;a:26:{s:5:"title";s:21:"Benzyl nicotinate_ACN";s:3:"nid";s:6:"195067";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:498:"Benzyl nicotinate is the benzyl ester of the naturally occurring compound Nicotinic acid (Niacin).  Nicotinate esters, such as Benzyl nicotinate, acts as topical prodrugs, which after crossing the skin enzymatic hydrolysis, releases the active Nicotinic acid. This product also is a combination product of NHPs, i.e. Benzyl alcohol and Nicotinic acid. Benzyl nicotinate will be considered as a source of Nicotinic acid, an NHP, under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82034";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Benzyl nicotinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195068;a:27:{s:5:"title";s:15:"L-Carnosine_ACN";s:3:"nid";s:6:"195068";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93756";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:265:"Carnosine (beta-Alanyl-L-histidine) is a dipeptide composed of the two amino acids beta-alanine and L-histidine. Carnosine is a naturally occurring dipeptide found in skeletal muscle, heart, brain and other innervated tissues, therefore will be considered as a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82035";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Carnosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195069;a:26:{s:5:"title";s:11:"Vitexin_ACN";s:3:"nid";s:6:"195069";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:533:"Vitexin is a flavonoid-type compound which has been isolated from many plants, such as Vitex littoralis, Anthurium versicolor, Ficaria verna, Cucumis sativus, Acer palmatuam and Gynostemma pentaphyllum.  This naturally occurring compound, just like other flavonoid compounds, has shown some antioxidant activity.  In addition, it has shown some hepatoprotectant, antibacterial and anti-metastatic activity.  For these reasons, Vitexin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82036";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Vitexin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195070;a:26:{s:5:"title";s:15:"Campestanol_ACN";s:3:"nid";s:6:"195070";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:910:"Campestanol is a member of the known family of naturally occurring compounds named plant stanols.  These stanols are structurally related to plant sterols, being their saturated forms.  Plant stanols, or plant sterols, are also structurally related to cholesterol; however, these are not produced by animals, but by plants.  Unlike their unsaturated forms which are abundantly present in plant cells, stanols are known to occur in nature as trace amounts; although in quantifiable amounts in cereals, fruits and vegetables.  They are generally obtained in larger quantities by hydrogenation (saturation) of their respective sterols.  Campestanol, just like any plant sterols and stanols, are known to lower cholesterol serum level by reducing the absorption of both dietary and biliary cholesterol. Campestanol will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82037";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Campestanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195071;a:26:{s:5:"title";s:19:"beta-Sitostanol_ACN";s:3:"nid";s:6:"195071";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:922:"beta-Sitostanol is a member of the known family of naturally occurring compounds named plant stanols.  These stanols are structurally related to plant sterols, being their saturated forms.  Plant stanols, or plant sterols, are also structurally related to cholesterol; however, these are not produced by animals, but by plants.  Unlike their unsaturated forms which are abundantly present in plant cells, stanols are known to occur in nature as trace amounts; although in quantifiable amounts in cereals, fruits and vegetables.  They are generally obtained in larger quantities by hydrogenation (saturation) of their respective sterols.  beta-Sitostanol, just like any plant sterols and stanols, are known to lower cholesterol serum level by reducing the absorption of both dietary and biliary cholesterol. beta-Sitostanol will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82038";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"beta-Sitostanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195072;a:26:{s:5:"title";s:13:"Hordenine_ACN";s:3:"nid";s:6:"195072";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:473:"Hordenine is a potent phenylethylamine alkaloid used as an antibacterial, antibiotic, diuretic and disinfectant.  It is also known as a sympathomimetic, activating both the nicotinic and adrenergic receptors.  This naturally occurring alkaloid has been isolated from many plant species, including barley, few algae and fungi; but mostly from the Cactaceae family. Hordenine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82039";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Hordenine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195073;a:27:{s:5:"title";s:21:"Aristolochic acid_ACN";s:3:"nid";s:6:"195073";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93188;93355";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:882:"Aristolochic acid is a naturally occurring compound, found mostly in Aristolochia and Asarum species, which are both in the Aristolochiaceae family of plants; as well as in some butterflies.  Its biological importance is associated with being used as a phospholipase A2 inhibitor, antineoplastic, antiseptic, antiinflammatory, bactericidal agent and platelet aggregation inhibitor.  Despite the fact that Aristolochic acid is a well known carcinogen and nephrotoxic molecule, which is why Aristolochic acid and all other herbs containing this compound is currently listed in the Restricted Substances not in the Food and Drug Regulations, it is still sometimes used as an herbal remedy for weight loss.  Despite these facts, Aristolochic acid meets the definition of a NHP; therefore will be considered as such, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:363:"This ingredient is on the Restricted Substances list in the Natural Health Products Compliance Guide. Unauthorized products with this ingredient are subject to the risk-based approach to compliance. A product licence must be obtained prior to marketing in Canada . Reference:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/complian-conform_guide-eng.php";s:24:"field_restriction_desc_f";s:548:"Cet ingrédient apparaît sur la liste des substances prohibées du Guide de conformité concernant les produits de santé naturels.  Les produits contenant cet ingrédient qui n'ont pas d'autorisation de mise en marché sont sujets à une approche de conformité qui est prise conjointement avec une approche basée sur les risques.  Une licence de mise en marché doit être obtenue avec de pouvoir poursuivre la commercialisation du produit.  Référence:  http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/complian-conform_guide-fra.php";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82040";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Aristolochic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195074;a:26:{s:5:"title";s:13:"Ubiquinol_ACN";s:3:"nid";s:6:"195074";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:612:"Ubiquinol is the reduced form of Coenzyme Q10, where both forms are naturally occurring compounds widely distributed in animals and humans.  Coenzyme Q10 owes its antioxidant properties to its reduced form, Ubiquinol, where it prevents the generation of free radicals as well as oxidative modifications of proteins, lipids, and DNA.  Also, Coenzyme Q10, through its reduced form, possesses the ability to regenerate other powerfull lipophilic antioxidants, such as alpha-Tocopherol.  For these reasons, Ubiquinol will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82041";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ubiquinol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195075;a:26:{s:5:"title";s:15:"Orotic acid_ACN";s:3:"nid";s:6:"195075";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:536:"Orotic acid is a naturally occurring compound which occurs in milk and other biological systems.  It is the pyrimidine precursor in animal organisms, being involved in the biosynthesis of nucleic acid pyrimidine bases.  Orotic acid has shown some bacteriostatic and cytostatic properties; however, it is now mostly used as a "mineral carrier", forming complexes with minerals used in dietary supplements.  For these reasons, Orotic acid will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82042";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Orotic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195076;a:27:{s:5:"title";s:42:"L-Arginine ethyl ester dihydrochloride_ACN";s:3:"nid";s:6:"195076";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82043";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"L-Arginine ethyl ester dihydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195077;a:26:{s:5:"title";s:37:"Ethyl L-ornithine dihydrochloride_ACN";s:3:"nid";s:6:"195077";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82044";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Ethyl L-ornithine dihydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195078;a:27:{s:5:"title";s:24:"alpha-Linolenic acid_ACN";s:3:"nid";s:6:"195078";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:188:"Alpha-Linolenic acid is an essential fatty acid and the major omega-3 fatty acid found in food. It will be considered as a NHP, under Schedule 1, item 5, Priority 2 (Essential fatty acid).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:114:"Classified as an NHP under Schedule 1, item 5 (an essential fatty acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:121:"Classifié comme PSN sous Annexe 1, article 5 (un acide gras essentiel) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82045";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"alpha-Linolenic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:4:"ESFA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195079;a:27:{s:5:"title";s:12:"Atropine_ACN";s:3:"nid";s:6:"195079";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:254:"Atropine and its salts meet the definition of an NHP only in oral dosage forms; not in ophthalmic or parenteral preparations which are on Schedule F.
Schedule F listing is as follows: 
Atropine and its salts in ophthalmic or parenteral preparations only.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82046";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Atropine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195080;a:26:{s:5:"title";s:13:"Berberine_ACN";s:3:"nid";s:6:"195080";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:557:"Berberine is a benzyl tetra isoquinoline alkaloid widely distributed in many different botanical species, but most frequently in Berberidaceae.  This naturally occurring tautomeric alkaloid is a component of many traditional medicines, since first isolated back in 1826.  It has been used as an antiprotozoal, antimalarial, antibacterial and antidiarrheal agent as well as in other medical disorders, both orally and topically.  For these reasons, berberine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82047";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Berberine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195081;a:26:{s:5:"title";s:23:"Chondroitin sulfate_ACN";s:3:"nid";s:6:"195081";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82048";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Chondroitin sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195082;a:26:{s:5:"title";s:17:"Cryptoxanthin_ACN";s:3:"nid";s:6:"195082";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:217:"Cartenoid pigment with vitamin A activity, best isolated from petals and berries. Widely distributed, also was isolated from orange rind. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82049";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Cryptoxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195083;a:27:{s:5:"title";s:11:"Emetine_ACN";s:3:"nid";s:6:"195083";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93622;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82050";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Emetine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195084;a:26:{s:5:"title";s:30:"Epigallocatechin 3-gallate_ACN";s:3:"nid";s:6:"195084";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:405:"Epigallocatechin gallate (EGCG) is part of a family of naturally occurring compounds called catechins, which are bioflavanoids isolated from plants.  EGCG is one of the most (or the most) potent antioxidant found in nature, where the major source of this antioxidant is green tea.  For these reasons, EGCG will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82051";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Epigallocatechin 3-gallate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195085;a:26:{s:5:"title";s:16:"Ferulic acid_ACN";s:3:"nid";s:6:"195085";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82052";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ferulic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195086;a:27:{s:5:"title";s:12:"Lecithin_ACN";s:3:"nid";s:6:"195086";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82053";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Lecithin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195087;a:27:{s:5:"title";s:13:"Noscapine_ACN";s:3:"nid";s:6:"195087";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:760:"Noscapine (also known as Narcotine) is an opioid alkaloid isolated from the opium poppy plant, Papaver somniferum, and from other plants in the papaveraceae family.  This naturally occurring chemical has been used mostly as an antitussive agent, and known as a by-product present in the water-insoluble extraction fraction of morphine from opium.  Despite the fact that it is listed in the List of Prohibited and Restricted Cosmetic Ingredients as follows:
Noscapine (128-62-1) and its salts 
Noscapine is not included in the Opium Poppy listing of the Schedule I of the Controlled Drugs and Substances Act; therefore, being a naturally occurring substance, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82055";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Noscapine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195088;a:26:{s:5:"title";s:18:"Silver nitrate_ACN";s:3:"nid";s:6:"195088";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1014:"Silver nitrate is the most important silver compound because of its versatility and low cost.  Silver salts are known for their antiseptic properties, which is why Silver nitrate have been used to treat or prevent many bacterial infections, such as in topical creams to treat burns and in newborn eye drops to prevent contraction of gonorrhoea or chlamydia from the mother.  SIlver itself is generally recognized as non-toxic; however, silver salts are, which is why silver and its salts are currently listed in the Cosmetic Ingredients Hotlist as follows: 
Silver (7440-22-4) and its salts 
Restricted to concentrations equal to or less than 0.04% in mouthwash. 
Any cosmetic containing silver and/or its salts shall carry cautionary statements to the effect: "This product contains silver and/or silver salts, avoid contact with broken or abraded skin." 
Despite this fact, Silver nitrate, being a salt of the naturally occurring element Silver, will be considered as such, a source of Silver; therefore, an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82056";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Silver nitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195089;a:26:{s:5:"title";s:12:"Hyoscine_ACN";s:3:"nid";s:6:"195089";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:789:"Scopolamine (also known as hyoscine) is a tropane alkaloid drug obtained from plants of the family Solanaceae (nightshades), such as henbane or jimson weed (Datura species). It is part of the secondary metabolites of plants. Scopolamine is named after the genus Scopolia. The name "hyoscine" is from the scientific name for henbane, Hyoscyamus niger. The drug is highly toxic and has to be used in minute doses. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. Scopolamine will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82057";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Hyoscine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195090;a:26:{s:5:"title";s:13:"Hypericin_ACN";s:3:"nid";s:6:"195090";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82058";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Hypericin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195091;a:26:{s:5:"title";s:21:"Hydrochloric acid_ACN";s:3:"nid";s:6:"195091";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:867:"Hydrochloric acid is a solution of hydrogen chloride gas in water.  This chemical is a strong inorganic acid that is used in many industrial processes, such as in the regeneration of ion exchange resins, in the regulation of pH and neutralization, in the prickling of steel, in the production of inorganic compounds, in the production of organic compounds and so on.  It has also been used medicinally as a pharmaceutical aid (acidifier) and as a gastric acidifier in animal medicine.  Even if Hydrochloric acid is mostly used in industrial processes, it is also known to occur in living organisms, being the major constituent of the human digestive fluid, gastric acid, which is secreted by parietal cells into the lumen of the stomach.  Therefore, Hydrochloric acid will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82061";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hydrochloric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195092;a:26:{s:5:"title";s:18:"Oleanolic acid_ACN";s:3:"nid";s:6:"195092";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:280:"Oleanolic acid occurs in the free state in different leaves. It belongs to triterpene acids that has been shown to protect against a number of hepatotoxicants, and is used in China to treat hepatitis. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82064";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Oleanolic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195093;a:26:{s:5:"title";s:14:"Oleuropein_ACN";s:3:"nid";s:6:"195093";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82065";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oleuropein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195094;a:26:{s:5:"title";s:13:"Quercetin_ACN";s:3:"nid";s:6:"195094";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:450:"Quercetin (or 3,3’,4’,5,7-pentahydroxyflavone) is part of a family of compounds called Flavonoids, which are widely distributed in the plant kingdom, and known for their anti-inflammatory and antioxidant activities. Quercetin is also the backbone of many naturally occurring glycosides, such as Hesperidin and Rutin.  For these reasons, Quercetin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82066";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Quercetin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195095;a:26:{s:5:"title";s:20:"Raspberry ketone_ACN";s:3:"nid";s:6:"195095";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:802:"Raspberry ketone has been isolated from many plants, such as raspberries (Rubus idaeus), rhubarb (Rheum spp.), European cranberry (Vaccinium oxycoccus), blackberry, loganberry and redcurrant.  It has also been found in the glands of the melon fly, Dacus cucurbitae, and of the North American beaver, Castor canadensis,as well as in cultured cells of the basidiomycete Nidula niveo-tomentosa. This chemical has mostly been used as an important flavour ingredient, which is why it is currently listed in the NHPD acceptable NMIs list.  Medicinally, this methylketone compound have showed antibacterial activity, skin-lightning activity and lipid degradation activity.  For these reasons, Raspberry ketone will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82068";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Raspberry ketone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195096;a:26:{s:5:"title";s:15:"Resveratrol_ACN";s:3:"nid";s:6:"195096";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:338:"Resveratrol is a polyphenolic compound that exists in nature as cis- and trans- stereoisomers. Resveratrol is primarily found in red wine, red grape skins, purple grape juice, mulberries, and in smaller amounts in peanuts. Resveratrol will be considered as an NHP that falls under plant isolate, item 2, schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82069";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Resveratrol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195097;a:26:{s:5:"title";s:9:"Rhein_ACN";s:3:"nid";s:6:"195097";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82070";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Rhein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195098;a:26:{s:5:"title";s:9:"Rutin_ACN";s:3:"nid";s:6:"195098";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:499:"Rutin (or 3,3’,4’5,7-Pentahydroxyflavone-3-rutinoside) is a glycoside part of a family of compounds called Flavonoids, which are widely found in the plant kingdom, especially in the Buckwheat plant (Fagopyrum esculentum Moench., Polygonaceae) in the case of Rutin.  Flavonoids, just like Rutin, are famously known for their anti-inflammatory and antioxidant activities.  For these reasons, Rutin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82071";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Rutin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195099;a:26:{s:5:"title";s:11:"Salicin_ACN";s:3:"nid";s:6:"195099";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82072";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Salicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195100;a:26:{s:5:"title";s:11:"Sesamin_ACN";s:3:"nid";s:6:"195100";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82073";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Sesamin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195101;a:27:{s:5:"title";s:24:"gamma-Linolenic acid_ACN";s:3:"nid";s:6:"195101";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"92628;100440";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:202:"Gamma-linolenic acid (GLA) is an omega-6 fatty acid, derived from the seeds of plants such as evening primrose and borage. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:445:"A transgenetic form of Carthamus tinctorius contains gamma-Linolenic acid. A transgenetic organism can serve as the source material for an isolated chemical compound that has been classified as a natural health product. However, a transgenetic organism, a part of a transgenetic organism, or an extracted mixture of chemical compounds from a transgenetic organism, such as seed oil, can not be a medicinal ingredient in a natural health product.";s:24:"field_restriction_desc_f";s:520:"Une forme transgénique de Carthamus tinctorius contient de l’acide gamma-linolénique. Un organisme transgénique peut servir comme matière d’origine d’un composant chimique isolé qui a été classifié comme produit de santé naturel. Toutefois, un organisme transgénique, une partie d’un organisme transgénique, ou un mélange de composants chimiques extraits d’un organisme transgénique, tel que l’huile de graine, ne peuvent pas être des ingrédients médicinaux dans un produit de santé naturel.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82074";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"gamma-Linolenic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195102;a:27:{s:5:"title";s:13:"l-Camphor_ACN";s:3:"nid";s:6:"195102";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82075";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"l-Camphor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195103;a:26:{s:5:"title";s:16:"Parthenolide_ACN";s:3:"nid";s:6:"195103";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82080";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Parthenolide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195104;a:26:{s:5:"title";s:20:"Isoascorbic acid_ACN";s:3:"nid";s:6:"195104";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:644:"Erythorbic acid  is a stereoisomer (epimer) of Ascorbic acid, which is why it is mostly known under the name Isoascorbic acid.  This chemical is mostly used as a flavoring ingredient and as an antioxidant for foods and soft drinks, which is why it is listed in the NHPD acceptable NMIs list.  It is also known to possess one twentieth of Vitamin C activity of L-Ascorbic acid and as an non-heme iron absorption enhancer.  Since Erythorbic acid can be produced from glucose by Penicillium spp., it is a naturally occurring substance; therefore, meet the definition of a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82083";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Isoascorbic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195105;a:26:{s:5:"title";s:23:"gamma-Butyrobetaine_ACN";s:3:"nid";s:6:"195105";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:651:"gamma-Butyrobetaine is a biosynthetic intermediate in the synthesis of L-Carnitine, an important compound in the metabolism of fat in the body, which is why gamma-Butyrobetaine has shown some potential in L-Carnitine supplementation therapy.  gamma-Butyrobetaine is a naturally occurring substance, since it occurs, for example, in the Sea-rose Actinia equina and in muscle of various snakes.  L-Carnitine and its salts and derivatives are listed in Schedule F to the Food and Drug Regulations.  However, gamma-Butyrobetaine is not a derivative of L-Carnitine and therefore, will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82084";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"gamma-Butyrobetaine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195106;a:26:{s:5:"title";s:12:"Graphite_ACN";s:3:"nid";s:6:"195106";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:495:"Graphite is one of the allotropes of carbon that is mostly used in industrial applications, such as in pencils, as a lubricant, and in matches and explosives.  It has also been used as a homeopathic remedy for its antipsoric properties in skin affections (eczema, psoriasis) topical creams.  Since Graphite is a naturally occurring mineral obtained by mining, especially in Canada and Ceylon, it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82085";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Graphite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195107;a:27:{s:5:"title";s:13:"d-Camphor_ACN";s:3:"nid";s:6:"195107";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82086";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"d-Camphor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195108;a:27:{s:5:"title";s:17:"Iron, reduced_ACN";s:3:"nid";s:6:"195108";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:225:"It is a general term for iron compounds in form of Fe(II) salt (Ferrous). Most salts in this category are acceptable sources for Iron. It (its salt) will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82087";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Iron, reduced";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195109;a:26:{s:5:"title";s:12:"Luteolin_ACN";s:3:"nid";s:6:"195109";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:623:"Luteolin is a flavone member of the well known antioxidant chemical family of flavonoids.  This substance, just like other flavonoids, is known for its antioxidant properties, which is why it has potential in the prevention of inflammation and as an anti-cancer agent.  Furthermore, it has shown some antitussive, antispasmodic and anti-HIV activities.  Luteolin is a naturally occurring compound, since occurring in many plants, such as in Leguminosae, Resedaceae, Euphorbiaceae, and Fabaceae.  For these reasons, Luteolin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82088";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Luteolin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195110;a:27:{s:5:"title";s:14:"Stevioside_ACN";s:3:"nid";s:6:"195110";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92931";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:261:"The maximum daily limit for stevioside as a medicinal ingredient without cautionary labelling and additional safety evidence is set at 4 mg/kg bw/day expressed as steviol content. This is equivalent to 10 mg/kg bw/day for stevioside or mixed steviol glycosides.";s:24:"field_restriction_desc_f";s:352:"La limite maximum journalère du stévioside comme ingrédient médicinal sans étiquetage de mise en garde et sans preuves d'innocuité additionnelles est établi à 4 mg/kg poids corporel par jour exprimé en contenu de stéviol.  Ceci est équivalent à 10 mg/kg poids corporel par jour pour le stévioside ou pour les glycosides de stéviol mixtes.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82089";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Stevioside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195111;a:27:{s:5:"title";s:18:"Rebaudioside A_ACN";s:3:"nid";s:6:"195111";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92931;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1137:"Rebaudioside A is a steviol glycoside isolated from the leaves of the paraguayan shrub, Stevia rebaudiana. It has taste properties superior to stevioside (US-NLM 2009) (CRC-DNP 2009). Rebaudioside A commercial used as a highly sweet natural product; its sweetness intensity rated as about 240 times sweeter than sucrose (Kim and Kinghorn 2002). Questions on specifications, safety and special population effects have prevented steviol glycosides from obtaining a legal status permitting their use as a sweetener in most countries. However, recent studies concluded that high purity Rebaudioside A produced to food-grade specifications and according to Good Manufacturing Practices is safe for human consumption under its intended conditions of use as a general purpose sweetener (Brusick 2008; Carakostas, Curry et al. 2008). Rebaudioside A may offer therapeutic benefits, as it has anti-hyperglycemic, anti-hypertensive, anti-inflammatory, anti-tumor, anti-diarrheal, diuretic, and immunomodulatory actions (Chatsudthipong and Muanprasat 2009). Rebaudioside A will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:241:"The maximum daily limit for Rebaudioside A as a medicinal ingredient without cautionary labelling and additional safety evidence is set at 4 mg/kg bw/day expressed as steviol content. This is equivalent to 12 mg/kg bw/day for rebaudioside A.";s:24:"field_restriction_desc_f";s:319:"La limite maximum journalère du Rébaudioside A comme ingrédient médicinal sans étiquetage de mise en garde et sans preuves d'innocuité additionnelles est établi à 4 mg/kg poids corporel par jour exprimé en contenu de stéviol. Ceci est équivalent à 12 mg/kg de poids corporel par jour pour le Rebaudioside A.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82090";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Rebaudioside A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195112;a:26:{s:5:"title";s:14:"Eriocitrin_ACN";s:3:"nid";s:6:"195112";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:509:"Eriocitrin is a naturally occurring flavonone glycoside present abundantly in lemon juice (citrus spp.).  It has also been isolated from peppermint (entha piperita) leaves and (Myoporum tenuifolium).  This polyphenolic compound, just like other compounds from the same family, has shown some potent antioxidant activity, as well as having suppressive effect on oxidative stress.  For these reasons, Eriocitrin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82092";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Eriocitrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195113;a:27:{s:5:"title";s:21:"Indole-3-carbinol_ACN";s:3:"nid";s:6:"195113";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:269:"Indole-3-carbinol is a constituent of cruciferous vegetables of the Brassica genus. Some of these vegetables include broccoli, brussels sprouts, cabbage, collards, cauliflower, kale, kohlrabi, mustard greens, rapeseed, and root vegetables such as turnips and rutabagas.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82093";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Indole-3-carbinol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195114;a:26:{s:5:"title";s:26:"Adenosine triphosphate_ACN";s:3:"nid";s:6:"195114";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1004:"Adenosine triphosphate (ATP) is a nucleotide composed of adenine, ribose and three phosphate units.  It is the universal energy molecule used by the body and has been used in a variety of medical conditions.  Since it is the energy molecule used by our body, some suggests that ATP supplementation can aid and assist in improving energy levels and help support conditions such as chronic fatigue, or related disorders usually caused by aging. Mammalian skeletal muscle at rest contains 350-400 mg of ATP per 100g and it has been isolated from animals, such as rabbits.  Because it is readily hydrolysed to ADP, AMP and down to adenosine itself, ATP must be administered by injection or by sublingual absorption.  However, its stabilized disodium salt is now used in energy-boosting bodybuilding supplementations, where it is known under the trade mark name PEAK ATP.  ATP, the non-injectable dosage form, will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82094";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Adenosine triphosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195115;a:26:{s:5:"title";s:16:"Formaldehyde_ACN";s:3:"nid";s:6:"195115";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:741:"Formaldehyde is the simplest aldehyde which readily results from the incomplete combustion of carbon-containing materials. Formaldehyde occurs naturally in the environment and is the product of many natural processes. It is released during biomass combustion, such as forest and brush fires. In water, it is also formed by the irradiation of humic substances by sunlight. As a metabolic intermediate, formaldehyde is present at low levels in most living organisms. It is emitted by bacteria, algae, plankton, and vegetation. It has been used as disinfectant (in medicine) and as precursor in chemical industry. However there is some concerns about its toxicity. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82095";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Formaldehyde";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195116;a:26:{s:5:"title";s:26:"Fructooligosaccharides_ACN";s:3:"nid";s:6:"195116";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:623:"Fructo-oligosaccharides (FOS) typically refer to short-chain oligosaccharides comprised of D-fructose and D-glucose, containing from 3 to 5 monosaccharide units. Similar molecules are obtained by partial enzymatic hydrolysis of inulins. Those are called oligofructose. FOS, also called neosugar and short-chain FOS (scFOS), are produced on a commercial scale from sucrose using a fungal fructosyltransferase enzyme. FOS is extracted from fruits and vegetables like bananas, onions, chicory root, garlic, asparagus, barley, wheat, and tomatoes. FOS will be considered as NHPs, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82096";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Fructooligosaccharides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195117;a:26:{s:5:"title";s:19:"Hyaluronic acid_ACN";s:3:"nid";s:6:"195117";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:318:"Hyaluronic acid is a glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is one of the chief components of the extracellular matrix, contributes significantly to cell proliferation and migration. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82097";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Hyaluronic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195118;a:26:{s:5:"title";s:22:"Hydroxycitric acid_ACN";s:3:"nid";s:6:"195118";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82098";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydroxycitric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195119;a:26:{s:5:"title";s:17:"Pangamic acid_ACN";s:3:"nid";s:6:"195119";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1277:"Pangamic acid (6-O-(dimethylaminoacetyl)-D-gluconic acid) has been detected in 1938 and described as a natural, universally occurring substance with multiple biological and medical functions. In this respect, pangamic acid has been worldwide on the market since decades as a drug stimulating cellular respiration. In addition to the natural pangamic acid, diisopropylammonium dichloroacetate (DIPA), a synthetic product not found in biological material, is on the market requesting similar biological functions. In commercially available drugs on the German market declared as pangamic acid three separate substances can be found by chemical identification of pangamic acid, namely: (1) gluconic acid, (2) glycine and (3) diisopropylamonium dichloroacetate.  In fact, these ingredients can be used as a raw material for pangamic acid but not necessarily mixing them would produce the intended product. Therefore, for our purpose, pangamic acid will represent one single ingredient having the structure indicated below.  Since pangamic acid (and its salts) is currently listed as a Natural Health Product on the Listing of Drugs Currently Regulated as New Drugs (April 1999), it will be considered as a NHP, under Schedule 1, item 2 (Priority 1; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82099";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Pangamic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195120;a:26:{s:5:"title";s:13:"1-Kestose_ACN";s:3:"nid";s:6:"195120";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:286:"1-Kestose is part of a family of short-chain sugars called short-chain fructooligosaccharides (sc-FOS), which are usually isolated from fruits and vegetables.  For this reason, 1-Kestose will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82100";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"1-Kestose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195121;a:26:{s:5:"title";s:14:"Coenzyme A_ACN";s:3:"nid";s:6:"195121";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:392:"Coenzyme A  is a coenzyme, notable for its role in the synthesis and oxidization of fatty acids, and the oxidation of pyruvate in the citric acid cycle. It synthesized in cells from pantothenate, ATP and cysteine. It is found ubiquitously in mammalian cells. It can also be isolated from animal sources. Coenzyme A will be considered as an NHP, under schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82101";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Coenzyme A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195122;a:26:{s:5:"title";s:14:"Evodiamine_ACN";s:3:"nid";s:6:"195122";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:303:"Evodiamine is a bioactive alkaloid extracted from a plant called Evodiae fructus (Evodia rutaecarpa). It is part of a Chinese herb named Wu-Chu-Yu that Chinese herbalists have used for centuries as a weight loss supplement. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82102";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Evodiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195123;a:26:{s:5:"title";s:32:"Omega-3 marine triglycerides_ACN";s:3:"nid";s:6:"195123";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:902:"Marine lipid triglyceride, or Omega-3 marine triglyceride, is a lipid concentrate manufactured by the extraction of the body oil of fatty fish species followed by the esterification or transesterification of the omega-3 acids concentrate obtained with glycerol.  These acids are mainly alpha-linoleic acid, moroctic acid, eicosatetraenoic acid, eicosapentaenoic acid (timnodonic acid), heneicosapentaenic acid, clupanodonic acid and docosahexaenoic acid (cervonic acid).  The total amount of omega-3 acids expressed as triglycerides is not less than 60% and that of both eicosapentaenoic acid and docosahexaenoic acid together, expressed as triglycerides, is not less than 45%. Since the source material is an extract obtained from a non-human animal materials, Marine lipid triglyceride will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract or Fatty acids) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82103";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Omega-3 marine triglycerides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195124;a:27:{s:5:"title";s:13:"Invertase_ACN";s:3:"nid";s:6:"195124";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:218:"Kind of enzyme obtained primarily from yeast as well as other sources, which catalize the hydrolysis of sucrose into fructose and glucose. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82104";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Invertase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195125;a:26:{s:5:"title";s:13:"Ornicetil_ACN";s:3:"nid";s:6:"195125";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:573:"Ornithine alpha-ketoglutarate is typically the amino acid ornithine compounded with alpha-ketoglutaric acid.  These are often compounded together since alpha-ketoglutaric acid plays an important role in the metabolism of amino acid, more specifically in the transamination process.  Since ornithine and alpha-ketoglutaric acid are already classified in the database as NHPs, and that Ornithine alpha-ketoglutarate can be considered as a source for these two ingredients, it will be considered as a NHP, under Schedule 1, item 2 (Priority 1; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82106";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ornicetil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195126;a:26:{s:5:"title";s:18:"Brassicasterol_ACN";s:3:"nid";s:6:"195126";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:486:"Brassicasterol is a phytosterol (also called plant sterols) which are a group of steroid alcohol, phytochemicals naturally occurring in plants. It is listed under 'Drugs Currently Regulated As New Drugs (April 1999 Edition)': Plant sterols when isolated or concentrated and sold as a single ingredient or added to other ingredients in a product that is manufactured, sold, or represented for use as an NHP. It will be considered as a NHP, under Schedule 1, item 2, Priority 1(new drug).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82107";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Brassicasterol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195127;a:26:{s:5:"title";s:12:"Spermine_ACN";s:3:"nid";s:6:"195127";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:76:"Spermine occurs as phosphate in semen, ox pancreas, yeast and meat products.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82108";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Spermine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195128;a:27:{s:5:"title";s:28:"Pyrroloquinoline quinone_ACN";s:3:"nid";s:6:"195128";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:941:"Pyrroloquinoline quinone (Methoxatin, PQQ) is an organic molecule, discovered in 1979, which was found initially in bacteria as a reductive-oxidative cofactor.  This molecule is now known to be present in various foods, such as in vegetables and meat.  In a Nature's 2003 communication, Kato et al. reported that when mice were fed a PQQ-deficient diet, they showed several abnormalities; they grew slowly, had fragile skin, and showed poor reproductive performance.  They also demonstrated that these abnormalities were due to an enzyme malfunction, because this enzyme was involved in the degradation of the amino acid lysine, and it required PQQ to function normally.  These results suggested that PQQ should be considered as a new B vitamin in mammals. Since PQQ is widely distributed in nature and that it is a potential new vitamin, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82109";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Pyrroloquinoline quinone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195129;a:27:{s:5:"title";s:14:"Cyclic AMP_ACN";s:3:"nid";s:6:"195129";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:293:"Cyclic adenosine monophosphate is a molecule that is important in many biological processes; it is derived from adenosine triphosphate (ATP). It is found in most animal cells, in bacteria, and in some higher plants. It will be considered as NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82110";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cyclic AMP";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195130;a:26:{s:5:"title";s:8:"NADH_ACN";s:3:"nid";s:6:"195130";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:243:"NADH is a natural substance found in most life forms and is necessary for energy production. NADH is located both in the mitochondria and cytosol of cells. Therefore, NADH is considered as a NHP under item 2, schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82111";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"NADH";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195131;a:26:{s:5:"title";s:23:"Glycyrrhetinic acid_ACN";s:3:"nid";s:6:"195131";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:729:"Glycyrrhetinic acid (also known as Glycyrrhetic acid or Enoxolone) is a pentacyclic triterpenoid used as a flavouring agent, in peptic ulcer treatment, as an expectorant and as a topical anti-inflammatory.  This chemical is easily obtained from the hydrolysis of the naturally occurring glycoside Glycyrrhizic acid, which is the active principle of Licorice (Glycyrrhiza glabra) root.  Since Glycyrrhetinic acid exist in nature in its glycoside form (being the aglycone of the naturally occurring Glycyrrhizic acid), it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.  It is important to notice that Carbenoxolone (or Glycyrrhetic acid hydrogen succinate) is a Schedule F drug.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82112";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Glycyrrhetinic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195132;a:26:{s:5:"title";s:14:"Spermidine_ACN";s:3:"nid";s:6:"195132";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:115:"Spermidine is produced by many microorganisms, isolated from the edible shaggy ink cap mushroom (Coprinus comatus).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82113";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Spermidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195133;a:26:{s:5:"title";s:26:"Titanium tetrafluoride_ACN";s:3:"nid";s:6:"195133";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:550:"Titanium tetrafluoride is a synthetically prepared compound composed of titanium and fluorine atoms, which is usually prepared by the reaction of hydrogen fluoride with titanium tetrachloride.  It is used in organic synthesis and also has proven to be effective topically (as a 1% aqueous solution) in the prevention of dental caries.  Since titanium tetrafluoride is composed of two naturally occurring elements and as a source of these elements, it will be considered as a NHP, under Schedule 1, item 7 (Priority 1; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82114";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Titanium tetrafluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195134;a:26:{s:5:"title";s:12:"Creatine_ACN";s:3:"nid";s:6:"195134";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:484:"Creatine is a naturally occurring amino acid (protein building block) found mainly in muscles. Fifty percent of creatine in our bodies is ingested through the foods we eat while the other 50% is made in the liver, kidney, and pancreas. Roughly one-third is in its free form as creatine, while the remainder is bound to phosphate and called creatine phosphate or phosphocreatine. Therefore, Creatine will be considered as a NHP under Isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82115";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Creatine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195135;a:26:{s:5:"title";s:14:"Putrescine_ACN";s:3:"nid";s:6:"195135";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:451:"Putrescine (or 1,4-Butanediamine) was originally detected in decaying animal tissues, but is now known to be present in all cells and certain bacterial cultures (O'Neil et al. 2001).  This small molecule is part of a family known as polyamines, which plays a key role in cell migration, proliferation and differentiation in plants and animals. Therefore Putrescine will be considered as a NHP, under isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82116";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Putrescine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195136;a:27:{s:5:"title";s:15:"Pyrethrin I_ACN";s:3:"nid";s:6:"195136";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:828:"Pyrethrins are a pair of natural organic compounds (Pyrethrin I and Pyrethrin II) that have potent insecticidal activity, which are isolated from the pyrethrum flowers (Chrysanthemum cinerariaefolium) that can be commercially grown to supply the insecticide. Other compounds, called pyrethroids, are synthetically prepared on the basis of the chemical structure of pyrethrins.  These compounds are also used to treat body, head and pubic lice infections. Since Pyrethrin I and Pyrethrin II can be isolated from a natural source, they will be considered as NHPs, under Schedule 1, item 2 (Priority 2; Isolates) of the NHP Regulations. Pyrethrins are associated with various side-effects, and may cause severe allergic attacks in sensitive people. This is also a safety issue that should be considered on assessing these products.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82117";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pyrethrin I";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195137;a:27:{s:5:"title";s:16:"Pyrethrin II_ACN";s:3:"nid";s:6:"195137";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:828:"Pyrethrins are a pair of natural organic compounds (Pyrethrin I and Pyrethrin II) that have potent insecticidal activity, which are isolated from the pyrethrum flowers (Chrysanthemum cinerariaefolium) that can be commercially grown to supply the insecticide. Other compounds, called pyrethroids, are synthetically prepared on the basis of the chemical structure of pyrethrins.  These compounds are also used to treat body, head and pubic lice infections. Since Pyrethrin I and Pyrethrin II can be isolated from a natural source, they will be considered as NHPs, under Schedule 1, item 2 (Priority 2; Isolates) of the NHP Regulations. Pyrethrins are associated with various side-effects, and may cause severe allergic attacks in sensitive people. This is also a safety issue that should be considered on assessing these products.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82118";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pyrethrin II";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195138;a:26:{s:5:"title";s:15:"D-Galactose_ACN";s:3:"nid";s:6:"195138";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82119";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"D-Galactose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195139;a:26:{s:5:"title";s:12:"Phytoene_ACN";s:3:"nid";s:6:"195139";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:382:"Phytoene is known to be a precursor in the biosynthesis of carotenoids, which are widely found in plant and animal life to protect their cells from oxidative damage. Recent findings indicate that phytoene acts in synergism with lycopene in prevention of degenerative diseases. Therefore phytoene will be considered as a NHP, under isolate, item 2, Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82120";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Phytoene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195140;a:26:{s:5:"title";s:14:"Mesoglycan_ACN";s:3:"nid";s:6:"195140";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:532:"Mesoglycan belongs to a broad class of compounds called glycosaminoglycans (GAG). GAGs, also called mucopolysaccharides, are amino hexose polysaccharides contained in mucoproteins, glycoproteins, and blood group substances. It is a type of substance found in many tissues in the body, including the joints, intestines, and the lining of blood vessels. Chemically, mesoglycan is related to the blood-thinning drug heparin and the supplement chondroitin. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82121";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Mesoglycan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195141;a:27:{s:5:"title";s:30:"Medium-chain triglycerides_ACN";s:3:"nid";s:6:"195141";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102543";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82122";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Medium-chain triglycerides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195142;a:26:{s:5:"title";s:18:"Corosolic acid_ACN";s:3:"nid";s:6:"195142";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:114:"Corosolic acid is the active component in banana leaf extract, which has been used for centuries as an herbal tea.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82123";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Corosolic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195143;a:26:{s:5:"title";s:19:"Arabinogalactan_ACN";s:3:"nid";s:6:"195143";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:448:"Arabinogalactan is a member of the carbohydrate family. It’s a natural polysaccharide that is made up of many galactose and arabinose sugar units linked together in a ratio of 6 galactose units to 1 arabinose unit. Arabinogalactan naturally occurs in small amounts in many plants and plant-based foods such as fruits, carrots, radishes, wheat flour and coffee beans. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82124";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Arabinogalactan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195144;a:26:{s:5:"title";s:16:"Iodotyrosine_ACN";s:3:"nid";s:6:"195144";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:452:"It has been reported that iodotyrosine deiodination occurs predominantly in the microsomes and is mediated by NADPH. Iodotyrosine dehalogenase (L-MIT) and diiodotyrosines (L-DIT) are released during thyroglobulin hydrolysis and liberates iodide, which can then reenter hormone-producing pathways. They are normally secreted by the thyroid and therefore they will be considered as NHPs that fall under isolate, item 2, schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82125";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Iodotyrosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195145;a:26:{s:5:"title";s:16:"Isomaltulose_ACN";s:3:"nid";s:6:"195145";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:641:"Isomaltulose (Palatinose) is a disaccharide which has been found naturally in relatively small quantities in honey and sugarcane.  It has physical and organoleptic properties very similar to Sucrose, except that Isomaltulose is known to be around 42% sweetner than its functional isomer Sucrose.  Isomaltulose is also known to be produced from Sucrose by various stains of bacteria, such as Protaminobacter rubrum, Erwinia rhapontici, Serratia plymuthica, Klebsiella planticola and Pseudomona mesoacidophila.  For these reasons, Isomaltulose will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82126";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Isomaltulose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195146;a:26:{s:5:"title";s:24:"Superoxide dismutase_ACN";s:3:"nid";s:6:"195146";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82127";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Superoxide dismutase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195147;a:26:{s:5:"title";s:25:"N1-Methylnicotinamide_ACN";s:3:"nid";s:6:"195147";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:285:"Since 1-Methylnicotinamide (MNA) is one of the two major primary metabolites of nicotinamide, along with nicotinamide-N-oxide and nicotinamide is a naturally occurring product, 1- Methylnicotinamide will be considered as a NHP, under Isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82128";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"N1-Methylnicotinamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195148;a:26:{s:5:"title";s:15:"Astaxanthin_ACN";s:3:"nid";s:6:"195148";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:547:"Astaxanthin (or 3,3’-Dihydroxy-beta,beta-carotene-4,4’-dione) is part of a family of compounds called carotenoids, which are widely found in many organisms, animals as well as plants.  This pigment compound is also responsible for the red color of krills, lobsters and shrimp when they are cooked, which is why it is used as a food additive (as well as for medical conditions for its antioxidant property) and as an acceptable NMI. Astaxanthin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82129";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Astaxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195149;a:26:{s:5:"title";s:21:"Pyroligneous acid_ACN";s:3:"nid";s:6:"195149";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:543:"Wood vinegar, wich is also known as Pyroligneous acid, is a dark liquid produced by the destructive distillation of wood, which is used as a natural aid for detoxification, mild pain relief, and to sterilize and heal minor wounds. Since it contains about 6% acetic acid, it was once used as the commercial source for this acid.  Since this liquid is produced by distillation, wood vinegar can be considered as an extract of wood; therefore, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82130";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Pyroligneous acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195150;a:26:{s:5:"title";s:13:"Vincamine_ACN";s:3:"nid";s:6:"195150";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:448:"Vincamine is the major alkaloid, occurring naturally as the d-form, of the Small Periwinkle (or Vinca minor L., Apocynaceae), which is widely used as a medicinal herb.  Since this alkaloid is found in nature, and this even if other alkaloids from Periwinkles are listed in Schedule F (vinblastine, vincristine, vindesine and vinorelbine), Vincamine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82131";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vincamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195151;a:26:{s:5:"title";s:14:"Hesperetin_ACN";s:3:"nid";s:6:"195151";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:765:"Hesperetin is a well known bioflavonoid, since it is the aglycone of the naturally occurring predominant flavonoid in lemons and sweet oranges, Hesperidin.  An aglycone is the non-sugar part of a glycoside, which consist of  any molecule attached to one or more sugar groups by its anomeric carbon.  Hesperetin is usually prepared by the hydrolysis of Hesperidin, or by synthesis.  Since several studies have shown that orally administered Hesperidin is hydrolyzed by beta-glucosidases to its aglycone Hesperetin before absorption, meaning that the active ingredient in Hesperidin is in fact Hesperetin and that Hesperidin is already classified as a NHP, Hesperetin will be considered as a NHP, under Schedule 1, item 2 (Priority 2: Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82132";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hesperetin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195152;a:27:{s:5:"title";s:15:"L-Norvaline_ACN";s:3:"nid";s:6:"195152";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:412:"Norvaline is an analog of the branched chain amino acid Valine. Norvaline inhibits the arginase enzyme thus increasing arginine concentrations for enhanced conversion to nitric oxide. It has been reported that Norvaline (in its active form of L-) is a natural component of an antifungal peptide produced by Bacillus subtilis. Norvaline will be considered as a NHP, under schedule 1, item 4, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82133";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Norvaline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195153;a:26:{s:5:"title";s:16:"Microcystins_ACN";s:3:"nid";s:6:"195153";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:703:"Microcystins are cyclic nonribosomal peptides produced by cyanobacteria.  Several variants of microcystins exists, such as Microcystin YR produced by Microcystis aeruginosa and Microcystis viridis Tac44 and Microcystin YA produced by Anacystis cyanea.  These chemicals are also known as cyanobacterial toxins; therefore very toxic (LD50 as low as 0.056 mg/kg in mice), which is why cyanobacterial toxins screening test methods and tolerance limits are required for products containing blue-green algae.  However, even if microcystins are known to be very toxic, they are naturally occurring; therefore meets the definition of a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82134";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Microcystins";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195154;a:26:{s:5:"title";s:14:"Fucosterol_ACN";s:3:"nid";s:6:"195154";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:131:"It is isolated from Fucus vericulosus L., Fucaceae. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82136";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Fucosterol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195155;a:26:{s:5:"title";s:31:"beta-Hydroxyisovaleric acid_ACN";s:3:"nid";s:6:"195155";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:313:"Beta-hydroxy-beta-methylbutyrate is a metabolite of the amino acid Leucine and is produced naturally by the human body. It can also be found in many of the foods we eat, such as grapefruit and catfish and can even be found in mother's milk. Therefore, beta-Hydroxy-bera-methylbutyrate will be considered as a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82137";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"beta-Hydroxyisovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195156;a:26:{s:5:"title";s:22:"Cetyl myristoleate_ACN";s:3:"nid";s:6:"195156";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:609:"Cetyl myristoleate (CMO or CM), a fatty acid ester, was discovered by Harry W. Diehl while researching a cure for arthritis. The first amount of Cetyl myristoleate was extracted from mice, but it is now known to be found in sperm whale oil and in a small gland in beaver.  Since the occurrence of this fatty acid ester is relatively rare, it is now produced synthetically by simple esterification of a natural compound, namely myristoleic acid with cetyl alcohol, another natural compound. Cetyl myristoleate will be considered as a NHP, under Schedule 1, item 2 (priority 2; Isolate)  of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82138";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Cetyl myristoleate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195157;a:26:{s:5:"title";s:15:"Phytofluene_ACN";s:3:"nid";s:6:"195157";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:264:"Phytofluene is part of naturally occurring compounds belonging to the carotenoids (polyene hydrocarbons) family that it is widely found in the vegetable kingdom, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82140";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Phytofluene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195158;a:26:{s:5:"title";s:10:"Ribose_ACN";s:3:"nid";s:6:"195158";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:64:"Naturally occurring five-carbon sugar found in all living cells.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82141";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Ribose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195159;a:26:{s:5:"title";s:12:"Squalene_ACN";s:3:"nid";s:6:"195159";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82142";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Squalene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195160;a:26:{s:5:"title";s:11:"Chrysin_ACN";s:3:"nid";s:6:"195160";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:200:"Chrysin is a naturally occurring isoflavone chemically extracted from the plants. Honeycomb also contains small amounts. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82143";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Chrysin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195161;a:26:{s:5:"title";s:20:"Ribonucleic acid_ACN";s:3:"nid";s:6:"195161";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:353:"RNA is the polynucleotide directly involved in protein synthesis. It is found in both the nucleus and the cytoplasm of cells. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).

RNA and DNA isolated from any sources in item 1 of Schedule 1 will be considered as NHPs; however, RNA and DNA isolated from humans is not an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82144";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Ribonucleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195162;a:26:{s:5:"title";s:14:"Citicoline_ACN";s:3:"nid";s:6:"195162";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:700:"Citicoline is a naturally occurring nucleotide and an intermediate in the major pathway of lecithin biosynthesis, synthesizing phosphatidylcholine from choline.  It is used mostly for improving memory in patients with Alzheimer's disease, head trauma, cerebrovascular disease and Parkinson's disease.  It has also demonstrated some efficacy in improving verbal memory in 50-85 years old patients with poor memory.  This product was originally prescribed in European countries for acute cerebrovascular events, and now available in U.S. as a dietary supplement for age-related impairments.  Citicoline will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82145";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Citicoline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195163;a:26:{s:5:"title";s:25:"Deoxyribonucleic acid_ACN";s:3:"nid";s:6:"195163";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:146:"RNA and DNA isolated from any sources in item 1 of Schedule 1 will be considered as NHPs; however, RNA and DNA isolated from humans is not an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82146";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Deoxyribonucleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195164;a:26:{s:5:"title";s:15:"Epinephrine_ACN";s:3:"nid";s:6:"195164";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:786:"Epinephrine (also known as Adrenaline) is both a hormone and a neurotransmitter.  This chemical is part of a family of compounds known as catecholamine, where Epinephrine have alpha- and beta-agonist activity and is the principal sympathomimetic hormone produced by the adrenal medulla.  The natural source of Epinephrine is L-Epinephrine, or its salt L-Epinephrine hydrochloride, while its synthetic duplicate is DL-Epinephrine, also produced as DL-Epinephrine hydrochloride. L-Epinephrine and L-Epinephrine hydrochloride will be considered as NHPs, under Schedule 1, item 2 (Priority 2; Isolates) of the NHP Regulations, and DL-Epinephrine and DL-Epinephrine hydrochloride will be considered as NHPs, under Schedule 1, item 6 (Priority 2; Synthetic duplicates) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82147";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Epinephrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195165;a:26:{s:5:"title";s:11:"Peptone_ACN";s:3:"nid";s:6:"195165";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:203:"Any of various water-soluble protein derivatives obtained by partial hydrolysis of a protein derived from soybean or wheat by an acid or enzyme during digestion and used in culture media in bacteriology.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82148";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Peptone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195166;a:26:{s:5:"title";s:13:"Lanthanum_ACN";s:3:"nid";s:6:"195166";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:606:"Lanthanum is a silvery white rare metallic earth metal (abundance in earth's crust: 18-35 ppm), member of the lanthanide series, occurring naturally in some rare minerals; monazite and bastnaesite. Lanthanum has no known biological role; however, some lanthanum salts (such as Lanthanum chloride and Lanthanum carbonate) have been sold as medication to absorb excess phosphate in end-stage reanl failure and known to have some anticoagulant properties.  Since Lanthanum is a naturally occurring element, it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82149";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Lanthanum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195167;a:26:{s:5:"title";s:10:"Papain_APN";s:3:"nid";s:6:"195167";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82150";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Papain";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195168;a:26:{s:5:"title";s:16:"Chymotrypsin_APN";s:3:"nid";s:6:"195168";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:939:"Chymotrypsin is a digestive enzyme that cleaves peptides at the carbonyl side of tyrosine, tryptophan, phenylalanine and other amide bonds; therefore classified as a proteolytic enzyme.  This enzyme is produced in the pancreas as its inactivated form, chymotrypsinogen, followed by transportation to the duodenum where it is activated by trypsin.  It exist in different forms, such as alpha-chymotrypsin, beta-chymotrypsin, gamma-chymotrypsin, etc.   In vivo, chymotrypsin is acting in the digestive systems of mammals and other organisms, where it performs its main function by hydrolysis of peptide bonds during the intestinal digestion of proteins.  Both orally and topically, chymotrypsin has been used in the prevention or treatment of several medical conditions, mainly associated with reducing inflammation.  Therefore, chymotrypsin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82151";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Chymotrypsin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195169;a:26:{s:5:"title";s:19:"Fruit bromelain_APN";s:3:"nid";s:6:"195169";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82152";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Fruit bromelain";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195170;a:26:{s:5:"title";s:18:"Stem bromelain_APN";s:3:"nid";s:6:"195170";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82153";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Stem bromelain";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195171;a:27:{s:5:"title";s:11:"Lactase_APN";s:3:"nid";s:6:"195171";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:287:"Lactase is a member of the beta-galactosidase family of enzyme: enzymes that cleave off beta-oxygen bonded attachments to galactose. Lactase is involved in the hydrolysis of lactose to galactose and glucose. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82154";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lactase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195172;a:27:{s:5:"title";s:23:"alpha-Galactosidase_APN";s:3:"nid";s:6:"195172";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:187:"Alpha-galactosidase is an enzyme derived from the fungus Aspergillus niger. It hydrolyzes the alpha 1-6 non-reducing galactoside residues from poly and oligosaccharides in an exo-fashion.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82155";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"alpha-Galactosidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195173;a:27:{s:5:"title";s:17:"alpha-Amylase_APN";s:3:"nid";s:6:"195173";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82157";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"alpha-Amylase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195174;a:27:{s:5:"title";s:20:"Oligopeptidase B_APN";s:3:"nid";s:6:"195174";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:248:"Protease II is an enzyme from prolyl oligopeptidase family. It is known from Escherichia coli and is responsible for hydrolysis of -Arg and -Lys bonds in oligopeptides. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82158";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Oligopeptidase B";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195175;a:26:{s:5:"title";s:13:"Cellulase_APN";s:3:"nid";s:6:"195175";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:526:"Cellulase is an enzyme complex which breaks down cellulose to beta-glucose. It is produced mainly by symbiotic bacteria in the ruminating chambers of herbivores. Aside from ruminants, most animals (including humans) do not produce cellulase, and are therefore unable to use most of the energy contained in plant material. Cellulase is also used for commercial food processing in coffee. It performs hydrolysis of cellulose during drying of beans. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82159";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Cellulase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195176;a:27:{s:5:"title";s:11:"Trypsin_APN";s:3:"nid";s:6:"195176";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:458:"Trypsin is a naturally occurring proteolytic enzyme, which is a group of enzyme that cleaves peptide bonds.  Orally, trypsin is used as a digestive enzyme supplementation, while it is used in wound and ulcer cleansing topically.  Trypsin supplements are generally derived from fungi or bacterial sources, pancreas of livestock, or from plant sources. Trypsin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82162";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Trypsin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195177;a:27:{s:5:"title";s:21:"Polygalacturonase_APN";s:3:"nid";s:6:"195177";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:333:"Pectinase is an enzyme that breaks up pectin, the substrate, in plants. Pectinase is commonly used to speed up fruit juice, the product and extraction from fruit such as apples. It is useful because pectin holds together cellulose fibers in plant cells. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82163";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Polygalacturonase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195178;a:27:{s:5:"title";s:32:"Glucan 1,4-alpha-glucosidase_APN";s:3:"nid";s:6:"195178";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:94:"Glucoamylase is obtained from various microorganisms, esp. Aspergillus niger and Rhizopium sp.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82164";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Glucan 1,4-alpha-glucosidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195179;a:27:{s:5:"title";s:21:"alpha-Glucosidase_APN";s:3:"nid";s:6:"195179";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"92628;100008";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82165";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"alpha-Glucosidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195180;a:26:{s:5:"title";s:11:"Ananain_APN";s:3:"nid";s:6:"195180";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82167";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Ananain";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195181;a:26:{s:5:"title";s:13:"Thaumatin_APN";s:3:"nid";s:6:"195181";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:340:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations, A mixture in the ratio 2:1 of two polypeptides, thaumatin I and II, each consisting of 207 amino acid residues and having a molecular weight of about 22,000, extracted from the aril of the tropical fruit Thaumatococcus daniellii[CHEMID];";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82168";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Thaumatin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195182;a:27:{s:5:"title";s:12:"Catalase_APN";s:3:"nid";s:6:"195182";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:452:"Enzymes which promote reactions involving the decomposition of hydrogen peroxide to water and oxygen. Catalase in mammalian liver and blood has been most intensively studied although widely distributed among animals, plants, bacteria and fungi. Catalase for commercial use obtained from animal liver, bacterial and fungal. It is isolated from mammalian livers and kidneys. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82169";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Catalase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195183;a:27:{s:5:"title";s:14:"Peroxidase_APN";s:3:"nid";s:6:"195183";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:227:"Lactoperoxidase is an enzyme which forms part of the body's natural defense system. It occurs in secretions such as saliva, tears, and breast milk. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82170";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Peroxidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195184;a:27:{s:5:"title";s:15:"Chymopapain_APN";s:3:"nid";s:6:"195184";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82171";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Chymopapain";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195185;a:27:{s:5:"title";s:8:"Whey_ACN";s:3:"nid";s:6:"195185";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95988";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82172";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Whey";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195186;a:27:{s:5:"title";s:24:"Whey protein isolate_APN";s:3:"nid";s:6:"195186";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95988";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:910:"Lactoserum proteins is a synonym for Whey proteins, where the word lactoserum is usually used in French for Whey.  Whey proteins is already classifed in the database as a NHP, so Lactoserum proteins should be included as another common name in this entry.

Whey proteins is considered as a NHP that falls under isolate, item 2 of schedule 1 of the NHP Regulations. Any product that have whey proteins as a medicinal ingredient in an acceptable dosage form and have a health claim will be considered as a NHP.  In addition, the source material for whey proteins should be declared by the applicant and will be assessed according our NHP Regulations.

Please note that "whey proteins supplement" is not a health claim. If it is just a dietary protein supplement with no health claims or other representation as a health product (dosage form, packaging/labelling etc.) it should be classified as a food, not a NHP";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82173";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Whey protein isolate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195187;a:27:{s:5:"title";s:28:"Whey protein concentrate_ACN";s:3:"nid";s:6:"195187";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95988";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:911:"Lactoserum proteins is a synonym for Whey proteins, where the word lactoserum is usually used in French for Whey.  Whey proteins is already classifed in the database as a NHP, so Lactoserum proteins should be included as another common name in this entry.

Whey proteins is considered as a NHP that falls under isolate, item 2 of schedule 1 of the NHP Regulations. Any product that have whey proteins as a medicinal ingredient in an acceptable dosage form and have a health claim will be considered as a NHP.  In addition, the source material for whey proteins should be declared by the applicant and will be assessed according our NHP Regulations.

Please note that "whey proteins supplement" is not a health claim. If it is just a dietary protein supplement with no health claims or other representation as a health product (dosage form, packaging/labelling etc.) it should be classified as a food, not a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82174";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Whey protein concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195188;a:26:{s:5:"title";s:22:"Bacterial Protease_APN";s:3:"nid";s:6:"195188";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:249:"Proteases are enzymes that break peptide bonds between amino acids of proteins. Proteases occur naturally in all organisms and constitute 1-5% of the gene content. Protease will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82175";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Bacterial Protease";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195189;a:26:{s:5:"title";s:10:"Casein_APN";s:3:"nid";s:6:"195189";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:381:"Casein is the predominant phosphoprotein found in fresh milk. One of the most nutritive milk proteins in that it contains all of the common amino acids and is rich in the essential ones. It is obtained from milk by removing the cream and acidifying the skimmed milk which causes casein to precipitate. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82176";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Casein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195190;a:26:{s:5:"title";s:18:"beta-Glucanase_APN";s:3:"nid";s:6:"195190";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:159:"A beta-Glucanase preparation, produced by a selected strain of Trichoderma harzianum, containing all the activities needed to hydrolyze beta-glucan to glucose.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82177";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"beta-Glucanase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195191;a:27:{s:5:"title";s:12:"Chymosin_APN";s:3:"nid";s:6:"195191";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:179:"An enzyme that catalyzes the coagulation of milk, found in the gastric juice of the fourth stomach of young ruminants and used in making cheeses and junkets. Also called chymosin.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82178";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Chymosin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195192;a:26:{s:5:"title";s:22:"beta-Lactoglobulin_APN";s:3:"nid";s:6:"195192";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:120:"Beta-lactoglobulin (BLG) is the major protein component of milk from a wide range of species but not human. It is a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82179";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"beta-Lactoglobulin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195193;a:26:{s:5:"title";s:15:"Phaseolamin_APN";s:3:"nid";s:6:"195193";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:373:"Phaseolamin is an inhibitor of alpha-amylase. Originally isolated from white kidney beans, the protein is now commercially produced and sold as a diet aid. It works by inhibiting the action of starch degradation enzyme alpha-amylase, so that less sugar is absorbed in the digestive tract. Phseolamin will be considered as NHP, under schedule 1, item2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82180";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Phaseolamin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195194;a:26:{s:5:"title";s:17:"Trichosanthin_APN";s:3:"nid";s:6:"195194";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:126:"Trichosanthin is a protein made of 234 amino acids, isolated from the roots of Trichosanthes Kirilowii Maxim. [Cucurbitaceae].";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82181";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Trichosanthin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195195;a:26:{s:5:"title";s:16:"Serrapeptase_APN";s:3:"nid";s:6:"195195";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:709:"Serrapeptase (or serratiopeptidase) is a proteolytic enzyme that is isolated from the non-pathogenic enterobacteria Serratia E15, is naturally present in the silkworm intestine which allows the emerging moth to dissolve its cocoon.  When consumed in unprotected tablets or capsules, the enzyme is destroyed by acid in the stomach. However, enterically-coated tablets enable the enzyme to pass through the stomach unchanged, and be absorbed in the intestine. Serrapeptase is found in negligible amounts in the urine, suggesting that it is transported directly from the intestine into the bloodstream. Serrapeptase will be considered as a NHP that falls under Isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82182";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Serrapeptase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195196;a:26:{s:5:"title";s:15:"Lactoferrin_APN";s:3:"nid";s:6:"195196";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:692:"Lactoferrin is an iron-binding protein found in milk and other secretory fluids of mammals, known for its anti-cancer, immunomodulation, anti-microbial, anti-viral and toxin binding properties.  In its native state, lactoferrin is only partially saturated (5-40%) and called Apolactoferrin when it is not iron-chelated. Even if lactoferrin can be produced from recombinant DNA procedures (Prohibited by Schedule D), it is usually isolated from whey, which is the watery part of milk that is separated from the curd in making cheese. Lactoferrin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations, when not produced by recombinant DNA procedures";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82183";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Lactoferrin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195197;a:26:{s:5:"title";s:33:"Aspergillus alkaline protease_APN";s:3:"nid";s:6:"195197";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82184";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Aspergillus alkaline protease";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195198;a:26:{s:5:"title";s:12:"Lysozyme_APN";s:3:"nid";s:6:"195198";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:213:"Lysozyme is an enzyme found in egg white, tears, and other secretions. It is responsible for breaking down the polysaccharide walls of many kinds of bacteria and thus it provides some protection against infection.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82185";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Lysozyme";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195199;a:26:{s:5:"title";s:13:"Serotonin_ACN";s:3:"nid";s:6:"195199";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:465:"Serotonin (or 5-Hydroxytryptamine or 5-HT) is a monoamine neurotransmitter widely found in tissues and fluids of vertebrates and invertebrates; and believed to play a key role in the biochemistry of depression, migraine, bipolar disorder and anxiety.  In the human body, Serotonin is synthesized starting from the amino acid Tryptophan by various enzymes. Serotonin will be considered as a NHP, under Schedule 1, item 2 (Priority 2: Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82187";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Serotonin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195200;a:27:{s:5:"title";s:25:"3,3'-Diindolylmethane_ACN";s:3:"nid";s:6:"195200";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100461";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:293:"Diindolylmethane is an acid-catalyzed dimer of indole-3-carbinol. These compounds are derived from the parent compound glucobrassicin found in cruciferous vegetables such as cabbage, broccoli and brussels sprouts. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82188";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"3,3'-Diindolylmethane";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195201;a:26:{s:5:"title";s:12:"Chitosan_ACN";s:3:"nid";s:6:"195201";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1517:"Chitosan is a linear polysaccharide, structurally similar to cellulose, composed of copolymers of glucosamine and N-acetylglucosamine, which is why chitosan is known to be an intermediate in the manufacture of glucosamine products.  This randomly distributed beta-(1-4)-linked polymer is produced commercially by deacetylation of chitin, which is extracted from shells of crustaceans such as shrimp, lobster, and crab.  Chitosan has been used in both commercial and medicinal areas.  Medicinally, it has been used for weight loss and obesity, in hypercholesterolemia, anemia, Crohn's disease, dental caries, enhancing physical strength, stimulating appetite, renal failure, and insomnia.  Topically, chitosan has also been used for periodontitis, as well as to promote donor site tissue regeneration in plastic surgery.  As a non-medicinal ingredient, Chitosan has been used as an excipient in tablets, as a disintegrant to improve drug dissolution, as a vehicle for parenteral drug delivery devices, as a carrier in controlled release drug systems, and to mask bitter tastes in oral solutions.  Commercially, chitosan is mostly used as a plant growth enhancer, by boosting the ability of plants to defend against fungal infections.  It is also used as part of a filtration process in water processing, causing fine sediment particles to bind together in addition to help in the removal of phosphorus, heavy metals, and oils from the water.  Therefore, Chitosan is considered as a NHP and also as NMI in NHP products.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82189";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Chitosan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195202;a:27:{s:5:"title";s:23:"N-Acetylglucosamine_ACN";s:3:"nid";s:6:"195202";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96686";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:277:"N-Acetylglucosamine is the acetylated derivative of the amino sugar glucosamine, which is a constituent of cartilage proteoglycans. It is derived from marine exoskeletons or produced synthetically. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82190";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"N-Acetylglucosamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195203;a:26:{s:5:"title";s:11:"Icariin_ACN";s:3:"nid";s:6:"195203";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:667:"Icariin is the major component extracted from the traditional Chinese herbal medicine Epimedii Herba (or Yinyanghuo), which has been used for more than a thousand years in China, as a tonic and in the treatment of rheumatic disease and hypertension.  This flavonoid glycoside has been isolated from the dried aerial parts of different Epimedium sp., such as Epimedium brevicornum and Epimedium whusanese, and also used as an immunostimulant, neuronal injury inhibitor, antineoplastic agent, calcium regulator and for enhancing estrogenic activity.  Therefore, Icariin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82191";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Icariin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195204;a:26:{s:5:"title";s:12:"Tyramine_ACN";s:3:"nid";s:6:"195204";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:176:"Product # 1: Since this product is a combination of traditional Chinese and Indian medicines and two plant isolates (evodiamine and tyramine), it will be  
considered as a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82192";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Tyramine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195205;a:26:{s:5:"title";s:26:"Tyramine hydrochloride_ACN";s:3:"nid";s:6:"195205";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82193";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Tyramine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195206;a:26:{s:5:"title";s:15:"Octacosanol_ACN";s:3:"nid";s:6:"195206";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82194";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Octacosanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195207;a:26:{s:5:"title";s:16:"Verbascoside_ACN";s:3:"nid";s:6:"195207";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:532:"Verbascoside (also known as Asteoside) is a phenylethanoid glycoside which has been isolated from Callicarpa dichotoma and several other plants, such as Asystasia intrusa.   Many studies have showed that this naturally occurring molecule possesses anti-oxidative, anti-inflammatory, anti-nephritic and anti-hepatotoxic properties, mainly because of its benzenediol moiety, which is a well known antioxidant.  Therefore, verbascoside will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82195";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Verbascoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195208;a:26:{s:5:"title";s:11:"Fisetin_ACN";s:3:"nid";s:6:"195208";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:150:"It is a flavanoid present in the bark and stems of a variety of trees. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82196";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Fisetin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195209;a:26:{s:5:"title";s:14:"Tangeretin_ACN";s:3:"nid";s:6:"195209";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:552:"Tangeretin (or 5,6,7,8,4’-Pentamethoxyflavone) is part of a group of flavonoids called Methoxylated flavones, which are plant pigments responsible for flowers and foods color.  Flavonoid compounds are found in every vascular plant; citrus foods being a predominant source, and are known to be beneficial in many medical conditions, such as cardiovascular diseases and cancer, for their antioxidant and anti platelet aggregation properties. Tangeretin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82197";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tangeretin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195210;a:26:{s:5:"title";s:15:"Ecdysterone_ACN";s:3:"nid";s:6:"195210";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1134:"Ecdysterone (20-Hydroxyecdysone) is a chemical found in insects, some aquatic animals, and some plants such as Brazilian ginseng and maral root (Rhaponticum carthamoides). In insects and arthropods, Ecdysterone promotes the act of molting.

Ecdysterone is chemically similar to testosterone, which has lead to the belief that it might possess anabolic properties. Animal research suggests that Ecdysterone affects steroid receptors. It is unclear whether this effect is mediated by receptor or feedback loop regulation rather than bioconversion into steroids. However, there is no research in humans demonstrating androgenic or myotrophic effect.

Many of the original studies on Ecdysterone were done in the Soviet Union around 1988, and the researchers theorized that the primary action was that it supposedly helped increase protein synthesis (the use of protein in your liver) and therefore promoted positive nitrogen balance, which would then theoretically lead to greater muscle gains. 

Since Ecdysterone is found in many natural sources, it will be considered as a NHP under isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82198";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Ecdysterone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195211;a:26:{s:5:"title";s:21:"Benzeneethanamine_ACN";s:3:"nid";s:6:"195211";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:481:"Phenylethylamine is found in human brain (and normal urine).  Phenylethylamine in nature is synthesized from the amino acid phenylalanine by enzymatic decarboxylation. It is also found in many foods, especially after microbial fermentation, e.g., in chocolate. Derivatives of Phenylethylamine (such as Amphetamine and its salts) have been widely used as drugs and are not NHP's. However, Phenylethylamine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82200";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Benzeneethanamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195212;a:26:{s:5:"title";s:13:"Histamine_ACN";s:3:"nid";s:6:"195212";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:490:"Histamine is a biogenic amine widely distributed in nature; present in most mammalian tissues (mast cells and basophils).  It is produced biosynthetically by the decarboxylation of the amino acid Histidine and responsible for many bio-functions, such as induction of bronchoconstriction and vasodilation, stimulation of gastric acid secretion and also acts as a neurotransmitter.  Histamine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82201";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Histamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195213;a:26:{s:5:"title";s:15:"Glutathione_ACN";s:3:"nid";s:6:"195213";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:561:"Glutathione (or GSH) is the major low molecular weight thiol compound of the living plant or animal cell, and is known to be in a relative equilibrium with its disulfide analog, glutathione disulfide (or GSSG).  This thiol/disulfide equilibrium is very important for the cell to prevent oxidative damage in various metabolic pathways, which can be correlated to aging and many degenerative diseases, such as Alzheimer’s and Parkinson’s disease.  Glutathione will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82202";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Glutathione";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195214;a:27:{s:5:"title";s:14:"L-Theanine_ACN";s:3:"nid";s:6:"195214";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82203";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"L-Theanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195215;a:26:{s:5:"title";s:16:"Ellagic acid_ACN";s:3:"nid";s:6:"195215";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:82:"Widely distributed in higher plants; also in raspberries , blueberries and grapes.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82204";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ellagic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195216;a:26:{s:5:"title";s:19:"Dimethylglycine_ACN";s:3:"nid";s:6:"195216";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82205";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Dimethylglycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195217;a:26:{s:5:"title";s:33:"Dimethylglycine hydrochloride_ACN";s:3:"nid";s:6:"195217";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82206";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Dimethylglycine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195218;a:26:{s:5:"title";s:12:"Pullulan_ACN";s:3:"nid";s:6:"195218";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:503:"Pullulan is a polysaccharide polymer, also known as alpha-1,4; alpha-1,6-glucans, produced from starch by the fungus Aureobasidium pullulans.  Because this polymer is edible and almost tasteless, it is used predominantly in the manufacture of edible films used in various breath freshener or in oral hygiene products, such as the well know Listerine.  Since this polysaccharide is naturally produced, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82207";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Pullulan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195219;a:26:{s:5:"title";s:14:"Hesperidin_ACN";s:3:"nid";s:6:"195219";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:297:"The flavonoid hesperidin is a flavanone glycoside (glucoside) comprised of the flavanone (a class of flavonoids) hesperitin and the disaccharide rutinose. Hesperidin is the predominant flavonoid in lemons and oranges. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82208";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Hesperidin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195220;a:26:{s:5:"title";s:21:"Nicotine tartrate_ACN";s:3:"nid";s:6:"195220";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:899:"Nicotine bitartrate dihydrate is a pure crystalline salt of nicotine derivative, offering the highest available degree of purity for nicotine or its salts. Nicotine bitartrate will be considered as a NHP, under schedule 1, item 2, Priority 1 (isolate). Please see below for the acceptable limits and dosage forms of Nicotine as NHP as indicated in the Schedule F:
Nicotine and its salts, for human use (acceptable as NHP);
(a) in natural substances;
(b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit;
(c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day; or
(d) in a form to be administered orally by means of an inhalation device delivering 4 mg or less of nicotine per dosage unit
(e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit.
Nicotine in other cases considers as drug (schedule F).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82209";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Nicotine tartrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195221;a:26:{s:5:"title";s:16:"4-Oxoretinol_ACN";s:3:"nid";s:6:"195221";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:381:"LEO80122 is a  synthetically prepared analog of retinol, namely 4-Oxoretinol.  This chemical has been identified to be a natural metabolite of retinoic acid, and proposed to be a biologically and physiologically active retinoid signaling molecule. In this perspective, 4-Oxoretinol will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82210";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"4-Oxoretinol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195222;a:26:{s:5:"title";s:15:"Fulvic acid_ACN";s:3:"nid";s:6:"195222";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82211";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fulvic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195223;a:26:{s:5:"title";s:30:"3,4-Dihydroxyphenylethanol_ACN";s:3:"nid";s:6:"195223";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:329:"Hydroxytyrosol (4-(2-Hydroxyethyl)benzene-1,2-diol) is a potent and protective polyphenol found mainly in olives, where polyphenols are known for their antioxidant properties. Since hydroxytyrosol is found in nature, therefore it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82212";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"3,4-Dihydroxyphenylethanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195224;a:26:{s:5:"title";s:15:"Humic acids_ACN";s:3:"nid";s:6:"195224";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:381:"Humic acids are Allomelanins found in soils, coals, and peat resulting from the decomposition of organic matter, particulary dead plants. Humic acids consists of a mixture of complex macromolecules having polymeric phenolic structures with the ability to chelate with metals, especially Iron. Humic acids will be considered as a NHP, under schedule 1, item 2, Priority 2 (Extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82213";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Humic acids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195225;a:26:{s:5:"title";s:27:"Guanidinopropionic acid_ACN";s:3:"nid";s:6:"195225";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:613:"Guanidinopropionic acid occurs in the sea anemone Anthopleura japonica [1-2]. It alters creatine metabolism [3]. Guanidinopropionic acid is a physiological constituent of mammalian blood plasma, erythrocytes, brain, liver, kidney, aorta, and urine [4]. Guanidinopropionic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
[1] Dictionary of Natural Products
[2] Makisumi S. 'Guanidino Compounds from a Sea-Anemone, Anthopleura japonica Verrill' 1961, J. Biochem. 1961, 49, 284-291
[3] ChemID
[4] Sigma-Aldrich at www.sigmaaldrich.com/sigma/product%20information%20sheet/g6878pis.pdf";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82214";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Guanidinopropionic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195226;a:26:{s:5:"title";s:21:"Hypochlorous acid_ACN";s:3:"nid";s:6:"195226";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1452:"Hypochlorous acid (HClO) is a weak and unstable acid. It occurs only in aqueous solutions when pure chlorine is added to water. In the presence of sunlight, hypochlorous acid decomposes into more hydrochloric acid and oxygen. It is widely used as a bleach, oxidizer, deodorant and disinfectant. Its potassium salt is well known to be the active ingredient in the bleach Javelle water or Eau de Javelle. It is also produced by neutrophyl granulocytes, also known as neutrophils, which are the most abundant type of white blood cells, which form a large part of the immune system.  These cells are active phagocytes, capable of ingesting or "destroying" unwanted microorganisms or foreign particles.  However, only one phagocytic event can be performed by these cells, resulting in the usage of all their glucose reserves in an extremely vigorous event, called "respiratory burst". This "respiratory burst" produces large quantities of reactive oxygen species, which kills the ingested organisms.  During this process, Myeloperoxidases (MPO), a peroxidase enzyme, produces Hypochlorous acid, which is one of the active oxygen species that contributes in the killing of the unwanted organisms, from hydrogen peroxide and chlorine anion.  Even if hypochlorous acid is only stable in solutions, it is naturally produced by immune system cells, therefore, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82215";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hypochlorous acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195227;a:26:{s:5:"title";s:11:"Pinitol_ACN";s:3:"nid";s:6:"195227";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:220:"D-pinitol is a form of pinitol, a naturally-occurring compound found in certain plants, trees and foods, such as soy. Studies show that it has insulin-like effects, driving creatine and other nutrients into muscle cells.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82216";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Pinitol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195228;a:26:{s:5:"title";s:16:"Glycocyamine_ACN";s:3:"nid";s:6:"195228";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:415:"Glycocyamine (as guanidinoacetate) is the direct metabolic precursor of creatine and is present in a variety of mammalian muscle samples and other foods. For example, the average concentration of glycocyamine in the muscle of untreated rabbits ranged from 7.5 to 17.0 mg per 100 g of tissue. Therefore. Glycocyamine will be considered as an NHP under Isolate (Priority 2), item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82217";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Glycocyamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195229;a:26:{s:5:"title";s:13:"Viniferin_ACN";s:3:"nid";s:6:"195229";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:710:"Viniferin is a naturally occurring stilbene, which has been isolated from different plant sources, such as Paeonia lactiflora,Caragana chamlague and Vitis vinifera.  This chemical exist in different isomeric forms, such as (+)-alpha-viniferin, trans-epsilon-viniferin and cis-epsilon-viniferin, which can be isolated as a mixture or separately depending on the source material.  Viniferins have been reported to possess inhibitory effects on tyrosinase and prostaglandin H-2 synthase; as well as some anti-inflammatory activity and antioxidant activity, being stilbene trimers.  Therefore, viniferins will be considered as NHPs, under Schedule 1, item 2 (Priority 2; Isolate or Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82219";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Viniferin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195230;a:26:{s:5:"title";s:23:"4-Hydroxyisoleucine_ACN";s:3:"nid";s:6:"195230";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:235:"4-Hydroxyisoleucine is an amino acid extracted from Fenugreek seeds and never found in mammalian tissues. It exhibits interesting insulinotropic activity. It will be considered as an NHP, under Schedule 1, item 2, priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82220";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"4-Hydroxyisoleucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195231;a:26:{s:5:"title";s:20:"Phytosphingosine_ACN";s:3:"nid";s:6:"195231";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:691:"Phytosphingosine is a free base lipid which is the key biochemical precursor/building block for Ceramide 3, Ceramide 6 and Phytoceramide 1. Phytosphingosine is one of the most widely distributed natural sphingoid bases, which is abundant in fungi and plants (e.g. isolated from the basidiomycete Russula cyanoxantha and Saccharomyces cerevisiae), and also found in animals including humans. Phytosphingosine is structurally similar to sphingosine; phytosphingosine possesses a hydroxyl group at C-4 of the sphingoid long-chain base, whereas sphingosine has a trans-double bond between C-4 and C-5. Phytosphingosine will be considered as a NHP, under schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82221";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Phytosphingosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195232;a:26:{s:5:"title";s:13:"Germanium_ACN";s:3:"nid";s:6:"195232";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82222";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Germanium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195233;a:27:{s:5:"title";s:37:"1,4-alpha-Glucan branching enzyme_APN";s:3:"nid";s:6:"195233";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:711:"1,4-alpha-glucan branching enzyme (glycogen branching enzyme) is an enzyme taking part in the synthesis of glycogen by adding branches to the glycogen molecule. Glycogen is a branching polymer of large numbers of glucose units linked together. The structure is based on chains of glucose units with linkages between carbon atoms 1 and 4 of each pair of units (alpha 1, 4 linkages).   
Glycogen storage disease type IV is a very rare hereditary metabolic disorder as a result of the absence of the glycogen branching enzyme. Transglucosidase has been found in Aspergillus niger and Aspergillus oryzae. 1,4-alpha-glucan branching enzyme will be considered as a NHP, under schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82223";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"1,4-alpha-Glucan branching enzyme";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195234;a:26:{s:5:"title";s:12:"Guaiacol_ACN";s:3:"nid";s:6:"195234";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:661:"Guaiacol is naturally occurring substance used medicinally as an expectorant, antitubercular, antiseptic and as a local anesthetic.  This yellowish aromatic oil can also be used as a flavouring agent, which is why it is currently listed as such in the NHPD acceptable NMIs list.  Guaiacol has been isolated from several plant oils, also present in guaicac resin and hardwood tar.  It can also be synthesized by the mercuric oxide oxidation of lignin, by oxidation of anisole with trifluoroperoxyacetic acid and by other synthetic reactions.  Therefore, guaiacol will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82226";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Guaiacol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195235;a:26:{s:5:"title";s:39:"Dibasic calcium phosphate dihydrate_ACN";s:3:"nid";s:6:"195235";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82227";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"Dibasic calcium phosphate dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195236;a:26:{s:5:"title";s:10:"Indium_ACN";s:3:"nid";s:6:"195236";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:294:"Since Indium is a trace element with natural occurrence in the earth’s crust of 
1 x 10-5 %, and this even if Indium sulfate is synthetically prepared, Indium sulfate will be considered as a source of Indium and as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82228";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Indium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195237;a:26:{s:5:"title";s:28:"Fructose-1,6-diphosphate_ACN";s:3:"nid";s:6:"195237";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:563:"Fructose 1,6-diphosphate is prepared by action of yeasts on Glucose, Sucrose and Fructose and also formed from Fructose 6-phosphate in the presence of Mg2(+), ATP and the enzyme phosphohexokinase.  Fructose 1,6-diphosphate is fructose sugar phosphorylated on carbons 1 and 6 (i.e. is a fructosephosphate). The β-D-form of this compound is very common in cells. The vast majority of glucose and fructose entering a cell will become converted to fructose 1,6-diphosphate at some point. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82229";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Fructose-1,6-diphosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195238;a:26:{s:5:"title";s:14:"Icodextrin_ACN";s:3:"nid";s:6:"195238";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:658:"Icodextrin is a complex alpha-D-glycopyranan produced by the enzymatic  hydrolysis of corn. It is primarily composed of (1-4)-alpha-D-glucopyrano linkage with less than 10 percent (1-6)-alpha linkage. Icodextrin is a dextrin (polysaccharides produced by the hydrolysis of starch), having more than 85% of its molecules with molecular masses between 1640 and 45,000 daltons with a claimed-average molecular mass of approximately 20,000 daltons. Icodextrin is used clinically to reduce postoperative adhesions and used as the osmotic agent in peritoneal dialysis solution. Icodextrin will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82230";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Icodextrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195239;a:26:{s:5:"title";s:15:"Polyphenols_ACN";s:3:"nid";s:6:"195239";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:631:"Polyphenols exist in various vegetables and fruits as plant pigment or component of bitterness and astringency. They consist of flavonoids, tannins, phenol carboxylic acids and lignins. Apples contain many kinds of polyphenols, such as procyanidin, epicatechin, catechin, p-coumaroyl qunic acid, chlorogenic acid, rutin and phloridzin. The main components of polyphenols are oligomeric procyanidins. The most important flavonoids present in apple and apple products are flavanols or catechins, flavonols, and anthocyanidins. Polyphenols (apple polyphenols) will be considered NHP’s, under schedule 1, item 2, Priority 2 (Extract)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82231";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Polyphenols";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195240;a:27:{s:5:"title";s:25:"Unhydrolyzed Collagen_APN";s:3:"nid";s:6:"195240";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95673";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:929:"Collagens are the most abundant proteins found in the animal kingdom. It is the major protein comprising the extracellular matrix (ECM). There are at least 12 types of collagen. Types I, II and III are the most abundant and form fibrils of similar structure. Type-II collagen is the basis for articular cartilage and hyaline cartilage.
It makes up 50% of all protein in cartilage and 85-90% of collagen of articular cartilage.Type II collagen adds structure and strength to connective tissues and is found primarily in cartilage, the jelly-like substance that fills the eyeball, the inner ear, and the center portion of the discs between the vertebrae in the spine. Chicken collagen II is type II collagen derived from the sternum of chickens. Type II chicken collagen shares some similar antigenic regions with type II human collagen. Collagen Type II will be considered as a NHP, under schedule 1, item 2, Priority 4 (extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82232";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Unhydrolyzed Collagen";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195241;a:27:{s:5:"title";s:33:"Unhydrolyzed collagen type II_APN";s:3:"nid";s:6:"195241";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95673";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:929:"Collagens are the most abundant proteins found in the animal kingdom. It is the major protein comprising the extracellular matrix (ECM). There are at least 12 types of collagen. Types I, II and III are the most abundant and form fibrils of similar structure. Type-II collagen is the basis for articular cartilage and hyaline cartilage.
It makes up 50% of all protein in cartilage and 85-90% of collagen of articular cartilage.Type II collagen adds structure and strength to connective tissues and is found primarily in cartilage, the jelly-like substance that fills the eyeball, the inner ear, and the center portion of the discs between the vertebrae in the spine. Chicken collagen II is type II collagen derived from the sternum of chickens. Type II chicken collagen shares some similar antigenic regions with type II human collagen. Collagen Type II will be considered as a NHP, under schedule 1, item 2, Priority 4 (extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82233";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Unhydrolyzed collagen type II";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195242;a:28:{s:5:"title";s:9:"5-HTP_ACN";s:3:"nid";s:6:"195242";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;98153";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:127:"If attesting to the NHPD 5-HTP monograph, tablets and capsules must be formulated to contain 100 milligrams or less of L-5-HTP.";s:24:"field_restriction_desc_f";s:170:"Si vous attestez à la monographie de la DPSN de 5-HTP, les comprimés et les capsules doivent être formulés de façon à contenir 100 milligrammes ou moins de L-5-HTP.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82234";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"5-HTP";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:5:"NHPDM";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195243;a:26:{s:5:"title";s:21:"D-Glucuronic acid_ACN";s:3:"nid";s:6:"195243";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:711:"Glucuronic acid is widely distributed in plants where it occurs in gums, mucilages, saponins and flavone glycosides and in animals as a constituent of mucopolysaccharides. It usually occurs in "paired" form, i.e. as a glycosidic combination with phenols, alcohols, etc. Such glucuronides form in the liver detoxify poisonous hydroxyl-containing substances. The glucuronides present in normal urine are those of phenol, cresol, and indoxyl. After the ingestion of poisons such as morphine, chloral hydrate, camphor, or turpentine, glucuronides formed with the poison or its hydroxylated derivatives appear in the urine. Glucuronic acid will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82237";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"D-Glucuronic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195244;a:26:{s:5:"title";s:27:"Isoleucine methyl ester_ACN";s:3:"nid";s:6:"195244";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:441:"Isoleucine methyl ester is the sex pheromone component of the larva, Phyllophaga anxia (Chiral capillary gas chromatographic-electroantennographic detection(GC-EAD) analysis indicates that L-valine and L-isoleucine methyl esters are the major sex pheromone components released by females of the cranberry white grub, Phyllophaga anxia [1]). Isoleucine methyl ester will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82238";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Isoleucine methyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195245;a:27:{s:5:"title";s:12:"Oleamide_ACN";s:3:"nid";s:6:"195245";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1185:"Oleamide is isolated from the cerebrospinal fluid of humans, cats and rats and also from lichen Stereocaulon alpinum and from Desmos cochinchinensis. Oleamide is an endogenous amide of the fatty acid oleic acid. The mechanism of action of oleamide's sleep inducing effects is an area of current research. It is likely that oleamide interacts with multiple neurotransmitter systems. While structurally related to the endogenous cannabinoid anandamide, the ability of oleamide to bind the cannabinoid receptor CB1 is controversial. Synthetically produced oleamide has a variety of industrial uses including as a slip agent, a lubricant for plastic films (polyolefin) which can be used in food packing material. It is used as a dispersant in printing and dying. It is used in paper and textile industry for water-proof as well as corrosion inhibitor in oil wells. It is also used for the synthesis of organic chemicals and surfactants used in detergent, ore floating agent, fabric softener, anti-static agent, germicide, insecticide, emulsifier, anti-caking agent, lubricant and water treatment agent. Oleamide will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82239";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Oleamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195246;a:27:{s:5:"title";s:27:"(S)2-Aminobutanoic acid_ACN";s:3:"nid";s:6:"195246";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:411:"alpha-Aminobutyric acid (AABA) is an isomer of the amino acid aminobutyric acid. There is also gamma-aminobutyric acid (GABA) and beta-aminobutyric acid.
alpha-aminobutyric acid is a key intermediate in the biosynthesis of ophthalmic acid or ophthalmate, which was first isolated from calf lens. It is widely distributed in nature. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82240";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"(S)2-Aminobutanoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195247;a:26:{s:5:"title";s:11:"Thujone_ACN";s:3:"nid";s:6:"195247";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1038:"Thujone is a ketone and a monoterpene that exists in two stereoisomeric forms: (+)-3-thujone or α-thujone and (-)-3-thujone or β-thujone. Thujone is found in a number of plants, such as arborvitae (genus Thuja, hence the derivation of the name), Nootka Cypress, some junipers, mugwort, sage, tansy and wormwood, most notably grand wormwood (Artemisia absinthium), usually as a mix of isomers (alpha:beta) in a 1:2 ratio.  Thujone is most famous for being a chemical in the drink absinthe and many modern producers list their supposed thujone levels on the bottle. However, by recent tests it has become evident absinthe contains very little thujone. In Canada, liquor laws are the domain of the provincial governments. British Columbia has no limits on thujone content; Alberta, Ontario and Nova Scotia allow 10 mg/kg (10 ppm) thujone; Québec allows 15 mg per kg (15 ppm); and all other provinces do not allow the sale of absinthe containing thujone. Thujone will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82241";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Thujone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195248;a:26:{s:5:"title";s:11:"Acetone_ACN";s:3:"nid";s:6:"195248";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1654:"Acetone is a colorless, mobile, flammable liquid. It is the simplest example of the ketones (as Dimethyl ketone or 2-Propanone).The most familiar household use of acetone is as the active ingredient in nail polish remover. Acetone is also used to make plastic, fibers, drugs, and other chemicals. Although mostly synthetically prepared, virtually every organ and tissue within the human body contains some acetone which is one of three biochemicals collectively referred to as ketone bodies. Acetone is produced within the body as a result of the breakdown and utilization of stored fats and lipids as a source of energy [1]. Acetone can be found as an ingredient in a variety of consumer products ranging from cosmetics to processed and unprocessed foods. Acetone has been rated as a GRAS (Generally Recognized as Safe) substance when present in beverages, baked goods, deserts, and preserves at concentrations ranging from 5 to 8 mg/L [2]. It can also be detected in measurable amounts in onions, grapes, cauliflower, tomatoes, milk, cheese, beans, peas, and other natural foods. Milk from dairy cattle may contain very high levels of acetone, ranging as high as 225 mg/L for the milk from hyperketo-nemic cows [3]. Acetone has also been identified, but not quantified, in air samples from numerous plants and microorganisms. In addition to its elimination in the expired air of all mammals, acetone is excreted as a metabolic end-product by some bacteria (Clostridium butylicium), molds, fungi (Paecilaomyces variotii), and algae (Cryptomonas ovata palustris) [4-6]. Acetone will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82242";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Acetone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195249;a:26:{s:5:"title";s:18:"Barium sulfate_ACN";s:3:"nid";s:6:"195249";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1162:"Barium sulfate is a white crystalline solid with the chemical formula BaSO4. It is poorly soluble in water and other traditional solvents but is soluble in concentrated sulfuric acid. The mineral barite is composed largely of barium sulfate and is a common ore of barium. Barium sulfate is frequently used clinically as a radiocontrast agent for X-ray imaging and other diagnostic procedures. It is most often used in imaging of the GI tract during what is colloquially known as a 'Barium meal'. Although barium is a heavy metal, and its water-soluble compounds are often highly toxic, the extremely low solubility of barium sulfate protects the patient from absorbing harmful amounts of the metal. Barium sulfate is also readily removed from the body. Other uses: manuf photographic papers, artificial ivory, cello -phane; filler for rubber, linoleum, oil cloth, polymeric fibers and resins, paper, lithographic inks; as a water-color pigment for colored paper, in wallpaper; as a size for modifying the colors of other pigments; in heavy concrete for radiation shield. Barium sulfate will be considered as a NHP, under Schedule 1, item 7, Priority 5 (Mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82243";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Barium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195250;a:26:{s:5:"title";s:12:"Capsiate_ACN";s:3:"nid";s:6:"195250";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:318:"Capsiate has been extracted from a non-pungent cultivar of red pepper, CH-19 sweet, and shown to be a capsaicin analogue (capsinoids) that has an ester bond instead of the amide bond between the vanillyl moiety and fatty acid chain. Capsiate will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82244";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Capsiate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195251;a:26:{s:5:"title";s:13:"Capsaicin_ACN";s:3:"nid";s:6:"195251";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:530:"Capsaicin is part of a family of compounds called capsaicinoids, which are isolated from different species of Capsicum, Solanaceae (e.g. Paprika and Cayenne).  In addition to its known use as a spice in foods (in Chilli peppers), Capsaicin is also used in topical ointments for its analgesic activity, as well as being part of the non-lethal weapon called "Pepper spray", for its irritant properties.  For these reasons, Capsaicin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82245";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Capsaicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195252;a:26:{s:5:"title";s:17:"Bioflavonoids_ACN";s:3:"nid";s:6:"195252";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:688:"Bioflavonoids refers to a class of naturally occurring compounds, which are recognized as plants secondary metabolites.  The role or functions of bioflavonoids in plants varies, going from providing pigmentation in flowers to the protection against microbes and insects.   These chemicals are most famously known for their antioxidant activity, since their chemical structure usually includes a polyphenol moiety, where polyphenols are considered as very good radical scavengers.  Since bioflavonoids are usually obtained via extraction of rich sources (e.g. citrus fruits), bioflavonoids will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82246";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Bioflavonoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195253;a:27:{s:5:"title";s:27:"Resistant maltodextrins_ACN";s:3:"nid";s:6:"195253";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1034:"Resistant Maltodextrins (RMD) are a subset of the general category of ‘maltodextrins’ for which there is no single chemical structure. Maltodextrins are derived from starches, and because starches can assume a wide variety of chemical structures, the actual chemical nature of maltodextrins –and thus RMD – is poorly understood. High temperature and enzymatic treatment can modify some starches to make them more resistant to digestion, which is purposefully characterized by the rearrangement of a portion of normal alpha-1,4-glucose linkages of corn starch molecules to random 1,2-, 1,3- and 1,4-alpha and beta linkages. The human digestive system effectively digests only alpha -1,4- linkages; therefore, other linkages created are resistant to digestion, so they are not absorbed in the small intestine and are passed on to the large intestine.  This is the reason why this type of maltodextrins is used as dietary fibre.  Resistant Maltodextrin will be considered as a NHP, under Schedule 1, item 2, Priotity 2 (Extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82247";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Resistant maltodextrins";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195254;a:26:{s:5:"title";s:19:"Mercuric iodide_ACN";s:3:"nid";s:6:"195254";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:471:"Mercury (II) iodide [or Mercuric iodide (HgI2)] is a red-orange crystal.  In medicine, mercury(II) iodide was formerly used as a treatment for syphilis. Nowadays, it has been used as an antiseptic (topical) [1]. In veterinary medicine, mercury(II) iodide is used in blister ointments in exostoses, bursal enlargement, etc [1,2]. Mercury and its salts and derivatives are in the list of 'Prohibited Substances in the Food and Drug Regulations' (with the torerance limit of";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82248";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Mercuric iodide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195255;a:26:{s:5:"title";s:28:"Sodium hexametaphosphate_ACN";s:3:"nid";s:6:"195255";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1316:"Sodium hexametaphosphate (SHMP) is a mixture of polymeric metaphosphates; therefore, not a single hexamer.  In aqueous solution, this substance depolymerize to Sodium trimetaphosphate and Sodium orthophosphates [1].  SHMP is mostly used as a sequestrant and in various industrial applications, such as in water softeners and detergents, for leather tanning, dyeing, laundry work, and textile processing [1,2].  Recently, this ingredient has been added to dentifrices as a calcium-sequestring (or anticalculus) agent for its mineralization inhibitor properties [3,4].  These mineralization inhibitors, such as pyrophosphates, are believed to bind to site on tooth surface, bind to calcium in tartar and solution, preventing calculus formation (which is the result of calcium phosphate mineralization in dental plaque above the free gingival margin) [3,5].  The fact that Sodium hexametaphosphate is a polymeric form of phosphates is believed to be the reason why it shows improved efficacy, having a higher affinity to enamel [3,5].  

Since various phosphate minerals exist in nature and because the effect of Sodium hexametaphosphate appears to be due to phosphates, Sodium hexametaphosphate meets the substance component of the NHP definition, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82249";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Sodium hexametaphosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195256;a:26:{s:5:"title";s:16:"beta-Alanine_ACN";s:3:"nid";s:6:"195256";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:556:"Beta-Alanine is the only naturally occurring beta amino acid (i.e. the amino group is at the beta-position from the carboxylate group).  It is widely distributed in plants including alga, fungi and many higher plants.   beta-Alanine is formed in vivo by the degradation of dihydrouracil and carnosine.  It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B5), which itself is a component of coenzyme A.  beta-Alanine will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82250";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"beta-Alanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195257;a:27:{s:5:"title";s:19:"epsi-Tocopherol_ACN";s:3:"nid";s:6:"195257";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92593";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82251";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"epsi-Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195258;a:26:{s:5:"title";s:19:"beta-Sitosterol_ACN";s:3:"nid";s:6:"195258";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82252";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"beta-Sitosterol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195259;a:26:{s:5:"title";s:15:"Naphthalene_ACN";s:3:"nid";s:6:"195259";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82253";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Naphthalene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195260;a:26:{s:5:"title";s:20:"5'-Uridylic acid_ACN";s:3:"nid";s:6:"195260";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:261:"5'-Uridylic acid is an uracil nucleotide containing one phosphate group esterified to the sugar moiety (ribose) in the 5' position. It is widely distributed in nature. 5'-Uridylic acid will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82254";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"5'-Uridylic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195261;a:26:{s:5:"title";s:14:"Polylysine_ACN";s:3:"nid";s:6:"195261";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:305:"ε-Polylysine is a peptide which is a homopolymer of lysine.  It comprises 25-30 L-lysine residues in an isopeptide linkage.  ε-Polylysine is produced from aerobic bacterial fermentation by Streptomyces albulus [4].  Polylysine will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82255";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Polylysine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195262;a:27:{s:5:"title";s:23:"Hydrolyzed collagen_ACN";s:3:"nid";s:6:"195262";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96666";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:884:"Hydrolyzed Collagen is the hydrolysate of animal (particularly bovine, porcine, poultry) or fish collagen derived by acid, enzyme or other method of hydrolysis to make it more digestible and more easily absorbed by the body. It is composed primarily of amino acids, peptides, and proteins.  It is characterized by a significant level of hydroxyproline residues[1,2].  For industrial production purposes, gelatin is first obtained from raw material by acidic or alkaline partial hydrolysis and thereafter the ‘hydrolyzed collagens’ are produced by enzymatic hydrolysis of the gelatin under controlled conditions.  The methods applied to characterize the molecular weight of hydrolyzed collagen has been recently investigated [3].  Hydrolyzed collagen will be considered as a NHP, under Schedule 1, item 2, Priority 4 (Extract).

Updated definition information is in ITS Issue 4253.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82256";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Hydrolyzed collagen";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195263;a:26:{s:5:"title";s:21:"N-Acetylhistidine_ACN";s:3:"nid";s:6:"195263";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:413:"N-Acetylhistidine is a constituent of the tissues of various fish, e.g. Atlantic salmon (Salmo salar), Rainbow trout (Salmo gairdneri), Nile tilapia (Oreochromis niloticus) and amphibian spp., e.g. frogs (Rana nigromaculata, Rana catesbiana and Bufo bufo japonicus) [1].  N-Acetylhistidine will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).

[1] Dictionary of Natural Products
[2] ChemID";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82257";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"N-Acetylhistidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195264;a:26:{s:5:"title";s:17:"Guggulsterone_ACN";s:3:"nid";s:6:"195264";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:594:"Guggulsterone is a plant sterol found in guggul (Commiphora mukul) and Ailanthus grandis.  It has two stereoisomers: E and Z [1].  It acts (in human) as an antagonist of the farnesoid X receptor [2].  Recent research shows Guggulsterone is ineffective in lowering Cholesterol (which was originally believed) [3]. Guggulsterone will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).

[1] Dictionary of Natural Products
[2] ChemID 
[3] Philippe O. et al., ‘Guggulipid for the Treatment of Hypercholesterolemia: A Randomized Controlled Trial’, JAMA, 2003; 290(6), 765-772";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82258";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Guggulsterone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195265;a:26:{s:5:"title";s:21:"Calcium hydroxide_ACN";s:3:"nid";s:6:"195265";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:436:"Calcium hydroxide is a natural mineral found in Portlandite.  It can be prepared by mixing calcium oxide with water (i.e. hydration of lime).  Calcium hydroxide is a white powder that has many therapeutic uses.  Because of its ability to stimulate mineralization, it is found in many dental formulations [2].  Calcium hydroxide will be considered as a NHP, under Schedule 1, item 7, Priority 5 (Mineral).

[1] The Merck Index
[2] ChemID";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82259";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium hydroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195266;a:26:{s:5:"title";s:22:"Ammonium carbonate_ACN";s:3:"nid";s:6:"195266";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:911:"Ammonium carbonate can be obtained by the dry distillation of nitrogenous organic matter, such as the shavings of animals horn, leather and hooves [1,2,3]. Today it is normally prepared synthetically.  Ammonium carbonate when crushed is used as a smelling salt (Smelling salts are chemical compounds used to arouse consciousness by releasing ammonia).  Ammonium carbonate is an acceptable food additive and non-medicinal ingredient in Canada [4,5].  Buckley's cough syrup (Canada) uses Ammonium carbonate as an active ingredient to help relive symptoms of bronchitis [6].  Ammonium carbonate will be considered as a NHP, under Schedule 1, item 7, Priority 5 (Mineral).

[1] Br J Sports Med. 2006 Aug;40(8):659-60
[2] 'Ammonium Compounds' by Charles W. Weston et al. Kirk-Othmer Encyclopedia of Chemical Technology
[3] 'Ammonium Compounds' by Karl-Heinz Zapp et al. Ullmann's Encyclopedia of Industrial Chemistry";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82260";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Ammonium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195267;a:26:{s:5:"title";s:25:"Potassium thiocyanate_ACN";s:3:"nid";s:6:"195267";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1208:"Potassium thiocyanate has been used in the manufacturing of artificial mustard oil, printing and dyeing textiles, in photography as intensifier, in analytical chemistry and also in medicine as hypotensive [1,2].  Thiocyanate is produced by the reaction of elemental sulfur or thiosulfate with cyanide. Thiocyanate is naturally present in saliva [3,4].  Potassium thiocyanate is particularly important as an intermediate and a final product in the pharmaceuticals industry.  It is added to toothpastes and mouthwashes to approximately double the quantity of natural thiocyanate.  In the lactoperoxidase system, it increases the antibacterial activity in combination with peroxides [5].  Potassium thiocyanate will be considered as a NHP, under Schedule 1, item 7, Priority 5 (Mineral).1] The Merck Index
[2] ChemID
[3] Schultz, CP, 'Thiocyanate levels in human saliva: quantitation by Fourier transform infrared spectroscopy' Anal. Biochem. 1996 Aug 15;240(1):7-12
[4] Paul BD et al. 'Cyanide and thiocyanate in human saliva by gas chromatography-mass spectrometry', J. Anal. Toxicol. 2006 Oct;30(8):511-5.
[5] Thiocyanates, Inorganic by Theo H. J. van Hoek in 'Ullmann's Encyclopedia of Industrial Chemistry'";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82261";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Potassium thiocyanate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195268;a:26:{s:5:"title";s:13:"Diacerein_ACN";s:3:"nid";s:6:"195268";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1079:"Diacerein is the di-acyl derivative of Rhein (a natural product) [1,2].  It is a slow-acting anti-arthritic drug used for the treatment of osteoarthritis [3,4]. Diacerein is entirely converted into Rhein before reaching the systemic circulation, which is why Rhein is believed to be responsible for the pharmacological activity of Diacerein [5].  For these reasons, Diacerein will be considered as a source for Rhein; a NHP, under Schedule 1, item 2, Priority 2 (Isolate).

[1] Dictionary of Natural Products
[2] The Merck Index
[3] Fidelix TS. Et al. 'Diacerein for osteoarthritis' Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005117. Review
[4] Pavelka K. et al. 'The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period 'Arthritis Rheum. 2007 Dec;56(12):4055-64.
[5] Nicolas, P. et al.  'Clinical Pharmacokinetics of Diacerein', Clinical Pharmacokinetics, 1998, Vol. 35 Issue 5, p347-359";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82262";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Diacerein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195269;a:26:{s:5:"title";s:12:"Daidzein_ACN";s:3:"nid";s:6:"195269";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:144:"Daidzein is one of the active isoflavones in Red clover (plant). It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82263";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Daidzein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195270;a:26:{s:5:"title";s:12:"Pine tar_ACN";s:3:"nid";s:6:"195270";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:2141:"Pine tar is a sticky material produced by the high temperature carbonization of pine wood in anoxic conditions (dry distillation or destructive distillation; the process of pyrolysis conducted in a distillation apparatus to allow the volatile products to be collected). The wood is decomposed by applying heat and pressure in a closed container. Pine tars are known to contain e.g. tricyclic diterpenoid resin acids, tricyclic diterpene hydrocarbons, alkylphenanthrenes and fatty acids. Identification of compounds and tar characterisation are now usually achieved by GC-MS [3-5,7]. Components of tar vary according to the pyrolytic process (e.g. method, duration, temperature) and origin of the wood (e.g. age of pine trees, type of soil and moisture conditions during tree growth). However, the four diterpenoids retene, abietic acid, dehydroabietic acid and methyl dehydroabietate are all major components in pine tar [7]. Pine tar in medicine has been used as topical antieczematic, rubefacient, and in vet. medicine as mild irritant, antiseptic in chronic skin conditions, and expectorant [1]. Although, some ingredients in original plant will be destroyed and/or methylated through the process, the remaining material contains many natural products. Therefore, ‘Pine Tar’ will be considered as a NHP, under schedule 1, item 2, Priority 4 (extract).

References:
[1] The Merck Index
[2] ChemID
[3] Evershed, R.P. et al. Nature, 314,1985, p. 528.
[4] Egenberg, I.M. et al. ‘Characterisation of naturally and artificially weathered pine tar coatings by visual assessment and gas chromatography-mass spectrometry’, Journal of Cultural Heritage, 4(3), 2003, Pages 221-241
[5] Egenberg, I.M. et al. ‘Characterisation of traditionally kiln produced pine tar by gas chromatography-mass spectrometry’, Journal of Analytical and Applied Pyrolysis, Volume 62(1), 2002, Pages 143-155
[6] Wikipedia at http://en.wikipedia.org/wiki/Pine_tar
[7] Hjulström B. et al. ‘Organic Geochemical Evidence for Pine Tar Production in Middle Eastern Sweden During the Roman Iron Age’, Journal of Archaeological Science,33(2), 2006, Pages 283-294";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82264";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Pine tar";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195271;a:26:{s:5:"title";s:24:"Cytochrome-c oxidase_APN";s:3:"nid";s:6:"195271";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:960:"Cytochrome C oxidase- The enzyme cytochrome c oxidase is a large transmembrane protein complex found in bacteria and the mitochondrion [1]. The complex is a large integral membrane protein composed of several metal prosthetic sites and 13 protein subunits in mammals.The complex contains two hemes, a cytochrome a and cytochrome a3, and two copper centers [2]. It can be isolated from various plants, e.g. pea shoots, sweet potato root; also from mammalian tissues. Cytochrome c oxidase catalyses the reaction of ferrocytochrome c with O2 to give ferricytochrome c and H2O; this is the final step in mitochondrial electron transport [3]. Cytochrom c oxidase will be considered as a NHP, under schedule 1, item 2, Priority 2 (Isolate).
[1]  www.expasy.org/cgi-bin/nicezyme.pl?1.9.3.1
[2] Tsukihara T. et al. 'Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 Å'. Science (1995) 269, 1069-1074    
[3] Dictionary of Natural Products";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82265";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Cytochrome-c oxidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195272;a:26:{s:5:"title";s:15:"Citric acid_ACN";s:3:"nid";s:6:"195272";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:186:"Citric acid exists in a variety of fruits and vegetables, but it is most concentrated in lemons and limes. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82266";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Citric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195273;a:26:{s:5:"title";s:22:"2-Oxoglutaric acid_ACN";s:3:"nid";s:6:"195273";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82267";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"2-Oxoglutaric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195274;a:26:{s:5:"title";s:18:"Glyoxylic acid_ACN";s:3:"nid";s:6:"195274";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:422:"Glyoxylic acid, which has both aldehyde and carboxylic acid functionality [1], occurs in unripe fruit, in young green leaves, and in young sugar beets [2]. It is found in plant and animal tissues and also produced by Aspergillus niger and other microorganisms [3]. Glyoxylic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (Isolate).
[1] ChemID
[2] The Merck Index
[3] Dictionary of Natural Products";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82268";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Glyoxylic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195275;a:26:{s:5:"title";s:16:"Tramiprosate_ACN";s:3:"nid";s:6:"195275";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1003:"The combination of the provided literature references (two of which [7,9] are also cited in the Dictionary of Natural Products [3] as references for its isolation from Grateloupia livida and Cladophora densa), and unpublished data confirm that Homotaurine can occur naturally in a few algae species.  Therefore, Homotaurine will be considered as an NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.
[1] http://en.wikipedia.org/wiki/Homotaurine  
[2] ChemIDplusAdvanced
[3] Dictionary of Natural Products on DVD, Version 16:2. Copyright © 1982-2008 Chapman & Hall/CRC
[4] Wright T. M. Tramiprosate. Drugs of Today 2006, 42(5): 291-298
[5] Aisen, Paul S. et al. Alzhemed: A Potential Treatment for Alzheimer's Disease. Current Alzheimer Research, 4(4), September 2007, pp. 473-478
[6] Fariello RG et al., Homotaurine (3-aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect or systemically administered kainic acid. Neurology 1982 Mar; 32(3): 241-5.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82269";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Tramiprosate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195276;a:26:{s:5:"title";s:20:"Aluminum lactate_ACN";s:3:"nid";s:6:"195276";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1183:"Aluminum Lactate is the aluminum salt of Lactic Acid. It is prepared from lactic acid and aluminum isopropoxide, aluminum chloride, or aluminum foil. It has been used in foam fire distinguishers and in dental-impression materials. It is an antiseptic [1]. It has also shown slight plaque and gingivitis reducing effect [2]. Another study shows daily home use of a dental rinse containing aluminum lactate is effective for treatment of dentinal hypersensitivity [3]. Aluminum lactae is also an acceptable non-medicinal ingredient [4]. Aluminum Lactate is a combination NHP and will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).
[1] The Merck Index
[2] Rathe F. et al. ‘The plaque and gingivitis reducing effect of a chlorhexidine and aluminium lactate containing dentifrice (Lacalut aktiv) over a period of 6 months’, J. Clin. Periodontol. 2007,34(8), 646-51
[3] Higuchi Y. et al. ‘Clinical evaluation of a dental rinse containing aluminum lactate for treatment of dentinal hypersensitivity’, J. Clin. Dent. 1996, 7(1), 9-12
[4] International Cosmetic Ingredient Dictionary at www.ctfa-gov.org/pls/ctfa_gov/main.home and search for 'Aluminum lactate'";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82270";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Aluminum lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195277;a:27:{s:5:"title";s:19:"Glucose oxidase_APN";s:3:"nid";s:6:"195277";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:915:"Glucose oxidase is an enzyme which catalyzes the oxidation of beta-D-glucose [1-3].The enzyme is produced by Penicillium notatum and other fungi (such as Aspergillus niger) and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction [4]. Its mechanism of action was studied [5]. Glucose oxidase will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate). 
[1] The Merck Index
[2] Dictionary of Natural Products
[3] http://kr.expasy.org/enzyme/1.1.3.4
[4] www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&term=Glucose+Oxidase
[5] Leskovac V. et al. ‘Glucose oxidase from Aspergillus niger: the mechanism of action with molecular oxygen, quinones, and one-electron acceptors’, Int. J. Biochem. Cell Biol. 2005, 37(4), 731-50 (Review)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82271";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Glucose oxidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195278;a:27:{s:5:"title";s:12:"Thiourea_ACN";s:3:"nid";s:6:"195278";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1277:"Thiourea (Fig.1) is an organic compound similar to urea, where the oxygen atom is replaced by a sulfur atom  [1,2].  This compound is mostly used industrially, as a photographic fixing agent and to remove stains from negatives, in the manufacture of resins, in the production of vulcanization accelarators, in organic synthesis, etc. [2,3].  Even if Thiourea for commercial and industrial use is prepared synthetically (by fusion of ammonoium thiocyanate or by the reaction of hydrogen sulfide with calcium cyanamide in the presence of carbon dioxide [3]), it has also been detected in laburnum shrubs (Laburnum anagyroides) and it is known as a natural metabolite of the fungi Verticillium alboatrum and Bortrylius cinerea [4,5].  For this reason, Thiourea will be considered as meeting the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations. 1] http://en.wikipedia.org/wiki/Thiourea
[2]http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?objectHandle=Search&actionHandle=getAll3DMViewFiles&nextPage=jsp%2Fcommon%2FChemFull.jsp%3FcalledFrom%3D&chemid=000062566&formatType=_3D
[3] The Merck Index
[4] Dictionary of Natural Products on DVD, Version 16:2
[5] http://www.inchem.org/documents/cicads/cicads/cicad49.htm#4.1";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82272";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Thiourea";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195279;a:26:{s:5:"title";s:30:"4-Methyl-2-oxovaleric acid_ACN";s:3:"nid";s:6:"195279";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:261:"L-Argenine alpha-ketoisocaproate is the Argenine salt of alpha-ketoisocaproic acid. It is a source of two NHPs (combination of NHPs), namely Argenine and alpha-ketoisocaproric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82273";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"4-Methyl-2-oxovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195280;a:26:{s:5:"title";s:12:"Ibogaine_ACN";s:3:"nid";s:6:"195280";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:794:"Ibogaine (Fig. 1) is a naturally occurring indole alkaloid found in many plants of the family Apocynaceae, principally in Iboga (Tabernanthe iboga) [1,2,3,4].     Despite its known hallucinogenic properties and its classification as a controlled drug in other countries (such as USA), Ibogaine is not included in any of the Schedule 2 excluded substances lists; therefore, it will be considered as meeting the substance component of the NHP definition, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations. [1] The Merck Index
[2] Dictionary of Natural Products
[3] http://en.wikipedia.org/wiki/Ibogaine
[4] http://www.naturaldatabase.com/(S(dxybr5qwbypue0yj3zxzt5i3))/nd/Search.aspx?cs=&s=ND&pt=100&id=440&fs=ND&searchid=9574686
[5] http://www.jbc.org/cgi/reprint/282/40/29441";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82274";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Ibogaine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195281;a:26:{s:5:"title";s:24:"N-Acetyl-L-glutamine_ACN";s:3:"nid";s:6:"195281";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:806:"N-Acetyl L-glutamine is the N-acetylated derivative of Glutamine [1]. Its higher stability [2-3] and safe decomposition profile [4] makes it an acceptable source for Glutamine. N-Acetyl L-glutamine, as a source for Glutamine, will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate).
[1] ChemID
[2] Snowden MK. et al.  'Stability of N-acetylglutamine and glutamine in aqueous solution and in a liquid nutritional product by an improved HPLC method' J. Food Sci. 2002, 67, 384–389
[3] Arnaud A. et al. 'Absorption of enterally administered N-acetyl-L-glutamine versus glutamine in pigs' 2004, Clin. Nutr., 23, 1303–1312
[4] Bergana MM. et al. ‘NMR and MS analysis of decomposition compounds produced from N-acetyl-L-glutamine at low pH’ 2000, J. Agric. Food Chem., 48(12), 6003-10";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82275";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"N-Acetyl-L-glutamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195282;a:26:{s:5:"title";s:25:"N-Acetyl-L-methionine_ACN";s:3:"nid";s:6:"195282";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:587:"N-acetyl L-methionine is the N-acetylated derivative of Methionine [1-2]. It is hydrolysed to L-methionine by acylase I, an enzyme found in several mammalian tissues, i.e. intestine, liver and kidney [3]. N-acetyl-L-methionine is known as an acceptable source for Methionine [4]. N-acetyl-L-methionine will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate).
[1] The Merck Index
[2] ChemID
[3] Baxter J. et al. ‘Hydrolysis of N-acetyl-L-glutamine by acylase I’ 2002, J. Food Sci. 66, 1428-1433
[4] www.efsa.europa.eu/EFSA/Scientific_Opinion/opinion_afc_05_en1.pdf";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82276";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"N-Acetyl-L-methionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195283;a:26:{s:5:"title";s:9:"Amber_ACN";s:3:"nid";s:6:"195283";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:613:"Shahriar Khadem and Tagenine Alladin
2008-05-10, 11:49 AM

Amber is the fossil resin from the extinct pine tree Pinites succinifera (Goepp.) Conway, Pinaceae. It is found along the Baltic coast, also mined in Samland (East Prussia). Baltic amber contains: C 79%, H 10.5%, O 10.5%, succinic acid 3-8%, alpha-amyrin 20-30% [1]. Amber's structure and chemical constitution were reported [2-3]. Amber is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes [4]. Amber will be considered as a NHP, under schedule1, item 2, Priority 4 (extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82277";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Amber";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195284;a:26:{s:5:"title";s:20:"Deoxycholic acid_ACN";s:3:"nid";s:6:"195284";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:483:"Deoxycholic acid is a bile acid (found in bile of man, ox, sheep, dog, goat, and rabbit) formed by bacterial action from cholate. It acts as a detergent to solubilize fats for intestinal absorption. It is reabsorbed itself, and is used as a choleretic and detergent (Sodium deoxycholic acid is an anionic surfactant) [1-3]. Deoxycholic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
[1] The Merck Index
[2] Dictionary of natural Products
[3] ChemID";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82278";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Deoxycholic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195285;a:26:{s:5:"title";s:22:"N-Glycyl-L-leucine_ACN";s:3:"nid";s:6:"195285";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1347:"Glycyl-L-leucine is a dipeptide [1] (a molecule consisting of two amino acids joined by a single peptide bond- in this case Glycine and Leucine). Dipeptides including Glycyl-L-leucine are hydrolized in small intestine [2-3]. Glycyl-leucine dipeptidase (Cytosol nonspecific dipeptidase) specifically hydrolizes Glycyl-L-leucine [4]. It is expected that Glycyl-L-leucine would be a source for both Glycine and Leucine [5]. Glycyl-L-leucine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
[1] ChemID
[2] http://en.wikipedia.org/wiki/Dipeptidase and http://en.wikipedia.org/wiki/Dipeptide
[3] http://kr.expasy.org/enzyme/3.4.13.18
[4] Tobey N. et al. ‘Human intestinal brush border peptidases' 1985, Gastroenterology, 88(4),913-26
[5] As examples:
(a) Adibi SA. ‘Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption’ 1971, J. Clin. Invest., 50(11), 2266-75
(b) Cheeseman CI. ‘The transport of dipeptides by the small intestine’ 1980, Can. J. Physiol. Pharmacol., 58(11), 1326-33.
(c) Crandell SS. Et al. ‘Hydrolysis of dipeptides by human and ovine placentas’ 1981, Pediatr. Res., 15(4 Pt 1), 357-61
(d) Lochs H. et al. ‘Metabolism of dipeptides and their constituent amino acids by liver, gut, kidney, and muscle’ 1988, Am. J. Physiol., 254(5 Pt 1), E588-94";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82279";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"N-Glycyl-L-leucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195286;a:26:{s:5:"title";s:20:"Ammonium lactate_ACN";s:3:"nid";s:6:"195286";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1021:"Ammonium lactate is the ammonium salt of Lactic acid. It can be prepared by neutralizing DL-lactic acid with ammonium hydroxide [1]. It can also be produced by Lactobacillus lactis BME5-18M in pH-controlled fed-batch fermentation [2]. Ammonium lactate is an antipruritic agent (in topical form) [3-4]. Both Lactic acid and ammonium lactate showed effectiveness in treatment of foot xerosis [5]. Ammonium lactate is also an acceptable non-medicinal ingredient. Ammonium lactate (alone or as a source for Lactic acid) will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
[1] The Merck Index
[2] Bai D. et al. ‘Ammonium lactate production by Lactobacillus lactis BME5-18M in pH-controlled fed-batch fermentations’ 2004, Biochemical Engineering Journal, 19 (1), p.47-51
[3] Dictionary of Natural Products
[4] ChemID
[5] Jennings MB. et al. ‘A comparative study of lactic acid 10% and ammonium lactate 12% lotion in the treatment of foot xerosis’ 2002, J. Am. Podiatr. Med. Assoc., 92(3), 143-8";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82280";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Ammonium lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195287;a:26:{s:5:"title";s:18:"Diiodotyrosine_ACN";s:3:"nid";s:6:"195287";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:717:"Diiodotyrosine is found in the skeletal proteins of corals, sponges, and other marine organisms such as Heterochordaria abietina, Undaria pinnatifida, Sargassum thunbergii, Polysiphonia urceolata, Dendrodoa grossularia and Porphyra umbilicalis [1-2]. It has been isolated from Gorgonia cavollini as the DL acid [1]. Diiodotyrosine is a product from the iodination of monoiodotyrosine. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones (Throxine and Triiodothyronine) [3]. It is used as 'Thyroid inhibitor' [1]. Diiodotyrosine will be considered as a NHP, under schedule 1, item2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82281";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Diiodotyrosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195288;a:27:{s:5:"title";s:16:"Iron sulfide_ACN";s:3:"nid";s:6:"195288";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:880:"Iron disulfide, FeS2 [1], is found in nature as the minerals pyrite (fool’s gold) and marcasite, both of which have a brassy yellow color and a metallic luster. Pyrite is frequently found in large, well-formed crystals and is composed of iron(II) and S2(II) ions in a distorted rock salt structure. Heating solid pyrite affords Fe2O3 and SO2 in air or FeS and sulfur in a vacuum. Roasting of pyrites has been used in the past to produce SO2 for sulfuric acid production and iron(III) oxide for use as an iron ore. Marcasite is less stable than pyrite and therefore is more reactive. Iron disulfide, FeS2, can be prepared by heating Fe2O3 in H2S [2]. Iron disulfide will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).
[1] ChemID
[2] 'Iron Compounds’ by Alan M. Stolzenberg, Kirk-Othmer Encyclopedia of Chemical Technology 2001 by John Wiley & Sons, Inc";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82282";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Iron sulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195289;a:26:{s:5:"title";s:12:"Agmatine_ACN";s:3:"nid";s:6:"195289";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:663:"Agmatine is a form of decarboxylated arginine, isolated from several plant and animal sources; present in ergot, pollen of Ambrosia artemisiifolia (Compositae), the sea anemone Anthopleura japonica, herring semen, and in octopus muscle. It is the metabolic intermediate for polyamines. Agmatine is synthesized in mammalian brain [1-3]. It is an endogenous neurotransmitter, a NMDA receptor antagonist and nitric oxide synthase inhibitor. Agmatine inhibits hyperalgesia and tolerance to morphine [2]. Agmatine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
References:
[1] The Merck Index
[2] Dictionary of Natural Products
[3] ChemID";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82283";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Agmatine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195290;a:26:{s:5:"title";s:24:"Creatine monohydrate_ACN";s:3:"nid";s:6:"195290";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:484:"Creatine is a naturally occurring amino acid (protein building block) found mainly in muscles. Fifty percent of creatine in our bodies is ingested through the foods we eat while the other 50% is made in the liver, kidney, and pancreas. Roughly one-third is in its free form as creatine, while the remainder is bound to phosphate and called creatine phosphate or phosphocreatine. Therefore, Creatine will be considered as a NHP under Isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82284";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Creatine monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195291;a:26:{s:5:"title";s:29:"Aluminum ammonium sulfate_ACN";s:3:"nid";s:6:"195291";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:904:"Aluminum ammonium sulfate NH4Al(SO4)2 [Ammonium Alum with 12H2O (dodecahydrate)], occurs in nature as Tschermigite [1], is a white crystalline double sulfate of aluminium used in purifying drinking water, in baking powders, dyeing and printing fabrics, manuf pigments, lakes, artificial gems, paper, vegetable glue, marble and porcelain cements; fire proofing, tanning,  electrolytic copperplating and in therapeutic application as astringent, and styptic [2]. Ammonium alum is made mainly by dissolving aluminum hydroxide in sulfuric acid and adding ammonium sulfate but sometimes by the reaction of ammonia gas with aluminum sulfate and sulfuric acid [1]. Aluminum ammonium sulfate will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral). 
[1] O.Helmboldt et al. 'Aluminum Compounds, Inorganic', Ullmann's Encyclopedia of Industrial Chemistry, Copyright © 2008 
[2] The Merck Index";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82285";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Aluminum ammonium sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195292;a:26:{s:5:"title";s:15:"Pea Protein_APN";s:3:"nid";s:6:"195292";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1635:"Protein(s) from Pea (Pisum sativum) [1] can be prepared by extraction and further purification to generate 'Pea Protein Isolate'. Peas, as other legumes, contain a variety of antitutritional and antiphysiological factors which negatively influence the quality of their proteins. A process for pea protein isolate production, resulting in low content of phytate and oligosaccharides had been developed which made it a suitable protein source for infant formula production [2]. Pea protein can also be used as a non-medicinal ingredient. Films based on pea protein combine good strength with high elongation at break, allowing for instance packaging applications. Its surface activity can be tailored by variation of molecular weight, and by modifying the hydrophobicity. This opens the possibility for pea protein to be used as surfactants in coatings, paints and adhesives. Pea protein isolate shows good potential as matrix material for the microencapsulation of b-carotene, by means of supercritical CO2 technology [3]. Pea protein(s) will be considered NHP, under schedule 1, item 2, Priority 2 or 4-depends on the information provided (Isolate or Extract).
References:
[1] S. Gwiazda et. Al. ‘Isolation and partial characterization of proteins from pea (Pisum sativum L.)’ 1980 Food / Nahrung, 24(1), pp. 939-950
[2] M. Fredrikson et al. ‘Production Process for High-Quality Pea Protein Isolate with Low Content of Oligosaccharides and Phytate’ 2001 J. Agric. Food Chem., 49, pp.1208-1212
[3] L. A. De Graaf et al. ‘Requirements for non-food applications of pea proteins. A Review’ 2001 Nahrung/Food, 45(6), pp. 408-411";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82286";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Pea Protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195293;a:26:{s:5:"title";s:15:"Brevetoxins_ACN";s:3:"nid";s:6:"195293";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1038:"Brevetoxins, i.e. Brevetoxin A, B,C, and many others, are structurally unique marine neurotoxins produced by the “red-tide” dinoflagellate Ptychodiscus brevis Davis (Karenia brevis, formerly Gymnodinium breve Davis). Dense growths of these algae have been responsible for massive fish kills, mollusk poisoning and human food poisoning in the Gulf of Mexico and along the Florida coast. Unlike previously isolated dinoflagellate toxins, such as saxitoxin which are water-soluble sodium channel blockers, the brevetoxins are lipid-soluble sodium channel activators [1-2]. Brevetoxin interact with at least three receptors located in neuronal, pulmonary, and enzymatic regulatory systems of living organisms [3]. However, since brevetoxins are natural products, they are considered as NHPs, under schedule 1, item 2, Priority 2 (isolate).
[1] The Merck Index
[2] ChemID
[3] Baden DG. Et al. ‘Natural and derivative brevetoxins: historical background, multiplicity, and effects’ 2005, Environ. Health. Perspect. 113(5), 621-5 (Review)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82288";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Brevetoxins";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195294;a:26:{s:5:"title";s:15:"Campesterol_ACN";s:3:"nid";s:6:"195294";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:208:"Small amounts are found in rape-seed oil derived from Brassica campestris L., Cruciferae, in soybean oil, and in wheat germ oil. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82289";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Campesterol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195295;a:26:{s:5:"title";s:28:"para-Hydroxybenzoic acid_ACN";s:3:"nid";s:6:"195295";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:437:"4-hydroxybenzoic acid was isolated from many plants in free or combined form; for example from fruit of Catalpa bignonioides [1]. It is a metabolic product of Penicillium patulum [2]. It shows antifungal activity [1-2].  4-hydroxybenzoic acid can also be  prepared synthetically [2]. 4-hydroxybenzoic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).
[1] Dictionary of Natural Products
[2] The Merck Index";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82290";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"para-Hydroxybenzoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195296;a:26:{s:5:"title";s:15:"Phytic acid_ACN";s:3:"nid";s:6:"195296";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:182:"Inositol hexaphosphate, also known as phytate, is a component of most cereal grains and seeds, occurring in conjunction with plant fiber, and is a source of myo-inositol in the diet.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82291";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Phytic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195297;a:26:{s:5:"title";s:23:"Choline alfoscerate_ACN";s:3:"nid";s:6:"195297";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:591:"L-alpha-Glycerylphosphorylcholine (or Choline alfoscerate) is naturally occurring phospholipid precursor of the biosynthesis of choline and a breakdown product of phosphatidylcholine.  After administration, this phospholipid is metabolized to form glycerophosphate and choline, which is why it is a nootropic agent, meaning it can boost human cognitive abilities.  This substance is usually derived from plant sources (such as soy) or from animal sources (such as bovine pancreas). Alpha-GPC will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82292";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Choline alfoscerate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195298;a:26:{s:5:"title";s:25:"Betaine hydrochloride_ACN";s:3:"nid";s:6:"195298";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:402:"Betaine, also known as Trimethylglycine, is a small molecule widely distributed in plants and animals. Betaine and its salts when sold or recommended for the treatment of homocystinuria is a schedule F drug. However, for other purposes, such as gastric acidifier, Betaine or Betaine Hydrochloride will be considered as an isolate, under Schedule 1, item 2 (Priority 1; New Drug) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82293";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Betaine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195299;a:26:{s:5:"title";s:30:"3,5-Dihydroxyphenylacetate_ACN";s:3:"nid";s:6:"195299";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:558:"3,5-Dihydroxyphenylacetate is a precursor for the amino acid 3,5-dihydroxyphenylglycine that occur in glycopeptide antibiotics (vancomycin and teicoplanin family). This biosynthetic pathway involves 5 enzymes, one of which is 3,5-dihydroxyphenylacetate synthase: the latter catalyses the formation of 3,5-dihydroxyphenylacetate from 4 malonyl-CoA units) [1][2]. 3,5-Dihydroxyphenylacetate will be considered as an NHP, as Schedule 1, Item 2 (isolate) of the NHP regulations.References:
[1] Chem. Communications, 2001, 2156-2157.
[2] Nature 447, 2007, 342-345";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82294";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"3,5-Dihydroxyphenylacetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195300;a:27:{s:5:"title";s:15:"Glucomannan_ACN";s:3:"nid";s:6:"195300";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92586";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82295";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Glucomannan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195301;a:27:{s:5:"title";s:12:"Spinosad_ACN";s:3:"nid";s:6:"195301";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;92632";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1559:"Spinosad (Fig. 1) is an insecticide derived/isolated from the fermentation broth of Saccharopolyspora spinosa [1,2,3,4].  This product is composed of numerous spinosyns; where spinosyns A and D are knonw as the most abundant (88% in a ratio of about 7:1) and regarded as the most active component of Spinosad [5].  These macrocyclic lactones are believed to exert their insecticidal activity by causing rapid excitation of the targeted insect central nervous system, probably through the interaction and binding at the nicotinacetylcholine and gamma-amino butyric acid receptors, while having little or no effect on non-targeted insects and mammals [6,7].  This is the reason why Spinosad is the main active ingredient in many marketed insecticide and animal health formulations, while being investigated for human health applications, such as against human lice [7,8].  Interestingly, the Dictionary of Natural Products [3] suggests, since the word 'antibiotic' is present in synonyms and in the general statement, that Spinosad or its constituents might have antibiotic properties; however, such information couldn't be verified and/or was not found elsewhere.  Therefore, Spinosad, as derived/isolated from the actomycete bacterium Saccharopolyspora spinosa and provided that it is not added to Schedule F without proper qualifier(s) and/or not used as an antibiotic, meets the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.

This substance is being proposed to be added to Schedule F by VDD.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82299";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Spinosad";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195302;a:27:{s:5:"title";s:15:"Huperzine A_ACN";s:3:"nid";s:6:"195302";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;92635";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:301:"Huperzine A is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The extract has been used in China for centuries for the treatment of swelling, fever and blood disorders. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82300";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Huperzine A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195303;a:27:{s:5:"title";s:24:"Phosphatidylinositol_ACN";s:3:"nid";s:6:"195303";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92641";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:178:"Phosphatidylinositol is an important lipid, both as a key membrane constituent and as a participant in essential metabolic processes in plants and animals (and in some bacteria).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82301";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Phosphatidylinositol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195304;a:27:{s:5:"title";s:15:"Acetic acid_ACN";s:3:"nid";s:6:"195304";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92645";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:83:"Acetic acid is considered as an NHP that falls under item 2 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82302";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Acetic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195305;a:27:{s:5:"title";s:20:"Stannous sulfide_ACN";s:3:"nid";s:6:"195305";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92595";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82303";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Stannous sulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195306;a:27:{s:5:"title";s:19:"Stannic sulfide_ACN";s:3:"nid";s:6:"195306";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92595";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82304";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Stannic sulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195307;a:27:{s:5:"title";s:15:"Cantharidin_ACN";s:3:"nid";s:6:"195307";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"92653;92722;93355";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1097:"Cantharidin occurs in Lytta vesicatoria and many other insects. Cantharides (the source of Cantharidin) have been used externally as rubefacients, counterirritants and vesicants, but their use in cosmetic products is banned in the UK. Reputed aphrodisiac, component of "Spanish fly" [1-2]. Cantharidin is a potent and specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). This compound can produce severe skin inflammation, and is extremely toxic if ingested orally. Its LDLo(lethal dose low) in oral form for human is 0.428mg/kg [3]. Cantharis vesicatoria and Cantharidin are listed in 'Restricted Substances not in the Food and Drug Regulations' [4], meaning the compliance approach to these substances should be taken in conjunction with the 'Risk-Based Approach'. However, Cantharis is acceptable in homeopathic medicines at potencies of 3X or higher, and Cantharidinum or Cantharidin is acceptable in homeopathic medicines at potencies of 8X or higher [4]. Cantharidin is, in fact, a natural product and will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:466:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. This ingredient is on the Restricted Substances list in the Natural Health Products Compliance Guide. Unauthorized products with this ingredient are subject to the risk-based approach to compliance. A product licence must be obtained prior to marketing in Canada . Reference:http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/complian-conform_guide-eng.php";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82305";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Cantharidin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195308;a:27:{s:5:"title";s:14:"Chloroform_ACN";s:3:"nid";s:6:"195308";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"92628;92722;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:793:"Chloroform (CHCl3, Fig. 1) is a chemical member of the family of compounds known as trihalomethanes [1,2].  It can be prepared from the addition of sulfuric acid to acetone and bleaching powder, or by the carefully controlled chlorination of methane [3].  Industrially, Chlorofrom has been mostly used as a solvent, or in the synthesis of other chlorinated compounds [1].  Medicinally, it was once used as a volatile halogenated anaesthetic, but nowadays safer drugs are preferred, because of its known toxicity [3,4].  Chloroform is also known to be found in many natural sources [5,6,7], including various algae [8,9]. For this reason, Chloroform will be considered as meeting the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82306";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Chloroform";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195309;a:27:{s:5:"title";s:23:"Phosphatidylcholine_ACN";s:3:"nid";s:6:"195309";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92679";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:245:"Phospholipids is found in every cell membrane in our bodies and its molecules is composed of a combination of an amino acid  and a fatty acid components. Since phosphatidylcholine is a natural extract of lecithin, it will be considered as a NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82307";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Phosphatidylcholine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195310;a:27:{s:5:"title";s:28:"Phosphatidylethanolamine_ACN";s:3:"nid";s:6:"195310";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92679";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82308";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Phosphatidylethanolamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195311;a:27:{s:5:"title";s:15:"Methenamine_ACN";s:3:"nid";s:6:"195311";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92657";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:946:"Methenamine (Fig. 1) is an anti-infective agent, prepared from formaldehyde and ammonia, used in the treatment of urinary tract infections [1,2,3].  This compound, mostly administered as its mandelate or hippurate salt, owes its activity to the naturally occurring compound formaldehyde, as Methenamine is slowly hydrolyzed to formaldehyde and ammonia when reaching acidic urine. Formaldehyde is a very strong astringent but is not pleasant to use as is which may cause skin irritation and systemic reactions. Methenamine, in water or when applied to the skin, decomposes to generate formaldehyde in small quantities which do not cause side effects [5]. Methenamine is used topically in antiperspirant products as it liberates formaldehyde in the presence of acid sweat [4].  As Methenamine is acting as a prodrug for the naturally occurring compound formaldehyde, it will be considered as a source of it and therefore it is classified as an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82309";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Methenamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195312;a:27:{s:5:"title";s:14:"Metadoxine_ACN";s:3:"nid";s:6:"195312";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92550";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:402:"Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate) is an equimolar mixture of pyrrolidone-carboxylic acid and  pyridoxine  and is used to help in recovering from alcohol addiction[1] [2].  It is an antioxidant, with few side effects.  Since Metadoxine is a mixture of pyridoxine (an NHP) and pyrrolidone carboxylic acid (another NHP [4]), it will be considered as an NHP, under item 6 of the NHP regs";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82310";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Metadoxine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195313;a:27:{s:5:"title";s:23:"Creatinol phosphate_ACN";s:3:"nid";s:6:"195313";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92676";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:435:"Creatinolfosfate (Creatinol-O-phosphate) [1] is distributed in all organs, and in particular, in the kidney, liver and myocardium. After being dephosphorylated, it is eliminated with urine. Creatinolfosfate has proved to possess anti-ischemic and anti-arrhythmic activities associated with improved ionic balance and heart performance [2-4]. Creatinolfosfate will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82312";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Creatinol phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195314;a:27:{s:5:"title";s:31:"Leucine alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195314";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92683";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:249:"Leucine alpha-ketoglutarate is the Leucine salt of alpha-ketoglutaric acid. It is a source of two NHPs (combination of NHPs), namely Leucine and alpha-ketoglutaric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82313";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Leucine alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195315;a:27:{s:5:"title";s:20:"D-Chiro-inositol_ACN";s:3:"nid";s:6:"195315";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:826:"D-chiro-Inositol (CAS # 643-12-9, Figure 1) [1] is a relatively rare isomer of the nine inositol isomers[2]. Free D-chiro-Insositol has been detected in many plants including Cucurbita ficifolia (Cucurbitaceae) fruit extracts, lupine, pigeon pea, soybean, chickpea, mungbean and buckwheat.[2][3].  It also occurs in the form of galactosyl derivatives known as fagopyritols.  Buckwheat has been shown to contain five different fagopyritols whereas soybean, lupine, lentil, chickpea seeds contain only one. D-chiro-Inositol has also been identified as components of two different inositolphosphoglycan molecules in mammalian systems [4]. This isomer of inositol has been greatly studied in the reduction of blood glucose levels in animals [5].
D-chiro-Inositol will be considered as an NHP, under item 2, of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82314";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"D-Chiro-inositol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195316;a:27:{s:5:"title";s:11:"Borneol_ACN";s:3:"nid";s:6:"195316";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92690";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:290:"Borneol exists as two enantiomers; the d-form which predominates occurs in the oil from Dryobalanops aromatica Gaertn., Dipterocarpaceae, and in many other plants. The l-form comes from Blumea balsamifera (L.). It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82315";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Borneol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195317;a:27:{s:5:"title";s:27:"L-Leucine pyroglutamate_ACN";s:3:"nid";s:6:"195317";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92682";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:235:"L-Leucine pyroglutamate is the Leucine salt of Pyroglutamic acid. It is a source of two NHPs (combination of NHPs), namely L-Leucine and Pyroglutamic acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82316";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"L-Leucine pyroglutamate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195318;a:27:{s:5:"title";s:35:"L-Histidine alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195318";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92673";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:255:"Histidine alpha-ketoglutarate is the Histidine salt of alpha-ketoglutaric acid. It is a source of two NHPs (combination of NHPs), namely Histidine and alpha-ketoglutaric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82317";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"L-Histidine alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195319;a:27:{s:5:"title";s:32:"L-Valine alpha-ketogluterate_ACN";s:3:"nid";s:6:"195319";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92684";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:246:"Valine alpha-ketoglutarate is the Valine salt of alpha-ketoglutaric acid. It is a source of two NHPs (combination of NHPs), namely Valine and alpha-ketoglutaric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82318";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"L-Valine alpha-ketogluterate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195320;a:27:{s:5:"title";s:22:"Creatine taurinate_ACN";s:3:"nid";s:6:"195320";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92675";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:209:"Creatine taurinate is the Creatine salt of Taurine. It is a source of two NHPs (combination of NHPs), namely Creatine and Taurine. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82319";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Creatine taurinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195321;a:27:{s:5:"title";s:13:"Bentonite_ACN";s:3:"nid";s:6:"195321";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92727";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:456:"Bentonite is a generally impure clay, found in the midwest of the USA and in Canada, which consists mostly of Montmorillonite, which is why these two very similar naturally occurring minerals are commonly known as synonyms. Bentonite is commonly used as emulsifier for oils or as a suspending agent, it is listed in the NHPD acceptable NMIs list. Bentonite will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82320";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Bentonite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195322;a:27:{s:5:"title";s:39:"Chlorophyllin copper complex sodium_ACN";s:3:"nid";s:6:"195322";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92662";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:546:"Chlorophyll is a green photosynthetic pigment found in plants, algae, and cyanobacteria. Sodium copper chlorophylline is used for the manufacture of medicine or used as a color additive in various foods, drugs and cosmetics, it is synthetically prepared from natural chlorophyll via ester hydrolysis followed by replacement of the magnesium ion of natural chlorophyll with copper. Sodium copper chlorophylline will be considered as an acceptable derivative of the naturally occurring chlorophyll and therefore it is considered as a NHP (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82321";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"Chlorophyllin copper complex sodium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195323;a:27:{s:5:"title";s:27:"Pseudoephedrine sulfate_ACN";s:3:"nid";s:6:"195323";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92648;94381";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82322";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Pseudoephedrine sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195324;a:27:{s:5:"title";s:19:"Alanylglutamine_ACN";s:3:"nid";s:6:"195324";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92533";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:276:"Alanyl-glutamine [1] is a dipeptide formed from Alanine and Glutamine. It has been used as a source of Glutamine due to its rapid hydrolysis and more stability (for example see [2-5]). Alanyl-glutamine will be considered as NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82324";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Alanylglutamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195325;a:27:{s:5:"title";s:12:"Piperine_ACN";s:3:"nid";s:6:"195325";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92709";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:633:"Piperine (CAS# 94-62-2, Figure 1) is an alkaloid that is isolated from the fruit of Piper longum L [ChemID]. It is considered to be the major active principle of Black pepper, and its extraction has been the subject of many publications (Borjihan et al, Ro et al). Many physiological effects have been associated with this isolate, including inhibitory effect on monoamine oxidase and antidepressant-like activity (Ro et al), antihyperlipidemic activity (Borjihan et al), and stimulation of the digestive enzyme of the pancreas (Srinivasen et al).
Piperine will be considered as an NHP, under item 2 (isolate) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82325";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Piperine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195326;a:27:{s:5:"title";s:21:"Citrulline malate_ACN";s:3:"nid";s:6:"195326";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92681";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:513:"Citrulline (or N5-(Aminocarbonyl)-L-ornithine) is an alpha-amino acid first isolated from the juice of watermelon (Citrullus vulgaris Schrad., Cucurbitaceae).  This amino acid, while being part of known proteins, is not synthesized during proteins synthesis, but generated by a family of enzymes, namely peptidylarginine deiminases, which are responsible for the conversion of Arginine into Citrulline. Citrulline will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82326";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Citrulline malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195327;a:27:{s:5:"title";s:21:"Manganese dioxide_ACN";s:3:"nid";s:6:"195327";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92769";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:385:"Manganese Oxide (MnO2, CAS # 1313-13-9) [1], also known as manganese dioxide, is a brown solid that occurs naturally as the mineral, pyrolusite, which is the main ore of manganese. It is cited as a source of manganese in the NHPD Multi-vitamin monograph [2] and in Martindale [3]. Therefore, Manganese Oxide will be considered as an NHP, under Item 7, Schedule 1of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82327";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Manganese dioxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195328;a:27:{s:5:"title";s:16:"L-Malic acid_ACN";s:3:"nid";s:6:"195328";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:575:"Malic acid is also known as the Apple acid, since it has been found in apples and many other fruits and plants.  Natural Malic acid is only present as the L-(-)-form, but has been synthesized also as the racemic form (DL-form). Malic acid is also present in the NHPD acceptable NMIs list.  It has also been used in combination with other chemicals (such as BHT, salicylic acid or arginine) for the treatment of ulcers, burns, wounds, liver disorders and dry mouth. Malic acid will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82328";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"L-Malic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195329;a:27:{s:5:"title";s:19:"Methylcobalamin_ACN";s:3:"nid";s:6:"195329";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:486:"Methylcobalamin (or mecobalamin) is one of the biologically active forms of Vitamin B12, which is a term referring to a group of cobalt-containing compounds. In addition, methylcobalamin itself has been used for treatment of pernicious anaemia, to promote nerve regeneration in animal models and used for the treatment of peripheral nervous system disorders.  Therefore, methylcobalamin will be considered as a NHP, under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:111:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82329";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Methylcobalamin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195330;a:27:{s:5:"title";s:12:"Dolomite_ACN";s:3:"nid";s:6:"195330";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92767";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:352:"Dolomite is the name of both a carbonate rock and a mineral (formula: CaMg(CO3)2) consisting of a calcium magnesium carbonate found in crystals. Dolomite is used as a mineral supplement of calcium and magnesium. Dolomite can be contaminated with heavy metals such as lead. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82330";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Dolomite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195331;a:27:{s:5:"title";s:27:"L-Phenylalanine orotate_ACN";s:3:"nid";s:6:"195331";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92672";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:235:"L-Phenylalanine orotate is the Phenylalanine salt of Orotic acid. It is a source of two NHPs (combination of NHPs), namely L-Phenylalanine and Orotic acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82331";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"L-Phenylalanine orotate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195332;a:27:{s:5:"title";s:22:"Milk basic protein_ACN";s:3:"nid";s:6:"195332";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92745";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:505:"Milk Basic Protein is the basic protein fraction of milk whey protein (Toba et al). It can be prepared from acid whey by packing the latter in a column with cation exchange resin and by eluting the bound protein with sodium chloride (Aoe et al). Milk basic protein has been shown to increase the bone mineral density and improves bone metabolism in healthy young women, among other beneficial effects (Takada et al). Milk Basic Protein will be considered as an NHP, under Item 2 (extract) of the NHP regs.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82332";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Milk basic protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195333;a:27:{s:5:"title";s:20:"Creatine orotate_ACN";s:3:"nid";s:6:"195333";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92747";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:353:"Creatine orotate is the Creatine salt of Orotic acid. It is a source of two NHPs (combination of NHPs), namely Creatine and Orotic acid. Three kinds of creatine orotates have been reported; creatine orotate, dicreatine orotate, and tricreatine orotate [ref.]. Creatine orotate will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82333";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Creatine orotate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195334;a:27:{s:5:"title";s:11:"Xylitol_ACN";s:3:"nid";s:6:"195334";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92782";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:346:"Xylitol is a naturally occurring substance that is crystalline in form and looks and tastes like sugar, it is commonly found in fruits, berries and other natural sources. Xylitol will be considered as a NHP that falls under isolate, item 2, schedule 1 of the NHP Regulations. Since Xylitol is an isolate, then it will be considered as priority 2.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82334";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Xylitol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195335;a:27:{s:5:"title";s:28:"Isomaltooligosaccharides_ACN";s:3:"nid";s:6:"195335";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92725";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:731:"Isomaltooligosaccharides are belong to a group of prebiotics in which there is α 1–6 glucosidic linkage in the molecular structure and they occur naturally in various fermented food and sugars, including soybean sauce and honey and sake (Duan et al). They are usually commercially produced enzymatically from starch and used in various food and drinks as sweetener (Takaesu et al).They  have been shown to increase the number of protective gut microflora (Yoshikai et al).They are stable in acidic conditions, and relatively less expensive than other oligosaccharides, including fructooligosaccharides and soybean oligosaccacharides (Duan et al). Isomaltooligosaccharides will be considered as NHP, under Item 2 of the NHP regs.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82335";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Isomaltooligosaccharides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195336;a:27:{s:5:"title";s:23:"Quercetin dihydrate_ACN";s:3:"nid";s:6:"195336";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92726";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82336";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Quercetin dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195337;a:27:{s:5:"title";s:29:"Polymethoxylated flavones_ACN";s:3:"nid";s:6:"195337";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92797";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:285:"The polymethoxylated flavones are one of several distinctive classes of flavonoids in citrus fruit, particularly in sweet orange (C. sinensis), sour orange (C. aurantium), and tangerines (C. reticulata). They will be considered as NHP's, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82337";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Polymethoxylated flavones";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195338;a:27:{s:5:"title";s:22:"Manganese chloride_ACN";s:3:"nid";s:6:"195338";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92770";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:315:"Manganese Chloride (MnCl2, CAS # 7773-01-5) [1] occurs naturally as Scacchite, a reddish mineral found mainly on volcanic rocks. It is cited as a source of manganese in the NHPD Multi-vitamin monograph [2] and in Martindale [3].It will be considered as an NHP, under Item 7 of the Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82338";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Manganese chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195339;a:27:{s:5:"title";s:11:"Eugenol_ACN";s:3:"nid";s:6:"195339";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92790";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:810:"Eugenol is a naturally occurring compound, member of the allylbenzene class of chemical, being an allyl chain-substituted analog of guaiacol.  This substance has been isolated from many natural essential oils, such as in those of Cinnamomum spp., Cistus spp., Camellia spp., Pelargonium spp., Thymus spp. and Citrus peel spp. It is also present in apple, apricot, banana and cherry fruits; and it is the major component of clove oil.  Having a strong clove-like odor and a spicy pungent taste, it is widely used in perfumeries and flavorings, which is why it is currently listed in the NHPD acceptable NMIs list.  Medicinally, it has been used as an antifungal agent, antiseptic and dental analgesic.  Eugenol will be considered as an NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82339";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Eugenol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195340;a:27:{s:5:"title";s:14:"Ruscogenin_ACN";s:3:"nid";s:6:"195340";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:406:"Ruscogenin is a sapogenin from Ruscus aculeatus, Ruscus alexandrinus, and Tribulus terrestris. Recently, it has also found in roots of Ophiopogon japonicus (Huang, Kou et al. 2008). Ruscogenin is an anti-inflammatory agent and venotonic which is used in the local treatment of haemorrhoids (CRC-DNP 2009; US-NLM 2009). Ruscogenin will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82340";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Ruscogenin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195341;a:27:{s:5:"title";s:16:"Silicic acid_ACN";s:3:"nid";s:6:"195341";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:694:"Silicic acid occurs in nature as Opal (a mineral with the formula SiO2.nH2O) (Merck 2006). Silicic acid is a general name for a family of chemical compounds of the element silicon, hydrogen, and oxygen, with the general formula [SiOx(OH)4-2x]n. Some simple silicic acids have been identified in very dilute aqueous solution, such as metasilicic acid (H2SiO3), orthosilicic acid (H4SiO4), disilicic acid (H2Si2O5), and pyrosilicic acid (H6Si2O7); however in the solid state these probably condense to form polymeric silicic acids of complex structure (Martin 2007). Silicic acid is an acceptable source for Silicon and will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82341";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Silicic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195342;a:27:{s:5:"title";s:14:"Solanidine_ACN";s:3:"nid";s:6:"195342";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:535:"Solanidine is a streoidal alkaloid found in Solanum tuberosum (potato), Cestrum purpureum, Fritillaria camtschatcensis, Rhinopetalum bucharicum and Rhinopetalum stenantherum (Merck 2006; CRC-DNP 2009). Solanidine is a toxin found in high-starch potatoes. It has a structure similar to that of diosgenine. However, the use of solanidine as a hormone precursor seems to be more difficult compared to diosgenine (De Brabander, Verheyden et al. 2007). Solanidine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82342";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Solanidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195343;a:27:{s:5:"title";s:13:"Sparteine_ACN";s:3:"nid";s:6:"195343";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92795;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1008:"Sparteine is a quinolizidine alkaloid from several genera of the family Fabaceae, notably many Lupinus and Adenocarpus spp., Piptanthus nanus, Sarothamnus spp., Chamaecytisus spp. (CRC-DNP 2009). It is found in yellow and black lupin beans, Lupinus luteus L. and Lupinus niger Hort., Cytisus scoparius (L.) Link., Anagyris foetida L. (Merck 2006). Sparteine is known to decrease the irritability and conductivity of cardiac muscle and has been used to treat cardiac arrhythmias, restoring normal rhythm in previously arrhythmic patients. Sparteine is also stated to be a powerful oxytocic drug, which was once used to stimulate uterine contractions (Barnes, Anderson et al. 2007).It has also been of interest as an indicator of CYP2D6 genotype (US-NLM 2009). Sparteine is listed in the "List of prohibited and restricted cosmetic ingredients hot list (HC 2007) as follow: “Sparteine and its salts” (HC 2007). However, Sparteine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82343";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sparteine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195344;a:27:{s:5:"title";s:12:"Syringin_ACN";s:3:"nid";s:6:"195344";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:638:"Syringin isolated from Syringa vulgaris, Ligustrum spp., Jasminum spp., Eleutherococcus senticosus Phillyrea latifolia, Phillyrea decora, Paulownia tomentosa, Forsythia suspensa, Fraxinus spp. (CRC-DNP 2009). It is also isolated from lilac bark, cambial sap of spruce and from various plants (Merck 2006). Syringin used as an immunomodulatory agent, as an antiproliferative and also showed platelet aggregation inhibiting and antitumour effects (CRC-DNP 2009). Syringin appears to be related with the increase of insulin secretion (Liu, Wu et al. 2008). Syringin will be considered as a NHP, under schedule1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82344";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Syringin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195345;a:27:{s:5:"title";s:16:"Ursolic acid_ACN";s:3:"nid";s:6:"195345";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:861:"Ursolic acid is a constituent of Rhododendron spp., Epigaea asiatica, black sea alga, family Cladophoraceae, found in wax of apples, pears and other fruits. It is widely distributed in plants (CRC-DNP 2009). Ursolic acid is also found in leaves and berries of Arctostaphylos uva-ursi (L.) Spreng (bearberry), Vaccinium macrocarpon Ait. (cranberry), Rhododendron hymenanthes Makino, and Ericaceae. It is used as an emulsifying agent in pharmaceuticals, and foods (Merck 2006). Ursolic acid acts as an antioxidative, anti-inflammatory, and anticancer. The effects of ursolic acid on normal cells and tissues, however, are occasionally pro-inflammatory, although ursolic acid is able to counteract endogenous and exogenous inflammatory stimuli (Ikeda, Murakami et al. 2008). Ursolic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82345";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ursolic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195346;a:27:{s:5:"title";s:15:"Xanthotoxol_ACN";s:3:"nid";s:6:"195346";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92795";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:623:"Xanthotoxol found in many plants including spp. of Fabaceae (Leguminosae), Apiaceae (Umbelliferae), and Rutaceae (Merck 2006; CRC-DNP 2009).It exhibits a wide range of biological properties, such as antioxidative activity, 5-HT antagonistic effect, and central nervous system activity. It was reported that xanthotoxol had a cytotoxic effect on transitional cell carcinoma (TCTC) cells, and they could be used as biological probes to investigate the structure and function of nucleic acid in molecular biology (He, Zhang et al. 2007). Xanthotoxol will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82346";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Xanthotoxol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195347;a:27:{s:5:"title";s:12:"Geraniol_ACN";s:3:"nid";s:6:"195347";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92819";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:574:"Geraniol is a monoterpenoid and an alcohol. It is the primary part of oil-of-rose and palmarosa oil. It also occurs in small quantities in geranium, lemon, citronella, and many other essential oils. It has a rose-like odor, for which it is commonly used in perfumes. It is used in flavors such as peach, raspberry, grapefruit, red apple, plum, lime, orange, lemon, watermelon, pineapple and blueberry. An alternate application has been found in the use of insect repellants or deterrants. Geraniol will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82347";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Geraniol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195348;a:27:{s:5:"title";s:28:"N-Acetylanthranilic acid_ACN";s:3:"nid";s:6:"195348";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92781;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:667:"Isolated from the culture filtrates of Aerobacter aerogenes N5-36 and Escherichia coli B37 (mutants lacking phosphoribose anthranilate transferase) (Paul and Ratledge 1970, Paul and Ratledge 1971, Paul and Ratledge 1973). Intermediate in the degradation of quinaldine to anthranilate by the soil bacterium Arthrobacter nitroguajacolicus Ru61a (Overhage et al. 2005, Kolkenbrock et al. 2006). 1 citation found in NAPRALERTsm 2009 for ‘Anthranilic acid,N-acetyl. Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82348";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"N-Acetylanthranilic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195349;a:27:{s:5:"title";s:15:"l-Ephedrine_ACN";s:3:"nid";s:6:"195349";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"92781;92925;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:676:"(1R,2S)-form is the main alkaloid from the Chinese drug ‘Ma-Huang’, and from many Ephedra spp., also in Aconitum napellus, Catha edulis, Taxus baccata, Sida cordifolia, Roemeria refracta and some other spp. (Ephedraceae, Ranunculaceae, Celastraceae, Taxaceae, Malvaceae, Papaveraceae) (DNP 2009). Occurs in plants of the genus Ephedra (Ephedraceae) known in traditional medicine as Ma Huang (O’Neil et al. 2006). Supported by 96 citations found in NAPRALERTsm 2009. Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82349";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"l-Ephedrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195350;a:27:{s:5:"title";s:14:"Isosafrole_ACN";s:3:"nid";s:6:"195350";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92781;92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:936:"(E)-form isolated from star anise oil (Illicium religiosum), seed oil of Ligusticum acutilobum and leaves of Murraya koenigii; (Z)-form present in essential oils (DNP 2009).  Of the two isomers (cis- and trans-), the trans-form is the more stable and has been isolated in the pure state, probably occurring in the essential oil of ylang-ylang; it has been identified in the oils of Illicium religiosum and Ligusticum acutilobum Sieb. and Zucc. (Burdock 2005). 11 citations found in NAPRALERTsm 2009 for ‘Safrole,iso:’, 2 articles were available: isolated from the defatted hexane extract of Nectandra glabrescens (Barbosa-Filho et al. 1989); identified in the leaves and stems essential oils of Piper sanctum (Mata et al. 2004).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82350";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Isosafrole";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195351;a:27:{s:5:"title";s:14:"Piperidine_ACN";s:3:"nid";s:6:"195351";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92781;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1468:"Present in free state in plants, e.g. Psilocaulon absimile, Petrosimonia monandra, Glycine max. Residue present in piperidine alkaloids. Present in black pepper (Piper nigrum) (DNP 2009). Found in small quantities in Piper nigrum L., Piperaceae (black pepper) (O’Neil et al. 2006). 13 citations found in NAPRALERTsm 2009, 5 articles were available: isolated from the essential oil of black pepper, Piper nigrum (Hasselstrom et al. 1957); possible presence of small amounts in the benzene extract of black pepper, Piper nigrum (Nakamura et al. 1981); identified in Cannabis sativa (Turner et al. 1980); found in samples of preserved vegetables (broken beans, kale, paprika red, and cornichons), pickles (paprika, paprika brine, pepperoni, pepperoni brine, celery, and celery brine), fish (herring, bismarck, salted, smoked, and cod roe), cheese (limburger), stimulants (coffee extract, coffee freezed dried, cocoa defatted, barley, hops, and malt), and surface waters (river Alster, river Stor, river Au near Hetlingen, river Kruckau, river Ammersbek, and Timmermoor swamp) (Neurath et al. 1977); tentatively identified from the essential oil of black pepper, Piper nigrum, based on retention value in close agreement with piperidine (Jennings and Wrolstad 1961).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82351";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Piperidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195352;a:27:{s:5:"title";s:13:"Piperonal_ACN";s:3:"nid";s:6:"195352";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92781;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:748:"Occurs in Robinia pseudoacacia. Also from leaves of Doryphora sassafras, Eryngium poterium, Baccharis rosmarinifolia and others (DNP 2009). 11 citations found in NAPRALERTsm 2009, 4 articles were available: isolated from the essential oil of black pepper, Piper nigrum (Hasselstrom et al. 1957); isolated from the ethanol extract of Rostrinucula dependens (Peng et al. 2005); reported to be found in Ocotea pretiosa (Aiba et al. 1976); isolated from the neutral volatile fraction of Burley tobacco, Nicotiana tabacum L. (Fujimori et al. 1976). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82352";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Piperonal";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195353;a:27:{s:5:"title";s:19:"Pseudoephedrine_ACN";s:3:"nid";s:6:"195353";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92781";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82353";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Pseudoephedrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195354;a:27:{s:5:"title";s:11:"Safrole_ACN";s:3:"nid";s:6:"195354";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92781";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:366:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82354";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Safrole";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195355;a:27:{s:5:"title";s:24:"Multi-anthocyanidins_ACN";s:3:"nid";s:6:"195355";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92787";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:381:"Multianthocyanidins are typically a complex extract, derived from several plants, containing flavonoids compounds known for their antioxidant activity, where anthocyanins (or anthocyanidins) is a subgroup of this family of flavonoid compounds.  For this reason, Multianthocyanidins will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82357";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Multi-anthocyanidins";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195356;a:27:{s:5:"title";s:22:"Diacylglycerol oil_ACN";s:3:"nid";s:6:"195356";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92842";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:735:"Diacyglcerol oil is manufactured through enzymatic (by lipase) esterification of fatty acids derived from natural, edible plant oils, such as soybean, rapeseed, corn, sunflower, cottonseed, sofflower, peanut, palm, coconut, or olive oil with either monoacylglycerol or glycerol. Oleic acid, linoleic acid, and linolenic acid are the main constituent fatty acids [1]. In many countries (e.g. USA, Japan, EU) diacylglycerol oil is an acceptable food additive [2]. Based on the research, intake of diacylglycerol oil is safe for human consumption when used in a manner similar to other edible oils [3]. Diacyglcerol oil as a mixture of fatty acids (ester forms) will be considered as a NHP, under schedule 1, item 2, Priority 4 (Extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82358";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Diacylglycerol oil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195357;a:27:{s:5:"title";s:23:"R-alpha-Lipoic acid_ACN";s:3:"nid";s:6:"195357";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92788;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82359";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"R-alpha-Lipoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195358;a:27:{s:5:"title";s:44:"Phosphatidylserine-enriched soy lecithin_ACN";s:3:"nid";s:6:"195358";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92661;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82360";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Phosphatidylserine-enriched soy lecithin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195359;a:27:{s:5:"title";s:19:"D-Phenylalanine_ACN";s:3:"nid";s:6:"195359";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92854";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82363";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"D-Phenylalanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195360;a:27:{s:5:"title";s:20:"DL-Phenylalanine_ACN";s:3:"nid";s:6:"195360";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92854";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82364";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"DL-Phenylalanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195361;a:27:{s:5:"title";s:19:"p-Coumaric acid_ACN";s:3:"nid";s:6:"195361";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92883";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:934:"p-Coumaric acid [on its (E)-form] found in many plants, e.g. peel of black cherry (Prunus serotina), lentil seeds and from red clover (Trifolium pratense) and Daviesia latifolia. It is found by Bate-Smith in 48% of investigated dicotyledonous and 55% of monocotyledonous spp. (CRC-DNP 2009) (US-NLM 2009) (Merck 2006). p-coumaric acid is the precursor of several simple phenylpropanoids, caffeic acid, ferulic acid, and sinapic acid. It plays a central role in the synthesis of lignin, lignans, flavonoids, and a wide range of other secondary phenolic constituents (Yildiz 2006). It shows cytostatic activity and acts as an immunoactivie agent, and inhibitor of stilbene oxidase (CRC-DNP 2009). A recent study demonstrated the antimelanogenic effect of p-coumaric acid in human melanocytes as well as in melanoma cells (An, Lee et al. 2008). p-Coumaric acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82365";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"p-Coumaric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195362;a:27:{s:5:"title";s:31:"Ascorbic acid 2-O-glucoside_ACN";s:3:"nid";s:6:"195362";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92883";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1431:"2-O-α-D-glucopyranosyl-L-ascorbic acid [Ascorbic acid 2-glucoside or simply AA-2G (US-NLM 2009)(CRC-DNP 2009)] is a stable ascorbic acid glucoside already used as a quasi-drug principal ingredient in skin care, was approved by the Japanese government as a food additive (Tai and Gohda 2007). AA-2G is synthesized from ascorbic acid and α-glucans by regioselective transglycosylation with cyclodextrin glucanotransferase from Bacillus stearothermophillus (Kwon, Kim et al. 2007). Cyclodextrin glucanotransferases from mesophilic, thermophilic, and halophilic bacteria and maltase from the yeast Saccharomyces cerevisiae were also used for transglycosylation of ascorbic acid with starch, maltodextrin, γ-cyclodextrin, and maltose (Markosyan, Abelyan et al. 2007). AA-2G is stable in neutral solution and resistant to heat, light and oxidation. This vitamin C derivative is hydrolyzed to ascorbic acid by α-glucosidase and exhibits physiological activities in vitro and in vivo (Kumano, Sakamoto et al. 1998). Therefore, AA-2G is considered to be promising as a pro-vitamin C agent in the field of foods and nutrition. Recently, AA-2G has been isolated as a naturally occurring compound from Kimchi, a Korean traditional fermented vegetable food (Jun, Bae et al. 1998). Ascorbic acid 2-glucoside will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate)- is also considered as a source of vitamin C (a prodrug).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82366";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Ascorbic acid 2-O-glucoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195363;a:27:{s:5:"title";s:14:"Anandamide_ACN";s:3:"nid";s:6:"195363";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:412:"Anandamide (N-arachidonoylethanolamine) is an endogenous lipid that binds to cannabinoid receptors in the central nervous system and in peripheral cells. AEA content has been found in pig, sheep, cow, in rat brains and rat peripheral tissues. AEA is also found in human brain and human cells. Therefore, Anandamide will be considered as an NHP that falls under isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82367";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Anandamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195364;a:27:{s:5:"title";s:23:"Quinidine gluconate_ACN";s:3:"nid";s:6:"195364";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82368";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Quinidine gluconate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195365;a:27:{s:5:"title";s:24:"Methylselenocysteine_ACN";s:3:"nid";s:6:"195365";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:772:"Methylselenocysteine is a naturally occurring seleno-amino acid, formed by seleniferous plants, such as Astragalus busulcatus, Stanleya pinnata, and Oonopsis condensata.  Selenium dietary supplements are more and more associated with the reduction of the incidence of lung, colorectal, and prostate cancer in humans, where Methylselenocysteine is known to be one of these compounds.  It has been proposed that the fact that Methylselenocysteine is not incorporated into any proteins, unlike its cousin Selenomethionine, makes it fully available for the synthesis of other selenium-containing enzymes such as glutathione peroxidase.  For these reasons, Methylselenocysteine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82369";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Methylselenocysteine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195366;a:27:{s:5:"title";s:33:"3-Methylcyclopentan-1,2-dione_ACN";s:3:"nid";s:6:"195366";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:373:"3-methyl-1,2-cyclopentanedione is a cyclic diketone in equilibrium with its enol form, i.e. 2-Hydroxy-5-methyl-2-cyclopenten-1-one [1]. It was isolated from coffee [2-4].  It is an important flavouring ingredient and also used as an intensifier in perfumery [1, 5]. 3-methyl-1,2-cyclopentanedione will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82370";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"3-Methylcyclopentan-1,2-dione";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195367;a:27:{s:5:"title";s:20:"Stearidonic acid_ACN";s:3:"nid";s:6:"195367";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92886";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82371";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Stearidonic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195368;a:27:{s:5:"title";s:15:"Rutecarpine_ACN";s:3:"nid";s:6:"195368";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:502:"Rutaecarpine is the major component of a Chinese medicine called Wou-chou-yu, obtained from the dried fruit of Evodia rutaecarpa, used against headache, abdominal pain, dysentery, and cholera for its vasodilation properties.  This compound has also been isolated from Hortia arborea, Hortia badinii, Zanthoxylum rhetsa, Zanthoxylum ovalifolium and Zanthoxylum integrifoliolum .  Therefore, Rutaecarpine will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82373";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Rutecarpine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195369;a:27:{s:5:"title";s:18:"Sodium nitrate_ACN";s:3:"nid";s:6:"195369";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:261:"Since Sodium nitrate can be found in nature as the mineral Nitratine, which is found in the Atacama desert of Chile as nitrate salt deposits (or caliche ore), it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82374";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium nitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195370;a:27:{s:5:"title";s:37:"Active hexose correlated compound_ACN";s:3:"nid";s:6:"195370";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:438:"AHCC (Active hexose correlated compound) is typically a dietary supplement rich in polysaccharides and fiber, which is processed from the mycelia of selected mushrooms (from basidiocymetes mushrooms) into a nutritive extract.  This extract is used to boost the immune system but also as a dietary supplement to maintain good health.  AHCC will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Extract) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82375";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Active hexose correlated compound";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195371;a:27:{s:5:"title";s:22:"alpha1-Antitrypsin_ACN";s:3:"nid";s:6:"195371";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:501:"Alpha1-antitrypsin (A1AT) is a serine protease inhibitor (serpin). It protects tissue from enzymes from inflammatory cells, especially elastase. It is present in human blood at 1.5 - 3.5 gram/liter. Recombinant alpha 1-antitrypsin is not yet commercially available, but is under investigation as a therapeutic modality in congenital deficiency. Therapeutic concentrates are prepared from the blood plasma of blood donors. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82376";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"alpha1-Antitrypsin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195372;a:27:{s:5:"title";s:20:"alpha-Casozepine_ACN";s:3:"nid";s:6:"195372";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:33:"Peptide isolated from Milk casein";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82377";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"alpha-Casozepine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195373;a:27:{s:5:"title";s:15:"Attapulgite_ACN";s:3:"nid";s:6:"195373";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92900";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1270:"Attapulgite or Palygorskite is a magnesium aluminium phyllosilicate with formula Mg(Al0.5-1 Fe0-0.5)Si4O10(OH). 4H2O (CAS no. 12174-11-7) [International Labour Organization] which occurs in a type of clay soil common to the Southeastern United States. It is one of the types of fuller's earth.The name attapulgite is derived from the U.S. town of Attapulgus, Georgia, in the extreme southwest corner of the state, where the mineral is abundant. It is surface-mined in the area, dry-ground and air-separated into precise particle sizes. It is characterized as having a chain structure rather than the usual sheet structure of other clays [Elmore AR, 2003].  Palygorskite is known to have been a key constituent of the pigment called "Maya Blue", which was used notably by the pre-Columbian Maya civilization of Mesoamerica on ceramics, sculptures, murals and (most probably) Maya textile. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For this reason, it has been used in several anti-diarrheal medications, including Diasorb, Donnagel, Kaopectate, and Parepectolin. As it is naturally occurring, Attapulgite will be considered as a NHP, under Schedule 1, item 7 (Priority 5, mineral) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82378";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Attapulgite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195374;a:27:{s:5:"title";s:34:"L-Tyrosine alpha ketoglutarate_ACN";s:3:"nid";s:6:"195374";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:252:"Tyrosine alpha-ketoglutarate is the Tyrosine salt of alpha-ketoglutaric acid. It is a source of two NHPs (combination of NHPs), namely Tyrosine and alpha-ketoglutaric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82379";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"L-Tyrosine alpha ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195375;a:27:{s:5:"title";s:21:"alpha-Lactalbumin_ACN";s:3:"nid";s:6:"195375";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:182:"Alpha-lactalbumin is a major whey protein, is a calcium metalloprotein that has been found in milk. It contains a large amount of essential and non-essential amino acids. It is a NHP";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82380";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"alpha-Lactalbumin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195376;a:27:{s:5:"title";s:18:"Apolactoferrin_ACN";s:3:"nid";s:6:"195376";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:696:"Lactoferrin is an iron-binding protein found in milk and other secretory fluids of mammals, known for its anti-cancer, immunomodulation, anti-microbial, anti-viral and toxin binding properties.  In its native state, lactoferrin is only partially saturated (5-40%) and called Apolactoferrin when it is not iron-chelated. Even if lactoferrin can be produced from recombinant DNA procedures (Prohibited by Schedule D), it is usually isolated from whey, which is the watery part of milk that is separated from the curd in making cheese. Apolactoferrin will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations, when not produced by recombinant DNA procedures.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82381";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Apolactoferrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195377;a:27:{s:5:"title";s:14:"Celgosivir_ACN";s:3:"nid";s:6:"195377";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:736:"Celgosivir is a O-6 butyl ester of Castanospermine (an alkaloid from the seeds of Castanospermum australe and the pods of Alexa leiopetala). Celgosivir is an oral prodrug of castanospermine and a potent inhibitor of alpha-glucosidase, an enzyme found in mammalian cells, which affects the early stages of glycoprotein processing. Celgosivir is a novel antiviral agent currently in clinical development for the treatment of chronic hepatitis C virus (HCV) infection. Non-clinical and clinical studies indicate that, following oral administration, celgosivir is readily converted to its primary metabolite castanospermine. Celgosivir will be considered as a NHP (source of Castanospermine), under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82382";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Celgosivir";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195378;a:27:{s:5:"title";s:15:"Glucosidase_ACN";s:3:"nid";s:6:"195378";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:27:"Isolated from Bakers yeast.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82384";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Glucosidase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195379;a:27:{s:5:"title";s:33:"Glutamine alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195379";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:171:"Glutamine alpha-ketoglutarate is the alpha-ketoglutarate salt fo Glutamine. It is a source of two NHPs (combination of NHPs), namely Glutamine and alpha-Ketoglutaric acid.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82385";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Glutamine alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195380;a:27:{s:5:"title";s:11:"Heparin_ACN";s:3:"nid";s:6:"195380";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82386";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Heparin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195381;a:27:{s:5:"title";s:17:"Hyaluronidase_ACN";s:3:"nid";s:6:"195381";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82387";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Hyaluronidase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195382;a:27:{s:5:"title";s:11:"Cynarin_ACN";s:3:"nid";s:6:"195382";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92914";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82388";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Cynarin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195383;a:27:{s:5:"title";s:19:"Sodium chloride_ACN";s:3:"nid";s:6:"195383";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92882";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:374:"Since Natural hylite salt meets both the substance (Halite) and function aspects of the NHP definition (Prophylaxis and treatment of acute and chronic respiratory, allergic or infectious complaints: asthma, bronchitis, rhinitis, and chronic obstructive pulmonary disease (COPD)), it is an NHP. A similar product, Aromatherapipe [1], has previously been classified as an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82389";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195384;a:27:{s:5:"title";s:15:"Isoflavones_ACN";s:3:"nid";s:6:"195384";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92920";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82390";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Isoflavones";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195385;a:27:{s:5:"title";s:22:"Glutamine peptides_ACN";s:3:"nid";s:6:"195385";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92922";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:645:"Glutamine peptides are basically L-glutamine linked with one or two other amino acids, usually L-Alanine and Glycine. Glutamine peptides are used as Glutamine supplement, since small peptides, such as Glutamine peptides, are known to be more rapidly absorbed by the organism compared to the free form of L-Glutamine. Since L-Glutamine is one of the acceptable amino acids included in the Schedule 1 of the NHP Regulations, and Glutamine peptides are most likely to be cleaved to their single amino acids after being metabolized, Glutamine peptides will be considered as NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82391";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Glutamine peptides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195386;a:27:{s:5:"title";s:13:"Genistein_ACN";s:3:"nid";s:6:"195386";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92920";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:124:"It is a phytoestrogen found in soy products. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82392";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Genistein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195387;a:27:{s:5:"title";s:11:"Glucose_ACN";s:3:"nid";s:6:"195387";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:629:"The D-form is the most common sugar, abundant in free and combined form. It occurs free in blood, cerebrospinal fluid, lymph, urine of diabetic subjects, fruits, honey and plant juices. It is the major component of many oligosaccharides and polysaccharides. It also occurs in sucrose combined with fructose. The L-form has been isolated from flowers of Grindelia robusta (DNP 2009).  It occurs naturally and in the free state in fruits and other parts of plants (O’Neil et al. 2006).  Its natural occurrence is also supported by 1 citation found for ’Dextrose’ and 504 citations found for ‘Glucose’ in NAPRALERTsm 2009.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82393";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Glucose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195388;a:27:{s:5:"title";s:14:"D-Mannitol_ACN";s:3:"nid";s:6:"195388";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92918;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:400:"D-form widespread in plants and their exudates particularly olive and plane trees. Obtained from manna and seaweeds (DNP 2009).  Widespread in plants and plant exudates; obtained from manna and seaweeds (O’Neil et al. 2006). Supported by 204 citations found in NAPRALERTsm 2009.  Mannitol will be considered as a NHP substance, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82394";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"D-Mannitol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195389;a:27:{s:5:"title";s:18:"Sodium lactate_ACN";s:3:"nid";s:6:"195389";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:214:"Sodium lactate is the sodium salt of the naturally occurring compound lactic acid (both D- and L-forms are naturally occurring) (DNP 2009, O’Neil et al. 2006, Supported by 25 citations found in NAPRALERTsm 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82395";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195390;a:27:{s:5:"title";s:18:"Cinnamaldehyde_ACN";s:3:"nid";s:6:"195390";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:314:"(E)-form is a constituent of cinnamon and cassia oils (DNP 2009). Found in Ceylon and Chinese cinnamon oils as the trans-form (O’Neil et al. 2006). Supported by 69 citations found in NAPRALERTsm 2009. It will be considered as a NHP substance, under Schedule 1, item 2 Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82396";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Cinnamaldehyde";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195391;a:27:{s:5:"title";s:18:"Sodium citrate_ACN";s:3:"nid";s:6:"195391";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:416:"Occurs in the free state in lemons, currants, beetroot etc. and the seeds and juices of many flowers and plants (DNP 2009).  It is also widely distributed in plants and in animal tissues and fluids (O’Neil et al. 2006).  Its natural occurrence is supported by 168 citations found in NAPRALERTsm 2009.  It will be considered as a NHP substance, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82397";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195392;a:27:{s:5:"title";s:20:"Intrinsic factor_ACN";s:3:"nid";s:6:"195392";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:112:"A thermolabile mucoprotein with mol wt about 60,000 that can be prepared from hog mucosa (O’Neil et al. 2006).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82398";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Intrinsic factor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195393;a:27:{s:5:"title";s:19:"L-Tartaric acid_ACN";s:3:"nid";s:6:"195393";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92918;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:889:"L-form widely distributed in nature, classified as a fruit acid.  Occurs in many fruits, free and combined with potassium, calcium or magnesium.  Observed in antiquity as the acid potassium salt found deposited as a fine crystalline crust during fermentation of grape juice or tamarind juice and termed faecula (little yeast) by the Romans. D-form found only in fruits and leaves of the West African tree Bauhinia reticulata (DNP 2009). D-form although termed “unnatural”, its occurrence in nature has been demonstrated.  Obtained in small amounts from racemic tartaric acid through biochemical cleavage using Penicillium notatum, Aspergillus griseus, A. niger or other microorganisms (O’Neil et al. 2006). Supported by 68 citations found in NAPRALERTsm 2009.Tartaric acid will be considered as an NHP that falls under Isolate (Priority 2), Item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82399";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"L-Tartaric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195394;a:27:{s:5:"title";s:23:"Histamine phosphate_ACN";s:3:"nid";s:6:"195394";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:218:"Histamine phosphate is the phosphate salt recognized in DNP 2009, O’Neil et al. 2006, and Sweetman 2002 as a source of the naturally occurring compound histamine (Supported by 49 citations found in NAPRALERTsm 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82400";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Histamine phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195395;a:27:{s:5:"title";s:32:"L-Lysine alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195395";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:113:"Most probably is a salt of Leucine and alpha-ketoglutaric acid, two naturally occurring compounds, therefore NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82401";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"L-Lysine alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195396;a:27:{s:5:"title";s:38:"alpha-keto-beta-Methylvaleric acid_ACN";s:3:"nid";s:6:"195396";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:305:"Metabolism of isoleucine in man, animals and bacteria.  Precursor to isoleucine in plants (DNP 2009).  Normally present in very low concentration as part of the metabolism of the branched-chain amino acids (Huang et al. 2004). Normally in equilibrium with its parent amino acid (Hoffner et al. 1993). NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82402";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"alpha-keto-beta-Methylvaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195397;a:27:{s:5:"title";s:32:"alpha-Hydroxyisocaproic acid_ACN";s:3:"nid";s:6:"195397";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:250:"Isol. from tobacco (Nicotiana tabacum) (DNP 2009, Fukuzumi et al. 1965). 1 citation found in NAPRALERT 2009sm for 'pentanoic acid,2-hydroxy-4-methyl:', article not available.  Detectable in human plasma and urine (Hoffner et al. 1993), therefore NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82403";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"alpha-Hydroxyisocaproic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195398;a:27:{s:5:"title";s:32:"alpha-Hydroxyisovaleric acid_ACN";s:3:"nid";s:6:"195398";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:81:"HIVA is detectable in human plasma and urine (Hoffner et al. 1993), it is an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82404";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"alpha-Hydroxyisovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195399;a:27:{s:5:"title";s:34:"2-Hydroxy-3-methylvaleric acid_ACN";s:3:"nid";s:6:"195399";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:81:"HMVA is detectable in human plasma and urine (Hoffner et al. 1993), it is an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82405";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"2-Hydroxy-3-methylvaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195400;a:27:{s:5:"title";s:29:"alpha-Ketoisovaleric acid_ACN";s:3:"nid";s:6:"195400";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92908";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:246:"Metabolism of Aspergillus niger and other microorganisms.  Also in banana and asparagus (DNP 2009).  Intermediate in the biosynthesis of valine (Arfin 1969).  Normally in equilibrium with its parent amino acid (Hoffner et al. 1993), it is an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82406";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"alpha-Ketoisovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195401;a:27:{s:5:"title";s:20:"Anthranilic acid_ACN";s:3:"nid";s:6:"195401";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:645:"Produced by bacteria and fungi (DNP 2009).  10 citations found in NAPRALERTsm 2009, 4 articles were available: identified in a corn (Zea mays) mutant known as Blue Fluorescent-1 (Singh and Widholm 1975); isolated from the mushroom Favolus arcularius TA 7 (Murao et al. 1984); isolated from the fungal culture of a strain of Chaetomium thielavioideum (Sekita et al. 1980); isolated from Tecoma stans leaves (Kunapuli and Vaikyanathan 1984).  Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82407";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Anthranilic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195402;a:27:{s:5:"title";s:16:"Norephedrine_ACN";s:3:"nid";s:6:"195402";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:405:"(1R,2S)-form is an alkaloid from ‘Ma Huang’, Ephedra vulgaris and Catha edulis (Ephedraceae, Celastraceae) (DNP 2009). Supported by 22 citations found in NAPRALERTsm 2009 for ‘Ephedrine,nor:’. Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82408";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Norephedrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195403;a:27:{s:5:"title";s:21:"Phenylacetic acid_ACN";s:3:"nid";s:6:"195403";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:778:"Found in essential oils, e.g. neroli, rose oil, free and as esters, and in many fruits. Also produced by microorganisms, e.g. by Fusarium oxysporum, Glomerella cingulata and a marine derived Streptomyces sp. Volatile component of tail gland secretion from red deer Cervus elaphus (DNP 2009, Hirota et al. 1993).  Detected in Freon 113 and ethyl acetate extracts of Rambutan fruit (Nephelium lappaceum L.) using GC/MS (Ong et al. 1998).  Isolated from the culture broth of Streptomyces humidus S5-55 (Hwang et al. 2001).  Supported by 36 citations found in NAPRALERTsm 2009. Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82409";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Phenylacetic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195404;a:27:{s:5:"title";s:23:"gamma-Butyrolactone_ACN";s:3:"nid";s:6:"195404";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:546:"Found in extracts from samples of unadulterated wines (WIKI 2009c).  Naturally occurring molecule in the body; found in all body tissues (Arneson and Goetze 2000). Occurs as a natural constituent of rat brain (Snead et al. 1989).  Available in industry solvents or as a “natural” component of dietary supplements (Wojtowicz et al. 2008). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82410";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"gamma-Butyrolactone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195405;a:27:{s:5:"title";s:18:"1,4-Butanediol_ACN";s:3:"nid";s:6:"195405";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:807:"Available in industry solvents or as a “natural” component of dietary supplements (Wojtowicz et al. 2008).  Identified as a component of a class of neutral lipids referred to as diol lipids, which have been identified in neutral fats found in plants, animals and microorganisms.  Unesterified 1,4-butanediol has been detected in rat brain and liver and presumably represents free diol released during the metabolic processing of diol lipids (Irwin 1996, Irwin 2006). Naturally occurring endogenous compound existing in rodent brain and liver and in human cortex and cerebellum (Barker et al. 1985). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82411";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"1,4-Butanediol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195406;a:27:{s:5:"title";s:18:"Red phosphorus_ACN";s:3:"nid";s:6:"195406";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:774:"Red phosphorus can be formed by heating white phosphorus to 250°C (482°F) or by exposing white phosphorus to sunlight. Phosphorus after this treatment exists as an amorphous network of atoms; further heating results in the red phosphorus becoming crystalline. Although phosphorus does not occur free in nature (O’Neil et al. 2006), it is commonly found in inorganic phosphate rocks that can act as a source for phosphorous. Elemental phosphorus is no longer used in medicine, as inorganic phosphates are given in deficiency states and bone diseases (Sweetman 2002). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:367:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82412";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Red phosphorus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195407;a:27:{s:5:"title";s:20:"White phosphorus_ACN";s:3:"nid";s:6:"195407";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1181:"White phosphorus, or yellow phosphorus, or simply tetraphosphorus (P4) exists as individual molecules made up of four atoms in a tetrahedral arrangement, resulting in very high ring strain and instability. The white allotrope can be produced using several different methods. In one process, calcium phosphate, which is derived from phosphate rock, is heated in an electric or fuel-fired furnace in the presence of carbon and silica. Elemental phosphorus is then liberated as a vapour and can be collected under phosphoric acid. This process is similar to the first synthesis of phosphorus from calcium phosphate in urine.Although phosphorus does not occur free in nature (O’Neil et al. 2006), it is commonly found in inorganic phosphate rocks that can act as a source for phosphorous. Elemental phosphorus is no longer used in (conventional) medicine, as inorganic phosphates are given in deficiency states and bone diseases, but used in homeopathic medicine (Sweetman 2002).Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:327:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:367:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82413";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"White phosphorus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195408;a:27:{s:5:"title";s:23:"Methyl ethyl ketone_ACN";s:3:"nid";s:6:"195408";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:377:"Isolated from tobacco (Nicotiana tabacum), hop oil (Humulus lupulus), white clover (Trifolium repens), tea, tomatoes, various fruits and other vegetable sources (DNP 2009). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82414";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Methyl ethyl ketone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195409;a:27:{s:5:"title";s:17:"Sulfuric acid_ACN";s:3:"nid";s:6:"195409";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:559:"Constituent of ‘acid rain’, which is mainly produced due to anthropogenic emissions of sulfur dioxide, a by-product of the combustion of fossil fuels (WIKI 2009b, Krupa 2002, Goyer et al. 1985). Naturally formed by the oxidation of sulfide minerals (e.g. pyrite or iron sulfide) or hydrogen sulfide vented from volcanoes fumaroles (Ezoe et al. 2002). Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82415";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Sulfuric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195410;a:27:{s:5:"title";s:11:"Toluene_ACN";s:3:"nid";s:6:"195410";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:2690:"Constituent of many mineral oils and major constituent of coal tar oil. Isolated from distilled tolu balsam (Myroxylon balsamum); also minor constituent of lime oil (Citrus aurantifolia). Manufactured by reforming and fractionation of petroleum fractions (DNP 2009). 43 citations found in NAPRALERTsm 2009, 28 articles were available: detected/identified as a volatile compound of Echinophora tenuifolia L. subsp. sibthorpiana (Akgul and Chialva 1989), Phallus impudicus (Borg-Karlson et al. 1994), Phaseolus vulgaris (Buttery et al. 1975), Sergia lucens and its fermented products (Choi and Kato 1984), edible Korean chamchwi (Aster scaber) (Chung et al. 1993), Psidium guajava (Ekundayo et al. 1991), prickly pear (Opuntia ficus indica) (Flath and Takahashi 1978), freesia flower (Freesia hybrida) (Harada and Mihara 1984), Farsetia aegyptia and Farsetia ramosissima (Gil and MacLoeod 1980), orchid Dendrobium superbum (Flath and Ohinata 1982), rabbiteye blueberry (Vaccinium ashei) (Horvat and Senter 1985), scuppernong berries (Vitis rotundifolia) (Horvat and Senter 1984), myoga (Zingiber mioga) (Kurobayashi et al. 1991), Sorghum bicolour (Lwande and Bentley 1987), Pinus radiata (Zabkiewicz and Allan 1975), cashew ‘apple’ (Anacardium occidentale) (MacLeod and Gonzalez de Troconis 1982a); globe (Cynara scolymus) and Jerusalem (Helianthus tuberosus) artichokes (MacLeod et al. 1982b), mangosteen (Garcinia mangostana) (MacLeod and Pieris 1982c), parsley (Petroselinum crispum) (MacLeod et al. 1985a), mango (Mangifera indica) (MacLeod and Snyder 1985b), sapodilla (Achras sapota) (MacLeod and Gonzales de Troconis 1982d), Kumazasa (Sasa albo-marginata) (Van Chuyen and Kato 1982), roasted cocoa (Vitzthum et al. 1975), kiwi fruit (Actinidia chinensis) (Takeoka et al. 1986), and Distichlis spicata (Mody et al. 1975). Note that Takeoka et al. (1986) indicated that the source of the aromatic hydrocarbons found is unknown, and may arise from the contamination during storage and handling of the fruit analyzed; that Vitzthum et al. (1975) indicated that peaks, including toluene, in earlier GC runs were due to compounds from the Porapak-adsorption material found in the blank runs with the FID; that Zabkiewicz and Allan (1975) indicated that toluene was possibly formed by decomposition of the non-monoterpene compounds of the oleoresin analyzed; that Horvat and Senter (1984) indicated that the aromatic compounds found in their study probably have a biochemical origin. Note that this substance, being outlined in Schedule VI of the CDSA, could also be subject to additional regulatory requirements in accordance with the Precursor Control Regulations (Justice Canada 2002).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:328:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. It should be noted that this ingredient is subject to additional regulatory requirements in accordance with the Precursor Control Regulations since it is listed on Schedule VI Part 1 of the Controlled Drugs and Substances Act";s:17:"field_rationale_f";s:365:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels. On doit noter que cet ingrédient est soumis à des exigences réglementaires additionnelles conformément aux Réglements sur les précurseurs à cause de sa présence à l'Annexe VI Partie 1 de la Loi réglementant certaines drogues et autres substances.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82416";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Toluene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195411;a:27:{s:5:"title";s:24:"Creatine ethyl ester_ACN";s:3:"nid";s:6:"195411";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92941";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:777:"Creatine ethyl ester is the ester derivative of creatine [1].The ethyl ester is said to have a much better absorption rate and a longer half-life in the body than regular creatine monohydrate because it is slightly more lipophilic. However, these claims have not yet been conclusively proven by independent research, and in fact a recent study demonstrated that the addition of the ethyl group to creatine actually reduces acid stability and accelerates its breakdown to creatinine. The researchers concluded that creatine ethyl-ester is inferior to creatine monohydrate as a source of creatine [2]. Despite this fact Creatine ethyl ester meets the definition of a NHP; therefore, will be considered a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82417";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Creatine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195412;a:27:{s:5:"title";s:26:"Creatine pyroglutamate_ACN";s:3:"nid";s:6:"195412";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92942";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:234:"Creatine pyroglutamate is the Creatine salt of Pyroglutamic acid. It is a source of two NHPs (combination of NHPs), namely Creatine and Pyroglutamic acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82418";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Creatine pyroglutamate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195413;a:27:{s:5:"title";s:27:"Creatine hydroxycitrate_ACN";s:3:"nid";s:6:"195413";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92943";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:237:"Creatine hydroxycitrate is the Creatine salt of Hydroxycitric acid. It is a source of two NHPs (combination of NHPs), namely Creatine and Hydroxycitric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82419";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Creatine hydroxycitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195414;a:27:{s:5:"title";s:16:"Maltodextrin_ACN";s:3:"nid";s:6:"195414";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92944";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:403:"Maltodextrin is part of a family of compounds named dextrins, which are polysaccharides produced by the hydrolysis of starch.  Maltodextrin is a moderately sweet polysaccharide commonly used as a food additive, it is listed in the NHPD acceptable NMIs list. Maltodextrin is prepared from corn starch and will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82420";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Maltodextrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195415;a:27:{s:5:"title";s:27:"Leucine isovaleric acid_ACN";s:3:"nid";s:6:"195415";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92949";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:249:"Leucine isovalerate is the Leucine salt of isovaleric acid (3-Methylbutanoic acid). It is a source of two NHPs (combination of NHPs), namely Leucine and isovaleric acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82421";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Leucine isovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195416;a:27:{s:5:"title";s:11:"Sucrose_ACN";s:3:"nid";s:6:"195416";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92964";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:482:"Sucrose is the most common sweetener in the industrialized world, although it has been replaced in industrial food production by other sweeteners such as glucose syrups or combinations of functional ingredients and high intensity sweeteners. It is generally extracted from sugar cane or sugar beet and then purified and crystallized. Other (minor) commercial sources are sweet sorghum and sugar maples. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82422";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Sucrose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195417;a:27:{s:5:"title";s:26:"L-Arginine L-aspartate_ACN";s:3:"nid";s:6:"195417";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92935";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:511:"L-Arginine aspartate (CAS # 7675-83-4) is a 1:1 mixture of L-Arginine (an NHP) and Aspartic acid (an NHP) (ChemIndustry) (NHP ID).  This product is often taken as a source of arginine and/or asparate, as nutritional ergogenics (Colombani, 1999) and its intake has often been linked to an increase in anabolic hormones such as the human growth hormone (hGH) and glucagon (Abel, 2005).  It will be considered as an NHP, under Item 4 (amino acid) of Schedule 1of the NHP regs since it is a source of 2 amino acids.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82423";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"L-Arginine L-aspartate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195418;a:27:{s:5:"title";s:22:"Vitexin rhamnoside_ACN";s:3:"nid";s:6:"195418";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92936";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:501:"Vitexin Rhamnoside is a derivative of Vitexin- a natural product (US-NLM 2009). It is found in Crataegus monogyna, Crataegus oxyacantha (Howthorn) and Passiflora incarnata (maypops) (CRC-DNP 2009) (Sweetman 2007). Extracts of Crataegus monogyna showed anti-radical (free radical scavenging) activity which might be responsible for their anti-cardiovascular diseases (Bernatoniene, Masteikova et al. 2008). Vitexin Rhamnoside will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82424";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Vitexin rhamnoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195419;a:27:{s:5:"title";s:17:"Carnosic acid_ACN";s:3:"nid";s:6:"195419";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92946";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:645:"Carnosic acid is a phenolic diterpene principally found in rosemary (Rosmarinus officinalis) and sage (Salvia officinalis) (Merck 2009; US-NLM 2009). It is also isolated from Salvia canariensis and Salvia apiana (CRC-DNP 2009). Carnosic acid has an antioxidant activity in lipid systems (Yanishlieva, Marinova et al. 2006) and, therefore, has been used as antioxidant in edible oils, meats, and other fat containing foods (Merck 2009). Carnosic acid is believed to be responsible for many bioactive properties of rosemary and sage (Braun and Cohen 2007). Carnosic acid will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82425";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Carnosic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195420;a:27:{s:5:"title";s:16:"Arginine PCA_ACN";s:3:"nid";s:6:"195420";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92967";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:293:"(Arginine L-Pyrrolidone Carboxylic acid) is the Arginine salt of Pyroglutamic acid (5-Oxo-DL-Proline). It is a source of two NHPs (combination of NHPs), namely L-Arginine and Pyroglutamic acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate-combination of NHPs).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82426";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Arginine PCA";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195421;a:27:{s:5:"title";s:19:"Arginine malate_ACN";s:3:"nid";s:6:"195421";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93012";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:573:"The Arginine malate substance (Fig. 1) is Arginine compounded with malic acid (i.e. a mixture of the two) (NIH 2009).  The information found in file 145389 suggest that Arginine malate (also identified as tri-arginine malate) is used as a source of Arginine. This is acceptable since ChemID specified at least 3 known 'Arginine malate' (CAS#16856-16-9, 41989-03-1, and 93964-77-3). Since we classified many similar combination of naturally occurring substances as NHP, Arginine malate would be considered as a source for Argenine and Malic acid and, therefore, it is an NHP";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82427";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Arginine malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195422;a:27:{s:5:"title";s:22:"Hydrolyzed keratin_ACN";s:3:"nid";s:6:"195422";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93038";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:455:"Keratin hydrolysate or 'hydrolyzed keratin' (US-NLM 2009)  is obtained by hydrolysis of keratin originating from hair, wool, skin, bristles, silks, feathers, scales, hooves or horns, and can contain quaternary groups grafted on the peptide chain or at the end of the chain. The hydrolysis can be performed by acids, enzymes, and other reagents (Winter 2009). Keratin hydrolysate will be considered as a NHP, under schedule 1, item 2, Priority 4 (Extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82428";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydrolyzed keratin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195423;a:27:{s:5:"title";s:15:"Azacitidine_ACN";s:3:"nid";s:6:"195423";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93052";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:2399:"Azacitidine (Fig. 1), as an analog and antimetabolite of the naturally occurring pyrimidine nucleoside cytidine, has been used as an antineoplastic agent for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) (NIH 2009, O’Neil et al. 2009, Sweetman 2009). Indeed, through its incorporation into DNA and RNA as well as by inhibiting cytosine residues methylation (hypomethylation), Azacitidine is causing direct cytotoxic effect on abnormally proliferating hematopoietic cells characteristic of MDS and AML; and consequently, restoring normal growth control and differentiation (Siddiqui and Scott 2005, Sullivan et al. 2005).  Although not exempt from adverse events (benign to severe), clinical studies have shown Azacitidine as a relatively safe and effective substance for malignant or premalignant conditions such as the ones mentioned above, which is why the U.S. Food and Drug Administration (FDA) approved Azacitidine injectable suspension for the treatment of all subtypes of MDS (Kaminskas et al. 2005).  Due to its rapid catabolism by cytidine deaminase and hydrolysis in aqueous solution, Azacitidine is generally administered by subcutaneous or intravenous injection.  However, recently, a pilot pharmacokinetic study using an oral film-coated formulation demonstrated measurable Azacitidine plasma concentrations, suggesting possible bioavailability in oral dosage forms (Garcia-Manero et al. 2008).  Furthermore and worth mentioning, some references also describe Azacitidine as a nucleoside antibiotic (DNP 2009, Torikata et al. 1983, Uematsu and Suhadolnik 1972).  However, based on the information outlined above, this substance does not seem to be used as an antibiotic nowadays, but as an antineoplastic agent.  Azacitidine can be synthetically prepared or produced and isolated from fermentation of Streptoverticillium ladakanus, Actinoplanes awajinensis or Actinoplanes missouriensis (O’Neil et al. 2009, DNP 2009, Torikata et al. 1983, Uematsu and Suhadolnik 1972).  For this reason, Azacitidine meets the substance aspect of the Natural Health Product (NHP) definition, as defined in the NHP Regulations (Justice Canada 2009a), provided that it is not excluded by Schedule 2 of those regulations (e.g. not used as an antibiotic or administered by puncturing the dermis) or Schedule F to the Food and Drug Regulations (Justice Canada 2009b).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82429";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Azacitidine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195424;a:27:{s:5:"title";s:19:"Diamine oxidase_ACN";s:3:"nid";s:6:"195424";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93045";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:487:"Diamine oxidase, also known as Copper amine oxidase and Histaminase (Enzyme Nomenclature database) is isolated from pig kidney and was first reported by McHenry and Gavin in 1932 (Lobley 1970). It has a molecular weight of 185000 and is known to contain Cu2+ ions and pyridoxal phosphate (Lobley 1970). The enzyme catalyzes the oxidation of diamines and sometimes that of monoamines too. Diamine oxidase will be considered as an NHP, under item 3 (isolate) of Schedule 1 of the NHP regs.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82430";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Diamine oxidase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195425;a:27:{s:5:"title";s:19:"Zinc propionate_ACN";s:3:"nid";s:6:"195425";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93061";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1922:"Zinc propionate (Fig. 1) is the 2:1 zinc salt of propionic acid, prepared by dissolving zinc oxide in dilute propionic acid and concentration of the resulting solution, mainly used as fungicide on adhesive tape to reduce plaster irritation caused by molds, fungi, and bacterial action (NIH 2009, O’Neil et al. 2009).Bioavailability studies in dogs showed that the bioavailability of zinc from zinc propionate, an organic source of zinc, was significantly higher than zinc from zinc oxide, an inorganic source of zinc, as measured by blood plasma levels (Brinkhaus et al. 1998). However, Beutler et al. (1998) showed that zinc uptake by cultured cells (monkey kidney fibroblasts and human intestinal epithelial cells) and by mouse intestine was not significantly different between zinc chloride, an inorganic source, and zinc methionine and propionate, organic sources of zinc. The authors attributed these latter observations to the ability of these sources to dissociate in aqueous solution to give equivalent amounts of ionic zinc, resulting to equivalent amounts transported into cells.Zinc propionate has also showed promises as a dietary zinc supplement to induce molt while maintaining postmolt egg quality and production (Park et al. 2004a, Park et al. 2004b), as well as limiting Salmonella enteritidis colonization (Moore et al. 2004) in laying hens, properties that have been attributed to both zinc and propionic acid counterparts of Zinc propionate.Although on animals and not convincing, the above information suggests a potential for Zinc propionate to be used as a source of both dietary zinc and propionic acid in humans. Therefore and because both zinc and propionic acid are naturally occurring substances (O’Neil et al. 2009, DNP 2009), Zinc propionate is considered as meeting the substance aspect of the NHP definition, as outlined in the Natural Health Products Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82431";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Zinc propionate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195426;a:27:{s:5:"title";s:18:"Propionic acid_ACN";s:3:"nid";s:6:"195426";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93061";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:197:"It occurs in dairy products in small amounts. It can be obtained from wood pulp waste liquor by fermentation process. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82432";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Propionic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195427;a:27:{s:5:"title";s:22:"d-alpha Tocopherol_ACN";s:3:"nid";s:6:"195427";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93075;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82433";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"d-alpha Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195428;a:27:{s:5:"title";s:24:"DL-alpha-Lipoic acid_ACN";s:3:"nid";s:6:"195428";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"92628;92788;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82434";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"DL-alpha-Lipoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195429;a:27:{s:5:"title";s:20:"Glutamine malate_ACN";s:3:"nid";s:6:"195429";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93081";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:301:"Glutamine malate is the salt between two NHPs , Glutamine (CAS# 56-85-9) and Malic acid (CAS# 6915-15-7) (ChemID Plus, NHP ID). Glutamine malate salt may enhance the bioavailability of glutamine. It will be considered as a source of Glutamine, under isolate, item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82435";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Glutamine malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195430;a:27:{s:5:"title";s:10:"Xylose_ACN";s:3:"nid";s:6:"195430";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93083";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:801:"Xylose (US-NLM 2009) is monosaccharide (sugar) widely distributed in plant materials, especially in wood (maple, cherry), in straw, in hulls. It is not found in free state, but in form of xylan, a polysaccharide built from D-Xylose units and occurring in association with cellulose. Xylose occurs also as part of glycosides. Peanut shells, corn cobs, and cottonseed hulls are practical sources of Xylose as well (CRC-DNP 2009; Merck 2009). Xylose has been used for the investigation of absorption from the gastrointestinal tract (Sweetman 2009). Xylose is also being used as non-medicinal ingredient mostly as flavoring agent, fragrance ingredient, humectant, or skin-Conditioning agent (Gottschalck and Bailey 2008). Xylose will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82436";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Xylose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195431;a:27:{s:5:"title";s:17:"Hemicellulase_ACN";s:3:"nid";s:6:"195431";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93099";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:328:"Hemicellulase is an enzyme that breaks down hemicellulose. Hemicellulose categorizes a variety of polysaccharides that are more complex than sugars and less complex than cellulose that is found in plant walls. Hemicellulase is often used in baking. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82437";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Hemicellulase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195432;a:28:{s:5:"title";s:22:"Carbamide peroxide_ACN";s:3:"nid";s:6:"195432";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"92722;92722;101739";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:112:"A combination of urea and hydrogen peroxide, it is considered as a source for hydrogen peroxide (plant isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82438";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Carbamide peroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:6:"DENTAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195433;a:28:{s:5:"title";s:21:"Hydrogen peroxide_ACN";s:3:"nid";s:6:"195433";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"92722;101740";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:173:"Hydrogen peroxide is found in raw, uncooked vegetables and fruits and therefore it is a NHP that falls under Schedule 1, item 2 (Priority 2: Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82439";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hydrogen peroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:6:"DENTAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195434;a:27:{s:5:"title";s:20:"beta-Glucosidase_ACN";s:3:"nid";s:6:"195434";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93096";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:478:"Beta-glucisidase, also known as amygdalase, beta-D-glucoside glucohydrolase, cellobiase and gentobiase, is mainly responsible for the hydrolysis of terminal, non-reducing beta-D-glycosyl residues with release of beta-D-glucose (Enzyme nomenclature database). It has been isolated from various plant (e.g sesame seeds), animal, and microbial sources (Kuriyama 1995, Seidle 2005).
It will be considered as a NHP substance, under Schedule 1, item 2 (Isolate) of the NHP Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82441";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"beta-Glucosidase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195435;a:27:{s:5:"title";s:15:"Carrageenan_ACN";s:3:"nid";s:6:"195435";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92730";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:706:"Carrageenan is a sulfated polygalactan with an average relative molecular mass well above 100 kDa. It is derived from a number of seaweeds of the class Rhodophyceae. It has no nutritive value and is used in food preparation for its gelling, thickening, and emulsifying properties. Three main types of carrageenan are used commercially, which are known in the food industry as iota-, kappa-, and lambda-carrageenan. These names do not reflect definitive chemical structures but only general differences in the composition and degree of sulfation at specific locations in the polymer [Greig, J.B. JECFA]. Carrageenan is considered an NHP under Schedule 1, Item 2 (priority 2, isolate) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82442";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Carrageenan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195436;a:27:{s:5:"title";s:22:"Creatine gluconate_ACN";s:3:"nid";s:6:"195436";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93138";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:242:"Creatine gluconate is the creatine salt of Gluconic acid. It is a source of two NHPs (combination of NHPs), namely Creatine and Gluconic acid. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate- source of creatine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82444";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Creatine gluconate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195437;a:27:{s:5:"title";s:31:"Disodium creatine phosphate_ACN";s:3:"nid";s:6:"195437";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93138";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:273:"Creatine disodium phosphate is a creatine compounded with sodium phosphate-dibasic (disodium phosphate). Since both Creatine and disodium phosphate are NHPs, their combination would be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate- source of Creatine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82445";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Disodium creatine phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195438;a:27:{s:5:"title";s:18:"Lysine acetate_ACN";s:3:"nid";s:6:"195438";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93112";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:305:"Lysine acetate (US-NLM 2009) can be prepared from Lysine and acetic acid (1:1 ratio) (Sun, Zhang et al. 2008). Lysine acetate is known as a source of amino acid Lysine (BPCO 2009; USP 2009) and therefore considered as a NHP, under schedule 1, item 4, Priority 1 [source of amino acid Lysine (priority 1)].";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82446";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Lysine acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195439;a:27:{s:5:"title";s:11:"Ectoine_ACN";s:3:"nid";s:6:"195439";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93134";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:966:"Ectoine (US-NLM 2009) was originally discovered in Halorhodospira halochloris, an extremely halophilic phototrophic eubacterium, isolated from Wadi Natrun, Egypt. Later the substance was found in a wide range of halophilic and halotolerant bacteria such as Ectothiorhodospira halochloris and Halomonas elongate. It is also isolated from the marine-derived Streptomyces sp. SA-3501 (Pyrostatin B)(Lentzen and Schwarz 2006; CRC-DNP 2009). Ectoine belongs to a group of natural compounds, termed compatible solutes, which can be defined as organic osmolytes that are accumulated by the cell in high concentrations without disturbing vital cellular functions and the correct folding of proteins (Klein, Schwarz et al. 2007). Ectoine is produced predominantly at very high salinities and confers resistance towards salt and temperature stress (Saum and Muller 2008; Sigma-Aldrich 2009). Ectoine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82447";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Ectoine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195440;a:27:{s:5:"title";s:19:"Sodium fluoride_ACN";s:3:"nid";s:6:"195440";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82448";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium fluoride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195441;a:27:{s:5:"title";s:30:"Sodium monofluorophosphate_ACN";s:3:"nid";s:6:"195441";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82449";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Sodium monofluorophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195442;a:27:{s:5:"title";s:15:"Hyoscyamine_ACN";s:3:"nid";s:6:"195442";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93118;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1073:"Hyoscyamine (or L-Hyoscaymine)  (CAS # 101-31-5), also known as (-)-atropine, is an alkaloid isolated from Atropa, Datura, Duboisia, Hyoscyamus, Anthocercis and Scopolia spp. , Mandragora officinarum and several other genera in the Solanaceae family (ChemID Plus,  DNP, Leete et al 1954, O'Neil 2009, NHP ID). The racemization of hyoscyamine to atropine is known to occur by heating or by treatment with alkalis during extraction (Broadley 1996) or after ingestion (Beyer J). Hyoscyamine is used as an antispasmodic agent and is also an antimuscarinic agent with almost twice potency of atropine (O'Neil 2009, DNP).  It has also been used medicinally as anticholinergic agent (Yun 1992).Atropine and its salts are listed under the Schedule F:Atropine and its salts in ophthalmic or parenteral preparations only. Hyoscyamine will meet the definition of an NHP only in oral or topical dosage forms; not in ophthalmic or parenteral preparations which are on Schedule F and therefore, it is considered as an NHP, under item 2 (isolate) of the Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82450";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Hyoscyamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195443;a:27:{s:5:"title";s:31:"Glutamic acid hydrochloride_ACN";s:3:"nid";s:6:"195443";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93158";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:244:"Glutamic acid HCl, is already classified as an acceptable source for Glutamic acid (an NHP). Therefore Glutamic acid hydrochloride will be considered as an acceptable source for Glutamic acid, under item2 (isolate) of Schedule 1 of the NHP regs";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82451";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Glutamic acid hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195444;a:27:{s:5:"title";s:11:"Lactose_ACN";s:3:"nid";s:6:"195444";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93222";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:128:"It is a disaccharide present in milk of mammals. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82452";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lactose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195445;a:27:{s:5:"title";s:21:"Potassium orotate_ACN";s:3:"nid";s:6:"195445";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93156";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:435:"Potassium orotate (CAS # 24598-73-0) is the salt formed between two NHPs, Potassium (CAS # 7440-09-7) and Orotic acid (CAS # 65-86-1) (NHP ID). It is often used as a source for orotic acid (Sweetman 2009). It is also advertised as a source for potassium too.
Potassium orotate will be cosidered as an NHP that act as a source for both potassium and orotic acid, under item 2 (isolate) and item 7 (mineral) of Schedule 1 of the NHP regs";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82453";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium orotate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195446;a:27:{s:5:"title";s:16:"Zinc orotate_ACN";s:3:"nid";s:6:"195446";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93157";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:670:"Zinc orotate (CAS # 68399-76-8) is the salt formed between two NHPs,zinc (CAS # 7440-66-6 ) and Orotic acid (CAS # 65-86-1) (NHP ID). It is often used as a source for orotic acid (Sweetman 2009). It is also advertised as a source of zinc too. Based on human data of plasma concentration, compared to zinc pantothenate and zinc sulfate, it has a faster distribution and elimination phase from parenteral administration, and a slower absorption phase when administered orally (Andermann 1982). Zinc orotate will be cosidered as an NHP that act as a source for both potassium and orotic acid, under item 2 (isolate) and item 7 (mineral) of Schedule 1 of the NHP regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82454";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Zinc orotate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195447;a:27:{s:5:"title";s:19:"Albumin tannate_ACN";s:3:"nid";s:6:"195447";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93173";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:576:"Albumin tannate (Proper name: Tannins, albumin complexes) (JPCo. 2009; US-NLM 2009) is a compound of tannin with albumin which is given orally for its astringent properties in the treatment of diarrhea (Sulman 1962; Gracia and deCastro 1997). It is stated to liberate tannic acid in the gastrointestinal tract (Sweetman 2009). Albumin tannate contains 50% tannic acid (Pei-Show 2001). Albumin tannate is also considered as a source for both Albumin and Tannic acid (NHP Combination). Albumin tannate will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82455";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Albumin tannate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195448;a:27:{s:5:"title";s:10:"Cesium_ACN";s:3:"nid";s:6:"195448";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93206";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:112:"Cesium will be considered as a NHP, under item 7, Priority 5 (mineral) of the schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82457";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Cesium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195450;a:27:{s:5:"title";s:26:"N-Methylphenethylamine_ACN";s:3:"nid";s:6:"195450";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93174";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:577:"N-Methyl-beta-phenylethylamine (or N-Methylphenethylamine, Fig. 2) is a secondary amine found in Acacia spp., such as in Acacia adunca, Acacia berlandieri and Acacia rigidula; as well as in other spp., such as Dolichothele sphaerica (DNP 2009, NAPRALERTsm 2009, NIH 2009, Clement et al. 1998, Pemberton et al. 1993, Keller 1982, Neurath et al. 1977, Camp and Moore 1960, Camp and Lyman 1956). As such, it is meeting the substance aspect of the natural health product (NHP) definition, under Schedule 1, item 2 (Priority 2: Isolate) of the NHP Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82459";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"N-Methylphenethylamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195451;a:27:{s:5:"title";s:17:"Terpinen-4-ol_ACN";s:3:"nid";s:6:"195451";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93199";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:488:"Terpinen-4-ol or 4-carvomenthenol (CAS # 562-74-3) is found in Tea tree oil (Melaleuca alternifolia), Liquidambar formosana, Alpinia galanga, Licaria puchuri-major and Cryptomeria japonica (ChemID Plus, DNP). It is used as flavouring agent (JECFA). It is also known to have medicinal properties, including anti-bacterial, antifungal, andanti-inflammatory properties (DNP, Hart 2000).
Terpinen-4-ol will be considered as an NHP, under item 2 (isolate) of Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82460";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Terpinen-4-ol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195452;a:27:{s:5:"title";s:15:"Artemisinin_ACN";s:3:"nid";s:6:"195452";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93226";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:497:"Artemisinin (US-NLM 2009) is an active anti-malarial constituent of the traditional Chinese medicinal herb Artemisia annua L., which has been known for almost 2000 years as 'Qinghaosu' (CRC-DNP 2009). It isolated in 1972 and shown to be a sesquiterpene lactone with a peroxide moiety (Merck 2009). Artemisinin combination treatments are now first-line drugs for uncomplicated falciparum malaria (White 2008). Artemisinin will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82461";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Artemisinin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195453;a:27:{s:5:"title";s:10:"Gluten_ACN";s:3:"nid";s:6:"195453";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93256";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1095:"Gluten is the proteinaceous mass that remains when wheat (or barley or rye) dough is washed under a stream of water.  It is composed of about 75% proteins on a dry basis, with the remainder being starch, lipids and carbohydrates.  The protein fraction, which in practice the term 'gluten' refers to, is characterized by numerous protein components present as monomers or oligomers and polymers linked by interchain disulfide bonds; the alcohol-water soluble gliadins and insoluble glutenins, type of proteins called prolamins.  Gluten, which is present in or intermixed with the starchy endosperm of the grain, is used as an adhesive and substitute for flour; while medicinally, it is mainly associated with the coeliac disease, as patients with this disease are sensitive to its protein fraction (O'Neil et al. 2009, Sweetman 2009, Wieser 2007, Anjum et al. 2007, Shewry et al. 2002).  Based on the information presented above, Gluten does meet the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Extract), as outlined in the NHP Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82462";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Gluten";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195454;a:27:{s:5:"title";s:10:"Glutin_ACN";s:3:"nid";s:6:"195454";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93256";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:421:"Glutin is a constituent of gluten, a proteinaceous mass from wheat, obtained when gluten is dissolved in alcohol; and therefore, a synonym for the gliadins portion of gluten (O'Neil et al. 2009, Gmelin and Watts 1871, Bell 1883, Johnston 1847). Consequently, Glutin meets the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Extract), as outlined in the NHP Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82463";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Glutin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195455;a:27:{s:5:"title";s:21:"N-Acetylcarnosine_ACN";s:3:"nid";s:6:"195455";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93249";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:630:"N-Acetylcarnosine (US-NLM 2009) exists in the cardiac and skeletal mammalian muscles (Odowd, Robins et al. 1988; Babizhayev, Deyev et al. 2001) and also in the brain (Sobue, Konishi et al. 1975). N-Acetylcarnosine, as a bioactivating antioxidant, is a potent agent with the pleiotropic effects for ophthalmic therapy of senile cataracts and diabetic ocular complications (Babizhayev, Guiotto et al. 2009). N-Acetylcarnosine is also showed to be a prodrug of L-Carnosine (Babizhayev, Yermakova et al. 1996). N-Acetylcarnosine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate and the source for Carnosine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82464";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"N-Acetylcarnosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195456;a:27:{s:5:"title";s:27:"Inositol hexanicotinate_ACN";s:3:"nid";s:6:"195456";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:407:"Since Inositol niacinate is a synthetic compound, used as a peripheral vasodilatator and as a niacin supplement, which is prepared starting from two naturally occurring molecule, namely Nicotinic acid (niacin) and Inositol. Inositol hexanicinate will be considered as an acceptable source for niacin and therefore it is a NHP that falls under Schedule 1, item 6 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82465";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Inositol hexanicotinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195457;a:27:{s:5:"title";s:15:"Chlorophyll_ACN";s:3:"nid";s:6:"195457";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93296";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:267:"It is the green pigment of plants. Higher plants and green algae contain chlorophyll a and chlorophyll b. Chlorophyll c is found together with chlorophyll a in many types of marine algae. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82466";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Chlorophyll";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195458;a:27:{s:5:"title";s:26:"Citrulline ethyl ester_ACN";s:3:"nid";s:6:"195458";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:599:"Citrulline ethyl ester is a derivative of Citrulline. It has been used as a synthetic substance in several scientific documents- for instance (Fischer 1994; Amato 2005). Citrulline ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from many suppliers. In supplementation, Citruline ethyl ester has been used as a source of Citrulline assuming its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Citrulline ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of Citrulline).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82467";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Citrulline ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195459;a:27:{s:5:"title";s:24:"Ethyl L-isoleucinate_ACN";s:3:"nid";s:6:"195459";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:665:"Isoleucine ethyl ester is a derivative of amino acid Isoleuine (Lide and Milne 1994; CRC-DNP 2009; US-NLM 2009). It has been used as a synthetic substance in several scientific documents- for instance (Lee, Chun et al. 2009). Isoleucine ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from many suppliers. In supplementation, Isoleucine ethyl ester has been used as a source of Isoleucine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Isoleucine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Isoleucine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82468";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Ethyl L-isoleucinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195460;a:27:{s:5:"title";s:24:"Leucine methyl ester_ACN";s:3:"nid";s:6:"195460";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:472:"Leucine methyl ester (CRC-DNP 2009; US-NLM 2009) is the sex pheromone component of scarab beetle Phyllophaga anxia (Robbins, Alm et al. 2006) . Chiral capillary gas chromatographic electroantennographic detection (GC-EAD) analysis indicates that Leucine methyl ester is the major sex pheromone component released by females of the P. lanceolata (Nojima, Robbins et al. 2003). Leucine methyl ester will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82469";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Leucine methyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195461;a:27:{s:5:"title";s:24:"L-Valine ethyl ester_ACN";s:3:"nid";s:6:"195461";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:705:"Valine ethyl ester is a derivative of amino acid Valine (Lide and Milne 1994; CRC-DNP 2009). It has been used as a synthetic substance in several scientific documents- for instance (Fathi, Patel et al. 1997; de los Santos, Ignacio et al. 2007; Edagwa and Taylor 2009). Valine ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from several suppliers (US-NLM 2009). In supplementation, Valine ethyl ester has been used as a source of Valine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Valine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Valine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82470";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"L-Valine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195462;a:27:{s:5:"title";s:23:"Taurine ethyl ester_ACN";s:3:"nid";s:6:"195462";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:580:"Taurine ethyl ester is a derivative of Taurine. In supplementation, Taurine ethyl ester has been used as a source of Taurine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Although no chemical characterizations (such as CAS#, certificate of analysis, manufacturing information, etc.) have been found in the submitted PLAs ,considering Taurine ethyl ester as an acceptable source of Taurine is recommended. Taurine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of Taurine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82471";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Taurine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195463;a:27:{s:5:"title";s:26:"L-Tyrosine ethyl ester_ACN";s:3:"nid";s:6:"195463";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:671:"Tyrosine ethyl ester is a derivative of amino acid Tyrosine (US-NLM 2009) (CRC-DNP 2009). It has been used as a synthetic substance in several scientific documents- for instance (Boehlow, Harburn et al. 2001; Edens, Sharling et al. 2001). Tyrosine ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from several suppliers. In supplementation, Tyrosine ethyl ester has been used as a source of Tyrosine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Tyrosine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Tyrosine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82472";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"L-Tyrosine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195464;a:27:{s:5:"title";s:19:"N-Acetylleucine_ACN";s:3:"nid";s:6:"195464";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:698:"N-Acetylleucine is the acetylated (amide) form of amino acid Leucine (US-NLM 2009). The racemic form DL is used for treating vestibular-related imbalance, vertigo, and as an antiemetic (CRC-DNP 2009) (Sweetman 2009) (Merck 2009). The exact mechanism for the anti-vertigo property of N-Acetyl-DL-Leucine is unknown (Przybyski 2008). However, such this activity (i.e. anti-vertigo) does not establish for N-Acetyl-L-Leucine. Several different acylases (aminoacylases) are present in the body and supplied N-Acetylleucine, could thus be expected to be deacetylated and used as a source of Leucine. N-Acertylleucine will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of Leucine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82473";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"N-Acetylleucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195465;a:27:{s:5:"title";s:25:"N-Acetyl-L-isoleucine_ACN";s:3:"nid";s:6:"195465";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:496:"N-Acetylisoleuice is the acetylated (amide) form of amino acid isoleucine (CRC-DNP 2009; US-NLM 2009). It produced by Streptomyces avermitilis (Nemecek, Novak et al. 1992). N-Acetylisoleuice also found in Mycobacterium ranae (Fowler, Dunn et al. 1961). Aminoacylases are capable of hydrolysis of N-Acetylisoleucine to isoleucine (Kiba, Oyama et al. 1995). N-Acetylisoleucine will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate and the source for the amino acid isoleucine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82474";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"N-Acetyl-L-isoleucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195466;a:27:{s:5:"title";s:28:"beta-Alanine ethyl ester_ACN";s:3:"nid";s:6:"195466";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:664:"ß-Alanine ethyl ester is a derivative of amino acid ß-Alanine (CRC-DNP 2009) (US-NLM 2009). It has been used as a synthetic substance in several scientific documents- for instance (Wright 1969) (Gao, Zhang et al. 2003). ß-Alanine ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from several suppliers. In supplementation, ß-Alanine ethyl ester has been used as a source of ß-Alanine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). ß-Alanine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid ß-Alanine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82475";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"beta-Alanine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195467;a:27:{s:5:"title";s:31:"Calcium alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195467";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:654:"Calcium alpha-Ketoglutarate is the calcium salt of alpha-ketoglutaric acid (US-NLM 2009). One research showed the administration of Calcium alpha-ketoglutarate to malnourished hemodialysis patients improves plasma arginine concentrations (Riedel, Hampl et al. 1996). Another study showed that long-term treatment with Calcium alpha-ketoglutarate normalizes secondary hyperparathyroidism by simultaneously Phosphor binding and correcting Ca/P ratio in serum without vitamin D treatment (Zimmermann, Wassmer et al. 1996). Calcium alpha-ketoglutarate will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate-source of alpha-ketoglutarate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82476";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Calcium alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195468;a:27:{s:5:"title";s:28:"L-Glutamine methyl ester_ACN";s:3:"nid";s:6:"195468";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:648:"Glutamine methyl ester is a derivative of amino acid Glutamine (CRC-DNP 2009). It has been used as a synthetic substance in several scientific documents- for instance (Amato 2005) (Lemoff, Bush et al. 2005). Glutamine methyl ester hydrochloride, as the more stable form, is accessible in commercial scale from several suppliers. In supplementation, Glutamine methyl ester has been used as a source of Glutamine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Glutamine methyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Glutamine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82478";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"L-Glutamine methyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195469;a:27:{s:5:"title";s:25:"L-Leucine ethyl ester_ACN";s:3:"nid";s:6:"195469";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:721:"Leucine ethyl ester is a derivative of Leucine (CRC-DNP 2009; US-NLM 2009). It has been used as a synthetic substance in several scientific documents- for instance (Goldenberg, Goldenberg et al. 1951; Bienvenue, Mathew et al. 2002). L- and DL-Leucine ethyl ester hydrochlorides, as the more stable forms, are accessible in commercial scale from many suppliers. In supplementation, Leucine ethyl ester has been used as a source of Leucine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters) or aminopeptidases (Bienvenue, Mathew et al. 2002). Leucine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Leucine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82479";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"L-Leucine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195470;a:27:{s:5:"title";s:32:"L-Phenylalanine methyl ester_ACN";s:3:"nid";s:6:"195470";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:692:"Phenylalanine methyl ester (CRC-DNP 2009; US-NLM 2009) is prepared using different methods including the esterfication of Phenylalanine (Mirviss, Dahod et al. 1990). A known artificial sweetener ‘Aspartame’ (N-L-a-Aspartyl-L-Phenylalanine 1-methyl ester) metabolised to L-Aspartic acid, L-Phenylalanine, and methanol in gut (Burgert, Andersen et al. 1991; Rowe, Sheskey et al. 2006; Magnuson, Burdock et al. 2007). One research showed the antilukemic activity of Phenylalanine methyl ester (Rosenfeld 1994). Since Phenylalanine methyl ester hydrolyses to Phenylalanine in the body, it will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Phenylalanine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82480";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"L-Phenylalanine methyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195471;a:27:{s:5:"title";s:28:"N-Acetyl-L-phenylalanine_ACN";s:3:"nid";s:6:"195471";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:952:"N-Acetylphenylalanine is the acetylated (amide) form of amino acid Phenylalanine (NIH-NCBI 2009; US-NLM 2009). Many amino acid supplements containing this ingredient are currently used. N-Acetylphenylalanine appears in large amount in urine of patients with phenylketonuria (a human genetic disorder due to the lack of enzyme phenylalanine hydroxylase). N-Acetylphenylalanine is a product of enzyme phenylalanine N-acetyltransferase in the pathway phenylalanine metabolism (Okajima, Inoue et al. 1985). N-Acetylphenylalanine is a non-translocated substrate for the mammalian peptide transporter PepT1 expressed in Xenopus laevis oocytes (Meredith 2002). Several different acylases (aminoacylases) are present in the body and supplied N-Acetylphenylalanine could thus be expected to be deacetylated and used as a source of phenylalanine. N-Acertylphenylalanine will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of phenylalanine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82481";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"N-Acetyl-L-phenylalanine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195472;a:27:{s:5:"title";s:21:"N-Acetyl-L-valine_ACN";s:3:"nid";s:6:"195472";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:567:"N-Acetyl-L-valine is the acetylated (amide) form of amino acid Valine (Wu and Xu 2004; CRC-DNP 2009; US-NLM 2009). Information concerning the biological availability of N-Acetylvaline is limited although amino acid supplements containing this ingredient are currently used. Several different acylases (aminoacylases) are present in the body and supplied N-Acetylvaline could thus be expected to be deacetylated and used as a source of Valine (Yang, Hu et al. 1994). N-Acertylvaline will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of valine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82482";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"N-Acetyl-L-valine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195473;a:27:{s:5:"title";s:26:"Cytidine monophosphate_ACN";s:3:"nid";s:6:"195473";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:484:"Cytidine monophosphate is a cytosine nucleotide containing one phosphate group esterified to the sugar moiety (D-Ribose) in the 5' position which found in RNA (US-NLM 2009). It acts as a carrier of N-acetylneuraminic acid in glycoprotein synthesis (NIH-NCBI 2009). Cytidine monophosphate is isolated from biological sources, e.g. Phaseolus aureus (mung bean) seedlings (CRC-DNP 2009). Cytidine monophosphate will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82483";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Cytidine monophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195474;a:27:{s:5:"title";s:26:"Tyrosine hydrochloride_ACN";s:3:"nid";s:6:"195474";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92814";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:319:"Tyrosine hydrochloride (CAS # 16870-43-2) is the hydrochloride salt of tyrosine, an amino acid that is already classified as an NHP (NHP ID, Sigma-Aldrich).  It is a known source of tyrosine (DNP). It will be considered as an NHP, as a source of tyrosine, under item 2 (isolate) of Schedule 1 under the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82484";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Tyrosine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195475;a:27:{s:5:"title";s:15:"Nattokinase_ACN";s:3:"nid";s:6:"195475";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93343";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:362:"Nattokinase is a potent fibrinolytic enzyme extracted and highly purified from a traditional Japanese food called Natto. Natto is a fermented cheese-like food that has been used in Japan for over 1000 years for its popular taste and as a folk remedy for heart and vascular diseases. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82485";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Nattokinase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195476;a:27:{s:5:"title";s:11:"Muscone_ACN";s:3:"nid";s:6:"195476";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93344";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1186:"Muscone (Fig. 1), in its naturally occurring R(-)-form, is the odorous principle of musk, the dried secretions from the preputial follicles of the musk deer, Moschus moschiferus; and other species, such as the Chinese civet (Veverricula Indica) and the muskrat (Ondatra zibethica) (DNP 2009, NAPRALERTsm 2009, O'Neil et al. 2009, Sweetman 2009).  Muscone has shown experimentally to induce rats liver microsomal cytochrome P450, suggesting potential interactions with other drugs activity and metabolism (Peng et al. 1986, Tanaka et al. 1987, Tanaka et al. 1991).  As a macrocyclic ketone and due to the presence of one chiral center, Muscone has been the target of many racemic and asymmetric syntheses (Blomquist et al. 1948, Nicolaou and Pfefferkorn 2001, Fujimoto et al. 2002, Ito et al. 2005, Erden et al. 2008); as well as the subject of isolation and assay methods apparently due to its increasing use in pharmaceutical preparations (Paik and Kim 2004).  As a naturally occurring substance, Muscone (in its R(-)-form, as well as its synthetic duplicate or racemate forms) meets the substance aspect of the NHP definition, as outlined in the NHP Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82486";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Muscone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195477;a:27:{s:5:"title";s:36:"Secoisolariciresinol diglucoside_ACN";s:3:"nid";s:6:"195477";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93347";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1037:"Secoisolariciresinol diglucoside,(CAS #: 148244-82-0) is an important releasable lignan present in Flaxseeds, in amounts significantly higher (60-700 times) than in other edible plant materials (ChemID Plus, Ford 2001). It was initially isolated from flaxseed and identified in 1947 (Ford 2001) and since then many variations of this isolation have been proposed, using mixtures of different solvents, including methanol, chloroform and water (Frank 2004). Lignans found in Flaxseed (including secoisolariciresinol diglucoside) have been reported to possess phyto-oestrogenic, anticarcinogenic and anti-atherogenic effects (Frank 2004). Secoisolariciresinol diglucoside is specifically known to be a natural cancer chemopreventive agent against breast, prostate and colon cancers. It is metabolized into mammalian lignans enterodiol and enterolactone through the effects of anaerobic fecal microflora (Ford 2001). Secoisolariciresinol diglucoside will be considered as an NHP, under item 2 (isolate) of Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82487";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Secoisolariciresinol diglucoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195478;a:27:{s:5:"title";s:17:"Tocophersolan_ACN";s:3:"nid";s:6:"195478";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93366";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:2397:"alpha-Tocopheryl polyethylene glycol succinate (TPGS, Fig. 1) is an esterified water-soluble vitamin E derivative, mainly used as a non-medicinal ingredient for its surfactant properties (e.g. as absorption enhancer, emulsifying agent, solubilizing agent) in pharmaceutical preparations; also medicinally as a source of vitamin E (Kibbe 2009, Sweetman 2009, USPD 2009). In vitro experiments using human fibroblasts, erythrocytes, or Caco-2 cells have demonstrated TPGS to be taking up as an intact molecule and subsequently be hydrolyzed slowly intracellularly (Traber et al. 1988).  These results have also been demonstrated by Youk et al. (2005) in human lung cancer cell lines, in addition to the observed improved anticancer efficacy compared to alpha-tocopherol succinate due to its increased ability to induce reactive oxygen species (ROS) generation and cell apoptosis in relevant doses.  Consequently to these results, as well as because of its amphiphilic and water solubility nature, TPGS has been studied and showed positive results as an absorption and bioavailability enhancer or vehicle for anticancer drugs, such as camptothecin, paclitaxel, and doxorubicin (Mu et al. 2005, Dong et al. 2008, Ho et al. 2008, Cao and Feng 2008); observations also correlated to its P-glycoprotein inhibition properties (Dintaman and Silverman 1999). Clinically, TPGS has been shown to normalize serum vitamin E levels and improve neurological development, but not improving the increased lipid peroxidation and poor polyunsaturated fatty acids status; after oral administration in cholestatic children (Socha et al. 1997). The information outlined above suggests that TPGS can be used as a source of vitamin E, as this molecule, at least in part, showed to be hydrolyzed to its parent NHP substance; consistent with other tocopherol esters (Fiume 2002).  Consequently, alpha-Tocopheryl polyethylene glycol succinate will be considered as a source of vitamin E and therefore, an NHP.  Note that 'Vitamin E polyethylene glycol succinate' (CAS# 9002-96-4), as a mixture consisting primarily of the mono-esterified polyethylene glycol and a small amount of di-esterified polyethylene glycol, seems to be the main substance used as NMI, whereas the above-mentioned substance seems to be a more purified form, most probably more used for medicinal purposes (Kibbe 2009, NIH 2009, USP/NF 2009, USPD 2009).)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82488";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Tocophersolan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195479;a:27:{s:5:"title";s:16:"Dexpanthenol_ACN";s:3:"nid";s:6:"195479";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93338";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1456:"Dexpanthenol is a synthetic product, reasonably stable under usual sterilization times and temperatures in aqueous solution adjusted to pH 3.0-4.0. However, long heating causes racemization. Dexpanthenol’s natural pH is about 9.5 and it can be hydrolyzed by alkali and strong acid. Panthenol is more stable than pure pantothenic acid, highly soluble in water and rapidly converted to the free acid within the body. It is also more stable than salts of pantothenic acid if the pH can be adjusted to between 3 and 5. Despite the fact that Dexpanthenol’s mechanism of action is unknown, it is readily converted to and excreted as pantothenic acid after oral or parenteral administration, and it is widely distributed into body tissues, mainly as coenzyme A. Dextropantothenyl alcohol has been used topically in the treatment of burns, wounds, decubitus ulcers, eczema, contact dermatitis and pruritus. It has also been used in treatment of lupus erythematosus. The topical use of Dexpanthenol, the stable alcoholic analog of pantothenic acid, is based on good skin penetration and high local concentrations of Dexpanthenol when administered in an adequate vehicle, such as a water-in-oil emulsion. Since Dexpanthenol is readily converted to and excreted as pantothenic acid after oral or parenteral administration, it will be considered as a source of pantothenic acid and therefore it is an NHP that falls under item 3, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82490";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dexpanthenol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195480;a:27:{s:5:"title";s:19:"Anthocyanosides_ACN";s:3:"nid";s:6:"195480";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93371";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:329:"Anthocyanins are naturally occurring compounds that impart color to fruit, vegetables, and plants.They are often observed in the plant kingdom, where they serve to color anything from fruits to the autumn leaves. Most frequent in nature are the glycosides of cyanidin, delphinidin, malvidin, pelargonidin, peonidin and petunidin.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82491";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Anthocyanosides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195481;a:27:{s:5:"title";s:17:"Benzylparaben_ACN";s:3:"nid";s:6:"195481";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93373";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:777:"Benzylparaben is normally prepared by the esterification of 4-hydroxybenzoic acid (a natural product) with benzyl alcohol. It is used as an antimicrobial preservative in cosmetics, food products, and pharmaceutical formulations (Gottschalck and Bailey 2008). Benzylparaben is hydrolyzed to 4-hydroxybenzoic acid in different parts of the body (Jewell, Prusakiewicz et al. 2007). Many other 4-hydroxybenzoic acid esters, such as methyl ester (Methyparaben), ethyl ester (Ethylparaben), butyl ester (Butylparaben) are naturally occurring materials (CRC-DNP 2009). Benzylparaben although not natural, but due to being a source for 4-hydroxybenzoic acid and similar properties with other natural parabens will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82492";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Benzylparaben";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195482;a:27:{s:5:"title";s:18:"Diethanolamine_ACN";s:3:"nid";s:6:"195482";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93271;92722";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:690:"Diethanolamine (Fig. 1) is a secondary amine manufactured commercially by the ammonolysis of ethylene oxide; mainly used, in relation to its pharmaceutical non-medicinal ingredient applications, as a buffering agent, alkalizing agent, emulsifying agent, pH adjuster, dispersant, and/or stabilizing agent (Kibbe 2009, O'Neil et al. 2009, Sweetman 2009). As this substance has been isolated from various Compositae species, such as Senecio dunedin and Echinops exaltatus (DNP 2009, NAPRALERTsm 2009, Brown and Gray 1986), Diethanolamine meets the substance aspect of the NHP definition, under Schedule 1, item 2 (Priority 2; Isolate), as outlined in the NHP Regulations (Justice Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82493";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Diethanolamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195483;a:27:{s:5:"title";s:13:"d-Menthol_ACN";s:3:"nid";s:6:"195483";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93320";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82498";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"d-Menthol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195484;a:27:{s:5:"title";s:26:"Esterified astaxanthin_ACN";s:3:"nid";s:6:"195484";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93407";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82499";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Esterified astaxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195485;a:27:{s:5:"title";s:34:"Magnesium sulfate heptahydrate_ACN";s:3:"nid";s:6:"195485";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93382";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82500";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Magnesium sulfate heptahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195486;a:27:{s:5:"title";s:41:"L-Norvaline ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195486";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82501";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"L-Norvaline ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195487;a:27:{s:5:"title";s:20:"Dihydromyricetin_ACN";s:3:"nid";s:6:"195487";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93428";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:815:"Dihydromyricetin (CAS #: 27200-12-0) is a flavonoid found in leaves of Ampelopsis meliaefolia, from bark of Pinus contoria, from Erythrophleum africanum ( ChemID Plus, O'Neil 2009, Zhang Y 2007). It is considered to be one of the main bioactive ingredients of Ampelopsis grossedentata (Rattan Tea), present in the range of 20-30%(w/w) in the tender stems and leaves of the plant (Zhang YS 2007). It is known for its antioxidant properties (Yang 2008). It has also been shown to have an antagonistic action to arterial systole reaction caused by arterenol and a high concentration of potassium ions, and medical activities in antiphlogosis, relieving cough, decreasing blood-fat, and protecting the liver (Li 2008). Dihydromyricetin will be considered as an NHP, under item 2 (isolate) of Schedule 1 of the NHP regs.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82502";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dihydromyricetin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195488;a:27:{s:5:"title";s:12:"Coumarin_ACN";s:3:"nid";s:6:"195488";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92863";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1484:"Coumarin is a benzopyrone compound. It has a pleasant, fragrant odor resembling that of vanilla beans with burning taste. It occurs in tonka beans, lavender oil, woodruff (Asperula species), in sweet clover (Melilotus) [1-2]. It also found in Cinnamons especially 'Cassia' (Cinnamomum aromaticum) [3]. Coumarin is used extensively in perfumery. It is an antineoplastic, antiinflammatory, antihyperglycaemic agent and  used for treatment of lymphoedema; as herbicide; as inhibitor of cellulose synthetase. It also shows antiprotozoal and antimalarial properties [2]. Coumarin will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).Both Cassia cinnamon (chinese cinnamon) and Ceylon cinnamon are acceptable as NHP which contain coumarin and the amount of coumarin in Cassia is much higher than other type of cinnamon . However, the amount of coumarin in cinnamon does not normally pose a risk for NHPs because the level of consumption is limited. The only federal regulatory which set a limit for coumarin (cinnamon) is Germany [4]; 'Tolerable Daily Intake (TDI) for coumarin= 0.1mg/kg b.w.' which means 7 mg/day for adult based on 70 kg body weight. Each gram of Cassia cinnamon powder contains 2.1-4.4 mg coumarin; therefore, the safest amount of acceptable Cassia would be 1.6 g/day according to the TDI (Germany).P.S. "NHPD has no limits for Coumarin.  However, any dose would have to be supported by safety and efficacy data during assessment before approval."";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82503";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Coumarin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195489;a:27:{s:5:"title";s:49:"Oligosaccharide 4-alpha-D-glucosyltransferase_ACN";s:3:"nid";s:6:"195489";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92760";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:460:"According to the Enzyme Nomenclature database [2], this oligosaccharide ‘transfers the non-reducing terminal alpha-D-glucose residue from a (1->4)-alpha-D-glucan to the 4-position of an alpha-D-glucan, thus bringing about the hydrolysis of oligosaccharides’[1].  It is isolated from Entamoeba histolytica, a human intestinal protozoan parasite [3]. therefore it will be considered as an NHP, under Item 2 (isolate) of the Schedule 1 of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82504";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:45:"Oligosaccharide 4-alpha-D-glucosyltransferase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195490;a:27:{s:5:"title";s:23:"Soy protein isolate_ACN";s:3:"nid";s:6:"195490";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93280";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82505";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Soy protein isolate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195491;a:27:{s:5:"title";s:23:"Soy protein extract_ACN";s:3:"nid";s:6:"195491";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93280";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82506";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Soy protein extract";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195492;a:27:{s:5:"title";s:26:"Soy isoflavone extract_ACN";s:3:"nid";s:6:"195492";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93280";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82507";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Soy isoflavone extract";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195493;a:27:{s:5:"title";s:22:"Free plant sterols_ACN";s:3:"nid";s:6:"195493";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93385";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82508";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Free plant sterols";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195494;a:27:{s:5:"title";s:22:"Free plant stanols_ACN";s:3:"nid";s:6:"195494";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93385";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82509";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Free plant stanols";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195495;a:27:{s:5:"title";s:23:"Plant stanol esters_ACN";s:3:"nid";s:6:"195495";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93385";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82510";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Plant stanol esters";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195496;a:27:{s:5:"title";s:23:"Plant sterol esters_ACN";s:3:"nid";s:6:"195496";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93385";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82511";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Plant sterol esters";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195497;a:27:{s:5:"title";s:21:"Creatine pyruvate_ACN";s:3:"nid";s:6:"195497";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92811";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:2663:"Creatine pyruvate is an organic salt formed between creatine and pyruvic acid. Apparently, this molecule exists in different molar ratios (e.g. 1:1, 1:2, 2:1), in anhydrous or hydrate forms (e.g. 0 to 10 moles of water), and can be synthesized at different temperatures (e.g. 10 to 30 oC) and in different solvents (e.g. alcohols, ethers, ketones, esters or mixtures). Even though the resulting compound would preferably contain a molar ratio of 1:1 (meaning about 60% creatine and 40% pyruvic acid), it is believed to be of relative purity, as it could also be a mixture of different ratio salts with or without unreacted creatine and pyruvic acid (Fang 1999, Pischel et al. 2000, Pischel et al. 2001). In terms of efficacy of Creatine pyruvate as compared to placebo or other creatine compounds (e.g. creatine monohydrate and creatine citrate), the available studies showed mixed results. For example, Creatine pyruvate (7 g per day for 7 days) did not have an impact on endurance capacity or intermittent sprint performance in trained cyclists as compared to placebo (Schuylenbergh R.V. et al. 2003), whereas a beneficial effect on performance during high intensity exercice was observed following the administration of Creatine pyruvate (5 g per day for 28 days) as compared to placebo with slightly better results than creatine citrate (Jager R. et al. 2008). Negative results (i.e. no additional advantage observed with the pyruvate combination) were also observed after 5 weeks creatine and pyruvate supplementation on anaerobic performance and body composition in football players, as compared to creatine monohydrate and calcium pyruvate alone (Stone M.H. et al. 1999). Following isomolar administration of Creatine pyruvate, creatine monohydrate, and creatine citrate, a pharmacokinetic study showed an increase in creatine plasma concentrations in all treatments and all doses, but with slithly higher concentrations of creatine with Creatine pyruvate (Jager R. et al. 2007). These studies show that the safety & efficacy profile, as well as the pharmacokinetics parameters, of Creatine pyruvate are still to be investigated. However, the consensus, at least theoretically, is that the beneficial effects (if any) of Creatine pyruvate, as compared to placebo or other creatine compounds, would be due to the combined effects of creatine and pyruvate individually, as it is expected that this molecule splits into its components in the acid environment of the stomach after ingestion. For this reason, Creatine pyruvate will be considered as a source of two naturally occurring substances, namely creatine and pyruvic acid (DNP 2009); therefore, an NHP.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82512";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Creatine pyruvate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195498;a:27:{s:5:"title";s:24:"Citrus bioflavonoids_ACN";s:3:"nid";s:6:"195498";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93391";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82513";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Citrus bioflavonoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195499;a:27:{s:5:"title";s:38:"L-Valine ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195499";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82514";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"L-Valine ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195500;a:27:{s:5:"title";s:39:"L-Leucine ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195500";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82515";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"L-Leucine ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195501;a:27:{s:5:"title";s:42:"beta-Alanine ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195501";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82516";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"beta-Alanine ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195502;a:27:{s:5:"title";s:40:"L-Leucine methyl ester hydrochloride_ACN";s:3:"nid";s:6:"195502";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92871";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82517";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:36:"L-Leucine methyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195503;a:27:{s:5:"title";s:25:"Eicosapentaenoic acid_ACN";s:3:"nid";s:6:"195503";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92623";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82518";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Eicosapentaenoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195504;a:27:{s:5:"title";s:24:"Docosahexaenoic acid_ACN";s:3:"nid";s:6:"195504";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92623";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82519";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Docosahexaenoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195506;a:27:{s:5:"title";s:30:"d-alpha Tocopheryl acetate_ACN";s:3:"nid";s:6:"195506";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;93278";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82521";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"d-alpha Tocopheryl acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195507;a:27:{s:5:"title";s:11:"Olaflur_ACN";s:3:"nid";s:6:"195507";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93523";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1163:"Olaflur (amine fluoride 297 or AmF) (US-NLM 2009) is an anticariogenic organic amine fluoride which often used in combination with stannous fluoride (SnF2) or sodium fluoride. It reduces surface tension of saliva, forming a protective film on tooth surfaces (Merck 2009). Olaflur is used as a source of fluoride (Sweetman 2009).Toothpastes containing the AmF/SnF2 complex have antimicrobial properties due to the amine and stannous parts and are well known for their inhibitory effects on growth of oral microorganisms and for the retardation of plaque growth. Moreover, the additional use of AmF/SnF2 mouthwash after brushing is effective in reducing the acid metabolism in dental plaque and tongue flora (Gerardu, van Loveren et al. 2006). In a recent study, at the same concentrations, acidic SnF2 and AmF (pH= 3.9) were shown to be more effective than NaF to protect enamel against erosion. Thus, the hypothesis that the different fluoride solutions will not differ in their potential to reduce enamel erosion is rejected (Wiegand, Bichsel et al. 2009). Olaflur will be considered as a NHP, under schedule 1, item 7 (mineral), Priority 1 (source of Fluoride).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82522";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Olaflur";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195508;a:27:{s:5:"title";s:37:"Nicotinamide adenine dinucleotide_ACN";s:3:"nid";s:6:"195508";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93562";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:441:"NAD (for Nicotinamide adenine dinucleotide), one of the bioactive forms of nicotinic acid, is a coenzyme widely distributed in living cells which serves as an hydrogen acceptor, forming NADH which then serves as a hydrogen donor in the respiratory chain.  Since Nicotinamide Adenine Dinucleotide can be found in cells of living organisms, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82523";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Nicotinamide adenine dinucleotide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195509;a:27:{s:5:"title";s:16:"Benzoic Acid_ACN";s:3:"nid";s:6:"195509";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1066:"Benzoic acid is the simplest aromatic carboxylic acid, which can be found in nature in its free form or as its combined forms.  For exemple, gum benzoin, which is the balsamic resin obtained from the bark of several species of trees in the genus Styrax, is known to contain up to 20% free benzoic acid and up to 40% benzoic acid esters, which is why gum resin was for a long time the only source of benzoic acid.  Now a days, Benzoic acid is commercially synthetized using the oxidation of toluene.  Benzoic acid (also as its sodium, calcium and potassium salts) is a well known preservative (which is why it is listed in the NHPD acceptable NMIs list) and is also used, mostly in combination with salicylic acid, as a topical antifungal, since Benzoic acid have the properties of inhibiting the growth of mold, yeast and certain bacteria.  Its sodium salt, sodium benzoate, is already classified in the database as a Priority 2 NHP.  For these reasons, Benzoic acid will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82524";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Benzoic Acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195510;a:27:{s:5:"title";s:32:"Magnesium phosphate, dibasic_ACN";s:3:"nid";s:6:"195510";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93566";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:305:"Magnesium phosphate, dibasic is found in nature as its trihydrate form, under the mineral names newberyite, phosphor-roesslerite.  It is also listed in the NHPD acceptable NMIs list.  For these reasons, it will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82526";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Magnesium phosphate, dibasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195511;a:27:{s:5:"title";s:42:"L-Isoleucine ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195511";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93639";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82527";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"L-Isoleucine ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195512;a:27:{s:5:"title";s:24:"Calcium D-saccharate_ACN";s:3:"nid";s:6:"195512";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93685";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82528";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Calcium D-saccharate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195513;a:27:{s:5:"title";s:22:"Ammonium succinate_ACN";s:3:"nid";s:6:"195513";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93531";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:460:"Ammonium succinate is ammonium salt of succinic acid (NIH 2009).  This substance has been used experimentally as a source for both ammonium and succinate, and shown to normalize adenine nucleotides in old rats (Kaminsky et al. 1983).  As such, Ammonium succinate is interpreted as an acceptable derivative and consequently, as meeting the substance aspect of the natural health product definition, as outlined in the NHP Regulations (Government of Canada 2009)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82529";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Ammonium succinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195514;a:27:{s:5:"title";s:11:"Silybin_ACN";s:3:"nid";s:6:"195514";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93603";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:691:"Silybin is a flavolignan that has been isolated as a mixture of two diastereoisomers, Silybin A and B, from the fruit or seeds of milk thistle, Silybum marianum (DNP 2009, NAPRALERTsm 2009, O’Neil et al. 2009).
This compound that is isolated or as a standardized extract of Silybum marianum called silymarin, has shown experimentally and/or clinically a potential for its use in a wide range of applications, due to its hepatoprotective, chemoprotective, neuroprotective, and other effects (Kren and Walterova 2005).
Based on the above information, Silybin meets the substance aspect of the natural health product definition, as outlined in the NHP Regulations (Government of Canada 2009).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82530";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Silybin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195515;a:27:{s:5:"title";s:13:"Taxifolin_ACN";s:3:"nid";s:6:"195515";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93530";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:776:"Taxifolin (CAS # 480-18-2 for the (2R,3R)-form), a plant flavonoid, is also known as dihydroquercetin and is found in Leguminosae, Labiateae, Cactaceae, Erythroxylaceae, Illiciaceae, Polygonaceae, Salicaceae, Winteraceae, Ericaceae, Moraceae, Dilleniaceae, Eucryphiaceae, Hamamelidaceae, Myrtaceae, Balanophoraceae, Lauraceae, Sapotaceae, Anacardiaceae, Fagaceae and Rosaceae (ChemID Plus, DNP). It is known to possess antiinflammatory, antineoplastic, antifungal, analgesic and antioxidant properties (DNP, Chem ID, Sheu 2009, Theriault 2000).
Taxifolin will be considered as an NHP, under item 2 (isolate) of Schedule 1 of the NHP regulations.
According to the CTFA (also known as Personal Care Products Council), Taxifolin can also be used as antioxidants in certain limits";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82532";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Taxifolin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195516;a:27:{s:5:"title";s:16:"Turkesterone_ACN";s:3:"nid";s:6:"195516";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93727";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:627:"Turkesterone (US-NLM 2009) is a phytoecdysteroid (ecdysteroid isolated from plants) (Merck 2009) found in Ajuga turkestanica, Tapinella panaoides (CRC-DNP 2009) and Vitex spicies (Sena, Duringer et al. 2008). Turkesterone does not bind to the cytosolic steroid receptors, instead, it is likely to influence signal transduction pathways, like the anabolic steroids, possibly via membrane bound receptors. It also may serve as an effective hepatoprotective, immunoprotective, antioxidant and hypoglycemic agent (Bathori, Toth et al. 2008). Turkesterone will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82533";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Turkesterone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195517;a:27:{s:5:"title";s:19:"Vanillylacetone_ACN";s:3:"nid";s:6:"195517";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93761";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:697:"Zingerone is the pungent principle of ginger and is also present in cranberry, raspberry and mango (DNP 2010, NIH 2010, O'Neil et al. 2009). It has been used in fragrances, flavors, cosmetics, and artificial spice oils (FCC 2008, Peter 2001). The reported usage range of zingerone in food and beverages is 0.4-60 ppm (Burdock 2005). Zingerone has been found to be an efficient peroxynitrite scavenger and therefore potentially useful in the prevention of peroxynitrite related diseases (Shin et al. 2005). Based on the above, zingerone meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 2 (isolate) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82534";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Vanillylacetone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195518;a:27:{s:5:"title";s:13:"Inulinase_ACN";s:3:"nid";s:6:"195518";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93744";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:829:"Inulase, or Inulinase (1-beta-D-fructan fructanohydrolase, EC 3.2.1.7), is an enzyme that is responsible for the endohydrolysis of (2->1)-beta-D-fructosidic linkages in inulin and has been isolated from a number of yeast and fungi including Aspergillus, Kluyveromyces and Penicillium strains (SIB 2010, Singh et al. 2006, Uhm et al. 1987). The hydrolysis of inulin by inulase produces fructose, through a single step method, and this method is used to make high fructose syrup (Singh et al. 2006). The enzyme inulase is also used in the production of ethanol, inulo-oligosaccharides, gluconic acid, sorbitol, pullulan and acetone-butanol (Singh et al. 2006).Inulase meets the substance aspect of the Natural Health Product (NHP) definition, under item 2 (isolate) of Schedule 1 to the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82535";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Inulinase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195519;a:27:{s:5:"title";s:32:"Phenethylamine hydrochloride_ACN";s:3:"nid";s:6:"195519";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93759";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:374:"Phenylethylamine is classified in the Natural Health Products Ingredients Database (NHPID) as an NHP substance and this, under the Approved Name Benzeneethanamine (Health Canada 2010, NIH 2010). As its hydrochloride salt is a source ingredient for this substance, it will be considered as such; and thefefore, an NHP substance (Government of Canada 2010, O'Neil et al. 2009)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82536";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Phenethylamine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195520;a:27:{s:5:"title";s:12:"Anserine_ACN";s:3:"nid";s:6:"195520";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93996";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:466:"Anserine is a naturally occurring methylated analog of carnosine. It is a dipeptide found in some animal tissues [1-2]. In model systems it is a potent antioxidant and scavener of hydroxyl radicals. It inhibits nonenzymatic protein glycation induced by aldose and ketose reducing sugars. It is much less potent than L-carnosine as an inhibitor of protein-protein crosslinking [3-4]. Anserine will be considered as NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82537";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Anserine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195521;a:27:{s:5:"title";s:17:"Fursultiamine_ACN";s:3:"nid";s:6:"195521";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93745";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82538";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Fursultiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195522;a:27:{s:5:"title";s:33:"Tocopherol concentrate, mixed_ACN";s:3:"nid";s:6:"195522";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93645";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:479:"Naturally occurring tocopherols are alpha-tocopherol, beta-tocopherol, gamma-tocopherol and delta-tocopherol.  They are all naturally occurring forms of vitamin E (tocotrienols being the other forms), alpha-tocopherol being the most bioactive, which is why Vitamin E is commonly referred to alpha-tocopherol only.  Since all these forms are naturally occurring, Mixed tocopherols will be considered as a NHP, under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82539";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Tocopherol concentrate, mixed";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195523;a:27:{s:5:"title";s:16:"Sulbutiamine_ACN";s:3:"nid";s:6:"195523";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93746";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:415:"Sulbutiamine is a derivative of Thiamine disulfide (which is a derivative of Thiamine -Vitamin B1), which acts as an enzyme cofactor (vitamin). Sulbutiamine is indicated for the treatment of asthenia and has been reported to reduce fatigue, memory difficulties, and intellectual tiredness. Sulbutiamine will be considered as a NHP (as a source of Thiamine disulfide), under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82540";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Sulbutiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195524;a:27:{s:5:"title";s:15:"Tannic acid_ACN";s:3:"nid";s:6:"195524";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93975";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:715:"The available evidence clearly indicates that tannic acid falls under item 2 of Schedule 1 to the Natural Health Products Regulations, i.e. an extract, or in some cases specific isolates that share the common name of tannic acid, of a plant material (Government of Canada 2010), as already set out in the NHP Ingredients Database.

With respect to its medicinal role, there is evidence to support this role in topical products. For oral administration, the NHPID needs a Toxicity Restriction:

    Crude tannic acid administered orally has been associated with hepatotoxicity, while certain ellagitannin isolates may protect against hepatotoxicity. Additional evidence of safety for oral administration is required.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:217:"Crude tannic acid administered orally has been associated with hepatotoxicity, while certain ellagitannin isolates may protect against hepatotoxicity. Additional evidence of safety for oral administration is required.";s:24:"field_restriction_desc_f";s:284:"L'acide tannique brute administrée par voie orale est associée à l'hépatoxicité, tandis que certains isolats d'ellagitannine peuvent protéger contre l'hépatoxicité. Des preuves à l'appui supplémentaires pour l'innocuité sont requises pour une administration par voie orale.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82541";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Tannic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195525;a:27:{s:5:"title";s:23:"Omega-3 Fatty acids_ACN";s:3:"nid";s:6:"195525";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93458";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82542";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Omega-3 Fatty acids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195526;a:27:{s:5:"title";s:25:"Whey, Reduced Lactose_ACN";s:3:"nid";s:6:"195526";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93840";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82544";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Whey, Reduced Lactose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195527;a:27:{s:5:"title";s:26:"Whey, Reduced Minerals_ACN";s:3:"nid";s:6:"195527";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93840";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82545";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Whey, Reduced Minerals";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195528;a:27:{s:5:"title";s:28:"Whey protein hydrolysate_ACN";s:3:"nid";s:6:"195528";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93840";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82546";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Whey protein hydrolysate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195529;a:27:{s:5:"title";s:17:"Homocarnosine_ACN";s:3:"nid";s:6:"195529";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93997";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82547";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Homocarnosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195530;a:27:{s:5:"title";s:20:"Nickel carbonate_ACN";s:3:"nid";s:6:"195530";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93949";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:181:"There is scientific evidence suggesting that Nickel carbonate can be carcinogenic under certain conditions. Safety of the ingredient should be considered when assessing the product.";s:24:"field_restriction_desc_f";s:213:"Il existe des preuves scientifiques suggérant que le Carbonate de nickel peut être cancérigène sous certaines conditions. On doit tenir compte de l'innocuité de l'ingrédient lors de l'évaluation du produit.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82548";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Nickel carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195531;a:27:{s:5:"title";s:18:"Isocitric acid_ACN";s:3:"nid";s:6:"195531";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82549";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Isocitric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195532;a:27:{s:5:"title";s:32:"Catechol O-methyltransferase_ACN";s:3:"nid";s:6:"195532";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82550";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Catechol O-methyltransferase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195533;a:27:{s:5:"title";s:25:"Polygalacturonic acid_ACN";s:3:"nid";s:6:"195533";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82551";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Polygalacturonic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195534;a:27:{s:5:"title";s:19:"beta-1,3-Glucan_ACN";s:3:"nid";s:6:"195534";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82552";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"beta-1,3-Glucan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195535;a:27:{s:5:"title";s:29:"L-ornithine hydrochloride_ACN";s:3:"nid";s:6:"195535";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93448;94095";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82553";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"L-ornithine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195536;a:27:{s:5:"title";s:20:"delta-Tocopherol_ACN";s:3:"nid";s:6:"195536";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82554";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"delta-Tocopherol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195537;a:27:{s:5:"title";s:16:"Ademetionine_ACN";s:3:"nid";s:6:"195537";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82555";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Ademetionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195538;a:27:{s:5:"title";s:15:"Sitogluside_ACN";s:3:"nid";s:6:"195538";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82556";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sitogluside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195539;a:27:{s:5:"title";s:10:"Chitin_ACN";s:3:"nid";s:6:"195539";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82557";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Chitin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195540;a:27:{s:5:"title";s:19:"Rosmarinic acid_ACN";s:3:"nid";s:6:"195540";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82558";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Rosmarinic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195541;a:27:{s:5:"title";s:19:"meso-Zeaxanthin_ACN";s:3:"nid";s:6:"195541";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93135";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82559";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"meso-Zeaxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195542;a:27:{s:5:"title";s:26:"L-Arginine ethyl ester_ACN";s:3:"nid";s:6:"195542";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93029";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82560";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"L-Arginine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195543;a:27:{s:5:"title";s:37:"Cellulose 1,4-beta-cellobiosidase_ACN";s:3:"nid";s:6:"195543";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82561";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Cellulose 1,4-beta-cellobiosidase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195544;a:27:{s:5:"title";s:26:"Trimagnesium dicitrate_ACN";s:3:"nid";s:6:"195544";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94091";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82562";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Trimagnesium dicitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195545;a:27:{s:5:"title";s:24:"L-Lysine-L-aspartate_ACN";s:3:"nid";s:6:"195545";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94091";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82563";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"L-Lysine-L-aspartate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195546;a:27:{s:5:"title";s:16:"Fumaric acid_ACN";s:3:"nid";s:6:"195546";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94361";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82564";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Fumaric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195547;a:27:{s:5:"title";s:16:"Pyruvic acid_ACN";s:3:"nid";s:6:"195547";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94361";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82565";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pyruvic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195548;a:27:{s:5:"title";s:20:"Sodium caseinate_ACN";s:3:"nid";s:6:"195548";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93811";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82566";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Sodium caseinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195549;a:27:{s:5:"title";s:21:"Berberine sulfate_ACN";s:3:"nid";s:6:"195549";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93351";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82567";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Berberine sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195550;a:27:{s:5:"title";s:54:"Casein phosphopeptide- amorphous calcium phosphate_ACN";s:3:"nid";s:6:"195550";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94772";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:913:"Casein phosphopeptide- amorphous calcium phosphate (CPP-ACP) is a complex delivering calcium and phosphate to the teeth enamel in a stable manner, then promotes remineralization. The peptide part (CPP) maintains calcium and phosphate in an amorphous, soluble form, and binds to the surface of the tooth thus presenting this soluble calcium phosphate at a high concentration to promote remineralization [1]. At the same time, it also prevents demineralization of teeth [2].
In a recent study, CPP-ACP sugar-free gum significantly slowed progression and enhanced regression of approximal caries relative to a control sugar-free gum [3]. Since every parts of the CPP-ACP complex are considered natural, the combination of these NHPs, i.e. Casein phosphopeptide- amorphous calcium phosphate, will be considered as a NHP, and also as a source for calcium and phosphorus, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82568";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:50:"Casein phosphopeptide- amorphous calcium phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195551;a:27:{s:5:"title";s:21:"Hydrolyzed casein_ACN";s:3:"nid";s:6:"195551";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94772";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:371:"Casein hydrolysate (or Casein peptides) is the break-down product of Casein protein, the predominant protein found in fresh milk.  It is composed essentially of different small peptide units, containing various essential and non-essential amino acids.  Casein hydrolysate will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82569";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hydrolyzed casein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195552;a:27:{s:5:"title";s:12:"Smectite_ACN";s:3:"nid";s:6:"195552";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94562";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:657:"Smectites are natural aluminum silicate mineral clays, from which the most common members are montmorillonite, nontronite, and saponite (Mindat 2010, Sweetman 2010). Some smectites, such as dioctahedral smectite, have been used in the management of diarrhea, and as antacid (PharmaSuisse 2008, Sweetman 2010). Smectites are also used as excipients, for example hectorite and saponite used as absorbent, emulsifying, and viscosity-increasing agent (Rowe et al. 2009). Based on the above, Smectites meet the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 7 (mineral) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82570";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Smectite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195553;a:27:{s:5:"title";s:21:"Calcium caprylate_ACN";s:3:"nid";s:6:"195553";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94560";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:617:"Calcium caprylate is the 1:2 calcium salt of caprylic acid, a substance found in and isolated from many plant oils (DNP 2010, NAPRALERTsm 2010, NIH 2010). Similar to caprylic acid, calcium caprylate has antifungal activity (Sweetman 2010). Calcium caprylate is also used as a binder, emulsifier, and anticaking agent in foods (Yannai 2004, Smith and Hong-Shum 2003).Based on the above, it is believed that calcium caprylate has the potential to act as a source ingredient for caprylic acid, a substance falling under Schedule 1, item 2 (isolate) of the Natural Health Products Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82571";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium caprylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195554;a:27:{s:5:"title";s:23:"Magnesium caprylate_ACN";s:3:"nid";s:6:"195554";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94560";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:628:"Magnesium caprylate is the 1:2 magnesium salt of caprylic acid, a substance found in and isolated from many plant oils (DNP 2010, NAPRALERTsm 2010, NIH 2010). Similar to caprylic acid, magnesium caprylate has antifungal activity (Sweetman 2010). Magnesium caprylate is also used as a binder, emulsifier, and anticaking agent in foods (Yannai 2004, Smith and Hong-Shum 2003). Based on the above, it is believed that magnesium caprylate has the potential to act as a source ingredient for caprylic acid, a substance falling under Schedule 1, item 2 (isolate) of the Natural Health Products Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82572";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Magnesium caprylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195555;a:27:{s:5:"title";s:18:"Zinc caprylate_ACN";s:3:"nid";s:6:"195555";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94560";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:699:"Zinc caprylate is the 1:2 zinc salt of caprylic acid, a substance found in and isolated from many plant oils (DNP 2010, NAPRALERTsm 2010, NIH 2010, O’Neil et al. 2010). The structure of pure anhydrous zinc caprylate consists of polymeric parallel sheets (Lacouture et al. 2000). Similar to caprylic acid, zinc caprylate has antifungal activity (O’Neil et al. 2010, Sweetman 2010). Zinc caprylate is also used as PVC stabilizer (Kirk-Othmer 2010). Based on the above, it is believed that zinc caprylate has the potential to act as a source ingredient for caprylic acid, a substance falling under Schedule 1, item 2 (isolate) of the Natural Health Products Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82573";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Zinc caprylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195556;a:27:{s:5:"title";s:18:"Procyanidin B2_ACN";s:3:"nid";s:6:"195556";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94852";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:593:"Procyanidins are derivatives of the flavan-3-o1 class of flavonoids. This class includes (+)-catechin, commonly referred to as catechin, and (-)-epicatechin, commonly referred to as epicatechin. Procyanidins are dimers and oligomers of catechin and epicatechin and their gallic acid esters. Procyanidins are widely distributed in the plant kingdom and are found in grape seeds, cocoa, chocolate, apples, peanuts, almonds, cranberries, blueberries and in the bark of pines, among other plant sources. Procyanidin B-2 will be considered as an NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82574";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Procyanidin B2";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195557;a:27:{s:5:"title";s:15:"Sierra clay_ACN";s:3:"nid";s:6:"195557";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94548";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:594:"Sierra clay is a natural mineral from the Sierra Mountains, Nevada, USA (Bailey 1945, USDA 1906). This mineral composition, having the commercial name SierraSil® and containing many minerals such as smectite, gypsum, quartz, feldspar, jarosite, kaolinite and/or zeolite, has been demonstrated to be relatively safe and effective in the treatment of osteoarthritis (Bentley 2009, Miller et al. 2005). Based on the above, Sierra clay meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 5 (mineral) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82575";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sierra clay";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195558;a:27:{s:5:"title";s:22:"Konjac glucomannan_ACN";s:3:"nid";s:6:"195558";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95020";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82577";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Konjac glucomannan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195559;a:27:{s:5:"title";s:13:"L-Cystine_ACN";s:3:"nid";s:6:"195559";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94999";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:537:"L-Cystine is a non-essential amino acid, widely distributed in proteins, that has been isolated from many biological sources, such as from horn hydrolysate (DNP 2010, NAPRALERTsm 2010, O’Neil et al. 2010). It has been used as a dietary supplement, as well in the treatment of congenital homocystinuria in low-methionine diets (Sweetman 2010).

Based on the above, L-Cystine meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 2 (isolate) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82578";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"L-Cystine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195560;a:27:{s:5:"title";s:19:"Ferric chloride_ACN";s:3:"nid";s:6:"195560";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95085";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82579";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Ferric chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195561;a:27:{s:5:"title";s:19:"Behenyl alcohol_ACN";s:3:"nid";s:6:"195561";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82580";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Behenyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195562;a:27:{s:5:"title";s:56:"Aluminium Hydroxide-Magnesium Carbonate Co-dried Gel_ACN";s:3:"nid";s:6:"195562";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82581";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:52:"Aluminium Hydroxide-Magnesium Carbonate Co-dried Gel";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195563;a:27:{s:5:"title";s:10:"Cresol_ACN";s:3:"nid";s:6:"195563";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82582";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Cresol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195564;a:27:{s:5:"title";s:20:"Aluminum acetate_ACN";s:3:"nid";s:6:"195564";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82583";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Aluminum acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195565;a:27:{s:5:"title";s:11:"Dextran_ACN";s:3:"nid";s:6:"195565";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82584";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Dextran";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195566;a:27:{s:5:"title";s:27:"Potassium pyrophosphate_ACN";s:3:"nid";s:6:"195566";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82585";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Potassium pyrophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195567;a:27:{s:5:"title";s:29:"Tetrasodium pyrophosphate_ACN";s:3:"nid";s:6:"195567";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82586";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Tetrasodium pyrophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195568;a:27:{s:5:"title";s:14:"Dextran 70_ACN";s:3:"nid";s:6:"195568";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82587";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dextran 70";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195569;a:27:{s:5:"title";s:19:"Sodium benzoate_ACN";s:3:"nid";s:6:"195569";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82588";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium benzoate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195570;a:27:{s:5:"title";s:19:"Sodium alginate_ACN";s:3:"nid";s:6:"195570";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82589";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium alginate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195571;a:27:{s:5:"title";s:17:"Palmitic acid_ACN";s:3:"nid";s:6:"195571";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82590";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Palmitic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195572;a:27:{s:5:"title";s:14:"Oleic acid_ACN";s:3:"nid";s:6:"195572";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82591";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Oleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195573;a:27:{s:5:"title";s:21:"Hydrofluoric acid_ACN";s:3:"nid";s:6:"195573";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82592";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hydrofluoric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195574;a:27:{s:5:"title";s:18:"Propyl alcohol_ACN";s:3:"nid";s:6:"195574";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82593";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Propyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195575;a:27:{s:5:"title";s:16:"Stearic acid_ACN";s:3:"nid";s:6:"195575";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82594";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Stearic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195576;a:27:{s:5:"title";s:18:"Sodium acetate_ACN";s:3:"nid";s:6:"195576";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82595";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Sodium acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195577;a:27:{s:5:"title";s:16:"Benzophenone_ACN";s:3:"nid";s:6:"195577";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82597";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Benzophenone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195578;a:27:{s:5:"title";s:24:"Bismuth subcarbonate_ACN";s:3:"nid";s:6:"195578";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82598";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Bismuth subcarbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195579;a:27:{s:5:"title";s:19:"Micellar casein_ACN";s:3:"nid";s:6:"195579";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"94911;93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:559:"Casein exists in milk as large colloidal particles called casein micelles, which are spherical particles with a mean radius of 80 nm, composed of four different casein molecules (αs1-, αs2-, β-, and κ-casein) and around 8% minerals such as calcium and phosphorus (Farrell et al. 2006, Panouille et al. 2005, Abbasi and Dickinson 2004, Schorsch et al. 2002).
Based on the above, micellar casein meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 2 (isolate) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82599";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Micellar casein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195580;a:27:{s:5:"title";s:25:"Cetylated fatty acids_ACN";s:3:"nid";s:6:"195580";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94338";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:317:"Celadrin is a novel compound developed through a proprietary process. The product is an all-natural ingredient which has been clinically shown to provide joint health, flexibility and improved quality of life on a cumulative basis with no reported side effects. Small modifications to fatty acids mean esterification.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82600";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Cetylated fatty acids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195581;a:27:{s:5:"title";s:23:"Hyodeoxycholic acid_ACN";s:3:"nid";s:6:"195581";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95075";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:656:"Hyodeoxycholic acid is a bile acid isolated from pig bile (Sacquet et al. 1983, O’Neil et al. 2010). It was also isolated from chicks (Haslewood 1971). Recently, Hyodeoxycholic acid was isolated from human plasma and quantified (Xiang et al. 2010). Some researchers showed that Hyodeoxycholic acid can reduce the formation of cholesterol and cholesterol-induced gallstones in animals (Sehayek et al. 2001, Cohen-Solal et al. 1995, Singhal et al. 1984). Based on the above, Hyodeoxycholic acid meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 2 (isolate) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82601";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Hyodeoxycholic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195582;a:27:{s:5:"title";s:23:"Tricreatine citrate_ACN";s:3:"nid";s:6:"195582";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95131";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:279:"Tricreatine citrate is the Creatine salt (3:1) of Citric acid. It is a source of two NHPs (combination of NHPs), namely Creatine and Citric acid (It is used as an acceptable source for Creatine [1]). It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82602";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Tricreatine citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195583;a:27:{s:5:"title";s:29:"8'-Apo-beta-caroten-8'-al_ACN";s:3:"nid";s:6:"195583";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95330";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1199:"This carotenoid is believed to be an intermediate in at least one of the metabolism pathways of β-carotene to vitamin A retinoids; and consequently, considered as a pro-vitamin A carotenoid (Ho et al. 2007, Wang et al. 1992).  Other than its vitamin A activity, β-Carotinal has shown, experimentally in rats and mice, to possess activities which β-carotene lacks, such as the relative ability to induce liver xenobiotic-metabolizing enzymes (Astorg et al. 1997, Gradelet et al. 1997).  Furthermore, pharmacokinetic studies in human suggested that, in addition to its possible direct vitamin A retinoids pathway, β-Carotinal is converted to its corresponding acid (also found in dogs), alcohol, and fatty acyl ester. Ultimately, it could also result in vitamin A retinoids (Zeng et al. 1992, Bagdon et al. 1962). Based on the above, β-Carotinal meets the substance aspect of the natural health product definition, under Schedule 1, item 2 (isolate) of the Natural Health Products Regulations (Government of Canada 2010).  However, it is not considered as a source ingredient for β-carotene, based on the definition of derivatives in the Product Licensing Guidance Document (Health Canada 2006).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82603";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"8'-Apo-beta-caroten-8'-al";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195584;a:27:{s:5:"title";s:24:"Xylooligosaccharides_ACN";s:3:"nid";s:6:"195584";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95117";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1011:"Xylooligosaccharides are oligomers of xylose units, produced by the chemical, enzymatic and/or thermal hydrolysis of lignocellulosic materials such hardwoods, corncobs, and bran. These oligosaccharides are mainly composed of two or three xylose units with β-1,4-linkages (Akpinar et al. 2009, Vazquez et al. 2000). They have been shown to possess a variety of health-related effects, such as improving sugar and lipids levels in patients with type 2 diabetes mellitus, inhibiting the development of precancerous lesions, promoting the growth of Bifidobacterium, and lowering the cecal pH in rats (Sheu et al. 2008, Hsu et al. 2004). Xylooligosaccharides also normalize bowel movement in pregnant women by regulating intestinal flora and increasing the intestinal contents (Tateyama et al. 2005).Based on the above, Xylooligosaccharides meet the substance aspect of the natural health product definition, under Schedule 1, item 2 (extract) of the Natural Health Products Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82604";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Xylooligosaccharides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195585;a:27:{s:5:"title";s:25:"Glyceryl monostearate_ACN";s:3:"nid";s:6:"195585";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94362";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1276:"Glyceryl monostearate is an ester prepared from the reaction of glycerine with the triglycerides from animal or vegetable sources or by the reaction of glycerine with stearoyl chloride (NIH 2010, Rowe et al. 2009). It has been used in pharmaceutical dispensing, cosmetics, and foods as emollient, emulsifying agent, solubilising agent, stabilizing agent, sustained-release agent, and tablet/capsule lubricant (O’Neil et al. 2010, PCPC 2010, Smith and Hong-Shum 2003, Sweetman 2010).It was reported that Glyceryl monostearate was isolated from cultures of Penicillium sp. (DNP 2010, Harri et al. 1963). The original report on the naturally occurring form of glyceryl monostearate was closely investigated. A considerable consistency between the isolated substance in the report and authentic samples (such as IR spectrum, melting point, and elemental analysis) was found (Discussion 2010). It is noteworthy to mention that Glyceryl monostearate, identified as 1-_O_-Stearylglycerin (α-Monostearin) in the article, has been reported by Harri et al. (1963) as a by-product.Based on the above, glyceryl monostearate meets the substance aspect of the Natural Health Product (NHP) definition, under Schedule 1, item 2 (isolate) of the NHP Regulations (Government of Canada 2010).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82605";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Glyceryl monostearate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195586;a:27:{s:5:"title";s:22:"Sodium Hyaluronate_ACN";s:3:"nid";s:6:"195586";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"95410;93133";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82606";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Sodium Hyaluronate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195587;a:27:{s:5:"title";s:30:"Bonito Peptide Hydrolysate_ACN";s:3:"nid";s:6:"195587";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"96404;95173;98584";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:837:"Obtained by the enzymatic hydrolysis of dried bonito muscle homogenates (Curtis et al. 2002, Yokoyama et al. 1992). The thermolysin digest of this Japanese traditional food, also known as Katsuobushi, has shown to possess antihypertensive activity both experimentally and clinically, with leucine-lysine-proline-asparagine-methionine (LKPNM) being the most potent of the eight peptides that has been isolated from this hydrolysate (Fujita and Yoshikawa 1999, Fujita et al. 1997a, Fujita et al. 1997b, Fujita et al. 1995). It meets meet the substance aspect of the natural health product definition, under Schedule 1, item 2 (extract) of the Natural Health Products Regulations (Government of Canada 2010). (Note that the name originally requested was Bonito fish peptides, however this name was not found in any authoritative reference.)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82607";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Bonito Peptide Hydrolysate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195588;a:27:{s:5:"title";s:44:"Leucyl-lysyl-prolyl-asparagyl-methionine_ACN";s:3:"nid";s:6:"195588";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"95173;93133";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:44:"See rational for Bonito muscle hydrolysates.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82608";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Leucyl-lysyl-prolyl-asparagyl-methionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195589;a:27:{s:5:"title";s:18:"Gluconolactone_ACN";s:3:"nid";s:6:"195589";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95279";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:440:"Gluconolactone is a naturally-occurring food additive. It is a lactone (cyclic ester) of D-gluconic acid. Biological oxidation of glucose at the C1 position yield δ-gluconolactone. The extent to which δ-gluconolactone is hydrolyzed to nondissociated gluconic acid and gluconate is strongly pH dependent.
Gluconolactone will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82609";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Gluconolactone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195590;a:27:{s:5:"title";s:17:"Pterostilbene_ACN";s:3:"nid";s:6:"195590";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95284";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:627:"Pterostilbene is a naturally occurring compound belonging to a group called
stilbenes, one of the group of phenolics found in grapes, blueberries and wine.
Pterostilbene is the dimethyl ether analog of Resveratrol.
Pterostilbene will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the Natural Health Products Regulations.

References: 
1. DNP 2010. Dictionary of Natural Products, Version 17.1, CRC Press. Hampden Data Services Ltd. Taylor & Francis Group. Electronic version.
2. Rimando et al. 2004. Resveratrol, Pterostilbene, and Piceatannol in Vaccinium Berries. J. Agric. Food Chem. 52:4713-4719";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82610";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Pterostilbene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195591;a:27:{s:5:"title";s:16:"Caffeic acid_ACN";s:3:"nid";s:6:"195591";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95284";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:832:"Caffeic acid exists in nature as cis- and trans- stereoisomers. Some of the best sources of caffeic acid are grapes, wine, and coffee. Caffeic acid is one of the hydroxycinnamic acids, which are the most widely dispersed class of phenylpropanoids in plants, and which also include ferulic acid and coumaric acid.
Caffeic acid will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the Natural Health Products Regulations.

References:
1. DNP 2010. Dictionary of Natural Products, Version 17.1, CRC Press. Hampden Data Services Ltd. Taylor & Francis Group. Electronic version.
2. O’Neil M.J., Heckelman P.E., Koch C.B., Roman K.J. (Eds). 2010. The Merck Index: an encyclopedia of chemicals, drugs, and Biologicals, Fourteenth Edition (2006). Merck & Co. Inc., Whitehouse Station, NJ, USA. Electronic version";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82611";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Caffeic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195592;a:27:{s:5:"title";s:16:"Tracheloside_ACN";s:3:"nid";s:6:"195592";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95284";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1339:"Tracheloside, a lignan glycoside, is one of the plant lignans extracted from the debris after safflower oil is produced from the seeds of Carthamus tinctorius. It can also be isolated from Trachelospermum spp [DNP]. It is an analogue of another plant lignan, arctiin, the side-chain C-2 of the five-membered ring being changed from a hydrogen to a hydroxyl group. Tracheloside will be considered a NHP under Schedule 1, item 2, (isolate)of the Natural Health Products Regulations.
References:
DNP 2010. Dictionary of Natural Products.
Duke JA. 1992. Handbook of phytochemical constituents of GRAS herbs and other economic plants. Boca Raton (FL): CRC Press. Available from: http://www.ars-grin.gov/cgi-bin/duke/chemical.pl?TRACHELOSIDE
Kitamura Y, Yamagishi M, Okazaki K, Furukawa F, Imazawa T, Nishikawa A, Hirose M. 2003. Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague–Dawley rats. Cancer Letters 200(2):133-139.
Xing-Qi Tan X, Chen H, Liu R, Tan H, Xu C, Xuan W, Zhang W. 2005. Lignans from Trachelospermum jasminoides. Planta Med 71(1):93-95.
Yoo HH, Park JH, Kwon SW. 2006. An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius. Biosci Biotechnol Biochem. 70(11):2783-5.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82612";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Tracheloside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195593;a:27:{s:5:"title";s:23:"beta-1,3/1,6-Glucan_ACN";s:3:"nid";s:6:"195593";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95322";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:970:"beta 1,3/1,6 Glucans are polysaccharides characterized by a basic structure of chains of glucose molecules that have a beta 1,3 linked backbone and 1,6 linked branches. beta-1,3/1,6-Glucan can be isolated from the cell wall of Saccharomyces cerevisiae. During the extraction process the mannoproteins in the surface of the cell walls can be removed in order to obtain a highly purified preparation of which the beta-1,3/1,6-glucans are exposed for optimum bioactivity. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (extract) of the NHP Regulations.

References:
Huff, G. R. et al. 2006, Limited Treatment with β-1,3/1,6-Glucan Improves Production Values of Broiler Chickens Challenged with Escherichia coli, Poultry Science 85: 613–618.
Wang, Z.; Shao, Y.; Guo, Y.; Yuan, J. 2008, Enhancement of peripheral blood CD8+ T cells and classical swine fever antibodies by dietary beta-1,3/1,6-glucan supplementation in weaned piglets. 55(9-10):369-76";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82613";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"beta-1,3/1,6-Glucan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195594;a:27:{s:5:"title";s:28:"High fructose corn syrup_ACN";s:3:"nid";s:6:"195594";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95344";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:792:"High fructose corn syrup is an aqueous solution containing glucose and fructose that is prepared from corn starch, which is hydrolyzed to glucose. Then enzyme activity converts some of the glucose to fructose. High fructose corn syrup is a nutritive sweetener (FCC). Hence, high fructose corn syrup is a mixture composed of water, glucose and fructose. Glucose and fructose are isolates.According to USP, high fructose corn syrup is available in two types: 1) High Fructose Corn Syrup 42%, in which about 42% of total solids is fructose, 2) High Fructose Corn Syrup 55%, in which about 55% of total solids is fructose.
References: 
FCC: Food Chemicals Codex, 7th edition. http://online.foodchemicalscodex.org/ online/
USP: United States Pharmacopeia (USP 32-NF 27) http://www.uspnf.com/uspnf/";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82615";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"High fructose corn syrup";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195595;a:27:{s:5:"title";s:17:"Sodium Iodide_ACN";s:3:"nid";s:6:"195595";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95703";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:173:"Sodium Iodide which is already in the NHPID acts as a source of Iodine. Therefore, Sodium iodide will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82616";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Sodium Iodide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195596;a:27:{s:5:"title";s:21:"delta-Tocotrienol_ACN";s:3:"nid";s:6:"195596";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95400";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:205:"delta-Tocotrienol is one of the naturally occurring forms of vitamin E. It is a constituent of palm oil and Iryanthera grandis. Also a component of Sargassum tortile, settling hormone for hydrocoan larvae.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82617";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"delta-Tocotrienol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195597;a:27:{s:5:"title";s:38:"Creatine ethyl ester hydrochloride_ACN";s:3:"nid";s:6:"195597";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95707";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:625:"Creatine ethyl ester is metabolized by esterases, present in many human tissues and within the serum, into creatine and ethyl alcohol. Creatine ethyl ester is probably more soluble than creatine monohydrate or other forms of creatine.
Creatine ethyl ester hydrochloride could be synthesized by treatment of anhydrous creatine with ethanolic HCl at room temperature and also by acid-catalyzed esterification of creatine monohyrdate.
Creatine ethyl ester hydrochloride can act as a source of Creatine and it will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82618";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"Creatine ethyl ester hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195598;a:27:{s:5:"title";s:27:"Berberine hydrochloride_ACN";s:3:"nid";s:6:"195598";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95551";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1811:"Berberine hydrochloride is a synonym for berberine chloride[CHEMID], and is a derivative of berberine[DNP]. Berberine hydrochloride is an isoquinoline alkaloid and exists as a quaternary ammonium cation in aqueous solution; it is present, usually as a hydrochloride or sulphate, in the roots, rhizomes and stem bark of various plants[Liu&Kong 2003]. These plants include Hydrastis canadensis (goldenseal), Coptis chinensis (goldenthread), Berberis aquifolium (Oregon grape), and Berberis vulgaris (barberry)[Natural Standards 2010]. Berberine hydrochloride has antimicrobial activity against bacteria, fungi, and viruses[Natural Standards 2010].
Berberine hydrochloride will be considered a NHP under Schedule 1, item 2, isolate, of the Natural Health Products Regulations.
ChemID 2010. Available from: http://chem.sis.nlm.nih.gov/chemidplus/ProxyServlet?objectHandle=DBMaint&actionHandle=default&nextPage=jsp/chemidheavy/ResultScreen.jsp&ROW_NUM=0&TXTSUPERLISTID=0007647010
Ling J, Sang Y, Huang C. 2008. Visual colorimetric detection of berberine hydrochloride with silver nanoparticles. Journal of Pharmaceutical and Biomedical Analysis 47(4-5):860-864.
Liu S, Kong L. 2003. Interaction between isopoly-tungstic acid and berberine hydrochloride by resonance Rayleigh scattering spectrum. Anal Sci. 19(7):1055-60.
Nakamoto K, Sadamori S, Hamada T. 1990. Effects of crude drugs and berberine hydrochloride on the activities of fungi. The Journal of Prosthetic Dentistry 64(6):691-694.
Natural Standards 2010.
Swabb EA, Tai YH, Jordan L. 1981. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol. 241(3):G248-52.
Vennerstrom JL, Lovelace JK, Waits VB, Hanson WL, Klayman DL. 1990. Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother. 34(5):918-21.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82619";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Berberine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195599;a:27:{s:5:"title";s:52:"Calcium-potassium salt of (-)-hydroxycitric acid_ACN";s:3:"nid";s:6:"195599";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95446";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:557:"Calcium/potassium salt of HCA that is highly water soluble (100%) and has been proven bioavailable in humans compare to the free form of Hydroxycitric acid. It can act as a good source of Calcium and/or Potassium. Calcium/potassium–HCA provides about 60% Hydroxycitric acid. Different procedures are listed in the literature for the preparation of salt of HCA with improved bioavailability.
Calcium/Potassium Salt of Hydroxycitric Acid will be considered as a NHP, under Schedule 1, item 2, Priority 2 (isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82620";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:48:"Calcium-potassium salt of (-)-hydroxycitric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195600;a:27:{s:5:"title";s:13:"Soy fiber_ACN";s:3:"nid";s:6:"195600";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95719";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:267:"Soy fiber is a natural source of dietary fiber that consists of both cellulosic and noncellulosic dietary fiber and derived from Soybean.
Soy fiber will be considered as a NHP, under Schedule 1, item 2, Priority 2 (extract) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82621";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Soy fiber";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195601;a:27:{s:5:"title";s:28:"Rice protein concentrate_ACN";s:3:"nid";s:6:"195601";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95717";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:711:"Rice protein concentrate can be prepared by a couple of methods such as the alkaline extraction of rice flour or of the broken rice kernels that are a byproduct in the milling of rice. The common method for the separation of rice protein from the starch of milled rice grains is by alkali solubilisation of the proteins followed by acid precipitation (Connor, Saunders, & Kohler, 1977; Yamamoto, Sumie, & Toshio, 1973). An alternative is to treat the flour or kernels with enzymes to partially remove the starch component. Rice protein concentrate can have high protein content (ranging from 60-80% or above).
Rice protein concentrate will be considered as a NHP, under Schedule 1, item 2, Priority 4 (Extract).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82622";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Rice protein concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195602;a:27:{s:5:"title";s:16:"[6]-Gingerol_ACN";s:3:"nid";s:6:"195602";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95286";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:176:"[6]-Gingerol is the major active phenol component found in Ginger and responsible for pungent characteristics of ginger oil. It is isolated from rhizome of Zingiber officinale.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82623";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"[6]-Gingerol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195603;a:27:{s:5:"title";s:15:"Acid casein_ACN";s:3:"nid";s:6:"195603";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95445";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:271:"Casein occurs as an off-white to cream-colored, granular or fine powder. It is derived from the coagulum formed by treating skim milk with a food-grade acid ( Acid Casein ).
Reference: 
FCC: Food Chemicals Codex, 7th edition. http://online.foodchemicalscodex.org/ online/";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82624";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Acid casein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195604;a:27:{s:5:"title";s:28:"Milk protein concentrate_ACN";s:3:"nid";s:6:"195604";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95445";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1234:"Milk protein concentrate is produced from skim milk using ultrafiltration and drying; some processes involve diafiltration also (Huffman and Harper 1999; Haque et al. 2010).  An upper limit for protein content is usually included in the definition, such as less than 85% (Haque et al. 2010); or less than 88% (UBIC Consulting 2010). However, because of the usual tolerances permitted in quality specifications, there is effectively no upper limit for protein content. Nonfat dry milk is 34% protein and the lower limit for protein content in milk protein concentrates is 40% protein (Huffman and Harper 1999, UBIC Consulting 2010).
References: 
Huffman LM, Harper WJ. 1999. Symposium: Marketing Dairy Value Through Technology. Maximizing the Value of Milk Through Separation Technologies. 1999 J Dairy Sci 82:2238–2244. 
Haque E, Bhandari BR, Gidley MJ, Deeth HC, Møller SM, Whittaker AK. Protein conformational modifications and kinetics of water-protein interactions in milk protein concentrate powder upon aging: effect on solubility. J Agric Food Chem. 2010 Jul 14;58(13):7748-55.
UBIC Consulting 2010. URL: http://www.ubic-consulting.com/template/fs/documents/Dairy-Ingredients/milkproteinconcentrate-tmp-ingredient-market.pdf";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82625";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Milk protein concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195605;a:27:{s:5:"title";s:21:"Calcium caseinate_ACN";s:3:"nid";s:6:"195605";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"95445;93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1222:"Calcium caseinate, although known to be present as is in bovine milk, is generally obtained by acid precipitation of casein after the cream has been removed from skimmed milk followed by neutralization with calcium hydroxide (O’Neil et al. 2010, Hernandez and Harte 2009). It has, medicinally, mostly been used as a source of protein, in the treatment of children malnutrition for example (Sweetman 2010, Doraiswamy et al. 1962).
References: 
Doraiswamy T.R., Kripanidhi I., Joseph K., Srinivasan M., Swaminathan M., Sreenivasan A., Subrahmanyan V. 1962. Use of calcium caseinate in the treatment of protein malnutrition in children. Indian J. Pediat. 29: 226-231. 
Hernandez A., Harte F.M. 2009. Isolation of caseins from whey proteins by microfiltration modifying the mineral balance in skim milk. J. Dairy Sci. 92: 5357-5362. 
O’Neil M.J., Heckelman P.E., Koch C.B., Roman K.J. (Eds). 2010. The Merck Index: an encyclopedia of chemicals, drugs, and Biologicals, Fourteenth Edition (2006). Merck & Co. Inc., Whitehouse Station, NJ, USA. Electronic version [Accessed 2010-04-30]. 
Sweetman S. (Ed.) 2010. Martindale: The Complete Drug Reference, Pharmaceutical Press, London. Electronic Version [Accessed 2010-04-30].";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82626";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium caseinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195606;a:27:{s:5:"title";s:24:"Milk protein isolate_APN";s:3:"nid";s:6:"195606";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95445";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1349:"Total protein isolate from milk contains both the casein and whey proteins (Rajagopalan and Cheryan 1991). In milk protein isolate the protein composition has “a substantially unaltered proportion of casein to whey proteins wherein the dry matter consists of greater than 85% milk protein” (Bhaskar et al. 2007). Another definition of milk protein isolate specifies 88% or higher protein content (UBIC Consulting 2010). Milk protein isolate can be produced from skim milk using a process that involves ultrafiltration, diafiltration, and drying (Huffman and Harper 1999). The name “milk protein isolate” is also applied to products with about 90% protein content produced from skim milk by a different method (Hoffman and Harper 1999).
References: 
Bhaskar GV, Singh H, Blazey ND. United States Patent 7,157,108. Milk Protein Products and Processes. January 2, 2007.
Huffman LM, Harper WJ. 1999. Symposium: Marketing Dairy Value Through Technology. Maximizing the Value of Milk Through Separation Technologies. 1999 J Dairy Sci 82:2238–2244.
Rajagopalan N, Cheryan M. 1991. Total Protein Isolate from Milk by Ultrafiltration: Factors Affecting Product Composition. J. Dairy Sci 74: 2435-2439.
UBIC Consulting 2010. URL: http://www.ubic-consulting.com/template/fs/documents/Dairy-Ingredients/milkproteinconcentrate-tmp-ingredient-market.pdf";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82627";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Milk protein isolate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195607;a:27:{s:5:"title";s:28:"Isomaltulose monohydrate_ACN";s:3:"nid";s:6:"195607";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95547";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1898:"Isomaltulose and its monohydrate are nutritive sweeteners (FCC 2010; FDA 2006). Crystals are the monohydrate (Merck Index). Although the monohydrate form is sometimes called isomaltulose (FDA 2006), isomaltulose is used as a name for the anhydrous form in CHEMID.
Isomaltulose is a disaccharide that is found in honey and in sugar cane juice (Lina et al. 2002). Isomaltulose is not recognized as a sweetener for foods in the Canadian Food and Drug Regulations (Table IX to section B16.100). However, isomaltulose is included in the Food Chemicals Codex (FCC 2010). The monohydrate form does have GRAS status in the United States for use as a nutritive sweetener “that would totally or partially replace sucrose…” (FDA 2006). Since isomaltulose is the form of the compound found in solution after the monohydrate is dissolved, both forms are permitted in food in the United States. In 2005 isomaltulose was authorized for sale as a novel food in the European Union, with the monohydrate as the commercial product (European Commission 2005). Isomaltulose has been a food in Japan since 1985 (Lina et al. 2002).
References: 
European Commission. 2005. Commission Decision 4 April 2005 authorising the placing on the market of isomaltulose as a novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (2005/457/EC). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32005D0457:EN:NOT
FDA. 2006. Agency Response Letter GRAS Notice No. GRN 000184. http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GRASListings/ucm154643.htm
FCC 2010: Food Chemicals Codex, 7th edition. http://online.foodchemicalscodex.org/
Lina BA, Jonker D, Kozianowski G. 2002. Isomaltulose (Palatinose): A review of biological and toxicological studies. Food Chem Toxicol. 40:1375-1381.
US Patent Office. 1993. US Patent 5,218,098";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82628";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Isomaltulose monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195608;a:27:{s:5:"title";s:31:"Hydrolyzed collagen type II_ACN";s:3:"nid";s:6:"195608";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95673";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82629";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Hydrolyzed collagen type II";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195609;a:27:{s:5:"title";s:26:"Modified citrus pectin_APN";s:3:"nid";s:6:"195609";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95771";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82630";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Modified citrus pectin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195610;a:27:{s:5:"title";s:20:"Ethyl ximeninate_ACN";s:3:"nid";s:6:"195610";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95642";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:525:"Ethyl ximeninate is a semi-synthetic derivative of Ximenynic acid (1). Ximenynic acid occurs widely in the seed lipids of many spp. of the Santalaceae and Oleaceae (2). The ethyl ester of ximenynic acid has been found to exert significant pharmacological properties which may be important for cosmetic and therapeutic uses (3). Moreover, considerable microvasculokinetic properties were observed (4).
Ethyl ximeninate will be considered as a NHP, under Schedule 1, item 2, isolate, of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82631";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Ethyl ximeninate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195611;a:27:{s:5:"title";s:13:"Silymarin_ACN";s:3:"nid";s:6:"195611";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95444";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:888:"Silymarin is an antihepatotoxic component of the seeds of Silybum marianum (Milk thistle). Commercial product consists of 70-80% silymarin flavonolignans: silydianin, silychristin, diastereoisomers of silybin (silybin A and B), and diastereoisomers of isosilybin (isosilybin A and B)[MI]. Silybin, the major constituent of the therapeutic extract silymarin, exists as a mixture of diastereomers, silybin A and silybin B[MI; Lee et al 2003] and is entered in the NHPID as a Medicinal Ingredient.
As Silymarin is a flavolignan complex from a plant source, it will be considered a NHP under Schedule 1, item 2, extract, of the Natural Health Products Regulations.
References:
Lee DY, Liu Y. 2003. Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle). J Nat Prod. 66(9):1171-4.
Merck Index Online 2010.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82632";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Silymarin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195612;a:27:{s:5:"title";s:44:"Calcium beta-hydroxy-beta-methylbutyrate_ACN";s:3:"nid";s:6:"195612";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95946";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:869:"Calcium beta-hydroxy-beta-methylbutyrate is a nutritional supplement, which represents a calcium salt of beta-hydroxy beta-methylbutyrate (HMB). HMB is a leucine metabolite produced in the body through oxidation of the ketoacid of leucine (ketoisocaproate). After leucine is metabolized to KIC, KIC is either metabolized into isovaleryl-CoA by the enzyme alpha-ketoacid dehydrogenase in the mitochondria, or into beta-hydroxy-beta-methylbutyrate (HMB) in the cytosol, by the enzyme alpha-ketoisocaproate dioxygenase.
Calcium β-hydroxy-β-methylbutyrate acts as a source of β-hydroxy-β-methylbutyrate and therefore meets the definition of a NHP derivative, as defined in the Product Licensing guidance document.
Calcium beta-hydroxy-beta-methylbutyrate will be considered as a NHP, under Schedule 1, item 2, (as an isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82636";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Calcium beta-hydroxy-beta-methylbutyrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195613;a:27:{s:5:"title";s:21:"Germanium dioxide_ACN";s:3:"nid";s:6:"195613";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95663";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82637";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Germanium dioxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195614;a:27:{s:5:"title";s:28:"Whey mineral concentrate_ACN";s:3:"nid";s:6:"195614";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95769";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82638";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Whey mineral concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195615;a:27:{s:5:"title";s:18:"Propagermanium_ACN";s:3:"nid";s:6:"195615";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95961";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82639";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Propagermanium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195616;a:27:{s:5:"title";s:57:"Calcium-beta-hydroxy beta-methyl butyrate monohydrate_ACN";s:3:"nid";s:6:"195616";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95947";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:947:"Calcium beta-hydroxy-beta-methylbutyrate is a nutritional supplement, which represents a calcium salt of beta-hydroxy beta-methylbutyrate (HMB). HMB is a leucine metabolite produced in the body through oxidation of the ketoacid of leucine (ketoisocaproate). After leucine is metabolized to KIC, KIC is either metabolized into isovaleryl-CoA by the enzyme alpha-ketoacid dehydrogenase in the mitochondria, or into beta-hydroxy-beta-methylbutyrate (HMB) in the cytosol, by the enzyme alpha-ketoisocaproate dioxygenase.
HMB is currently marketed as calcium-HMB-monohydrate.
Calcium β-hydroxy-β-methylbutyrate monohydrate acts as a source of β-hydroxy-β-methylbutyrate and therefore meets the definition of a NHP derivative, as defined in the Product Licensing guidance document.
Calcium beta-hydroxy-beta-methylbutyrate monohydrate will be considered as a NHP, under Schedule 1, item 2, (as an isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82640";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:53:"Calcium-beta-hydroxy beta-methyl butyrate monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195617;a:27:{s:5:"title";s:34:"Calcium 4-methyl-2-oxovalerate_ACN";s:3:"nid";s:6:"195617";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96136";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:411:"Calcium ketoisocaproate is the Calcium salt of alpha-Ketoisocaproic acid.
Commercially, Calcium ketoisocaproate is used as a source of alpha-Ketoisocaproic acid, which is classified as an NHP, under Schedule 1, item 2 (isolate) of the Natural Health Product Regulations.
Calcium salt of ketoisocaproic acid will be considered an NHP, under Schedule 1, item 2 (isolate) of the Natural Health Product Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82641";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Calcium 4-methyl-2-oxovalerate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195618;a:27:{s:5:"title";s:17:"Glucoraphanin_ACN";s:3:"nid";s:6:"195618";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95953";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:493:"Glucoraphanin which is also know as sulforaphane glucosinolates is the glucosinolate precursor of sulforaphane. Broccoli sprouts contain high concentrations of sulforaphane glucosinolates. Sulforaphane is released when sulforaphane glucosinolate undergoes hydrolysis by myrosinase released from plant tissues during the chewing process.
Glucoraphanin (sulforaphane glucosinolate) will be considered as a NHP, under Schedule 1, item 2 (as an isolate) of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82642";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Glucoraphanin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195619;a:27:{s:5:"title";s:36:"Potassium 4-methyl-2-oxovalerate_ACN";s:3:"nid";s:6:"195619";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95283";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1357:"The Natural Health Products Ingredients Database (NHPID) indicates that 4-methyl-2-oxovaleric acid (synonym: alpha-ketoisocaproic acid) is classified as an NHP, under Schedule 1, item 2 (isolate) of the Natural Health Product Regulations, and has an NMI role as flavour enhancer. Potassium 4-methyl-2-oxovalerate is the potassium salt of 4-methyl-2-oxovaleric acid. The sodium salt of 4-methyl-2-oxovaleric acid is included in NHPID with the NHPID name 4-Methyl-2-oxopentanoic acid, sodium salt and CAS RN 4502-00-5. Synonyms for the sodium salt include sodium 4-methyl-2-oxovalerate, sodium alpha-ketoisocaproate and 4-methyl-2-oxovaleric acid, sodium salt [CHEMID; JECFA]. NHPID indicates that sodium 4-methyl-2-oxovalerate has the NMI role of flavour enhancer, but does not indicate whether it is considered an NHP. The compound 4-methyl-2-oxovaleric acid is present in male rats (Grootegoed et al. 1985). Since potassium ions are present in the biological fluids of mammals, the potassium salt of 4-methyl-2-oxovaleric acid, is considered an NHP. Hence, potassium 4-methyl-2-oxovalerate will be considered an NHP, under Schedule 1, item 2 (isolate) of the Natural Health Product Regulations.
Reference:
Grootegoed JA, Jansen R, Van der Molen HJ. 1985. Intercellular pathway of leucine catabolism in rat spermatogenic epithelium. Biochem. J. 226, 889-892";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82643";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Potassium 4-methyl-2-oxovalerate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195620;a:27:{s:5:"title";s:35:"Adenosine triphosphate disodium_ACN";s:3:"nid";s:6:"195620";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95952";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82644";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"Adenosine triphosphate disodium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195621;a:27:{s:5:"title";s:24:"Beef protein isolate_APN";s:3:"nid";s:6:"195621";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96226";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82645";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Beef protein isolate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195622;a:27:{s:5:"title";s:22:"Ascorbyl palmitate_ACN";s:3:"nid";s:6:"195622";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"95957;95957";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:182:"Classified as an NHP because it is used as a source of vitamin C, and therefore is considered an NHP under Schedule 1, item 3 (a vitamin), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:201:"Classifié comme PSN parce qu'utilisé comme source de Vitamine C, et par conséquent est considéré comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82646";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Ascorbyl palmitate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195623;a:27:{s:5:"title";s:26:"L-arginine monohydrate_ACN";s:3:"nid";s:6:"195623";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95945";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82647";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"L-arginine monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195624;a:27:{s:5:"title";s:19:"Calcium lactate_ACN";s:3:"nid";s:6:"195624";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96437";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:200:"Calcium lactate is classified as an NHP, because it is used as a source of Calcium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:241:"Le Lactate de calcium est classifié comme PSN, parce qu'il est utilisé comme matière d'origine du Calcium, et par conséquent est considéré un PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82648";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Calcium lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195625;a:27:{s:5:"title";s:32:"Transgalactooligosaccharides_ACN";s:3:"nid";s:6:"195625";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96223";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:3502:"The word transgalactooligosaccharides is also spelled trans-galactooligosaccharides and transgalacto-oligosaccharides (Vulevic et al. 2008; Bouhnik et al. 1997). Transgalactooligosaccharides are produced from lactose by enzymatic action of beta-galactosidases that have transgalactosylation activity (Mikkelsen et al. 2004). According to Alles et al. (1999) transgalactooligosaccharide molecules are linear polymers of galactose and lactose with beta-1,6 or beta-1,4 linkages. However, according to Houdijk et al. (2002) transgalactooligosaccharides are beta-linked galactose units. Transgalactooligosaccharides vary in the degree of polymerization (Vulevic et al. 2008). According to van den Heuvel et al. (2002), transgalactooligosaccharides consist of chains of galactose molecules ending usually with a glucose molecule and with the chain length or degree of polymerization from 2 to 8 units. They are considered nondigestible oligosaccharides, since they are largely not affected by human digestive enzymes and reach the colon where they can serve as prebiotics that nourish intestinal microflora (Alles et al. 1999; Vulevic et al. 2008). There is evidence that oral intake of transgalactooligosaccharides can influence intestinal bacteria and have beneficial effects in humans (Silk et al. 2009; Vulevic et al. 2008). During fermentation of milk to produce yogurt, bacteria produce transgalactooligosaccharides from milk sugars (Houdijk et al. 2002). A laboratory analysis found evidence for transgalactooligosaccarides in orange juice, yogurt drink and some other foods (de Slegte 2002).
References:
Alles MS, Hartemink R, Meyboom S, Harryvan JL, Van Laere KM, Nagengast FM, Hautvast JG. 1999. Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr. 69(5):980-91.
Bouhnik Y, Flourié B, D'Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud JC. 1997. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr. 127(3):444-448.
de Slegte J. 2002. Determination of trans-Galactooligosaccharides in Selected Food
Products by Ion-Exchange Chromatography: Collaborative Study. Journal of AOAC International 85 (2):417-423.
Houdijk JGM, Verstegen MWA, Bosch MW, van Laere KJM. 2002. Dietary fructooligosaccharides and transgalactooligosaccharides can affect fermentation characteristics in gut contents and portal plasma of growing pigsLivestock Production Science 73: 175-184.
Mikkelsen LL, Knudsen KEB, Jensen BB. 2004. In vitro fermentation of fructo-oligosaccharides and transgalacto-oligosaccharides by adapted and unadapted bacterial populations from the gastrointestinal tract of piglets. Animal Feed Science and Technology
116(Issues 3-4): 225-238.
Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. 2009. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 29(5):508-518.
van den Heuvel EG, Schoterman MH, Muijs T. 2000. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. Journal of Nutrition 130:2938-2942.
Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. 2008, Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 88(5):1438-1446.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82649";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Transgalactooligosaccharides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195626;a:27:{s:5:"title";s:20:"7-methoxyflavone_ACN";s:3:"nid";s:6:"195626";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96232";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:819:"The name 7-methoxyflavone is found in Chemical Book, PubChem and the MeSH of PubMed (NIH). Because of evidence that 7-methoxyflavone can inhibit aromatase, it has been suggested that it might be useful in the prevention or treatment of cancer (Ta and Walle 2007). This compound has been extracted from the plant Conchocarpus heterophyllus, which is in the family Rutaceae (Ambrozin et al. 2004).
References:
Ambrozin ARP, Vieira PC, Fernandes JB, da Silva MFdGF, de Albuquerque S. 2004. Trypanocidal activity of Meliaceae and Rutaceae plant extracts. Mem Inst Oswaldo Cruz. 99(2):227-31.
NIH: National Library of Medicine. MeSH, PubMed. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed
Ta N, Walle T. 2007. Aromatase inhibition by bioavailable methylated flavones.
J Steroid Biochem Mol Biol. 2007 Oct;107(1-2):127-9.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82650";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"7-methoxyflavone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195627;a:27:{s:5:"title";s:27:"Hydrolyzed beef protein_ACN";s:3:"nid";s:6:"195627";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96228";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1361:"The name “hydrolyzed beef protein” appears in a paper by Lee and colleagues (1998). There is a monograph in the Food Chemicals Codex (FCC 2010) for Acid Hydrolysates of Proteins, which states that they “occur as liquids, pastes, powders, or granules. They are composed primarily of amino acids, small peptides (peptide chains of five or fewer amino acids), and salts resulting from the essentially complete hydrolysis of peptide bonds in edible proteinaceous materials, catalyzed by food-grade acids and/or heat. Cleavage of peptide bonds typically ranges from a low of 85% to essentially 100%.” For the substance :”hydrolyzed beef protein”, enzymes that break peptide bonds could also be used for hydrolysis.
Hydrolyzed beef protein is prepared from material from a non-human animal. Other hydrolyzed protein substances (Protein hydrolysate and Whey protein hydrolysate) have been classified as NHPs (Health Canada 2010). Hydrolyzed beef protein will be considered an NHP, under Schedule 1, item 2 (an extract), of the Natural Health Products Regulations.
References:
Lee B, Pometto AL, Demirci A, Hinz PN. 1998, Media Evaluation for the Production of Microbial Enzymes J. Agric. Food Chem. 46 (11):4775–4778. http://pubs.acs.org/doi/abs/10.1021/jf980476q
FCC 2010: Food Chemicals Codex, 7th edition. http://online.foodchemicalscodex.org/ online/";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82651";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Hydrolyzed beef protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195628;a:27:{s:5:"title";s:9:"Water_ACN";s:3:"nid";s:6:"195628";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96469";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82653";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Water";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195629;a:27:{s:5:"title";s:27:"L-ornithine-L-aspartate_ACN";s:3:"nid";s:6:"195629";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96524";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:843:"L-ornithine-L-aspartate (LOLA) is a stable salt of L-amino acids: ornithine and aspartic acid1.
Both ornithine and aspartate are endogenic amino acids, which are required by the body for a large number of metabolic processes. L-ornithine is a non-protein, basic amino acid and in the natural way, gets into the urea cycle, which produces urea from ammonia in the liver2.
L-ornithine is used also as a nutritional supplement principally for its putative anabolic activity. Some of the evidence suggests that LOLA restores muscle protein synthesis, an effect which can be exploited in patients suffering from cancer or HIV infections3.

L-Aspartic acid is a non-essential amino acid use for human development.
LOLA will be considered as an NHP, under Schedule 1, Item 4 (amino acid) of the NHP Regulations, since it is a source of 2 amino acids.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82654";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"L-ornithine-L-aspartate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195630;a:27:{s:5:"title";s:12:"Curcumin_ACN";s:3:"nid";s:6:"195630";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96656";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82655";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Curcumin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195631;a:27:{s:5:"title";s:23:"Manganese ascorbate_ACN";s:3:"nid";s:6:"195631";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96593";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:219:"Manganese ascorbate is classified as an NHP because it is used as a source of Manganese and Vitamin C, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:248:"L'ascorbate de manganèse est classifié comme PSN parce qu'utilisé comme source de Manganèse et de Vitamine C, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82656";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Manganese ascorbate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195632;a:27:{s:5:"title";s:23:"Omega-9 fatty acids_ACN";s:3:"nid";s:6:"195632";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96640";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82657";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Omega-9 fatty acids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195633;a:27:{s:5:"title";s:27:"Potassium molybdate(VI)_ACN";s:3:"nid";s:6:"195633";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96590";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:207:"Potassium molybdate is classified as an NHP, because it is used as a source of Molybdenum, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:231:"Le molybdate de potassium est classifié comme PSN parce qu'utilisé comme source de Molybdène, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82658";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Potassium molybdate(VI)";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195634;a:27:{s:5:"title";s:12:"Shilajit_ACN";s:3:"nid";s:6:"195634";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94474";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82659";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Shilajit";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195635;a:27:{s:5:"title";s:23:"Crinis Carbonisatis_ACN";s:3:"nid";s:6:"195635";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95954";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82660";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Crinis Carbonisatis";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195636;a:27:{s:5:"title";s:19:"Gypsum Fibrosum_ACN";s:3:"nid";s:6:"195636";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"96509;102694";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:80:"Classified as an NHP under Schedule 1 item 7 (a mineral) of the NHP Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82661";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Gypsum Fibrosum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195637;a:27:{s:5:"title";s:23:"Potassium aspartate_ACN";s:3:"nid";s:6:"195637";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96891";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:206:"Potassium aspartate is classified as an NHP, because it is used as a source of Potassium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:227:"Aspartate de potassium est classifié comme PSN parce qu'utilisé comme source de Potassium, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82662";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Potassium aspartate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195638;a:27:{s:5:"title";s:23:"Chromium picolinate_ACN";s:3:"nid";s:6:"195638";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96893";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:205:"Chromium picolinate is classified as an NHP, because it is used as a source of Chromium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:222:"Picolinate de chrome est classifié comme PSN parce qu'utilisé comme source de Chrome, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82663";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Chromium picolinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195639;a:27:{s:5:"title";s:20:"Ferrous sulphate_ACN";s:3:"nid";s:6:"195639";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93186;92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:198:"Ferrous sulphate is classified as an NHP, because it is used as a source of Iron, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:214:"Sulfate ferreux est classifié comme PSN parce qu'utilisé comme source de Fer, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82664";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Ferrous sulphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195640;a:27:{s:5:"title";s:20:"Dermatan sulfate_ACN";s:3:"nid";s:6:"195640";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95546";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82665";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dermatan sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195641;a:27:{s:5:"title";s:19:"Phosphoric acid_ACN";s:3:"nid";s:6:"195641";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97032";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82666";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Phosphoric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195642;a:27:{s:5:"title";s:17:"Octanoic acid_ACN";s:3:"nid";s:6:"195642";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96943";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82667";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Octanoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195643;a:27:{s:5:"title";s:15:"Sorbic acid_ACN";s:3:"nid";s:6:"195643";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96719";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:151:"It can be obtained from unripe berries of the Rowan (Sorbus aucuparia). It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82668";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Sorbic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195644;a:27:{s:5:"title";s:27:"Sodium glycerophosphate_ACN";s:3:"nid";s:6:"195644";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96968";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:226:"Sodium glycerophosphate will be classified as an NHP, because it is used as a source of Phosphorus, and therefore is considered an NHP under Schedule 1, item 7, (Priority 5; Mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:232:"Glycérophosphate de sodium est classifié comme PSN parce qu'utilisé comme source de Phosphore, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82669";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Sodium glycerophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195645;a:27:{s:5:"title";s:14:"D-Fructose_ACN";s:3:"nid";s:6:"195645";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96970";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82670";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"D-Fructose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195646;a:27:{s:5:"title";s:14:"Green clay_ACN";s:3:"nid";s:6:"195646";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96897";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82671";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Green clay";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195647;a:28:{s:5:"title";s:53:"Ethanol (96%), denatured with methyl ethyl ketone_ACN";s:3:"nid";s:6:"195647";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96712";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82672";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:49:"Ethanol (96%), denatured with methyl ethyl ketone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195648;a:27:{s:5:"title";s:14:"Carnallite_ACN";s:3:"nid";s:6:"195648";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96466";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82673";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Carnallite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195649;a:27:{s:5:"title";s:22:"Creatine phosphate_ACN";s:3:"nid";s:6:"195649";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97121";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82674";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Creatine phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195650;a:27:{s:5:"title";s:32:"Creatine-alpha-ketoglutarate_ACN";s:3:"nid";s:6:"195650";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97183";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82675";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Creatine-alpha-ketoglutarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195651;a:27:{s:5:"title";s:13:"Glabridin_ACN";s:3:"nid";s:6:"195651";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96563";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82676";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Glabridin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195652;a:28:{s:5:"title";s:23:"Clove essential oil_ACN";s:3:"nid";s:6:"195652";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96170";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82677";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Clove essential oil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195653;a:28:{s:5:"title";s:28:"Turpentine essential oil_ACN";s:3:"nid";s:6:"195653";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96170";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82678";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Turpentine essential oil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195654;a:27:{s:5:"title";s:26:"Arabinoxylan rice bran_ACN";s:3:"nid";s:6:"195654";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96455";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82680";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Arabinoxylan rice bran";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195655;a:27:{s:5:"title";s:31:"Alfalfa protein concentrate_ACN";s:3:"nid";s:6:"195655";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96946";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82681";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Alfalfa protein concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195656;a:27:{s:5:"title";s:21:"Nicotine resinate_ACN";s:3:"nid";s:6:"195656";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96863";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:143:"Classified as an NHP, because it is a source of nicotine, and under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:141:"Classifié comme PSN, parce que source de nicotine, et sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82682";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Nicotine resinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195657;a:27:{s:5:"title";s:17:"Schisandrol A_ACN";s:3:"nid";s:6:"195657";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96267";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82683";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Schisandrol A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195658;a:27:{s:5:"title";s:30:"Magnesium creatine chelate_ACN";s:3:"nid";s:6:"195658";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97128";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82684";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Magnesium creatine chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195659;a:27:{s:5:"title";s:21:"Potassium oxalate_ACN";s:3:"nid";s:6:"195659";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97330";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82685";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Potassium oxalate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195660;a:27:{s:5:"title";s:31:"Defatted wheat germ protein_ACN";s:3:"nid";s:6:"195660";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96327";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82686";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Defatted wheat germ protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195661;a:27:{s:5:"title";s:19:"Vanadyl Sulfate_ACN";s:3:"nid";s:6:"195661";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97591";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:201:"Vanadyl sulfate is classified as an NHP, because it is used as a source of Vanadium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:223:"Sulfate de vanadyle est classifié comme PSN parce qu'utilisé comme source de Vanadium, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82687";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Vanadyl Sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195662;a:27:{s:5:"title";s:16:"Butylparaben_ACN";s:3:"nid";s:6:"195662";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82688";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Butylparaben";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195663;a:27:{s:5:"title";s:20:"Cinnamyl alcohol_ACN";s:3:"nid";s:6:"195663";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82689";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Cinnamyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195664;a:27:{s:5:"title";s:22:"Hydroxycitronellal_ACN";s:3:"nid";s:6:"195664";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82690";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydroxycitronellal";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195665;a:27:{s:5:"title";s:14:"Isoeugenol_ACN";s:3:"nid";s:6:"195665";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82691";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Isoeugenol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195666;a:27:{s:5:"title";s:19:"Cupric sebacate_ACN";s:3:"nid";s:6:"195666";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97140";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82693";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cupric sebacate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195667;a:27:{s:5:"title";s:15:"Polaprezinc_ACN";s:3:"nid";s:6:"195667";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97525";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:215:"Polaprezinc will be classified as an NHP, because it is used as a source of L-Carnosine and Zinc, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:233:"Polaprezinc sera classifié comme PSN, car il est utilisé comme source de L-Carnosine et de Zinc, par conséquent il est considéré comme un PSN sous Annexe 1, article 2(un isolat) du règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82694";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Polaprezinc";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195668;a:27:{s:5:"title";s:22:"Halloysitum Rubrum_ACN";s:3:"nid";s:6:"195668";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97434";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82695";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Halloysitum Rubrum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195669;a:27:{s:5:"title";s:18:"Nickel sulfate_ACN";s:3:"nid";s:6:"195669";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:198:"Nickel sulfate is classified as an NHP, because it is used as a source of Nickel, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:219:"Sulfate de nickel est classifié comme PSN parce qu'utilisé comme source de Nickel, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82696";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Nickel sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195670;a:27:{s:5:"title";s:17:"Propylparaben_ACN";s:3:"nid";s:6:"195670";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:221:"Propylparaben will be classified as an NHP, because it is used as a source of para-Hydroxybenzoic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:253:"(p)-hydroxybenzoate de propyle classifié comme PSN, car il est utilisé comme source de Acide para-hydroxybenzoïque, par conséquent il est considéré comme un PSN sous Annexe 1, article 2(un isolat) du règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82697";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Propylparaben";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195671;a:27:{s:5:"title";s:39:"Alpha S1-Casein Tryptic Hydrolysate_ACN";s:3:"nid";s:6:"195671";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97496";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82698";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"Alpha S1-Casein Tryptic Hydrolysate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195672;a:27:{s:5:"title";s:29:"Copper amino acid chelate_ACN";s:3:"nid";s:6:"195672";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"97362;98786";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:209:"Copper amino acid chelate is classified as an NHP, because it is used as a source of copper, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:240:"Chélate d'acide aminé de cuivre est classifié comme PSN, parce qu'il est utilisé comme source de Cuivre, et par conséquent est considéré un PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82699";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Copper amino acid chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195673;a:27:{s:5:"title";s:31:"Selenium amino acid chelate_ACN";s:3:"nid";s:6:"195673";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97360";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82700";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Selenium amino acid chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195674;a:27:{s:5:"title";s:11:"S-Equol_ACN";s:3:"nid";s:6:"195674";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97309";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82701";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"S-Equol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195675;a:27:{s:5:"title";s:22:"Sodium-D-aspartate_ACN";s:3:"nid";s:6:"195675";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96964";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82702";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Sodium-D-aspartate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195676;a:27:{s:5:"title";s:13:"D-Leucine_ACN";s:3:"nid";s:6:"195676";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:104:"Classified as an NHP under Schedule 1, item 4 (an amino acid) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82703";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"D-Leucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"AA";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195677;a:27:{s:5:"title";s:17:"Atelocollagen_ACN";s:3:"nid";s:6:"195677";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93448;99957";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:337:"Atelocollagen is a highly purified pepsin-treated type I collagen used in peridontal procedures [Noburihu et al 2004; EP 1996] and as a mediator in protein and gene delivery[Sano et al. 2003; Yoshiko et al. 2004]. Atelocollagen is therefore considered a NHP under Schedule 1, item 2 (extract), of the Natural Health Products Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82704";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Atelocollagen";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195678;a:27:{s:5:"title";s:37:"4-Aminobutyric acid hydrochloride_ACN";s:3:"nid";s:6:"195678";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:237:"4-Aminobutyric acid hydrochloride will be classified as an NHP, because it is used as a source of 4-Aminobutanoic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:252:"Chlorhydrate d'acide 4-Aminobutyrique est classifié comme PSN parce qu'utilisé comme source d'acide 4-Aminobutyrique, et par conséquent est considéré comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82705";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"4-Aminobutyric acid hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195679;a:27:{s:5:"title";s:76:"alpha-D-Glucopyranosyl-[beta-D-fructofuranosyl](n-1)-D-fructofuranosides_ACN";s:3:"nid";s:6:"195679";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82706";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:72:"alpha-D-Glucopyranosyl-[beta-D-fructofuranosyl](n-1)-D-fructofuranosides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195680;a:27:{s:5:"title";s:20:"Barium carbonate_ACN";s:3:"nid";s:6:"195680";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:200:"Barium carbonate is classified as an NHP, because it is used as a source of Barium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:221:"Carbonate de baryum est classifié comme PSN parce qu'utilisé comme source de Baryum, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82707";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Barium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195681;a:27:{s:5:"title";s:28:"Proline-rich polypeptide_ACN";s:3:"nid";s:6:"195681";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82708";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Proline-rich polypeptide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195682;a:27:{s:5:"title";s:27:"Trigonellamide chloride_ACN";s:3:"nid";s:6:"195682";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82710";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Trigonellamide chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195683;a:27:{s:5:"title";s:15:"Gallic acid_ACN";s:3:"nid";s:6:"195683";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82712";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Gallic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195684;a:27:{s:5:"title";s:14:"Glauconite_ACN";s:3:"nid";s:6:"195684";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82713";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Glauconite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195685;a:27:{s:5:"title";s:20:"Palmitoleic acid_ACN";s:3:"nid";s:6:"195685";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82714";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Palmitoleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195686;a:27:{s:5:"title";s:17:"Silver iodide_ACN";s:3:"nid";s:6:"195686";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82715";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Silver iodide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195687;a:27:{s:5:"title";s:18:"Iron peptonate_ACN";s:3:"nid";s:6:"195687";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82716";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Iron peptonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195688;a:27:{s:5:"title";s:32:"Hydrolyzed alpha-lactalbumin_ACN";s:3:"nid";s:6:"195688";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97451";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82717";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Hydrolyzed alpha-lactalbumin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195689;a:27:{s:5:"title";s:26:"Lysozyme hydrochloride_ACN";s:3:"nid";s:6:"195689";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97774";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82718";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Lysozyme hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195690;a:27:{s:5:"title";s:19:"Calcium citrate_ACN";s:3:"nid";s:6:"195690";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97786";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:200:"Calcium citrate is classified as an NHP, because it is used as a source of Calcium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:222:"Citrate de calcium est classifié comme PSN parce qu'utilisé comme source de Calcium , et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82719";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Calcium citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195691;a:27:{s:5:"title";s:13:"Kaolinite_ACN";s:3:"nid";s:6:"195691";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82720";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Kaolinite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195692;a:27:{s:5:"title";s:42:"L-Citrulline alpha-ketoglutarate (2:1)_ACN";s:3:"nid";s:6:"195692";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:256:"L-Citrulline alpha-ketoglutarate (2:1) will be classified as an NHP, because it is used as a source of Citrulline and alpha-ketoglutarate, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:268:"L-Citrulline alpha-ketoglutarate (2:1) sera classifié comme PSN, car il est utilisé comme source de Citrulline et d'alpha-ketoglutarate, et par conséquent, il est considéré PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82721";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"L-Citrulline alpha-ketoglutarate (2:1)";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195693;a:27:{s:5:"title";s:24:"N-Acetylcysteinamide_ACN";s:3:"nid";s:6:"195693";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82722";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"N-Acetylcysteinamide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195694;a:27:{s:5:"title";s:22:"Lipoprotein lipase_ACN";s:3:"nid";s:6:"195694";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82723";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Lipoprotein lipase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195695;a:27:{s:5:"title";s:21:"Manganous acetate_ACN";s:3:"nid";s:6:"195695";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82724";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Manganous acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195696;a:27:{s:5:"title";s:24:"L-Arginine decanoate_ACN";s:3:"nid";s:6:"195696";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82725";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"L-Arginine decanoate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195697;a:27:{s:5:"title";s:26:"Pantethine octahydrate_ACN";s:3:"nid";s:6:"195697";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82726";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Pantethine octahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195698;a:27:{s:5:"title";s:21:"Mercurous acetate_ACN";s:3:"nid";s:6:"195698";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82727";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Mercurous acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195699;a:27:{s:5:"title";s:22:"5′-Adenylic acid_ACN";s:3:"nid";s:6:"195699";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82728";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"5′-Adenylic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195700;a:27:{s:5:"title";s:20:"Myristoleic acid_ACN";s:3:"nid";s:6:"195700";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82729";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Myristoleic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195701;a:27:{s:5:"title";s:30:"L-Isoleucine pyroglutamate_ACN";s:3:"nid";s:6:"195701";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:244:"L-Isoleucine pyroglutamate will be classified as an NHP, because it is used as a source of L-isoleucine and Pyroglutamic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:256:"Pyroglutamate de L-leucine sera classifié comme PSN, car il est utilisé comme source de L-leucine et d'acide pyroglutamique, et par conséquent, il est considéré PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82730";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"L-Isoleucine pyroglutamate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195702;a:27:{s:5:"title";s:21:"Feruloyl esterase_ACN";s:3:"nid";s:6:"195702";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82731";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Feruloyl esterase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195703;a:27:{s:5:"title";s:17:"Neohesperidin_ACN";s:3:"nid";s:6:"195703";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82732";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Neohesperidin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195704;a:27:{s:5:"title";s:45:"Calcium-beta-hydroxy beta-methyl butyrate_ACN";s:3:"nid";s:6:"195704";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82733";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:41:"Calcium-beta-hydroxy beta-methyl butyrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195705;a:27:{s:5:"title";s:30:"Putrescine dihydrochloride_ACN";s:3:"nid";s:6:"195705";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82734";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Putrescine dihydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195706;a:27:{s:5:"title";s:22:"Arsenic trisulfide_ACN";s:3:"nid";s:6:"195706";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"99896;93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1785:"Arsenic trisulfide (As2S3), also called orpiment or yellow arsenic sulphide, is one of a variety of arsenic sulfide minerals[Merck Index]. It occurs in granular, compact, or powdery form, often in association with the related mineral, red arsenic sulfide (As4S4), or Realgar. These two compounds were used as a pigment in ancient civilizations, and have long history of therapeutic use in traditional medicines. Arsenic trisulfide (As2S3) is mainly used externally as louse-killer, a cure for scabies, snake bites, insect stings, and skin diseases [Chinese Pharmacopeia Committee 2005; Liu et al 2008]. Currently, Arsenic trisulfide (As2S3) has been used to treat MUTZ-1 cells by inhibiting cell proliferation and induce apoptosis, which maybe through activating caspase-3 pathways and increasing the proportion of G2/M phase. Treatment with As2S3 at concentrations of 2, 4, 8 and 16 micromol/L for 48 h resulted in 14.5%, 25.4%, 34.7% and 51.5% inhibition, respectively, and (5.3 +/- 1.8%)%, (11.1 +/- 2.6)%, (19.3 +/- 2.3)% and (25.5 +/- 2.5)% apoptosis rates, respectively[Shao et al. 2009]. Arsenic trisulfide (As2S3) will be considered as NHP, under schedule 1, item 7, Priority 5 (mineral). References:
Merck 2011: The Merck Index Version 14.1. [Online]. Whitehouse Station (NJ): Merck & Co, Inc. [Accessed 2011 October 04]. Available from: http://www.medicinescomplete.com/mc/merck/current/monographs.htm
Shao ZY, Tang M, Chen BA, Xia GH, Zhang L, Zhu HG. 2009. [Experimental study of effect of As2S3 nanoparticles on human MDS cell line (MUTZ-1)]. [Article in Chinese] Zhonghua Xue Ye Xue Za Zhi. 30(1):29-32.
Liu J, Lu Y, Wu Q, Goyer RA, Waalkes MP. 2008. Mineral arsenicals in traditional medicines: Orpiment, realgar, and arsenolite. J Pharmacol Exp Ther. 326(2): 363–368.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82735";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Arsenic trisulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195707;a:27:{s:5:"title";s:16:"Polyphenon E_ACN";s:3:"nid";s:6:"195707";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82736";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Polyphenon E";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195708;a:27:{s:5:"title";s:37:"Eicosapentaenoic acid ethyl ester_ACN";s:3:"nid";s:6:"195708";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82737";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Eicosapentaenoic acid ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195709;a:27:{s:5:"title";s:36:"Docosahexaenoic acid ethyl ester_ACN";s:3:"nid";s:6:"195709";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82738";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:32:"Docosahexaenoic acid ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195710;a:27:{s:5:"title";s:28:"Omega-3 acid ethyl ester_ACN";s:3:"nid";s:6:"195710";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82739";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Omega-3 acid ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195711;a:27:{s:5:"title";s:23:"Rutoside trihydrate_ACN";s:3:"nid";s:6:"195711";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82740";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Rutoside trihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195712;a:27:{s:5:"title";s:13:"Scapolite_ACN";s:3:"nid";s:6:"195712";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82741";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Scapolite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195713;a:27:{s:5:"title";s:19:"Saccharolactone_ACN";s:3:"nid";s:6:"195713";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82742";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Saccharolactone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195714;a:27:{s:5:"title";s:12:"Seawater_ACN";s:3:"nid";s:6:"195714";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97758";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:194:"Seawater is classified as an NHP, because it is used as a source of minerals, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:221:"Eau de mer est classifié comme PSN, car elle est utilisée comme source de minéraux, et par conséquent, elle est considérée PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82743";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Seawater";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195715;a:27:{s:5:"title";s:11:"Bismuth_ACN";s:3:"nid";s:6:"195715";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82744";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Bismuth";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195716;a:27:{s:5:"title";s:18:"Zinc ascorbate_ACN";s:3:"nid";s:6:"195716";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82745";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Zinc ascorbate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195717;a:27:{s:5:"title";s:14:"Sphalerite_ACN";s:3:"nid";s:6:"195717";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82746";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sphalerite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195718;a:27:{s:5:"title";s:12:"Stibnite_ACN";s:3:"nid";s:6:"195718";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82747";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Stibnite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195719;a:27:{s:5:"title";s:22:"Bismuth subnitrate_ACN";s:3:"nid";s:6:"195719";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82748";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Bismuth subnitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195720;a:27:{s:5:"title";s:17:"Bismuth oxide_ACN";s:3:"nid";s:6:"195720";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82749";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Bismuth oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195721;a:27:{s:5:"title";s:19:"Isovaleric acid_ACN";s:3:"nid";s:6:"195721";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82750";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Isovaleric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195722;a:27:{s:5:"title";s:23:"Molybdenum trioxide_ACN";s:3:"nid";s:6:"195722";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82751";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Molybdenum trioxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195723;a:27:{s:5:"title";s:11:"Diamond_ACN";s:3:"nid";s:6:"195723";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82752";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Diamond";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195724;a:27:{s:5:"title";s:21:"Mercurous bromide_ACN";s:3:"nid";s:6:"195724";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:51:"Hg2Br2, Occurs in nature as Kuzminite [Hg2(Br,Cl)2]";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82753";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Mercurous bromide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195725;a:27:{s:5:"title";s:37:"Transforming growth factor beta 1_ACN";s:3:"nid";s:6:"195725";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82754";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Transforming growth factor beta 1";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195726;a:27:{s:5:"title";s:22:"Mercurous chloride_ACN";s:3:"nid";s:6:"195726";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82755";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Mercurous chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195727;a:27:{s:5:"title";s:12:"Antimony_ACN";s:3:"nid";s:6:"195727";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82756";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Antimony";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195728;a:27:{s:5:"title";s:11:"Ulexite_ACN";s:3:"nid";s:6:"195728";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82757";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Ulexite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195729;a:27:{s:5:"title";s:13:"Uraninite_ACN";s:3:"nid";s:6:"195729";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82758";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Uraninite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195730;a:27:{s:5:"title";s:11:"Granite_ACN";s:3:"nid";s:6:"195730";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:128:"Containing 80–100% by volume. quartz, alkali feldspar, and plagioclase in specific proportions, and 20–0% accessory minerals";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82759";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Granite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195731;a:27:{s:5:"title";s:12:"Hematite_ACN";s:3:"nid";s:6:"195731";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82760";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Hematite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195732;a:27:{s:5:"title";s:12:"Lazulite_ACN";s:3:"nid";s:6:"195732";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82761";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Lazulite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195733;a:27:{s:5:"title";s:14:"Lepidolite_ACN";s:3:"nid";s:6:"195733";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82762";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Lepidolite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195734;a:27:{s:5:"title";s:12:"Monazite_ACN";s:3:"nid";s:6:"195734";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82763";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Monazite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195735;a:27:{s:5:"title";s:12:"Obsidian_ACN";s:3:"nid";s:6:"195735";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82764";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Obsidian";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195736;a:27:{s:5:"title";s:10:"Pyrite_ACN";s:3:"nid";s:6:"195736";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82765";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Pyrite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195737;a:27:{s:5:"title";s:14:"Pyrolusite_ACN";s:3:"nid";s:6:"195737";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82766";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pyrolusite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195738;a:27:{s:5:"title";s:13:"Rhodonite_ACN";s:3:"nid";s:6:"195738";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82767";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Rhodonite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195739;a:27:{s:5:"title";s:11:"Bromine_ACN";s:3:"nid";s:6:"195739";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82768";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Bromine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195740;a:27:{s:5:"title";s:28:"Celgosivir hydrochloride_ACN";s:3:"nid";s:6:"195740";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82769";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Celgosivir hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195741;a:27:{s:5:"title";s:12:"Diopside_ACN";s:3:"nid";s:6:"195741";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82770";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Diopside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195742;a:27:{s:5:"title";s:23:"Gelatin hydrolyzate_ACN";s:3:"nid";s:6:"195742";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82771";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Gelatin hydrolyzate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195743;a:27:{s:5:"title";s:23:"Quartz conglomerate_ACN";s:3:"nid";s:6:"195743";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82772";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Quartz conglomerate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195744;a:27:{s:5:"title";s:21:"Magnesium lactate_ACN";s:3:"nid";s:6:"195744";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97567";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:204:"Magnesium lactate is classified as an NHP, because it is used as a source of Magnesium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:227:"Lactate de magnésium est classifié comme PSN, car il est utilisé comme source de Magnésium, et par conséquent, il est considéré PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82774";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Magnesium lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195745;a:27:{s:5:"title";s:25:"Glutathione disulfide_ACN";s:3:"nid";s:6:"195745";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97909";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82775";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Glutathione disulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195746;a:27:{s:5:"title";s:22:"Salvianolic acid B_ACN";s:3:"nid";s:6:"195746";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97576";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82776";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Salvianolic acid B";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195747;a:27:{s:5:"title";s:16:"Lumbrokinase_ACN";s:3:"nid";s:6:"195747";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97832";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82777";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Lumbrokinase";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195748;a:27:{s:5:"title";s:12:"Soya Oil_ACN";s:3:"nid";s:6:"195748";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97851";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82778";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Soya Oil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195749;a:27:{s:5:"title";s:13:"Amygdalin_ACN";s:3:"nid";s:6:"195749";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97925";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82779";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Amygdalin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195750;a:27:{s:5:"title";s:17:"Chitin-glucan_ACN";s:3:"nid";s:6:"195750";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"97934";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82780";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Chitin-glucan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195751;a:27:{s:5:"title";s:16:"Thymomodulin_ACN";s:3:"nid";s:6:"195751";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98018";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82781";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Thymomodulin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195752;a:27:{s:5:"title";s:30:"Ferric subsulfate solution_ACN";s:3:"nid";s:6:"195752";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98086";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82782";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Ferric subsulfate solution";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195753;a:27:{s:5:"title";s:30:"Calcium chloride dihydrate_ACN";s:3:"nid";s:6:"195753";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98205";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:211:"Calcium chloride dihydrate is classified as an NHP, because it is used as a source of Calcium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:233:"Chlorure de calcium dihydraté est classifié comme PSN, car il est utilisé comme source de Calcium, et par conséquent, il est considéré PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82783";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Calcium chloride dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195754;a:27:{s:5:"title";s:34:"Magnesium chloride hexahydrate_ACN";s:3:"nid";s:6:"195754";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98206";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:217:"Magnesium chloride hexahydrate is classified as an NHP, because it is used as a source of Magnesium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:241:"Chlorure de magnésium hexahydraté est classifié comme PSN, car il est utilisé comme source de Magnésium, et par conséquent, il est considéré PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82784";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Magnesium chloride hexahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195755;a:27:{s:5:"title";s:15:"Fucoxanthin_ACN";s:3:"nid";s:6:"195755";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98236";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82785";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Fucoxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195756;a:27:{s:5:"title";s:20:"Calcium pyruvate_ACN";s:3:"nid";s:6:"195756";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96768";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:219:"Calcium pyruvate is classified as an NHP, because it is used as a source of Calcium and Pyruvic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:240:"Pyruvate de calcium est classifié comme PSN, car il est utilisé comme source de Calcium et d'Acide pyruvique, et par conséquent, il est considéré PSN sous Annexe 1, article 2(un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82786";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Calcium pyruvate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195757;a:27:{s:5:"title";s:19:"Sodium pyruvate_ACN";s:3:"nid";s:6:"195757";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"96768";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:206:"Sodium pyruvate is classified as an NHP, because it is used as a source of Pyruvic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:225:"Pyruvate de sodium est classifié comme PSN, car il est utilisé comme source d'Acide pyruvique, et par conséquent, il est considéré PSN sous Annexe 1, article 2(un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82787";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Sodium pyruvate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195758;a:27:{s:5:"title";s:16:"Curcuminoids_ACN";s:3:"nid";s:6:"195758";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93541";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82788";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Curcuminoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195759;a:27:{s:5:"title";s:20:"Potassium iodide_ACN";s:3:"nid";s:6:"195759";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98360";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:200:"Potassium iodide is classified as an NHP, because it is used as a source of Iodine, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:219:"Iodure de potassium est classifié comme PSN, car il est utilisé comme source d'Iodure, et par conséquent, il est considéré PSN sous Annexe 1, article 7(un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82789";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Potassium iodide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195760;a:27:{s:5:"title";s:25:"D-Glucose monohydrate_ACN";s:3:"nid";s:6:"195760";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98216";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:207:"D-Glucose monohydrate is classified as an NHP, because it is used as a source of Glucose, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:222:"D-Glucose monohydraté est classifié comme PSN, car il est utilisé comme source de Glucose, et par conséquent, il est considéré PSN sous Annexe 1, article 2(un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82790";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"D-Glucose monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195761;a:27:{s:5:"title";s:28:"Sodium citrate dihydrate_ACN";s:3:"nid";s:6:"195761";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98209";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:214:"Sodium citrate dihydrate is classified as an NHP, because it is used as a source of Citric acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:234:"Citrate de sodium dihydraté est classifié comme PSN, car il est utilisé comme source d'Acide citrique, et par conséquent, il est considéré PSN sous Annexe 1, article 2(un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82791";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Sodium citrate dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195762;a:27:{s:5:"title";s:19:"Silicon dioxide_ACN";s:3:"nid";s:6:"195762";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98437";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:200:"Silicon dioxide is classified as an NHP, because it is used as a source of Silicon, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:222:"Dioxyde de silicium est classifié comme PSN parce qu'utilisé comme source de silicium, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82792";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Silicon dioxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195763;a:27:{s:5:"title";s:19:"D-Aspartic acid_ACN";s:3:"nid";s:6:"195763";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98464";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82793";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"D-Aspartic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195764;a:27:{s:5:"title";s:48:"Iron hydrolyzed animal protein (HAP) chelate_ACN";s:3:"nid";s:6:"195764";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98308";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:226:"Iron hydrolyzed animal protein (HAP) chelate is classified as an NHP, because it is used as a source of Iron, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:268:"Produit de chélation de fer et de protéine animale hydrolysée (PAH) est classifié comme PSN parce qu'utilisé comme source de Fer, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82794";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:44:"Iron hydrolyzed animal protein (HAP) chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195765;a:27:{s:5:"title";s:48:"Zinc hydrolyzed animal protein (HAP) chelate_ACN";s:3:"nid";s:6:"195765";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98309";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:226:"Zinc hydrolyzed animal protein (HAP) chelate is classified as an NHP, because it is used as a source of Zinc, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:270:"Produit de chélation de zinc et de protéine animale hydrolysée (PAH) est classifié comme PSN parce qu'utilisé comme source de Zinc, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82795";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:44:"Zinc hydrolyzed animal protein (HAP) chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195766;a:27:{s:5:"title";s:50:"Copper hydrolyzed animal protein (HAP) chelate_ACN";s:3:"nid";s:6:"195766";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98310";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:230:"Copper hydrolyzed animal protein (HAP) chelate is classified as an NHP, because it is used as a source of Copper, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:274:"Produit de chélation de cuivre et de protéine animale hydrolysée (PAH) est classifié comme PSN parce qu'utilisé comme source de cuivre, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82796";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:46:"Copper hydrolyzed animal protein (HAP) chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195767;a:27:{s:5:"title";s:21:"gamma-Tocotrienol_ACN";s:3:"nid";s:6:"195767";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98487";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82797";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"gamma-Tocotrienol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195768;a:27:{s:5:"title";s:49:"Aluminium zirconium tetrachlorohydrex glycine_ACN";s:3:"nid";s:6:"195768";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82798";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:45:"Aluminium zirconium tetrachlorohydrex glycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195769;a:27:{s:5:"title";s:21:"Aluminum chloride_ACN";s:3:"nid";s:6:"195769";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82799";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Aluminum chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195770;a:27:{s:5:"title";s:26:"Aluminum chlorohydrate_ACN";s:3:"nid";s:6:"195770";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82800";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Aluminum chlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195771;a:27:{s:5:"title";s:29:"Aluminum chlorohydrex PEG_ACN";s:3:"nid";s:6:"195771";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82801";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Aluminum chlorohydrex PEG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195772;a:27:{s:5:"title";s:42:"Aluminum chlorohydrex propylene glycol_ACN";s:3:"nid";s:6:"195772";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82802";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"Aluminum chlorohydrex propylene glycol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195773;a:27:{s:5:"title";s:28:"Aluminum dichlorohydrate_ACN";s:3:"nid";s:6:"195773";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82803";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Aluminum dichlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195774;a:27:{s:5:"title";s:31:"Aluminum Dichlorohydrex PEG_ACN";s:3:"nid";s:6:"195774";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82804";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Aluminum Dichlorohydrex PEG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195775;a:27:{s:5:"title";s:30:"Aluminum Dichlorohydrex PG_ACN";s:3:"nid";s:6:"195775";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82805";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Aluminum Dichlorohydrex PG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195776;a:27:{s:5:"title";s:32:"Aluminum sesquichlorohydrate_ACN";s:3:"nid";s:6:"195776";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82806";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Aluminum sesquichlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195777;a:27:{s:5:"title";s:35:"Aluminum Sesquichlorohydrex PEG_ACN";s:3:"nid";s:6:"195777";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82807";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:31:"Aluminum Sesquichlorohydrex PEG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195778;a:27:{s:5:"title";s:34:"Aluminum Sesquichlorohydrex PG_ACN";s:3:"nid";s:6:"195778";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82808";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Aluminum Sesquichlorohydrex PG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195779;a:27:{s:5:"title";s:39:"Aluminum zirconium trichlorohydrate_ACN";s:3:"nid";s:6:"195779";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82809";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"Aluminum zirconium trichlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195780;a:27:{s:5:"title";s:46:"Aluminum zirconium trichlorohydrex glycine_ACN";s:3:"nid";s:6:"195780";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82810";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:42:"Aluminum zirconium trichlorohydrex glycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195781;a:27:{s:5:"title";s:41:"Aluminum zirconium tetrachlorohydrate_ACN";s:3:"nid";s:6:"195781";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82811";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"Aluminum zirconium tetrachlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195782;a:27:{s:5:"title";s:44:"Aluminum zirconium tetrachlorohydrex PEG_ACN";s:3:"nid";s:6:"195782";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82812";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Aluminum zirconium tetrachlorohydrex PEG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195783;a:27:{s:5:"title";s:43:"Aluminum zirconium tetrachlorohydrex PG_ACN";s:3:"nid";s:6:"195783";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82813";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:39:"Aluminum zirconium tetrachlorohydrex PG";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195784;a:27:{s:5:"title";s:41:"Aluminum zirconium pentachlorohydrate_ACN";s:3:"nid";s:6:"195784";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82814";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"Aluminum zirconium pentachlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195785;a:27:{s:5:"title";s:48:"Aluminum zirconium pentachlorohydrex glycine_ACN";s:3:"nid";s:6:"195785";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82815";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:44:"Aluminum zirconium pentachlorohydrex glycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195786;a:27:{s:5:"title";s:40:"Aluminum zirconium octachlorohydrate_ACN";s:3:"nid";s:6:"195786";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82816";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:36:"Aluminum zirconium octachlorohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195787;a:27:{s:5:"title";s:47:"Aluminum zirconium octachlorohydrex glycine_ACN";s:3:"nid";s:6:"195787";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93237";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:349:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations. Antiperspirants indicated for hyperhydrosis, or otherwise providing a more permanent effect than simple reduction of underarm perspiration, are classified as NHPs. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-eng.php";s:17:"field_rationale_f";s:382:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels. Les antisudorifiques qui visent à combattre l'hyperhidrose, ou qui exercent un effet plus durable que celui qui a été susmentionné, sont classifiés comme produits de santé naturels. http://www.hc-sc.gc.ca/cps-spc/pubs/indust/cosmet-antiperspir-sudorif/index-fra.php";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82817";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:43:"Aluminum zirconium octachlorohydrex glycine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195788;a:27:{s:5:"title";s:20:"Dihydroxyacetone_ACN";s:3:"nid";s:6:"195788";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98440";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82818";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dihydroxyacetone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195789;a:27:{s:5:"title";s:12:"Sea Salt_ACN";s:3:"nid";s:6:"195789";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98554";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:194:"Sea salt is classified as an NHP, because it is used as a source of minerals, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:221:"Sel de mer est classifié comme PSN, car elle est utilisée comme source de minéraux, et par conséquent, elle est considérée PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82819";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Sea Salt";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195790;a:27:{s:5:"title";s:26:"Ibogaine hydrochloride_ACN";s:3:"nid";s:6:"195790";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98515";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82820";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Ibogaine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195791;a:27:{s:5:"title";s:23:"Calcium L-threonate_ACN";s:3:"nid";s:6:"195791";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:204:"Calcium L-threonate is classified as an NHP, because it is used as a source of Calcium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:227:"L-thréonate de calcium est classifié comme PSN, car il est utilisé comme source de Calcium, et par conséquent, il est considérée PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82821";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Calcium L-threonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195792;a:27:{s:5:"title";s:19:"Calcium orotate_ACN";s:3:"nid";s:6:"195792";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:205:"Calcium orotate is classified as an NHP, because it is used as a source of Orotic acid, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:226:"Orotate de calcium est classifié comme PSN, car il est utilisé comme source d'acide orotique, et par conséquent, il est considérée PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82822";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Calcium orotate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195793;a:27:{s:5:"title";s:26:"Calcium D-pantothenate_ACN";s:3:"nid";s:6:"195793";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82823";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Calcium D-pantothenate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195794;a:27:{s:5:"title";s:21:"Calcium sennoside_ACN";s:3:"nid";s:6:"195794";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:206:"Calcium sennoside is classified as an NHP, because it is used as a source of Sennosides, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:225:"Sennoside de calcium est classifié comme PSN, car il est utilisé comme source de Sennosides, et par conséquent, il est considérée PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82824";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium sennoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195795;a:27:{s:5:"title";s:21:"Chromium fumarate_ACN";s:3:"nid";s:6:"195795";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:203:"Chromium fumarate is classified as an NHP, because it is used as a source of Chromium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:221:"Fumarate de chrome est classifié comme PSN, car il est utilisé comme source de Chrome, et par conséquent, il est considérée PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82825";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Chromium fumarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195796;a:27:{s:5:"title";s:16:"Phytosterols_ACN";s:3:"nid";s:6:"195796";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93385";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82826";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Phytosterols";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195797;a:27:{s:5:"title";s:19:"D-Tartaric acid_ACN";s:3:"nid";s:6:"195797";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82827";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"D-Tartaric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195798;a:27:{s:5:"title";s:24:"L-Arginine taurinate_ACN";s:3:"nid";s:6:"195798";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:221:"L-Arginine taurinate is classified as an NHP, because it is used as a source of L-Arginine and Taurine, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:238:"Taurinate de l-arginine est classifié comme PSN, car il est utilisé comme source de L-arginie et taurine, et par conséquent, il est considérée PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82828";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"L-Arginine taurinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195799;a:27:{s:5:"title";s:21:"Methylsilanetriol_ACN";s:3:"nid";s:6:"195799";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93977";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:202:"Methylsilanetriol is classified as an NHP, because it is used as a source of Silicon, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:223:"Méthylsilanetriol est classifié comme PSN, car il est utilisé comme source de Silicium, et par conséquent, il est considérée PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82829";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methylsilanetriol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195800;a:27:{s:5:"title";s:18:"Potassium Alum_ACN";s:3:"nid";s:6:"195800";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98680";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82830";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Potassium Alum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195801;a:27:{s:5:"title";s:38:"Polyethylene glycosylated creatine_ACN";s:3:"nid";s:6:"195801";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98582";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:221:"Polyethylene glycosylated creatine is classified as an NHP, because it is used as a source of Creatine, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:243:"Créatine glycosylée de polyéthylène est classifié comme PSN, car il est utilisé comme source de Créatine, et par conséquent, il est considérée PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82832";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"Polyethylene glycosylated creatine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195802;a:27:{s:5:"title";s:34:"Potassium hydrogen D-glucarate_ACN";s:3:"nid";s:6:"195802";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98649";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82833";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Potassium hydrogen D-glucarate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195803;a:27:{s:5:"title";s:22:"N-Formylmethionine_ACN";s:3:"nid";s:6:"195803";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98761";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82834";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"N-Formylmethionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195804;a:27:{s:5:"title";s:20:"Magnesium malate_ACN";s:3:"nid";s:6:"195804";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98784";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:203:"Magnesium malate is classified as an NHP, because it is used as a source of Magnesium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:231:"Malate de magnésium est classifié comme PSN, parce qu'il est utilisé comme source de Magnésium, et par conséquent est considéré un PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82835";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Magnesium malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195805;a:27:{s:5:"title";s:13:"Palladium_ACN";s:3:"nid";s:6:"195805";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98758";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:186:"Scientific evidence indicates Palladium is toxic. Please note that new evidence of its safety and efficacy will be considered to determine if it favorably affects the benefit-risk ratio.";s:24:"field_restriction_desc_f";s:233:"Des preuves scientifiques indiquent que Palladium est toxique. Veuillez noter que de nouvelles preuves de son innocuité et efficacité seront considérées afin de déterminer s'il affecte favorablement le rapport bénéfice/risque.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82836";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Palladium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195806;a:27:{s:5:"title";s:13:"Ruthenium_ACN";s:3:"nid";s:6:"195806";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98759";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82837";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ruthenium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195807;a:27:{s:5:"title";s:11:"Rhodium_ACN";s:3:"nid";s:6:"195807";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98760";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82838";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Rhodium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195808;a:27:{s:5:"title";s:16:"Hydroquinine_ACN";s:3:"nid";s:6:"195808";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98852";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82839";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Hydroquinine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195809;a:27:{s:5:"title";s:30:"Nicotinyl alcohol tartrate_ACN";s:3:"nid";s:6:"195809";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98852";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:211:"Nicotinyl alcohol tartrate is classified as an NHP, because it is used as a source of Niacin, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:237:"Tartrate d'alcool nicotinylique est classifié comme PSN, parce qu'il est utilisé comme source de Niacine, et par conséquent est considéré un PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82840";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Nicotinyl alcohol tartrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195810;a:27:{s:5:"title";s:45:"Concentrated desalinated Inland Sea water_ACN";s:3:"nid";s:6:"195810";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98813";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82841";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:41:"Concentrated desalinated Inland Sea water";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195811;a:27:{s:5:"title";s:10:"Alumen_ACN";s:3:"nid";s:6:"195811";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98916";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82842";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Alumen";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195812;a:27:{s:5:"title";s:14:"Zeaxanthin_ACN";s:3:"nid";s:6:"195812";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98972";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82843";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Zeaxanthin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195813;a:27:{s:5:"title";s:10:"Lutein_ACN";s:3:"nid";s:6:"195813";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98972";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82844";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Lutein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195814;a:27:{s:5:"title";s:17:"Lutein esters_ACN";s:3:"nid";s:6:"195814";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98972";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82845";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Lutein esters";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195815;a:27:{s:5:"title";s:21:"Zeaxanthin esters_ACN";s:3:"nid";s:6:"195815";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98972";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82846";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Zeaxanthin esters";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195816;a:27:{s:5:"title";s:20:"L-Hydroxyproline_ACN";s:3:"nid";s:6:"195816";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98982";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82847";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"L-Hydroxyproline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195817;a:27:{s:5:"title";s:19:"Dihydrocapsiate_ACN";s:3:"nid";s:6:"195817";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99020";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82848";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Dihydrocapsiate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195818;a:27:{s:5:"title";s:14:"Capsinoids_ACN";s:3:"nid";s:6:"195818";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99014";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82849";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Capsinoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195819;a:27:{s:5:"title";s:22:"Nordihydrocapsiate_ACN";s:3:"nid";s:6:"195819";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99021";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82850";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Nordihydrocapsiate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195820;a:27:{s:5:"title";s:50:"Partially hydrolysed chicken eggshell membrane_ACN";s:3:"nid";s:6:"195820";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99039";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82851";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:46:"Partially hydrolysed chicken eggshell membrane";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195821;a:27:{s:5:"title";s:30:"Sodium acetate, trihydrate_ACN";s:3:"nid";s:6:"195821";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99042";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82852";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Sodium acetate, trihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195822;a:27:{s:5:"title";s:32:"Magnesium amino acid chelate_ACN";s:3:"nid";s:6:"195822";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99057";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:215:"Magnesium amino acid chelate is classified as an NHP, because it is used as a source of Magnesium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:248:"Chélate d'acide aminé de magnésium est classifié comme PSN, parce qu'il est utilisé comme source de Magnésium, et par conséquent est considéré un PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82853";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Magnesium amino acid chelate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195823;a:27:{s:5:"title";s:32:"Undenatured type II collagen_ACN";s:3:"nid";s:6:"195823";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99080";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82854";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Undenatured type II collagen";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195824;a:27:{s:5:"title";s:27:"Dipeptidyl-peptidase IV_ACN";s:3:"nid";s:6:"195824";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99118";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82855";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Dipeptidyl-peptidase IV";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195825;a:27:{s:5:"title";s:23:"D-Ribose-L-cysteine_ACN";s:3:"nid";s:6:"195825";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99148";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82857";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"D-Ribose-L-cysteine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195826;a:27:{s:5:"title";s:10:"Talcum_ACN";s:3:"nid";s:6:"195826";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98881";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82858";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Talcum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195827;a:27:{s:5:"title";s:17:"Zinc chloride_ACN";s:3:"nid";s:6:"195827";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99208";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:193:"Zinc chloride is classified as an NHP, because it is used as a source of Zinc, and therefore is considered an NHP under Schedule 1, item 7 (mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:212:"Chlorure de zinc est classifié comme PSN parce qu'utilisé comme source de zinc, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82859";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Zinc chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195828;a:27:{s:5:"title";s:28:"Natrii Sulfas Exsiccatus_ACN";s:3:"nid";s:6:"195828";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99429";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82860";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Natrii Sulfas Exsiccatus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195829;a:27:{s:5:"title";s:27:"Citric acid monohydrate_ACN";s:3:"nid";s:6:"195829";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99435";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82861";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Citric acid monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195830;a:27:{s:5:"title";s:8:"Clay_ACN";s:3:"nid";s:6:"195830";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99187";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1439:"Silicate mineral complex is most commonly known as clay, which is typically a term referring to an aggregate of hydrous silicate particles less than 2 micrometers in diameter. Clay is generally composed of a variety of naturally occurring phyllosilicate minerals (e.g. kaolinite, montmorillonite, pyrophyllite, illite, halloysite), which are rich in silicon and aluminum oxides and hydroxides, including variable amounts of water. These kind of mineral aggregates are generally formed by the chemical weathering of silicate-bearing rocks or by hydrothermal activity, which generally occurs near volcanic activity. Some medicinal roles of phyllosilicates include their use as  antacids, gastrointestinal protectants, antidiarrhoeaics, dermatological protectants and anti-inflammatories [Carretero et al. 2010; Gomes & Silva 2007]. Silicate mineral complex, or Clay, will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations. 
Carretero MI, Pozo M. 2010. Review Article: Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients. Applied Clay Science 47:171-181.
Gomes CdSF, Silva JBP. 2007. Minerals and clay minerals in medical geology. Applied Clay Science 36:4–21. Lopez-Galindo A, Viseras C, Cerezo P. 2007. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Applied Clay Science 36:51-63.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82862";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Clay";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195831;a:27:{s:5:"title";s:19:"Fungal protease_APN";s:3:"nid";s:6:"195831";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99561";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82863";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Fungal protease";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195832;a:27:{s:5:"title";s:15:"Salidroside_ACN";s:3:"nid";s:6:"195832";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99611";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82864";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Salidroside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195833;a:27:{s:5:"title";s:13:"d-Borneol_ACN";s:3:"nid";s:6:"195833";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99830";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82865";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"d-Borneol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195834;a:27:{s:5:"title";s:25:"Borneolum Syntheticum_ACN";s:3:"nid";s:6:"195834";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99830";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82866";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Borneolum Syntheticum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195835;a:27:{s:5:"title";s:23:"Inca Peanut Protein_APN";s:3:"nid";s:6:"195835";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99845";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82868";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Inca Peanut Protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195836;a:27:{s:5:"title";s:20:"Flaxseed Protein_APN";s:3:"nid";s:6:"195836";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99847";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82869";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Flaxseed Protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195837;a:27:{s:5:"title";s:26:"Creatine hydrochloride_ACN";s:3:"nid";s:6:"195837";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99918";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82870";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Creatine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195838;a:27:{s:5:"title";s:16:"Rice Protein_ACN";s:3:"nid";s:6:"195838";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99846";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82871";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Rice Protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195839;a:27:{s:5:"title";s:10:"Nitrum_ACN";s:3:"nid";s:6:"195839";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99967";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82872";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Nitrum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195840;a:27:{s:5:"title";s:17:"Natrii Sulfas_ACN";s:3:"nid";s:6:"195840";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107452";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82873";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Natrii Sulfas";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195841;a:27:{s:5:"title";s:11:"Lignans_ACN";s:3:"nid";s:6:"195841";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100436";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82874";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lignans";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:20:"BRIT_J_NUTR_99(1301)";s:15:"field_other_ref";s:0:"";}i:195842;a:27:{s:5:"title";s:23:"Hydroxymatairesinol_ACN";s:3:"nid";s:6:"195842";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100436";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82884";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Hydroxymatairesinol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:19:"NUTR_CANCER_36(207)";s:15:"field_other_ref";s:0:"";}i:195843;a:27:{s:5:"title";s:20:"Xylose isomerase_APN";s:3:"nid";s:6:"195843";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100873";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82886";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Xylose isomerase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195844;a:27:{s:5:"title";s:12:"Apigenin_ACN";s:3:"nid";s:6:"195844";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100964";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82887";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Apigenin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195845;a:27:{s:5:"title";s:11:"Halitum_ACN";s:3:"nid";s:6:"195845";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100984";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82890";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Halitum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195846;a:28:{s:5:"title";s:11:"Paeonol_ACN";s:3:"nid";s:6:"195846";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100686";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82891";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Paeonol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:3:"DNP";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195847;a:27:{s:5:"title";s:9:"Borax_ACN";s:3:"nid";s:6:"195847";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100243";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:421:"This Medicinal Ingredient is specifically for use in Traditional Chinese Medicine (TCM) products, and its preparation must comply with the method(s) described in the most current edition of the Pharmacopoeia of the People's Republic of China. Borax should be used orally with caution, as there are concerns that long-term oral use can cause renal dysfunction. The submission of additional safety evidence may be required.";s:24:"field_restriction_desc_f";s:518:"Cet ingrédient médicinal est spécifiquement destiné à être utilisé dans les produits de médecine chinoise traditionnelle (MCT), et sa préparation doit se conformer à la ou les méthodes décrites dans l'édition la plus récente de la pharmacopée de la République populaire de Chine. Borax doit être utilisé avec précaution oralement, car l'utilisation à long terme pourrait causer un dysfonctionnement rénal. La soumission de preuves supplémentaires relatives à l'innocuité pourrait être exigée.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82892";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Borax";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195848;a:27:{s:5:"title";s:28:"Agave tequilana fructans_ACN";s:3:"nid";s:6:"195848";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101008";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82893";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Agave tequilana fructans";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195849;a:27:{s:5:"title";s:20:"Agmatine sulfate_ACN";s:3:"nid";s:6:"195849";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101118";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82894";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Agmatine sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:0:"";s:15:"field_other_ref";s:0:"";}i:195850;a:27:{s:5:"title";s:25:"Magnesium L-threonate_ACN";s:3:"nid";s:6:"195850";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101317";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:208:"Magnesium L-threonate is classified as an NHP, because it is used as a source of magnesium, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:235:"L-thréonate de magnésium est classifié comme PSN car il est utilisé comme source de magnésium, et par conséquent, est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82896";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Magnesium L-threonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195851;a:27:{s:5:"title";s:21:"Glycerol dioleate_ACN";s:3:"nid";s:6:"195851";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101283";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82897";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Glycerol dioleate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195852;a:27:{s:5:"title";s:17:"1-Hexacosanol_ACN";s:3:"nid";s:6:"195852";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101413";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82898";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"1-Hexacosanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195853;a:27:{s:5:"title";s:12:"Succinum_ACN";s:3:"nid";s:6:"195853";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101372";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82902";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Succinum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195854;a:28:{s:5:"title";s:15:"beta-glucan_ACN";s:3:"nid";s:6:"195854";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101620";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82904";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"beta-glucan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195855;a:27:{s:5:"title";s:12:"Genistin_ACN";s:3:"nid";s:6:"195855";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101375";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82905";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Genistin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195856;a:28:{s:5:"title";s:22:"Carbamide peroxide_ACN";s:3:"nid";s:6:"195856";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101739";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:112:"A combination of urea and hydrogen peroxide, it is considered as a source for hydrogen peroxide (plant isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82906";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Carbamide peroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195857;a:28:{s:5:"title";s:21:"Hydrogen peroxide_ACN";s:3:"nid";s:6:"195857";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101740";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:173:"Hydrogen peroxide is found in raw, uncooked vegetables and fruits and therefore it is a NHP that falls under Schedule 1, item 2 (Priority 2: Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82907";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hydrogen peroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195858;a:27:{s:5:"title";s:18:"alpha-Carotene_ACN";s:3:"nid";s:6:"195858";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101848";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:111:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82908";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"alpha-Carotene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195859;a:27:{s:5:"title";s:24:"Thiamine diphosphate_ACN";s:3:"nid";s:6:"195859";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101830";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82909";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Thiamine diphosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195860;a:27:{s:5:"title";s:28:"Zinc sulfate monohydrate_ACN";s:3:"nid";s:6:"195860";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"101852";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:176:"Classified as an NHP, because it is used as a source of Zinc, and therefore is considered an NHP under Schedule 1, item 7 (mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:194:"Classifié comme PSN parce qu'utilisé comme source de Zinc, et par conséquent est considéré comme PSN sous Annexe 1, article 7(un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82911";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Zinc sulfate monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195861;a:27:{s:5:"title";s:15:"Actinolitum_ACN";s:3:"nid";s:6:"195861";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102043";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82912";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Actinolitum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195862;a:27:{s:5:"title";s:17:"Capsaicinoids_ACN";s:3:"nid";s:6:"195862";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102057";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82913";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Capsaicinoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195863;a:27:{s:5:"title";s:20:"dl-Mandelic acid_ACN";s:3:"nid";s:6:"195863";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102049";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82914";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"dl-Mandelic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195864;a:27:{s:5:"title";s:24:"Homodihydrocapsaicin_ACN";s:3:"nid";s:6:"195864";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102128";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 2, (isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:104:"Classifié comme PSN sous Annexe 1, item 2, (isolate) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82915";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Homodihydrocapsaicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195865;a:27:{s:5:"title";s:23:"Nordihydrocapsaicin_ACN";s:3:"nid";s:6:"195865";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102027";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 2, (isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:104:"Classifié comme PSN sous Annexe 1, item 2, (isolate) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82916";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Nordihydrocapsaicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195866;a:27:{s:5:"title";s:20:"Dihydrocapsaicin_ACN";s:3:"nid";s:6:"195866";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102026";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 2, (isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:104:"Classifié comme PSN sous Annexe 1, item 2, (isolate) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82917";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Dihydrocapsaicin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195867;a:27:{s:5:"title";s:30:"Hydrolyzed Collagen Type I_ACN";s:3:"nid";s:6:"195867";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102125";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82918";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Hydrolyzed Collagen Type I";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195868;a:27:{s:5:"title";s:17:"Glycolic Acid_ACN";s:3:"nid";s:6:"195868";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102129";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82919";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Glycolic Acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195869;a:27:{s:5:"title";s:10:"Halite_ACN";s:3:"nid";s:6:"195869";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102039";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82920";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Halite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195870;a:28:{s:5:"title";s:24:"Hemp Protein Isolate_ACN";s:3:"nid";s:6:"195870";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98714";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:292:"Hemp seed derivatives such as hemp seed oil and protein fall under Item 2 of Schedule 1 to the Natural Health Products Regulations, as extracts of a substance described in item 1, the primary molecular structure of which is identical to that which it had prior to its extraction or isolation.";s:17:"field_rationale_f";s:340:"Les dérivés de graines de cannabis comme l'huile et les protéines sont couverts par l'article 2 de l'annexe 1 du Règlement sur les produits de santé naturels, comme extraits d'une substance décrite à l'article 1, dont la structure moléculaire principale est identique à celle qu'ils avaient avant leur extraction ou leur isolement.";s:24:"field_restriction_desc_e";s:166:"Hemp products cannot contain more than 10 ppm of delta-9-tetrahydro-cannabinol (THC), and their production must be in compliance with the Industrial Hemp Regulations.";s:24:"field_restriction_desc_f";s:178:"Les produits du chanvre ne peuvent contenir plus de 10 ppm de delta 9-tétrahydrocannabinol (THC), et leur production doit être conforme au Règlement sur le chanvre industriel.";s:17:"field_upper_limit";s:11:"10.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82921";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Hemp Protein Isolate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:3:"ppm";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195871;a:28:{s:5:"title";s:21:"Hemp Seed Protein_ACN";s:3:"nid";s:6:"195871";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102134";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:292:"Hemp seed derivatives such as hemp seed oil and protein fall under Item 2 of Schedule 1 to the Natural Health Products Regulations, as extracts of a substance described in item 1, the primary molecular structure of which is identical to that which it had prior to its extraction or isolation.";s:17:"field_rationale_f";s:340:"Les dérivés de graines de cannabis comme l'huile et les protéines sont couverts par l'article 2 de l'annexe 1 du Règlement sur les produits de santé naturels, comme extraits d'une substance décrite à l'article 1, dont la structure moléculaire principale est identique à celle qu'ils avaient avant leur extraction ou leur isolement.";s:24:"field_restriction_desc_e";s:166:"Hemp products cannot contain more than 10 ppm of delta-9-tetrahydro-cannabinol (THC), and their production must be in compliance with the Industrial Hemp Regulations.";s:24:"field_restriction_desc_f";s:178:"Les produits du chanvre ne peuvent contenir plus de 10 ppm de delta 9-tétrahydrocannabinol (THC), et leur production doit être conforme au Règlement sur le chanvre industriel.";s:17:"field_upper_limit";s:11:"10.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82922";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Hemp Seed Protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:3:"ppm";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195872;a:27:{s:5:"title";s:27:"Zinc citrate trihydrate_ACN";s:3:"nid";s:6:"195872";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102156";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:205:"Zinc citrate trihydrate is classified as an NHP, because it is used as a source of Zinc, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:228:"Citrate de zinc trihydraté est classifié comme PSN, car il est utilisé comme source de Zinc, et par conséquent, il est considéré PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82923";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Zinc citrate trihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195873;a:27:{s:5:"title";s:31:"Magnesium sulfate dihydrate_ACN";s:3:"nid";s:6:"195873";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102155";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:113:"Classifié comme PSN sous Annexe 1, article 4 (un acide aminé) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82924";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Magnesium sulfate dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195874;a:27:{s:5:"title";s:14:"PGG-glucan_ACN";s:3:"nid";s:6:"195874";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102257";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82926";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"PGG-glucan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195875;a:27:{s:5:"title";s:24:"Magnesium dibutyrate_ACN";s:3:"nid";s:6:"195875";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102293";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82927";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Magnesium dibutyrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195876;a:27:{s:5:"title";s:22:"Calcium dibutyrate_ACN";s:3:"nid";s:6:"195876";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102293";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82928";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Calcium dibutyrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195877;a:27:{s:5:"title";s:25:"Leucyl aminopeptidase_APN";s:3:"nid";s:6:"195877";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102466";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82929";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Leucyl aminopeptidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195878;a:27:{s:5:"title";s:15:"Vinpocetine_ACN";s:3:"nid";s:6:"195878";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"94265";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:118:"Classified as a derivative of an NHP under Schedule 1, Item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:125:"Classifié comme un dérivé d'un PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82930";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vinpocetine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195879;a:27:{s:5:"title";s:22:"Lapis Micae Aureus_ACN";s:3:"nid";s:6:"195879";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102608";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:242:"This Medicinal Ingredient is specifically for use in Traditional Chinese Medicine (TCM) products, and its preparation must comply with the method(s) described in the most current edition of the Pharmacopoeia of the People's Republic of China.";s:24:"field_restriction_desc_f";s:295:"Cet ingrédient médicinal est spécifiquement destiné à être utilisé dans les produits de médecine chinoise traditionnelle (MCT), et sa préparation doit se conformer à la ou les méthodes décrites dans l'édition la plus récente de la pharmacopée de la République populaire de Chine.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82931";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Lapis Micae Aureus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:2:"CP";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195880;a:27:{s:5:"title";s:28:"Fish Protein Hydrolysate_APN";s:3:"nid";s:6:"195880";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102541";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82932";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Fish Protein Hydrolysate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195881;a:27:{s:5:"title";s:15:"L-Arabinose_ACN";s:3:"nid";s:6:"195881";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102536";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82933";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"L-Arabinose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195882;a:27:{s:5:"title";s:16:"Zinc citrate_ACN";s:3:"nid";s:6:"195882";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102009";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82934";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Zinc citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195883;a:27:{s:5:"title";s:22:"Potassium tartrate_ACN";s:3:"nid";s:6:"195883";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102717";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:181:"Classified as an NHP, because it is used as a source of potassium, and therefore is considered an NHP under Schedule 1, item 7 (mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:199:"Classifié comme PSN parce qu'utilisé comme source de potassium, et par conséquent est considéré comme PSN sous Annexe 1, article 7(un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82936";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Potassium tartrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195884;a:27:{s:5:"title";s:17:"Wheat dextrin_ACN";s:3:"nid";s:6:"195884";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103087";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82939";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Wheat dextrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195885;a:27:{s:5:"title";s:12:"Glycogen_ACN";s:3:"nid";s:6:"195885";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103101";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82940";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Glycogen";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195886;a:27:{s:5:"title";s:28:"Hepatocyte growth factor_ACN";s:3:"nid";s:6:"195886";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103129";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82941";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Hepatocyte growth factor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195887;a:27:{s:5:"title";s:28:"Fibroblast Growth Factor_ACN";s:3:"nid";s:6:"195887";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103128";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82942";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Fibroblast Growth Factor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195888;a:27:{s:5:"title";s:37:"Glucan endo-1,3-alpha-glucosidase_APN";s:3:"nid";s:6:"195888";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103253";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82943";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Glucan endo-1,3-alpha-glucosidase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195889;a:27:{s:5:"title";s:14:"Dextranase_APN";s:3:"nid";s:6:"195889";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103252";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82944";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Dextranase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195890;a:27:{s:5:"title";s:16:"Butyric acid_ACN";s:3:"nid";s:6:"195890";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102567";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82945";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Butyric acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195891;a:27:{s:5:"title";s:14:"d-Glaucine_ACN";s:3:"nid";s:6:"195891";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103298";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82946";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"d-Glaucine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195892;a:27:{s:5:"title";s:22:"Trans-Ferulic acid_ACN";s:3:"nid";s:6:"195892";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103480";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82947";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Trans-Ferulic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195893;a:27:{s:5:"title";s:43:"7-Hydroxymatairesinol potassium acetate_ACN";s:3:"nid";s:6:"195893";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103470";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:195:"Classified as an NHP, because it is used as a source of Hydroxymatairesinol, and therefore is considered an NHP under Schedule 1, item 2 (an isolate) , of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:209:"Classifié comme PSN parce qu'utilisé comme source de [Sub-ingredient name], et par conséquent est considéré comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82948";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:39:"7-Hydroxymatairesinol potassium acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195894;a:27:{s:5:"title";s:17:"Calcium oxide_ACN";s:3:"nid";s:6:"195894";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99133";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82949";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Calcium oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195895;a:28:{s:5:"title";s:17:"D-Lactic acid_ACN";s:3:"nid";s:6:"195895";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103519";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:78:"Classified as an NHP under Schedule 1 item 2 (isolate) of the NHP Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82950";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"D-Lactic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:15:"NHPD-ProperName";s:9:"field_ref";s:15:"NHPD-ProperName";s:15:"field_other_ref";s:0:"";}i:195896;a:27:{s:5:"title";s:17:"Cuprous oxide_ACN";s:3:"nid";s:6:"195896";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103579";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82951";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Cuprous oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195897;a:27:{s:5:"title";s:17:"Adeps solidus_ACN";s:3:"nid";s:6:"195897";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"99532";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82952";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Adeps solidus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195898;a:27:{s:5:"title";s:8:"Peat_ACN";s:3:"nid";s:6:"195898";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103515";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:96:"Classified as an NHP under Schedule 1, items 1 and 2 of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:102:"Classifié comme PSN sous Annexe 1, articles 1 et 2 du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82953";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Peat";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195899;a:27:{s:5:"title";s:16:"Peat extract_ACN";s:3:"nid";s:6:"195899";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103515";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:98:"Classified as an NHP under Schedule 1 item 2 (extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82954";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Peat extract";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195900;a:27:{s:5:"title";s:19:"Soybean Protein_APN";s:3:"nid";s:6:"195900";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103460";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:78:"Classified as an NHP under Schedule 1 item 2 (isolate) of the NHP Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82955";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Soybean Protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195901;a:27:{s:5:"title";s:18:"Ferric sulfate_ACN";s:3:"nid";s:6:"195901";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103845";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:194:"Ferric sulfate is classified as an NHP, because it is used as a source of Iron, and therefore is considered an NHP under Schedule 1, item 7 (mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:212:"Sulfate ferrique est classifié comme PSN parce qu'utilisé comme source de Fer, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82956";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Ferric sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195902;a:27:{s:5:"title";s:20:"Zinc hyaluronate_ACN";s:3:"nid";s:6:"195902";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103819";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82957";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Zinc hyaluronate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195903;a:27:{s:5:"title";s:19:"Androstadienone_ACN";s:3:"nid";s:6:"195903";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103739";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82958";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Androstadienone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195904;a:27:{s:5:"title";s:16:"Dead Sea Mud_ACN";s:3:"nid";s:6:"195904";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103499";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:99:"Classified as an NHP under Schedule 1 item 7 (a mineral) of the Natural Health Product Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82959";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Dead Sea Mud";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195905;a:27:{s:5:"title";s:20:"iota-Carrageenan_ACN";s:3:"nid";s:6:"195905";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104008";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:98:"Classified as an NHP under Schedule 1 item 2, (isolate) of the Natural Health Product Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82960";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"iota-Carrageenan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195906;a:27:{s:5:"title";s:18:"Mandelonitrile_ACN";s:3:"nid";s:6:"195906";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104164";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:123:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82963";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Mandelonitrile";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:15:"NHPD-ProperName";s:15:"field_other_ref";s:0:"";}i:195907;a:27:{s:5:"title";s:17:"Ergothioneine_ACN";s:3:"nid";s:6:"195907";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103271";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82964";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Ergothioneine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195908;a:27:{s:5:"title";s:16:"Polydextrose_ACN";s:3:"nid";s:6:"195908";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104208";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82965";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Polydextrose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195909;a:27:{s:5:"title";s:41:"Isoquercitrin, enzymatically modified_ACN";s:3:"nid";s:6:"195909";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104396";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82966";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:37:"Isoquercitrin, enzymatically modified";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:33:"INT_ARCH_ALLERGY_IMMUNOL_149(359)";s:15:"field_other_ref";s:20:"ALLERGOL_INT_58(373)";}i:195910;a:27:{s:5:"title";s:23:"Tetrahydrobiopterin_ACN";s:3:"nid";s:6:"195910";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104786";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82967";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Tetrahydrobiopterin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195911;a:27:{s:5:"title";s:13:"Sarcosine_ACN";s:3:"nid";s:6:"195911";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104194";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Product Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82968";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Sarcosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:2:"MI";s:15:"field_other_ref";s:0:"";}i:195912;a:28:{s:5:"title";s:28:"Hemp Protein Concentrate_ACN";s:3:"nid";s:6:"195912";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104986";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:292:"Hemp seed derivatives such as hemp seed oil and protein fall under Item 2 of Schedule 1 to the Natural Health Products Regulations, as extracts of a substance described in item 1, the primary molecular structure of which is identical to that which it had prior to its extraction or isolation.";s:17:"field_rationale_f";s:340:"Les dérivés de graines de cannabis comme l'huile et les protéines sont couverts par l'article 2 de l'annexe 1 du Règlement sur les produits de santé naturels, comme extraits d'une substance décrite à l'article 1, dont la structure moléculaire principale est identique à celle qu'ils avaient avant leur extraction ou leur isolement.";s:24:"field_restriction_desc_e";s:166:"Hemp products cannot contain more than 10 ppm of delta-9-tetrahydro-cannabinol (THC), and their production must be in compliance with the Industrial Hemp Regulations.";s:24:"field_restriction_desc_f";s:178:"Les produits du chanvre ne peuvent contenir plus de 10 ppm de delta 9-tétrahydrocannabinol (THC), et leur production doit être conforme au Règlement sur le chanvre industriel.";s:17:"field_upper_limit";s:11:"10.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82969";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Hemp Protein Concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:3:"ppm";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195913;a:27:{s:5:"title";s:14:"Actinidain_ACN";s:3:"nid";s:6:"195913";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104953";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82970";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Actinidain";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195914;a:27:{s:5:"title";s:23:"Polyarginyl lactate_ACN";s:3:"nid";s:6:"195914";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"104756";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:208:"Polyarginyl lactate is classified as an NHP, because it is used as a source of L-Arginine, and therefore is considered an NHP under Schedule 1, item 2 (an isolate), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:220:"Lactate de poly(arginyle) est classifié comme PSN, car il est utilisé comme source de L-arginie et taurine, il est considérée PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82971";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Polyarginyl lactate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195915;a:27:{s:5:"title";s:21:"Copper nicotinate_ACN";s:3:"nid";s:6:"195915";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"105793";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82975";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Copper nicotinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195916;a:27:{s:5:"title";s:17:"DL-Methionine_ACN";s:3:"nid";s:6:"195916";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"105643";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82976";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"DL-Methionine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195917;a:28:{s:5:"title";s:53:"Galactoarabinan polyglucoronic acid cross polymer_ACN";s:3:"nid";s:6:"195917";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"105890";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82977";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:49:"Galactoarabinan polyglucoronic acid cross polymer";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"VAGL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:18:"EUR_OBS_GYN_7(111)";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195918;a:27:{s:5:"title";s:13:"Calomelas_ACN";s:3:"nid";s:6:"195918";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106107";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2, (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82978";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Calomelas";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195919;a:27:{s:5:"title";s:13:"Mentholum_ACN";s:3:"nid";s:6:"195919";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106110";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2, (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82979";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Mentholum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195920;a:27:{s:5:"title";s:25:"Wheat protein isolate_APN";s:3:"nid";s:6:"195920";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106252";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82980";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Wheat protein isolate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195921;a:27:{s:5:"title";s:16:"Zinc sulfate_ACN";s:3:"nid";s:6:"195921";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106669";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82981";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Zinc sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195922;a:27:{s:5:"title";s:22:"Dimagnesium malate_ACN";s:3:"nid";s:6:"195922";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106888";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82982";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Dimagnesium malate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195923;a:27:{s:5:"title";s:16:"Casanthranol_ACN";s:3:"nid";s:6:"195923";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106654";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82983";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Casanthranol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195924;a:27:{s:5:"title";s:26:"Tetrahydrocurcuminoids_ACN";s:3:"nid";s:6:"195924";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106749";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82984";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Tetrahydrocurcuminoids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195925;a:27:{s:5:"title";s:14:"Bile salts_ACN";s:3:"nid";s:6:"195925";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106655";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82985";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Bile salts";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195926;a:27:{s:5:"title";s:30:"Shrimp protein hydrolysate_APN";s:3:"nid";s:6:"195926";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106621";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82986";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Shrimp protein hydrolysate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195927;a:27:{s:5:"title";s:47:"Glycine propionyl L-carnitine hydrochloride_ACN";s:3:"nid";s:6:"195927";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"106599";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82987";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:43:"Glycine propionyl L-carnitine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195928;a:27:{s:5:"title";s:25:"L-Tetrahydropalmatine_ACN";s:3:"nid";s:6:"195928";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82990";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"L-Tetrahydropalmatine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195929;a:27:{s:5:"title";s:32:"Humic acids, potassium salts_ACN";s:3:"nid";s:6:"195929";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107469";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82991";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Humic acids, potassium salts";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195930;a:28:{s:5:"title";s:39:"Methylmethionine sulfonium chloride_ACN";s:3:"nid";s:6:"195930";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107470";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82992";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:35:"Methylmethionine sulfonium chloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:20:"J_CHROMAT_A_479(361)";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195931;a:27:{s:5:"title";s:18:"Liquid glucose_ACN";s:3:"nid";s:6:"195931";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107585";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82993";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Liquid glucose";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195932;a:27:{s:5:"title";s:14:"Higenamine_ACN";s:3:"nid";s:6:"195932";s:7:"changed";s:10:"2013-10-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107407";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82994";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Higenamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195933;a:26:{s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"92628";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1007:"Sesamin is a lignan (Lignans, found in plants, are one type of phytoestrogens, which are estrogen-like chemicals and act as antioxidants). Sesamin in (+) form was isolated from Sideritis canariensis, the guggula resin from Commiphora mukul, Xanthoxylum spp., and also pyrethrum flowers (Chrysanthemum cinerariaefolium) and Talauma hodgsoni. It is a constituent of sesame oil and present in the Rutaceae, Piperaceae, Scrophulariaceae, Compositae and Ginkgoaceae. (-)-Sesamin was isolated from the leaves of Magnolia mutabilis and from the bark of Xanthoxylum tingoassuiba, and Acanthopanax sessiliflorus. The racemic form of sesamin is a constituent of Xanthoxylum senegalense and Fagara xanthoxyloides (CRC-DNP 2009). (+)-Sesamin is an insecticide synergist (Merck 2006). Sesamin affects the fatty acid metabolism and lipoprotein production in the liver, and hence lowers the serum lipid levels (Ide, Kushiro et al. 2003). Sesamin will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82440";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"(-)-Sesamin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:75:" (Referred field is not set. Please set the referred fields for field_unit)";s:20:"field_limitation_ref";s:85:" (Referred field is not set. Please set the referred fields for field_limitation_ref)";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:80:" (Referred field is not set. Please set the referred fields for field_other_ref)";s:5:"title";s:15:"ACN:(-)-Sesamin";s:3:"nid";s:6:"195933";s:7:"changed";s:10:"2017-11-15";s:14:"workflow_state";s:9:"Published";}i:195952;a:27:{s:5:"title";s:20:"Egg Yolk Protein_APN";s:3:"nid";s:6:"195952";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"102168";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82925";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Egg Yolk Protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195954;a:27:{s:5:"title";s:22:"Tetrahydrocurcumin_ACN";s:3:"nid";s:6:"195954";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107060";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82995";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Tetrahydrocurcumin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195955;a:27:{s:5:"title";s:20:"Benzyl cinnamate_ACN";s:3:"nid";s:6:"195955";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107753";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82996";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Benzyl cinnamate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195956;a:27:{s:5:"title";s:21:"N-Acetyl tyrosine_ACN";s:3:"nid";s:6:"195956";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107838";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82997";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"N-Acetyl tyrosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195957;a:27:{s:5:"title";s:19:"Benzyl benzoate_ACN";s:3:"nid";s:6:"195957";s:7:"changed";s:10:"2013-12-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107752";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82998";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Benzyl benzoate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195958;a:27:{s:5:"title";s:38:"Dihydroxyaluminum sodium carbonate_ACN";s:3:"nid";s:6:"195958";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81693";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"Dihydroxyaluminum sodium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195960;a:27:{s:5:"title";s:17:"beta-Carotene_ACN";s:3:"nid";s:6:"195960";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81702";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"beta-Carotene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195963;a:27:{s:5:"title";s:10:"Biotin_ACN";s:3:"nid";s:6:"195963";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81706";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Biotin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195965;a:27:{s:5:"title";s:9:"Boron_ACN";s:3:"nid";s:6:"195965";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81710";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:5:"Boron";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195970;a:27:{s:5:"title";s:12:"Calamine_ACN";s:3:"nid";s:6:"195970";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81715";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Calamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195972;a:27:{s:5:"title";s:11:"Calcium_ACN";s:3:"nid";s:6:"195972";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92574;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81717";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Calcium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195973;a:27:{s:5:"title";s:21:"Calcium carbonate_ACN";s:3:"nid";s:6:"195973";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral)  of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81718";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Calcium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195982;a:27:{s:5:"title";s:10:"Cobalt_ACN";s:3:"nid";s:6:"195982";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81736";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Cobalt";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195984;a:27:{s:5:"title";s:10:"Copper_ACN";s:3:"nid";s:6:"195984";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81738";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Copper";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195987;a:27:{s:5:"title";s:13:"Vitamin E_ACN";s:3:"nid";s:6:"195987";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:99:"Classified as an NHP under Schedule 1, item 3 (a vitamin)of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81745";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin E";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195988;a:27:{s:5:"title";s:26:"Disodium pyrophosphate_ACN";s:3:"nid";s:6:"195988";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81748";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Disodium pyrophosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195989;a:27:{s:5:"title";s:16:"DL-Ephedrine_ACN";s:3:"nid";s:6:"195989";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81750";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"DL-Ephedrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195992;a:27:{s:5:"title";s:10:"Iodine_ACN";s:3:"nid";s:6:"195992";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81765";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Iodine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195994;a:27:{s:5:"title";s:8:"Iron_ACN";s:3:"nid";s:6:"195994";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81767";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Iron";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:195999;a:27:{s:5:"title";s:10:"Kaolin_ACN";s:3:"nid";s:6:"195999";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:225:"Kaolin is one of the most highly divided and highly refined naturally occurring minerals, the chemical formula Al4Si4O10(OH)8. Kaolin is a clay composed essentially of the mineral kaolinite which is a combination of minerals.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81773";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Kaolin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196000;a:27:{s:5:"title";s:14:"Magaldrate_ACN";s:3:"nid";s:6:"196000";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81778";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Magaldrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196002;a:27:{s:5:"title";s:13:"Magnesium_ACN";s:3:"nid";s:6:"196002";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81780";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Magnesium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196003;a:27:{s:5:"title";s:23:"Magnesium carbonate_ACN";s:3:"nid";s:6:"196003";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81781";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Magnesium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196004;a:27:{s:5:"title";s:23:"Magnesium hydroxide_ACN";s:3:"nid";s:6:"196004";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:40:"Occurs in nature as the mineral brucite.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81784";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Magnesium hydroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196005;a:27:{s:5:"title";s:19:"Magnesium oxide_ACN";s:3:"nid";s:6:"196005";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81785";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Magnesium oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196006;a:27:{s:5:"title";s:25:"Magnesium trisilicate_ACN";s:3:"nid";s:6:"196006";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81788";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Magnesium trisilicate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196008;a:27:{s:5:"title";s:13:"Manganese_ACN";s:3:"nid";s:6:"196008";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81791";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Manganese";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196009;a:27:{s:5:"title";s:14:"Molybdenum_ACN";s:3:"nid";s:6:"196009";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81794";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Molybdenum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196011;a:27:{s:5:"title";s:10:"Nickel_ACN";s:3:"nid";s:6:"196011";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81797";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Nickel";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196013;a:27:{s:5:"title";s:10:"Niacin_ACN";s:3:"nid";s:6:"196013";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:17:"92688;93582;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:223:"Nicotinic acid (Niacin) is a water-soluble vitamin whose derivatives such as NADH play essential roles in energy metabolism in the living cell. It will be considered as a NHP, under schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:111:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81800";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Niacin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196017;a:27:{s:5:"title";s:20:"Pantothenic acid_ACN";s:3:"nid";s:6:"196017";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81804";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Pantothenic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196019;a:27:{s:5:"title";s:14:"Phosphorus_ACN";s:3:"nid";s:6:"196019";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81807";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Phosphorus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196023;a:27:{s:5:"title";s:13:"Potassium_ACN";s:3:"nid";s:6:"196023";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81812";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Potassium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196024;a:27:{s:5:"title";s:24:"Potassium bitartrate_ACN";s:3:"nid";s:6:"196024";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81816";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Potassium bitartrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196027;a:27:{s:5:"title";s:19:"Povidone-iodine_ACN";s:3:"nid";s:6:"196027";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81823";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Povidone-iodine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196030;a:27:{s:5:"title";s:14:"Riboflavin_ACN";s:3:"nid";s:6:"196030";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81832";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Riboflavin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196032;a:27:{s:5:"title";s:12:"Selenium_ACN";s:3:"nid";s:6:"196032";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81835";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Selenium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196033;a:27:{s:5:"title";s:20:"Selenium sulfide_ACN";s:3:"nid";s:6:"196033";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81836";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Selenium sulfide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196035;a:27:{s:5:"title";s:11:"Silicon_ACN";s:3:"nid";s:6:"196035";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81839";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Silicon";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196039;a:27:{s:5:"title";s:22:"Sodium bicarbonate_ACN";s:3:"nid";s:6:"196039";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81845";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Sodium bicarbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196041;a:27:{s:5:"title";s:10:"Sulfur_ACN";s:3:"nid";s:6:"196041";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81853";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Sulfur";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196042;a:27:{s:5:"title";s:8:"Talc_ACN";s:3:"nid";s:6:"196042";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:222:"Talc (Talcum, French chalk) is a mineral composed a hydrated magnesium silicate, commonly found worldwide. Therefore, talc will be considered as a NHP, under Schedule 1, item 7 (Priority 5; Mineral) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81854";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Talc";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196045;a:27:{s:5:"title";s:12:"Thiamine_ACN";s:3:"nid";s:6:"196045";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81857";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Thiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196047;a:27:{s:5:"title";s:7:"Tin_ACN";s:3:"nid";s:6:"196047";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81860";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:3:"Tin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196048;a:27:{s:5:"title";s:20:"Titanium dioxide_ACN";s:3:"nid";s:6:"196048";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81861";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Titanium dioxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196050;a:27:{s:5:"title";s:12:"Vanadium_ACN";s:3:"nid";s:6:"196050";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81866";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Vanadium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196056;a:27:{s:5:"title";s:15:"Vitamin B12_ACN";s:3:"nid";s:6:"196056";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81873";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Vitamin B12";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196062;a:27:{s:5:"title";s:8:"Zinc_ACN";s:3:"nid";s:6:"196062";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"94693;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81882";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Zinc";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196064;a:27:{s:5:"title";s:16:"Zinc acetate_ACN";s:3:"nid";s:6:"196064";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81884";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Zinc acetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196066;a:27:{s:5:"title";s:18:"Zinc carbonate_ACN";s:3:"nid";s:6:"196066";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81886";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Zinc carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196072;a:27:{s:5:"title";s:14:"Zinc oxide_ACN";s:3:"nid";s:6:"196072";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81892";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Zinc oxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196073;a:27:{s:5:"title";s:18:"Hydrocortisone_ACN";s:3:"nid";s:6:"196073";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92785;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:281:"Schedule F listing is as follows:
Adrenocortical hormones and their salts and derivatives, (except hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin)";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:113:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate)  of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81893";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Hydrocortisone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196077;a:27:{s:5:"title";s:26:"Resorcinol monoacetate_ACN";s:3:"nid";s:6:"196077";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81900";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Resorcinol monoacetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196078;a:28:{s:5:"title";s:12:"Glycerol_ACN";s:3:"nid";s:6:"196078";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"103663;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:149:"For oral use, other than when present as part of the capsule shell, Glycerol shall contain no more than 0.1% diethylene glycol and related compounds.";s:24:"field_restriction_desc_f";s:151:"Pour usage oral, sauf lorsque faisant partie d'une capsule, le glycérol ne doit pas contenir plus de 0,1% de diéthylène glycol et composés reliés.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81901";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Glycerol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:5:"USP35";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196083;a:27:{s:5:"title";s:12:"Sorbitol_ACN";s:3:"nid";s:6:"196083";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81906";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Sorbitol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196085;a:27:{s:5:"title";s:24:"Calcium undecylenate_ACN";s:3:"nid";s:6:"196085";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81910";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Calcium undecylenate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196087;a:27:{s:5:"title";s:23:"Copper undecylenate_ACN";s:3:"nid";s:6:"196087";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81913";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Copper undecylenate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196089;a:27:{s:5:"title";s:19:"Undecenoic acid_ACN";s:3:"nid";s:6:"196089";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:99:"Undecylenic acid is isolated from castor bean oil extract, it also occurs naturally in human sweat.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81915";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Undecenoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196091;a:27:{s:5:"title";s:21:"Zinc undecylenate_ACN";s:3:"nid";s:6:"196091";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81917";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Zinc undecylenate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196092;a:27:{s:5:"title";s:21:"Isopropyl alcohol_ACN";s:3:"nid";s:6:"196092";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81918";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Isopropyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196095;a:27:{s:5:"title";s:13:"Allantoin_ACN";s:3:"nid";s:6:"196095";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81922";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Allantoin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196097;a:27:{s:5:"title";s:18:"DL-Lactic acid_ACN";s:3:"nid";s:6:"196097";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93278;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81924";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"DL-Lactic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196101;a:27:{s:5:"title";s:11:"Lanolin_ACN";s:3:"nid";s:6:"196101";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81928";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Lanolin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196102;a:27:{s:5:"title";s:8:"Urea_ACN";s:3:"nid";s:6:"196102";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81929";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Urea";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196106;a:27:{s:5:"title";s:14:"Benzocaine_ACN";s:3:"nid";s:6:"196106";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:346:"Benzocaine (Ethyl-4-aminobenzoate) is a natural product that is found in the stems of Strychnos cathayensis which is a scandent shrub distributed throughout southern China. The roots and seeds of this plant are used as antipyretics and hemastatics in folk medicine. Benzocaine falls under plant isolate, item 2, schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81934";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Benzocaine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196110;a:27:{s:5:"title";s:18:"Benzyl alcohol_ACN";s:3:"nid";s:6:"196110";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81938";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Benzyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196111;a:27:{s:5:"title";s:11:"Gelatin_ACN";s:3:"nid";s:6:"196111";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81939";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Gelatin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196112;a:27:{s:5:"title";s:10:"Pectin_ACN";s:3:"nid";s:6:"196112";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81940";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Pectin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196116;a:27:{s:5:"title";s:10:"Phenol_ACN";s:3:"nid";s:6:"196116";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81944";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Phenol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196117;a:27:{s:5:"title";s:19:"Salicyl alcohol_ACN";s:3:"nid";s:6:"196117";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:455:"Salicyl alcohol (a local anesthetic) is obtained by the action of emulsin, which is the extract of bitter almonds or other vegetable juices that effects the decomposition of certain glucosides, on the natural form of Salicyl alcohol, namely Salicin (salicyl alcohol glucoside).  Since Salicyl alcohol can be found in nature as its glucoside derivative, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81945";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Salicyl alcohol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196119;a:27:{s:5:"title";s:22:"Choline salicylate_ACN";s:3:"nid";s:6:"196119";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:278:"Since Choline salicylate is synthetically prepared using two naturally occurring starting materials (salts), namely choline chloride and sodium salicylate, it will be considered as a combination of two NHPs, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81947";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Choline salicylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196121;a:27:{s:5:"title";s:24:"Magnesium salicylate_ACN";s:3:"nid";s:6:"196121";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:214:"Since Magnesium salicylate is a salt of two naturally occurring compounds, namely salicylic acid and magnesium, it will be considered as a NHP, under Schedule 1, item 2 (Priority 2; Isolate) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81949";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Magnesium salicylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196123;a:27:{s:5:"title";s:21:"Sodium salicylate_ACN";s:3:"nid";s:6:"196123";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81951";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Sodium salicylate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196128;a:27:{s:5:"title";s:22:"Aluminum hydroxide_ACN";s:3:"nid";s:6:"196128";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81956";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Aluminum hydroxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196132;a:27:{s:5:"title";s:14:"dl-Camphor_ACN";s:3:"nid";s:6:"196132";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93278;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81960";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"dl-Camphor";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196134;a:27:{s:5:"title";s:23:"l-Ephedrine sulfate_ACN";s:3:"nid";s:6:"196134";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93278;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81963";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"l-Ephedrine sulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196138;a:27:{s:5:"title";s:14:"Resorcinol_ACN";s:3:"nid";s:6:"196138";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81967";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Resorcinol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196139;a:27:{s:5:"title";s:16:"Alginic acid_ACN";s:3:"nid";s:6:"196139";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81968";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Alginic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196140;a:27:{s:5:"title";s:34:"Dihydroxyaluminum aminoacetate_ACN";s:3:"nid";s:6:"196140";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:199:"Aluminium glycinate is a combination of two natural products which is hydrolyzing to glycine and aluminium hydroxide in human stomach and therefore it will be considered as a combination of two NHPs.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81969";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:30:"Dihydroxyaluminum aminoacetate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196141;a:27:{s:5:"title";s:29:"l-Ephedrine hydrochloride_ACN";s:3:"nid";s:6:"196141";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92628;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81978";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"l-Ephedrine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196142;a:27:{s:5:"title";s:32:"Cellulose - microcrystalline_ACN";s:3:"nid";s:6:"196142";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81979";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Cellulose - microcrystalline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196144;a:27:{s:5:"title";s:14:"Sennosides_ACN";s:3:"nid";s:6:"196144";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81983";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Sennosides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196145;a:27:{s:5:"title";s:20:"Phenolate sodium_ACN";s:3:"nid";s:6:"196145";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81986";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Phenolate sodium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196146;a:27:{s:5:"title";s:11:"Ethanol_ACN";s:3:"nid";s:6:"196146";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:395:"Ethyl alcohol is considered as a natural health product based on the evidence that this ingredient is found naturally in plants and fruits. Ethanol can also be manufactured by fermentation of carbohydrates from different sources, such as plant, fungi, bacteria, yeast, alga and non-human animal material. Ethanol is classified as a NHP that falls under item 2, Schedule 1 of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81987";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Ethanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196148;a:27:{s:5:"title";s:14:"Vitamin B6_ACN";s:3:"nid";s:6:"196148";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:672:"Vitamin B6 is most commonly referring to pyridoxine hydrochloride.  However, Vitamin B6 is a general term for different closely related compounds, namely pyridoxine, pyridoxal and pyridoxamine.  In addition of these 3 acceptable sources of Vitamin B6, different analogs and salts of these derivatives are also considered as acceptable sources of Vitamin B6, such as pyridoxine hydrochloride, pyridoxine 5'-phosphate, pyridoxal hydrochloride, pyridoxal 5'-phosphate, pyridoxamine dihydrochloride and pyridoxamine 5'-phosphate.  Vitamin B6 is considered here as the primary proper name, since it is listed in the NHPD Included Natural Health Product Substances (Schedule 1).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81991";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vitamin B6";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196151;a:27:{s:5:"title";s:12:"Inositol_ACN";s:3:"nid";s:6:"196151";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:294:"Inositol is a biological molecule (a sugar alcohol) that plays an important role as a second messenger in a cell, in the form of inositol phosphate. It is found in many foods, namely cereals with high bran content. It will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82059";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Inositol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196154;a:27:{s:5:"title";s:12:"Lycopene_ACN";s:3:"nid";s:6:"196154";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82063";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Lycopene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196155;a:27:{s:5:"title";s:21:"Methyl nicotinate_ACN";s:3:"nid";s:6:"196155";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:1140:"Methyl nicotinate (MN) is an active ingredient in a number of medicinal products as a rubifacient and vasodilator for the treatment of a variety of diseases such as respiratory, vascular and rheumatoid disorders. It has been widely used in cosmetics as an ingredient in skin products like soaps, shampoo and creams due to its rubefacient nature. Aenictus species utilizes MN in its chemical communication system [1]. MN is also an active flavour compound found in fruits like Cupuacu (Theobroma grandiflora) [2-3], Soursop (Annona muricata) [4], Mammee apple (Mammea americana) [5], Strawberries (Fragraria Vesca) [6], Papaya, Guava, headspace of the living orchids Calanthe izu-insularis Ohwi et Satomi (Orcidaceae), Calanthe sieboldii Decne (Orcidaceae) and Tuberose and flowers like calanthe (Orchidaceae) [7]. MN is also reported as an ingredient in rice and rice bran [8]. In the joint meeting of FAO/ WHO experts committee on food additives (JECFA), MN has been accepted as a flavouring agent and there is no safety concern for intake [9]. Methyl nicotinate will be considered as a NHP, under Schedule 1, item 2, Priority 2 (Isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82218";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Methyl nicotinate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196157;a:27:{s:5:"title";s:15:"Lutein(USP)_ACN";s:3:"nid";s:6:"196157";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92988;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82225";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Lutein(USP)";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196159;a:27:{s:5:"title";s:11:"Choline_ACN";s:3:"nid";s:6:"196159";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:241:"Basic constituent of lecithin found in many plants and animal organs. Usually made synthetically from trimethylamine and ethylene chlorohydrin or ethylene oxide. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82236";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Choline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196160;a:27:{s:5:"title";s:30:"Calcium phosphate, dibasic_ACN";s:3:"nid";s:6:"196160";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92574;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:160:"Occurs in nature as the mineral monetite. It is an acceptable source of Calcium. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82296";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Calcium phosphate, dibasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196161;a:27:{s:5:"title";s:32:"Calcium phosphate, monobasic_ACN";s:3:"nid";s:6:"196161";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92574;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:192:"Commercial prepared for fertilizers by treating pulverized phosphate rock with sulfuric acid or phosphoric acid. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82297";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Calcium phosphate, monobasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196162;a:27:{s:5:"title";s:31:"Calcium phosphate, tribasic_ACN";s:3:"nid";s:6:"196162";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92574;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:287:"It occurs in nature as the minerals oxydapatit, voelicherite, whitlockite. The technical product is also known as 'bone ash'. Prepared commercially from phosphate rock. It is an acceptable source of Calcium. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82298";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Calcium phosphate, tribasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196168;a:27:{s:5:"title";s:14:"dl-Menthol_ACN";s:3:"nid";s:6:"196168";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93320;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:9:"TPDCAT-IV";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82497";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"dl-Menthol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196169;a:27:{s:5:"title";s:12:"Chromium_ACN";s:3:"nid";s:6:"196169";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"93610;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82525";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Chromium";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196170;a:27:{s:5:"title";s:12:"Dopamine_ACN";s:3:"nid";s:6:"196170";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100454";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82875";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Dopamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196171;a:27:{s:5:"title";s:8:"Gold_ACN";s:3:"nid";s:6:"196171";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100455";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82876";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:4:"Gold";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196172;a:27:{s:5:"title";s:10:"Uracil_ACN";s:3:"nid";s:6:"196172";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100456";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82877";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Uracil";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196173;a:27:{s:5:"title";s:22:"Dimethyl sulfoxide_ACN";s:3:"nid";s:6:"196173";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100457";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82878";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Dimethyl sulfoxide";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196174;a:27:{s:5:"title";s:17:"Levocarnitine_ACN";s:3:"nid";s:6:"196174";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100458";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82879";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Levocarnitine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196175;a:27:{s:5:"title";s:10:"Deanol_ACN";s:3:"nid";s:6:"196175";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98169";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:537:"Part I of Schedule F to the Food and Drug Regulations is amended by repealing (removing from Schedule F) the following: Deanol, and its salts and derivatives. Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended the above naturally sourced medicinal ingredient be removed from Schedule F to the Food and Drug Regulations as none of the factors for listing in Schedule F were found to apply. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82882";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Deanol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196176;a:27:{s:5:"title";s:15:"Theobromine_ACN";s:3:"nid";s:6:"196176";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"98171";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:526:"Part I of Schedule F to the Food and Drug Regulations is amended by repealing (removing from Schedule F) the following: Theobromine and its salts. Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended the above naturally sourced medicinal ingredient be removed from Schedule F to the Food and Drug Regulations as none of the factors for listing in Schedule F were found to apply. Canada Gazette Part II: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-07/pdf/g2-14525.pdf.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82883";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Theobromine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196177;a:27:{s:5:"title";s:25:"Propionyl-L-carnitine_ACN";s:3:"nid";s:6:"196177";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"100874;100458";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82888";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Propionyl-L-carnitine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196178;a:27:{s:5:"title";s:22:"Acetyl-L-Carnitine_ACN";s:3:"nid";s:6:"196178";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"100965;100458";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82889";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Acetyl-L-Carnitine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196182;a:27:{s:5:"title";s:13:"Vitamin C_ACN";s:3:"nid";s:6:"196182";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:11:"92910;95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:494:"Vitamin C is considered here as the primary proper name, since it is listed in the NHPD Included Natural Health Product Substances (Schedule 1). Vitamin C (Ascorbic acid) is found in green peppers, citrus fruits, strawberries, tomatoes, broccoli, turnip greens and other greens, sweet and white potatoes, and cantaloupe. Most other fruits and vegetables contain some Vitamin C; fish and milk contain small amounts. It will be considered as a NHP, under Schedule 1, item 3, Priority 5 (Vitamin).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82962";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin C";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196184;a:27:{s:5:"title";s:10:"Mucins_ACN";s:3:"nid";s:6:"196184";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107836";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105692";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Mucins";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196185;a:27:{s:5:"title";s:11:"Elastin_ACN";s:3:"nid";s:6:"196185";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107949";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105693";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Elastin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196186;a:27:{s:5:"title";s:14:"Durapatite_ACN";s:3:"nid";s:6:"196186";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107802";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105694";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Durapatite";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196187;a:27:{s:5:"title";s:24:"Valyl-prolyl-proline_ACN";s:3:"nid";s:6:"196187";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107502";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105696";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:20:"Valyl-prolyl-proline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196188;a:27:{s:5:"title";s:28:"Isoleucyl-prolyl-proline_ACN";s:3:"nid";s:6:"196188";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107501";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105697";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Isoleucyl-prolyl-proline";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196189;a:27:{s:5:"title";s:17:"Myristic acid_ACN";s:3:"nid";s:6:"196189";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"103063";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105698";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Myristic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196190;a:28:{s:5:"title";s:26:"Zinc acetate dihydrate_ACN";s:3:"nid";s:6:"196190";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108422";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105699";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:22:"Zinc acetate dihydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:20:"field_route_of_admin";s:6:"BUCCAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:22:"ACT_ODONT_SCAN_70(224)";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196191;a:27:{s:5:"title";s:17:"Peptidoglycan_ACN";s:3:"nid";s:6:"196191";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108479";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105700";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Peptidoglycan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196193;a:27:{s:5:"title";s:10:"Ajoene_ACN";s:3:"nid";s:6:"196193";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108513";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105702";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Ajoene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196194;a:27:{s:5:"title";s:28:"L-Asparagine monohydrate_ACN";s:3:"nid";s:6:"196194";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108300";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105703";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"L-Asparagine monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196195;a:27:{s:5:"title";s:21:"Lipoteichoic acid_ACN";s:3:"nid";s:6:"196195";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108474";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105704";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Lipoteichoic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196196;a:27:{s:5:"title";s:13:"Ceramides_ACN";s:3:"nid";s:6:"196196";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108201";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105705";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Ceramides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196197;a:27:{s:5:"title";s:22:"Moschus Artifactus_ACN";s:3:"nid";s:6:"196197";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"100878";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:98:"Classified as an NHP under Schedule 1 item 2, (isolate) of the Natural Health Product Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105706";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Moschus Artifactus";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196198;a:27:{s:5:"title";s:16:"Montbretin A_ACN";s:3:"nid";s:6:"196198";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108914";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105707";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Montbretin A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196199;a:27:{s:5:"title";s:12:"Zeolites_ACN";s:3:"nid";s:6:"196199";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109141";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1 item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"106055";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Zeolites";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196200;a:27:{s:5:"title";s:20:"Sodium carbonate_ACN";s:3:"nid";s:6:"196200";s:7:"changed";s:10:"2014-01-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"108809";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"106056";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Sodium carbonate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196201;a:27:{s:5:"title";s:17:"Serum albumin_APN";s:3:"nid";s:6:"196201";s:7:"changed";s:10:"2014-01-17";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109263";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-01-17";s:16:"field_legacy_nid";s:6:"106077";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Serum albumin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196202;a:27:{s:5:"title";s:12:"Cytisine_ACN";s:3:"nid";s:6:"196202";s:7:"changed";s:10:"2014-01-17";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109352";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-01-17";s:16:"field_legacy_nid";s:6:"106095";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Cytisine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196204;a:27:{s:5:"title";s:19:"Hydrated Silica_ACN";s:3:"nid";s:6:"196204";s:7:"changed";s:10:"2014-01-28";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109441";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-01-28";s:16:"field_legacy_nid";s:6:"106166";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Hydrated Silica";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196207;a:27:{s:5:"title";s:28:"Hydrolyzed Wheat Protein_ACN";s:3:"nid";s:6:"196207";s:7:"changed";s:10:"2014-01-30";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109367";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-01-30";s:16:"field_legacy_nid";s:6:"106201";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:24:"Hydrolyzed Wheat Protein";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196208;a:27:{s:5:"title";s:31:"Calcium acetate monohydrate_ACN";s:3:"nid";s:6:"196208";s:7:"changed";s:10:"2014-01-30";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109468";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-01-30";s:16:"field_legacy_nid";s:6:"106202";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Calcium acetate monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196209;a:27:{s:5:"title";s:16:"Hydroquinone_ACN";s:3:"nid";s:6:"196209";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"93830;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:961:"Hydroquinone occurs in a variety of forms as a natural product from plants and animals. It has been found in non-volatile extracts of coffee beans and other foods, and as Arbutin (a glucoside of hydroquinone) in the leaves of blueberry, cranberry, cowberry and bearberry plants. Hydroquinones have been isolated from marine sponges of  Dysidea sp. and from the marine colonial tunicate Aplidium californicum. Hydroquinone is also found in the bombardier beetle where it is involved in defensive biochemistry: the beetle can shoot a hot cloud of quinone, formed by the action of hydrogen peroxide, hydroquinone and catalase-peroxidase in the explosion chamber of the beetle, towards an oncoming enemy. The occurrence of hydroquinone in nature can originate from metabolic processes. Hydroquinone can also occur as a metabolite in the biodegradation of substituted phenols. Therefore, hydroquinone will be considered as a NHP that falls under isolate, priority 2.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:131:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact its acceptability as an NHP.";s:17:"field_rationale_f";s:170:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur son acceptabilité comme PSN.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82054";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Hydroquinone";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196210;a:27:{s:5:"title";s:13:"Exendin 4_ACN";s:3:"nid";s:6:"196210";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"94002;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:131:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact its acceptability as an NHP.";s:17:"field_rationale_f";s:170:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur son acceptabilité comme PSN.";s:24:"field_restriction_desc_e";s:95:"Exendin 4 is considered medicinal when not sold or recommended for administration by injection.";s:24:"field_restriction_desc_f";s:113:"Exendine 4 est considéré médicinal lorsqu'il n'est pas vendu ou recommandé d'être administré par injection.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82543";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Exendin 4";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196211;a:27:{s:5:"title";s:23:"Magnesium ascorbate_ACN";s:3:"nid";s:6:"196211";s:7:"changed";s:10:"2014-02-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109103";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-02-03";s:16:"field_legacy_nid";s:6:"106233";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Magnesium ascorbate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196213;a:27:{s:5:"title";s:31:"Sodium phosphate, monobasic_ACN";s:3:"nid";s:6:"196213";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:24:"92879;92955;95650;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:132:"It has been used, in medicine, as urinary acidifier. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:293:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact the acceptability of an NHP containing phosphate sodium salts equivalent to 20 grams or more of sodium phosphate per oral dose in a 24 hour period and/or products for a purgative indication.";s:17:"field_rationale_f";s:338:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur l'acceptabilité d'un PSN contenant des sels de sodium phosphate équivalent à 20 grammes ou plus de phosphate de sodium par dose orale en 24 heures et (ou) de produits avec allégation purgative.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81981";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Sodium phosphate, monobasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196214;a:27:{s:5:"title";s:11:"Betaine_ACN";s:3:"nid";s:6:"196214";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:384:"Betaine, also known as Trimethylglycine, is a small molecule widely distributed in plants and animals. 
Schedule F listing is as follows:
Betaine and its salts when sold or recommended for the treatment of homocystinuria
For other purposes, such as gastric acidifier, Betaine will be considered as an isolate, under Schedule 1, item 2 (Priority 1; New Drug) of the NHP Regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:238:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.  Considered a non-NHP due to its appearance on the Prescription Drug List when sold or recommended for the treatment of homocystinuria.";s:17:"field_rationale_f";s:269:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  Considéré comme non PSN à cause de sa présence sur la Liste des drogues sur ordonnance s'il est vendu ou recommandé pour le traitement de l'homocystinurie";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82067";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Betaine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196215;a:27:{s:5:"title";s:29:"Sodium phosphate, dibasic_ACN";s:3:"nid";s:6:"196215";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:24:"92879;92955;94381;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:293:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact the acceptability of an NHP containing phosphate sodium salts equivalent to 20 grams or more of sodium phosphate per oral dose in a 24 hour period and/or products for a purgative indication.";s:17:"field_rationale_f";s:338:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur l'acceptabilité d'un PSN contenant des sels de sodium phosphate équivalent à 20 grammes ou plus de phosphate de sodium par dose orale en 24 heures et (ou) de produits avec allégation purgative.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82076";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Sodium phosphate, dibasic";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196216;a:27:{s:5:"title";s:13:"Adenosine_ACN";s:3:"nid";s:6:"196216";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"95627;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:272:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. Adenosine and its salts are considered non-NHPs when sold or recommended for administration by intravenous injection due to their presence of the Prescription Drug List.";s:17:"field_rationale_f";s:311:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  L'adénosine et ses sels sont considérés comme non PSN lorsque vendus ou recommandés pour administration par injection intraveineuse à cause de sa présence sur la Liste des drogues sur ordonnance.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82135";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Adenosine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196217;a:27:{s:5:"title";s:23:"Quinidine bisulfate_ACN";s:3:"nid";s:6:"196217";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:159:"Natural Health Products on the 'Listing of Drugs Currently Regulated As New Drugs (April 1999 Edition)'. It will be considered as a NHP, Priority 1 (new drug).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:230:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations. This ingredient is pending a decision on its addition to Prescription Drug List which would impact its acceptability as an NHP.";s:17:"field_rationale_f";s:280:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur son acceptabilité comme PSN.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82139";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Quinidine bisulfate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196218;a:27:{s:5:"title";s:42:"Sodium phosphate, dibasic heptahydrate_ACN";s:3:"nid";s:6:"196218";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"92879;92955;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:293:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact the acceptability of an NHP containing phosphate sodium salts equivalent to 20 grams or more of sodium phosphate per oral dose in a 24 hour period and/or products for a purgative indication.";s:17:"field_rationale_f";s:338:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur l'acceptabilité d'un PSN contenant des sels de sodium phosphate équivalent à 20 grammes ou plus de phosphate de sodium par dose orale en 24 heures et (ou) de produits avec allégation purgative.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82361";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:38:"Sodium phosphate, dibasic heptahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196219;a:27:{s:5:"title";s:44:"Sodium phosphate, monobasic, monohydrate_ACN";s:3:"nid";s:6:"196219";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"92879;92955;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:293:"This ingredient is pending a decision on its addition to the Prescription Drug List which would impact the acceptability of an NHP containing phosphate sodium salts equivalent to 20 grams or more of sodium phosphate per oral dose in a 24 hour period and/or products for a purgative indication.";s:17:"field_rationale_f";s:338:"Cet ingrédient est en attente d'une décision sur son ajout à la Liste des drogues sur ordonnance qui pourrait avoir des conséquences sur l'acceptabilité d'un PSN contenant des sels de sodium phosphate équivalent à 20 grammes ou plus de phosphate de sodium par dose orale en 24 heures et (ou) de produits avec allégation purgative.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82362";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:40:"Sodium phosphate, monobasic, monohydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196220;a:27:{s:5:"title";s:17:"Physostigmine_ACN";s:3:"nid";s:6:"196220";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"93119;92722;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:648:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  Il est important de noter que cet ingrédient est un non-PSN sous certaines conditions à cause de la présence d'un de ses dérivés dans la Liste des drogues sur ordonnance ("Physostigmine (salicylate de), (sauf dans les préparations pour usage oral et topique seulement)").  Lorsque la Physostigmine est utilisée par voie ophthalmique comme myotique, le produit doit être évalué pour son innocuité.  Oralement, la Physostigmine est très toxique, ce qui nécessitera des renseignements approfondis sur l'innocuité chez l'humain.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:526:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.  It's important to note that this ingredient is a non-NHP under certain circumstances because the Prescription Drug List contains one of its derivative ("Physostigmine salicylate (except preparations for oral or topical use only)").  When Physostigmine is used ophthalmically as a miotic, the product should be assessed for safety. Orally, Physostigmine is very toxic, which will require extensive human safety information.";s:17:"field_rationale_f";s:634:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.  Il est important de noter que cet ingrédient est un non-PSN sous certaines conditions à cause de la présence d'un de ses dérivés en Partie II de l'Annexe F ("Physostigmine (salicylate de), (sauf dans les préparations pour usage oral et topique seulement)").  Lorsque la Physostigmine est utilisée par voie ophthalmique comme myotique, le produit doit être évalué pour son innocuité.  Oralement, la Physostigmine est très toxique, ce qui nécessitera des renseignements approfondis sur l'innocuité chez l'humain.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82443";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Physostigmine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196221;a:28:{s:5:"title";s:19:"Cholecalciferol_ACN";s:3:"nid";s:6:"196221";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"96356;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:478:"The vitamin that mediates intestinal calcium absorption, bone calcium metabolism and probably, muscle activity. Canada recognizes the importance of vitamin D in the prevention of osteoporosis in its health claim for foods that contain calcium: "A healthy diet with adequate calcium and vitamin D, and regular physical activity, help to achieve strong bones and may reduce the risk of osteoporosis". It will be considered as a NHP, under Schedule 1, item 3, Priority 5 (vitamin).";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:97:"The maximum dose of vitamin D is 1000 IU/day, as per the Prescription Drug List (unless topical).";s:24:"field_restriction_desc_f";s:120:"La dose maximale de vitamine D est de 1000 UI/day, selon la Liste des drogues sur ordonnance (à moins d'être topique).";s:17:"field_upper_limit";s:13:"1000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81727";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cholecalciferol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:4:"IU/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196222;a:28:{s:5:"title";s:14:"Vitamin K1_ACN";s:3:"nid";s:6:"196222";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"93278;95335;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:227:"Schedule F listing is as follows:    Vitamin K, except Vitamin K1 and Vitamin K2 sold   (a) for external use in humans; or   (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:96:"Must be less than or equal to 120 mcg/day in oral dosage forms as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:122:"Doit être égale ou inférieure à 120 mcg/jour sous formes posologiques orales selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:12:"120.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81808";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vitamin K1";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:11:"microgram/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196223;a:28:{s:5:"title";s:23:"Vitamin A palmitate_ACN";s:3:"nid";s:6:"196223";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:1143:"Vitamin A, or all-trans retinol, is an essential nutrient which occurs preformed only in animals, but metabolized from carotenoids, such as â-carotene, in other living organisms.  It is stored primarily in the liver in esterified form (Vitamin A palmitate) and it is a key component of the visual system (when oxidized to retinal) and gene expression (when oxidized to retinoic acid). Retinol/retinyl acetate/retinyl palmitate will be considered as a NHP, acceptable sources of vitamin A will be all-trans retinyl acetate (synthetically prepared from retinol), all-trans retinyl palmitate and all-trans â-carotene. In addition, Vitamin A is also listed in Schedule F as follows:     Vitamin A in oral dosage form containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A. Therefore, Vitamin A over 10,000 IU is considered as drug while below 10,000 is an NHP under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP regulations.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:118:"In oral dosage forms providing not greater than 10 000 IU/day of Vitamin A activity, as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:148:"Sous formes posologiques orales ne fournissant pas plus de 10 000 UI/jour de vitamine A sous forme active, selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81829";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:19:"Vitamin A palmitate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196224;a:28:{s:5:"title";s:13:"Vitamin A_ACN";s:3:"nid";s:6:"196224";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:1292:"Vitamin A, or all-trans retinol, is an essential nutrient which occurs preformed only in animals, but metabolized from carotenoids, such as â-carotene, in other living organisms.  It is stored primarily in the liver in esterified form (Vitamin A palmitate) and it is a key component of the visual system (when oxidized to retinal) and gene expression (when oxidized to retinoic acid). Retinol/retinyl acetate/retinyl palmitate will be considered as a NHP, acceptable sources of vitamin A will be all-trans retinyl acetate (synthetically prepared from retinol), all-trans retinyl palmitate and all-trans â-carotene. In addition, Vitamin A is also listed in Schedule F as follows:     Vitamin A in oral dosage form containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A.  Therefore, Vitamin A over 10,000 IU is considered as drug while below 10,000 is an NHP under Schedule 1, item 3 (Priority 5; Vitamin) of the NHP regulations.    Vitamin A is considered here as the primary proper name, since it is listed in the NHPD Included Natural Health Product Substances (Schedule 1).";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:118:"In oral dosage forms providing not greater than 10 000 IU/day of Vitamin A activity, as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:148:"Sous formes posologiques orales ne fournissant pas plus de 10 000 UI/jour de vitamine A sous forme active, selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:14:"10000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81867";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin A";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:4:"IU/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196225;a:28:{s:5:"title";s:13:"Vitamin D_ACN";s:3:"nid";s:6:"196225";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"96356;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:658:"Schedule F listing is as follows if limit is exceeded:    Vitamin D in oral dosage form containing more than 1,000 International Units of Vitamin D per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1,000 International Units of Vitamin D.  Vitamin D is a general term referring to different compounds, both natural  and synthetic.  Acceptable sources of Vitamin D are Vitamin D2 and Vitamin D3.  Vitamin D is considered here as the primary proper name, since it is listed in the NHPD Included Natural Health Product Substances (Schedule 1).";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:97:"The maximum dose of vitamin D is 1000 IU/day, as per the Prescription Drug List (unless topical).";s:24:"field_restriction_desc_f";s:120:"La dose maximale de vitamine D est de 1000 UI/day, selon la Liste des drogues sur ordonnance (à moins d'être topique).";s:17:"field_upper_limit";s:13:"1000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81874";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Vitamin D";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:4:"IU/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196226;a:28:{s:5:"title";s:14:"Vitamin K2_ACN";s:3:"nid";s:6:"196226";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"95335;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:404:"Vitamin K2 is a general term referring to different menaquinones, which are naphtoquinone molecules containing a side chain composed of a varying number of isoprenoid residues. Schedule F listing is as follows:    Vitamin K, except Vitamin K1 and Vitamin K2 sold   (a) for external use in humans; or   (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:96:"Must be less than or equal to 120 mcg/day in oral dosage forms as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:122:"Doit être égale ou inférieure à 120 mcg/jour sous formes posologiques orales selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:12:"120.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81877";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Vitamin K2";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:11:"microgram/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196227;a:28:{s:5:"title";s:17:"Menaquinone 4_ACN";s:3:"nid";s:6:"196227";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:407:"Vitamin K2 is a general term referring to different menaquinones, which are naphtoquinone molecules containing a side chain composed of a varying number of isoprenoid residues.

Schedule F listing is as follows:

Vitamin K, except Vitamin K1 and Vitamin K2 sold 
(a) for external use in humans; or 
(b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:68:"< 120 mcg/day in oral dosage forms as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:88:"< 120 mcg/jour sous formes posologiques orales selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:12:"120.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82077";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Menaquinone 4";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:14:"microgram/24 h";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196228;a:28:{s:5:"title";s:17:"Menaquinone 6_ACN";s:3:"nid";s:6:"196228";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:407:"Vitamin K2 is a general term referring to different menaquinones, which are naphtoquinone molecules containing a side chain composed of a varying number of isoprenoid residues.

Schedule F listing is as follows:

Vitamin K, except Vitamin K1 and Vitamin K2 sold 
(a) for external use in humans; or 
(b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:68:"< 120 mcg/day in oral dosage forms as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:88:"< 120 mcg/jour sous formes posologiques orales selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:12:"120.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82078";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Menaquinone 6";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:14:"microgram/24 h";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196229;a:28:{s:5:"title";s:17:"Menaquinone 7_ACN";s:3:"nid";s:6:"196229";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:407:"Vitamin K2 is a general term referring to different menaquinones, which are naphtoquinone molecules containing a side chain composed of a varying number of isoprenoid residues.

Schedule F listing is as follows:

Vitamin K, except Vitamin K1 and Vitamin K2 sold 
(a) for external use in humans; or 
(b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:68:"< 120 mcg/day in oral dosage forms as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:88:"< 120 mcg/jour sous formes posologiques orales selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:12:"120.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82079";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Menaquinone 7";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:14:"microgram/24 h";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196230;a:27:{s:5:"title";s:16:"Pancrelipase_APN";s:3:"nid";s:6:"196230";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:25:"93636;100354;93636;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:340:"This ingredient is pending a decision on its addition to Schedule F of the Food and Drug Regulations which would impact its acceptability as an NHP. Pancrelipase is porcine pancreatic enzyme concentrate containing principally lipase, with amylase and protease. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 1 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 1 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:134:"The maximum dose of Pancrelipase, in terms of lipase activity, is 20 000 USP units per dosage unit, as per the Prescription Drug List.";s:24:"field_restriction_desc_f";s:162:"La dose maximale de Pancrélipase, en fonction d'activité lipasique, est de 20 000 unités USP par unité posologique, selon la Liste des drogues sur ordonnance.";s:17:"field_upper_limit";s:14:"20000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82156";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Pancrelipase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:6:"USP lu";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196231;a:27:{s:5:"title";s:54:"2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside_ACN";s:3:"nid";s:6:"196231";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109117";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-02-04";s:16:"field_legacy_nid";s:6:"106253";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:50:"2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196232;a:27:{s:5:"title";s:14:"Pancreatin_APN";s:3:"nid";s:6:"196232";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:25:"93636;100354;93636;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:663:"This ingredient is pending a decision on its addition to Schedule F of the Food and Drug Regulations which would impact its acceptability as an NHP.  Pancreatin is a substance from the fresh pancreas of the hog or ox, containing the enzymes amylopsin, trypsin and steapsin (digestive enzymes). Each mg of pancreatin contains not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin that is more potent is labeled as a multiple of these three minimum activities, e.g., Pancreatin 4X. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 1 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 1 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:132:"The maximum dose of Pancreatin, in terms of lipase activity, is 20 000 USP units per dosage unit, as per the Prescription Drug List.";s:24:"field_restriction_desc_f";s:161:"La dose maximale de Pancréatine, en fonction d'activité lipasique, est de 20 000 unités USP par unité posologique, selon la Liste des drogues sur ordonnance.";s:17:"field_upper_limit";s:14:"20000.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82160";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Pancreatin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:6:"USP lu";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196233;a:28:{s:5:"title";s:11:"Quinine_ACN";s:3:"nid";s:6:"196233";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:18:"92786;95325;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:337:"This ingredient is pending a decision on its addition to Schedule F of the Food and Drug Regulations which would impact its acceptability as an NHP.
Cet ingrédient est en attente d'une décision sur son ajout à l'Annexe F du Règlement sur les aliments et drogues qui pourrait avoir des conséquences sur son acceptabilité comme PSN.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 1 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 1 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:155:"The maximum dose, per dosage unit or per daily dose, of Quinine and its salts and derivatives is 50 mg, as per the Prescription Drug List (unless topical).";s:24:"field_restriction_desc_f";s:185:"La dose maximale, par unité posologique ou par dose quotidienne, de Quinine et ses sels et dérivés est de 50 mg, selon la Liste des drogues sur ordonnance (à moins d'être topique).";s:17:"field_upper_limit";s:11:"50.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82355";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Quinine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:2:"mg";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196234;a:28:{s:5:"title";s:14:"Tryptophan_ACN";s:3:"nid";s:6:"196234";s:7:"changed";s:10:"2014-02-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:20:"100459;100565;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:304:"Following the review of the naturally sourced medicinal ingredients on Schedule F, the Committee recommended that the above naturally sourced medicinal ingredient be revised to allow nonprescription status for strengths, doses, dosage forms or uses that do not meet the factors for listing in Schedule F.";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:232:"As per the Prescription Drug List, in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other ingredients, Tryptophan is classified as a non-NHP.";s:24:"field_restriction_desc_f";s:279:"Selon la Liste des drogues sur ordonnance, sous forme posologique orale à une concentration de plus de 220 mg par unité posologique ou par dose quotidienne, comme ingrédient unique ou en combinaison avec d’autres ingrédients, le Tryptophane est classifié comme un non PSN.";s:17:"field_upper_limit";s:12:"220.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82880";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Tryptophan";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:2:"mg";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196235;a:27:{s:5:"title";s:38:"N-Acetyl L-carnitine hydrochloride_ACN";s:3:"nid";s:6:"196235";s:7:"changed";s:10:"2014-02-06";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:20:"100689;100458;109569";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82885";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:34:"N-Acetyl L-carnitine hydrochloride";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196236;a:27:{s:5:"title";s:32:"Magnesium ascorbyl phosphate_ACN";s:3:"nid";s:6:"196236";s:7:"changed";s:10:"2014-02-28";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109103";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-02-28";s:16:"field_legacy_nid";s:6:"106383";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:28:"Magnesium ascorbyl phosphate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196237;a:27:{s:5:"title";s:15:"Chitosanase_APN";s:3:"nid";s:6:"196237";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"107742";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:6:"105691";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Chitosanase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196238;a:27:{s:5:"title";s:13:"Myricetin_ACN";s:3:"nid";s:6:"196238";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109984";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-03-04";s:16:"field_legacy_nid";s:6:"106391";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Myricetin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196239;a:27:{s:5:"title";s:17:"Malt diastase_APN";s:3:"nid";s:6:"196239";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"101429;110190";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82899";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"Malt diastase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196240;a:27:{s:5:"title";s:10:"Pepsin_APN";s:3:"nid";s:6:"196240";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"101429;110190";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82900";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Pepsin";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196241;a:27:{s:5:"title";s:11:"Phytase_APN";s:3:"nid";s:6:"196241";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"101429;110190";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP, under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82901";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Phytase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196242;a:27:{s:5:"title";s:12:"Xylanase_APN";s:3:"nid";s:6:"196242";s:7:"changed";s:10:"2014-03-04";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:13:"101546;110190";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82903";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Xylanase";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196243;a:27:{s:5:"title";s:12:"Protease_APN";s:3:"nid";s:6:"196243";s:7:"changed";s:10:"2014-03-06";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110221";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-03-06";s:16:"field_legacy_nid";s:6:"106417";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:8:"Protease";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196244;a:27:{s:5:"title";s:22:"Phosphatidic acids_ACN";s:3:"nid";s:6:"196244";s:7:"changed";s:10:"2014-03-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"109844";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-03-20";s:16:"field_legacy_nid";s:6:"106487";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Phosphatidic acids";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196245;a:28:{s:5:"title";s:40:"Hydrolysed chicken eggshell membrane_ACN";s:3:"nid";s:6:"196245";s:7:"changed";s:10:"2014-04-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110565";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-02";s:16:"field_legacy_nid";s:6:"106572";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:36:"Hydrolysed chicken eggshell membrane";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:6:"NHANML";s:20:"field_route_of_admin";s:6:"TOPICL";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:22:"INT_J_POUL_SCI_10(908)";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196246;a:27:{s:5:"title";s:20:"Inland sea water_ACN";s:3:"nid";s:6:"196246";s:7:"changed";s:10:"2014-04-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110519";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-03";s:16:"field_legacy_nid";s:6:"106585";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Inland sea water";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196247;a:27:{s:5:"title";s:13:"Anatabine_ACN";s:3:"nid";s:6:"196247";s:7:"changed";s:10:"2014-04-03";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110525";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-03";s:16:"field_legacy_nid";s:6:"106589";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Anatabine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:20:"EUR_J_PHARM_728(161)";s:15:"field_other_ref";s:0:"";}i:196248;a:27:{s:5:"title";s:25:"Nicotinamide riboside_ACN";s:3:"nid";s:6:"196248";s:7:"changed";s:10:"2014-04-08";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110526";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-08";s:16:"field_legacy_nid";s:6:"106611";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:21:"Nicotinamide riboside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:19:"J_MED_CHEM_50(6458)";s:15:"field_other_ref";s:0:"";}i:196249;a:27:{s:5:"title";s:21:"Yeast hydrolysate_ACN";s:3:"nid";s:6:"196249";s:7:"changed";s:10:"2014-04-10";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110165";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-10";s:16:"field_legacy_nid";s:6:"106617";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Yeast hydrolysate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:21:"ANN_NUTR_METAB_61(89)";s:15:"field_other_ref";s:0:"";}i:196250;a:27:{s:5:"title";s:29:"Tauroursodeoxycholic acid_ACN";s:3:"nid";s:6:"196250";s:7:"changed";s:10:"2014-04-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110807";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-16";s:16:"field_legacy_nid";s:6:"106682";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Tauroursodeoxycholic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196251;a:27:{s:5:"title";s:33:"Red Clover Isoflavone Extract_ACN";s:3:"nid";s:6:"196251";s:7:"changed";s:10:"2014-05-06";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"111056";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:103:"Classified as an NHP under Schedule 1, item 2 (an extract ) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-04-15";s:16:"field_legacy_nid";s:6:"106661";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Red Clover Isoflavone Extract";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196252;a:27:{s:5:"title";s:21:"Cranberry protein_APN";s:3:"nid";s:6:"196252";s:7:"changed";s:10:"2014-06-11";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"111506";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-11";s:16:"field_legacy_nid";s:6:"106955";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Cranberry protein";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196253;a:27:{s:5:"title";s:30:"Sesame protein hydrolysate_ACN";s:3:"nid";s:6:"196253";s:7:"changed";s:10:"2014-06-12";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"111480";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-12";s:16:"field_legacy_nid";s:6:"107027";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:26:"Sesame protein hydrolysate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196254;a:27:{s:5:"title";s:22:"Hydrolyzed elastin_ACN";s:3:"nid";s:6:"196254";s:7:"changed";s:10:"2014-06-17";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"110875";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:98:"Classified as an NHP under Schedule 1 item 2 (Extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:106:"Classifié comme PSN sous Annexe 1, article 2 (Extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-17";s:16:"field_legacy_nid";s:6:"107035";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"Hydrolyzed elastin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196255;a:27:{s:5:"title";s:15:"Xanthan Gum_ACN";s:3:"nid";s:6:"196255";s:7:"changed";s:10:"2014-06-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"111980";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-20";s:16:"field_legacy_nid";s:6:"107038";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:11:"Xanthan Gum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196256;a:27:{s:5:"title";s:17:"L-Lactic acid_ACN";s:3:"nid";s:6:"196256";s:7:"changed";s:10:"2014-06-20";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"105560";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82974";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:13:"L-Lactic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196257;a:27:{s:5:"title";s:33:"Partially hydrolysed guar gum_ACN";s:3:"nid";s:6:"196257";s:7:"changed";s:10:"2014-06-25";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"112310";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-25";s:16:"field_legacy_nid";s:6:"107057";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Partially hydrolysed guar gum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196258;a:27:{s:5:"title";s:11:"Retinal_ACN";s:3:"nid";s:6:"196258";s:7:"changed";s:10:"2014-06-26";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"112373";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-06-26";s:16:"field_legacy_nid";s:6:"107073";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Retinal";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196259;a:27:{s:5:"title";s:49:"1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol_ACN";s:3:"nid";s:6:"196259";s:7:"changed";s:10:"2014-07-09";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"112231";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-07-09";s:16:"field_legacy_nid";s:6:"107162";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:45:"1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196260;a:27:{s:5:"title";s:18:"Gamma-Carotene_ACN";s:3:"nid";s:6:"196260";s:7:"changed";s:10:"2014-07-16";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"112336";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-07-16";s:16:"field_legacy_nid";s:6:"107180";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Gamma-Carotene";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196261;a:27:{s:5:"title";s:25:"L-Glutamineethylester_ACN";s:3:"nid";s:6:"196261";s:7:"changed";s:10:"2014-07-29";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93166";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:615:"Glutamine ethyl ester is a derivative of amino acid Glutamine. It has been used as as a synthetic substance in several scientific documents- for instance (Lennon 2001; Amato 2005). Glutamine ethyl ester hydrochloride, as the more stable form, is accessible in commercial scale from some suppliers. In supplementation, Glutamine ethyl ester has been used as a source of Glutamine due to its dissociation to the free form in the body by hydrolysis or by esterases (enzymes which cleaves esters). Glutamine ethyl ester will be considered as a NHP, under schedule 1, item 2, Priority 2 (source of amino acid Glutamine).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82477";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"L-Glutamine ethyl ester";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196262;a:27:{s:5:"title";s:10:"Galena_ACN";s:3:"nid";s:6:"196262";s:7:"changed";s:10:"2014-07-30";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"93448";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:178:"Classified as an NHP, because it is used as a source of Lead, and therefore is considered an NHP under Schedule 1, item 7 (a mineral), of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:196:"Classifié comme PSN parce qu'utilisé comme source de Plomb, et par conséquent est considéré comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82711";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Galena";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196263;a:27:{s:5:"title";s:16:"Allithiamine_ACN";s:3:"nid";s:6:"196263";s:7:"changed";s:10:"2014-08-06";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"113405";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-08-06";s:16:"field_legacy_nid";s:6:"107208";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Allithiamine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196264;a:27:{s:5:"title";s:21:"Glucosylceramides_ACN";s:3:"nid";s:6:"196264";s:7:"changed";s:10:"2014-08-15";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"113474";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-08-15";s:16:"field_legacy_nid";s:6:"107266";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:17:"Glucosylceramides";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196266;a:27:{s:5:"title";s:11:"Dextrin_ACN";s:3:"nid";s:6:"196266";s:7:"changed";s:10:"2014-08-21";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"113690";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-08-21";s:16:"field_legacy_nid";s:6:"107351";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:7:"Dextrin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196270;a:27:{s:5:"title";s:27:"Soy protein concentrate_APN";s:3:"nid";s:6:"196270";s:7:"changed";s:10:"2014-09-17";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114189";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-09-17";s:16:"field_legacy_nid";s:6:"107439";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:23:"Soy protein concentrate";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196271;a:27:{s:5:"title";s:31:"Dihomo-gamma-linolenic acid_ACN";s:3:"nid";s:6:"196271";s:7:"changed";s:10:"2014-09-18";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114127";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-09-18";s:16:"field_legacy_nid";s:6:"107520";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:27:"Dihomo-gamma-linolenic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196272;a:27:{s:5:"title";s:18:"trans-Anethole_ACN";s:3:"nid";s:6:"196272";s:7:"changed";s:10:"2014-09-22";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"93451;114404";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82596";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"trans-Anethole";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196273;a:27:{s:5:"title";s:16:"Asiaticoside_ACN";s:3:"nid";s:6:"196273";s:7:"changed";s:10:"2014-10-02";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"113493";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an extract) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-10-02";s:16:"field_legacy_nid";s:6:"107634";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:12:"Asiaticoside";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196275;a:27:{s:5:"title";s:10:"Rennet_APN";s:3:"nid";s:6:"196275";s:7:"changed";s:10:"2014-10-10";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114667";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-10-10";s:16:"field_legacy_nid";s:6:"107718";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Rennet";s:20:"field_ingredient_cat";s:3:"APN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196276;a:27:{s:5:"title";s:19:"Cycloastragenol_ACN";s:3:"nid";s:6:"196276";s:7:"changed";s:10:"2014-10-14";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114747";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-10-14";s:16:"field_legacy_nid";s:6:"107734";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:15:"Cycloastragenol";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196277;a:27:{s:5:"title";s:37:"Aluminum sulfate tetradecahydrate_ACN";s:3:"nid";s:6:"196277";s:7:"changed";s:10:"2014-10-28";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114958";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-10-28";s:16:"field_legacy_nid";s:6:"107936";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:33:"Aluminum sulfate tetradecahydrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196278;a:27:{s:5:"title";s:29:"Ocean Mineral Concentrate_ACN";s:3:"nid";s:6:"196278";s:7:"changed";s:10:"2014-11-06";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"114520";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-11-06";s:16:"field_legacy_nid";s:6:"108079";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:25:"Ocean Mineral Concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196279;a:27:{s:5:"title";s:14:"Synephrine_ACN";s:3:"nid";s:6:"196279";s:7:"changed";s:10:"2014-11-13";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"93653;108957";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:191:"Synephrine is derived from the fruit plant zhi shi, also known as green orange, sour orange, and bitter orange. It will be considered as a NHP, under schedule 1, item 2, Priority 2 (isolate).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:656:"No risk information is required for products containing less than or equal to 3 mg synephrine + octopamine in a daily dose. Risk information is required for products containing: No caffeine, but more than 3 to less than 50 mg of synephrine + octopamine in a total daily dose, OR Less than or equal to 320 mg/day of caffeine, plus more than 3 to less than 40 mg of synephrine + octopamine in a total daily dose. If the product contains more than 320 mg/day of caffeine, plus more than 3 to less than 40 mg of synephrine + octopamine in a total daily dose, a product-specific review of safety for the specific recommended conditions of use will be conducted.";s:24:"field_restriction_desc_f";s:737:"Aucune mention de risque n'est requise pour les produits qui fournissent 3 mg ou moins de la combinaison synéphrine et octopamine dans une dose quotidienne. L'information sur les risques est requise pour les produits qui fournissent: Aucune caféine, et entre 3 et 50 mg de la combinaison synéphrine et octopamine dans une dose quotidienne totale, OU Moins que 320 mg/jour de caféine, et entre 3 et 40 mg de la combinaison synéphrine et octopamine dans une dose quotidienne totale. Si le produit contient plus que 320 mg/jour de caféine, et entre 3 et 40 mg de la combinaison synéphrine et octopamine dans une dose quotidienne totale, l’innocuité du produit sera évaluée compte tenu les conditions d'utilisation recommandées.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"82000";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Synephrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196280;a:27:{s:5:"title";s:33:"Mung-bean protein concentrate_ACN";s:3:"nid";s:6:"196280";s:7:"changed";s:10:"2014-12-11";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115696";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1 item 2 (an extract) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 2 (un extrait) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2014-12-11";s:16:"field_legacy_nid";s:6:"108422";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:29:"Mung-bean protein concentrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"EXT";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196282;a:27:{s:5:"title";s:14:"Naringenin_ACN";s:3:"nid";s:6:"196282";s:7:"changed";s:10:"2015-01-05";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115493";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:102:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2015-01-05";s:16:"field_legacy_nid";s:6:"108487";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Naringenin";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196283;a:27:{s:5:"title";s:22:"L-Arginine nitrate_ACN";s:3:"nid";s:6:"196283";s:7:"changed";s:10:"2015-01-08";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115522";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:112:"Classified as an NHP under Schedule 1, item 6 (a synthetic duplicate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:122:"Classifié comme PSN sous Annexe 1, article 6 (un duplicat synthétique) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2015-01-08";s:16:"field_legacy_nid";s:6:"108490";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:18:"L-Arginine nitrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196288;a:27:{s:5:"title";s:13:"Theacrine_ACN";s:3:"nid";s:6:"196288";s:7:"changed";s:10:"2015-01-12";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115999";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:98:"Classified as an NHP under Schedule 1 item 2 (isolate) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:108:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2015-01-12";s:16:"field_legacy_nid";s:6:"108526";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Theacrine";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196289;a:27:{s:5:"title";s:20:"Disodium citrate_ACN";s:3:"nid";s:6:"196289";s:7:"changed";s:10:"2015-01-21";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"116131";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2015-01-21";s:16:"field_legacy_nid";s:6:"108572";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:16:"Disodium citrate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:2:"SD";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196292;a:27:{s:5:"title";s:13:"Fluoritum_ACN";s:3:"nid";s:6:"196292";s:7:"changed";s:10:"2015-02-17";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115654";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:0:"";s:19:"field_old_rationale";s:0:"";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:110:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:242:"This Medicinal Ingredient is specifically for use in Traditional Chinese Medicine (TCM) products, and its preparation must comply with the method(s) described in the most current edition of the Pharmacopoeia of the People's Republic of China.";s:24:"field_restriction_desc_f";s:295:"Cet ingrédient médicinal est spécifiquement destiné à être utilisé dans les produits de médecine chinoise traditionnelle (MCT), et sa préparation doit se conformer à la ou les méthodes décrites dans l'édition la plus récente de la pharmacopée de la République populaire de Chine.";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:10:"2015-02-17";s:16:"field_legacy_nid";s:6:"108789";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:9:"Fluoritum";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:4:"NHPD";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196296;a:27:{s:5:"title";s:14:"Cinnabaris_ACN";s:3:"nid";s:6:"196296";s:7:"changed";s:10:"2015-02-24";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:6:"115654";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:213:"Cinnabar is the mineral ore of cinnabaris (hexagonal system) which is chiefly produced in China. It is a source for mercuric sulfide. It will be considered as a NHP, under schedule 1, item 7, Priority 5 (mineral).";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:100:"Classified as an NHP under Schedule 1, item 7 (a mineral) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:109:"Classifié comme PSN sous Annexe 1, article 7 (un minéral) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81731";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:10:"Cinnabaris";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"MIN";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196300;a:27:{s:5:"title";s:18:"Salicylic acid_ACN";s:3:"nid";s:6:"196300";s:7:"changed";s:10:"2015-02-26";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:5:"95650";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:29:"field_quantity_restriction_on";s:0:"";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations";s:17:"field_rationale_f";s:107:"Classifié comme PSN sous Annexe 1, article 2 (un isolat) du Règlement sur les produits de santé naturels";s:24:"field_restriction_desc_e";s:0:"";s:24:"field_restriction_desc_f";s:0:"";s:17:"field_upper_limit";s:0:"";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81899";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:14:"Salicylic acid";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"ISO";s:10:"field_unit";s:0:"";s:20:"field_limitation_ref";s:0:"";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}i:196301;a:28:{s:5:"title";s:10:"Folate_ACN";s:3:"nid";s:6:"196301";s:7:"changed";s:10:"2015-02-26";s:14:"workflow_state";s:9:"Published";s:4:"body";s:0:"";s:21:"field_ingredient_role";s:2:"MI";s:13:"field_its_ids";s:12:"92628;109420";s:17:"field_lower_limit";s:0:"";s:22:"field_monograph_source";s:4:"NHPD";s:19:"field_old_rationale";s:443:"Schedule F listing is as follows:     Folic acid in oral dosage form containing more than 1.0 mg of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 mg of folic acid.  Folate is considered here as the primary proper name since it is listed in the NHPD Included Natural Health Product Substances (Schedule 1).";s:29:"field_quantity_restriction_on";s:10:"Daily Dose";s:17:"field_rationale_e";s:101:"Classified as an NHP under Schedule 1, item 3 (a vitamin) of the Natural Health Products Regulations.";s:17:"field_rationale_f";s:111:"Classifié comme PSN sous Annexe 1, article 3 (une vitamine) du Règlement sur les produits de santé naturels.";s:24:"field_restriction_desc_e";s:57:"< 1mg/day of folic acid as per the Prescription Drug List";s:24:"field_restriction_desc_f";s:68:"< 1mg/jour d'acide folique selon la Liste des drogues sur ordonnance";s:17:"field_upper_limit";s:10:"1.00000000";s:10:"field_date";s:0:"";s:16:"field_legacy_nid";s:5:"81756";s:18:"field_parent_space";s:12:"MI Chemicals";s:14:"field_workflow";s:9:"Published";s:30:"field_approved_ingredient_name";s:6:"Folate";s:20:"field_ingredient_cat";s:3:"ACN";s:25:"field_nhpd_classification";s:3:"VIT";s:20:"field_route_of_admin";s:4:"ORAL";s:10:"field_unit";s:4:"mg/d";s:20:"field_limitation_ref";s:4:"HCSF";s:9:"field_ref";s:4:"NHPD";s:15:"field_other_ref";s:0:"";}}